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INTRODUCTION 
The bound copy of The ppoceedings appears in two volumes. The papers 
re~eived for reproduction have been grouped into three major sections: 
Introduction, Detailed Test Objectives and Medical Experiments, and 
Symposium Summary. The. Detailed Test Objectives and Medical Experiments
have been further divided into five subsections: Introduction, Neuro­
physiology, and Musculoskeletal Function comprise Volume I; Body Fluids/
Hematology, Cardiovascular/Metabolic Function and Symposium Summary
comprise Volume II. The papers appear according to the order of pre­
sentation at the Symposium, but there are minor variances between con­
tents of The Proceedings and the presentation due to the constraint of 
time imposed by the length of the program. Two papers included "in 
The Proceedings were "read by title only" at the Symposium because of 
late submittal, i.e., Red Blood Metabolism and Determination of Cardiac 
Size from Chest Roentgenograms Following Skylab Missions. Another 
paper, Immunity (M1l2), also IIread by title only" has not, as yet, been 
submitted. 
A separate Table of CDntents and Index of Authors/Panelists is included 
in each volume for ease of reference. Every attempt had been made to 
minimize the size of The Proceedings and to facilitate reference of an 
author or his/her paper. 
Sylvia A. Rose 
November, 1974. 
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FOREWORD 
Good morning ladies and gentlemen; I would like to welcome you to the 
Skylab Life Sciences. Symposium•. For the next three days we will pre­
sent the results of an exhaustive series of medical studies conducted 
on missions of 28, 54 and 84 days. . 
Before we move into the business at hand, I might take a few minutes to 
set the stage for our later presentations • 
In the history of man's first small steps toward ultimate flight to 
the planets and to distant stars, some notable milestones have "been 
achieved. As we have moved along, step by step, the impact of our 
accomp1ishements has swung from one discipline to another. The success­
ful launch of Alan Shepard into subor.bita1 flight in 1961 was a tre­
mendous boost for rocket specialists. It was, in fact, possible for 
U.S. rockets to launch a manned spacecraft. In the mid-1960s·, the 
Gemini rendezvous ahd docking successes were particularly rewarding
for guidance engineers and those concerned with space mechanics. In 
Apollo. the materials brought back from the lunar surface had a special 
impact for the physical scientist. Now we come to Skylab, and the 
focus· of attention moves to the life scientist. Skylab was, in ma"y 
respects, our flight. The reams of data returned from these missions 
provide our first real picture of how man lives in space. We already
knew, of course, that man could exist in space and that he could wopk
in space. Well before Sky1ab we solved or understood the principal 
problems of life support, of food service, and of waste management.
But it was not until Sky1ab that we learned that man could truly live 
in space. 
I am happy to report that no major medical finding will be presented
which might curtal1 man's dreams of more extensive space exploration, 
rather we have found that man can adapt to the new and wonderous envi· 
ronment of space. 
Many individuals have made a personal commitment to the success of 
Skylab and previous manned spaceflights, unfortunately all of these 
people will not be able to take part in these presentations. All of 
us with NASA appreciate the outstanding contributions of these individ­
uals from other nations, the aerospace industry, universites, medical 
schools and other departments of government in making the space program 
one which we can all look to with pride. It is truely our honor to 
open this symposium and to have been a part of the Skylab medical team. 
Deputy Director of Life Sciences 
Lyndon B, Johnson Space Center 
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SYMPOSIUM INTRODUCTION 
, 
SKYLAB MEDICAL PROGRAM OVERVIEW 
Richard S. Johnston 
Director of Life Sciences 
NationaZ Aeronautics and Space Administration 
Lyndon B. Johnson Space Center 
Houston, Texas 
INTRODUCTION 
History is filled with examples of man's desire to exp~ore new frontiers. 
Having sensed the thrill of discovery, man has pressed on to scale new 
heights, not weighing the cost or personal risk, but mindful only of 
his destiny to conquer the unknown. He crossed the seas in open boats 
and the wastes of the arctics on dog sleds. He perished, but rose 
again until there were no longer any new seas to cross or mountains to 
climb, or arctic poles to visit. He had explored his Earth. 
Exploration has always been a risky undertaking and preservation of 
life and health is essential to the successful conquest of the unknown. 
Few explorers, however, have conducted studies on themselves in order 
to document their responses to new environments. A notable exception 
was the work conducted during the 1935 International High Altitude 
Expedition to the Chilean Andes, when the members of that team conducted 
studies on themselves to record for medical science the effects of 
exposure to the hypoxic environment of high altitudes. Every student 
of space medicine has used some of the data obtained on that expedition. 
Manis opportunity to explore is largely dependent upon the advancement 
of technologies in transportation and life support. 
Some provocative fiction had been written about rocket trips to the 
Moon, but the technology was not available to make the dreams come true. 
With the development of chemical propellants and the application of some 
fundamental laws of physics high velocity rocket propulsion became a 
reality; it was all man needed to kindle his imagination to reach.be­
yond his Earth to start the e~ploration of his universe. 
Utilizing the Sature V launch system, man has successfully completed
the lunar exploration program epoch. Through the use of this same 
propulsion system, the United States has launched its first long-term
space station and has now made giant advancements in acquiring know­
ledge concerning the physiological effects of increasingly extended 
periods of exposure to the space flight environment and in determing 
how well man can function while performing tasks in space. 
Space medical studies using experimental animals were initiated prior 
to 1959. The Project Mercury Program afforded the first opportunity for 
the United States to perform limited medical studies and observations 
on men in space. After Project Mercury (1-4), many basic concerns 
about the frailties of the human space explorer were dispelled. It was 
shown that man could operate effectively during the acceleration periods 
of launch and entry. and he could adapt to the weightless environment. 
and perform .useful tasks. Medical measurements made during the early 
flights showed that normal body functions were not adversely altered. 
A few changes occurred which were moderate but reversible. Postural 
hypotension, for example, was observed when the astronauts returned • 
to the Earth's gravity field. 
The Gemini Program (5) provided the opportunity to conduct the first 
series of medical studies during weightless flights. One of the 
objectives of the Gemini flights was to evaluate the performance of 
men in the space environment for 14 days to insure that they could 
operate effectively on a trip to and from the Moon. The results of 
the Gemini flights further demonstrated that man could perform useful 
tasks, could adapt to the weightless environment, and could enter Eirth's 
atmosphere and readapt to Earth's gravity. 
The Apollo Program originally included a series of medical studies to 
be performed during the early orbital missions. After the tragic 
Apollo 204 accident, the decision was made to delete the medical studies 
and to dedicate all resources to the complex lunar landing program.
Consequently, medical studies were conducted with the Apollo crewmen 
primarily before and after each flight. 
Skylab, originally called the Apollo Applications Program was a natural 
and necessary follow-on to the Gemini and Apollo programs. The tested 
and proven spacecraft and launch vehicles from the Apollo missions 
were used in the design and flights of the Skylab program. The develop­
ment of medical experiments was initiated in the mid 1960 ' s and a 
decision was made to design the experimental program along classical 
lines of medical and physiological research; namely, to group related 
studies together according to their contribution to the understanding of 
the functioning of a major body system. Of course the results from 
the previous flights influenced the planning and placement of emphasis
for the new program. Experiments were developed to study the cardio- ~ 
vascular, musculoskeletal, hematologic, vestibular, metabolic, and 
endocrine systems in the body. It could be noted that, with few excep­
tions, the basic experiment protocols as originally developed remained 
unchanged throughout the Skylab program. 
This paper is intended to provide an introduction and overview of the 
Skylab medical program. The papers that follow will present the 
significant results of the three Skylab missions. 
2 
OPERATIONAL EQUIPMENT 

Several major medical subsystems were provided in the Skylab orbital 
workshop to sustain the crew and to protect their health. 
Food System 
The Skylab food system (fig. 1) was developed to provide a balanced 
and palatable diet which also met the necessary requirements for 
calories, electrolytes, and other constituents for the metabolic 
balance experiment. Seventy foods were available from which the crew 
could select their in-flight diets. Food types included frozen, 
thermostabilized, and freeze-dried foods. Menus were planned for 6-day 
turnaround cycles. Each crewman was required to consume his individ­
ually planned diet for 21 days prior to flight, throughout the flight, 
and for 18 days postflight. Approximately one ton of food was stowed' 
in the orbital workshop at launch to provide approximately 400 man days
of food. The ambient food was packaged and stowed in six-day supply 
increments and these were moved by the crewmen to the galley area for 
intermediate stowage, preparation, and eating. The galley area con­
tained a freezer, a food chiller, and a pedestal which provided hot 
and cold water outlets, attachment points for three food trays, and 
body restraints to permit each crewman to sit and eat. Each food tray
contained seven recessed openings to hold cans or other containers, 
three of which had heaters for warming the food. The food cans were 
constructed with membranes or other designed devices to restrain the 
food within the container when in zero gravity and to permit the crew 
to eat with conventional tableware. Drinks in a powdered form were 
packaged into individual bellows-like containers constructed with a 
drinking valve. Water when needed, was added from the hot or cold 
water outlets located on the pedestal. The crewmen drank from the 
container by collapsing the bellows. 
The variety of foods provided and the general design of the food system 
were acceptable to the Skylab crewmen. At the suggestion of the re­
turned 'Skylab 2 crew, more and varied spices were included in the later 
missions to improve the taste of the food. 
The extension of the Skylab 4 mission for an additional 28 days re­
quired that 250 pounds of additional Skylab food would have to be 
launched in the Command Module. This food weight and the resulting 
stowage volume were excessive, therefore, a high density, high-caloric 
type food bar was stowed in the Command Module to provide the caloric 
requirements for the mission extension. The crewmen's in-flight menus 
were modified to include apporoximately 800-1000 calories of the food 
bars every third day. For Skylab 4, in addition to the 50 pounds of 
high-caloric type food bars, approximately 100 pounds of Skylab-type 
food and drinks were launched in the Command Module. 
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Waste Management System 
The Skylab Waste Management System included equipment for the collec:.., 
tion, measurement, and processing of all urine and feces and for the 
management of trash such as equipment wrappers, food residues, et 
cetera (fi g. 2). 
Waste Management 
Equipment used by the crew for the collection of urine and feces, and 
in addition, equipment used for personal hygiene were stowed and used 
in the waste management compartment. Feces were individually collected 
into a bag attached under a form-fitted commode seat. The bag was 
permeable to air and impermeable to liquids. An electric blower, 
actuated by the crewman during use, provided a positive airflow around 
the anal area to carry the feces into the collection bag. After each 
defecation, the crewman weighed the bagged stool on a mass measuring
device, and then labeled and placed it into a vacuum drying processor. 
After 16 to 20 hours of drying, the bag of fecal residue was removed 
from the processor and stowed for return to Earth for postmission ana­
lysis. 
Each crewman's urine was collected in an individual 24-hour pooling 
bag. A centrifugal fluid/gas separator was actuated at the start of 
urination to create a positive airflow to carry the urine into the 
equipment where urine was separated from the gas and was then collected 
into the pooling bag. A measured quantity of lithium chloride, added 
to each pooling bag prior to flight, permitted urine volumes to be 
calculated after analysis postflight. In addition, the crew used a 
gage to measure the filled pooling-bag thickness to give a real time 
estimate of daily urine output. Once every 24 hours each crewman 
collected a 120 milliliters urine aliquot from his pooled urine ba'g and 
placed this sample in a freezer for return and postflight analysis. The 
used pooling bag was di~carded and a new bag installed for each day. 
Trash accumulated from food wrappers, used equipment bags, used towels, 
et cetera, were discarded through an airlock into a large volume tank 
in the orbital workshop dome. 
The Waste Management System and trash airlock operated satisfactorily
throughout the Skylab missions and the crews reported complete satis­
faction with the design of this equipment. 
Personal Hygiene 
Provisions were included in the orbital workshop for daily personal 
hygiene. Wet wipes, towels, toothbrushes, razor, deodorant, et cetera" 
5 
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were provided to maintain body cleanliness. In addition a shower 
contained in a collapsible cylindrical cloth bag (fig. 3) was provided
to permit full body bathing. Warm water and a liquid soap were avail­
able in limited quantity for one shower per week for each man. The 
Skylab crewmen reported satisfaction with the shower and other personal 
hygiene equipment; however, the crewmen did indicate that an excessive 
amount of time was required to vacuum the collected water and dry out 
the shower after use. Microbiological studies conducted on the Skylab 
crewmen indicated that the personal hygiene techniques used were com­
pletely adequate. 
Inflight Medical Support System 
The Inflight Medical Support System was desi~ned to provide for the 
conduct of selected in-flight medical evaluation experiments and, as 
required, first level medical diagnosis and treatment for an ill or 
injured crewman (fig. 4). The equipment was stowed in the wardroom 
and included: diagnostic, minor surgery, dental, catheterization, and 
bandage kits. Sixty-two medications for the three missions were stowed 
in modules to insure an adequate and fresh supply. Prior to flight, 
drug-sensitivity testing was conducted on mission designated Skylab 
crewmen. In addition, microbiological equipment and slide-staining
capabilities were provided. Petri dishes, an incubator, microscope, 
and slide stainer were available for use by the crew. The microbio­
logical equipment was used to collect airborne and surface microbial 
samples in flight. As part of his mission preparation, each Skylab 
crewman underwent 80 hours of paramedical training in the use of the 
Inflight Medical Support System for diagnosis and in treatment of 
injury or illness. 
Cardiovascular Counterpressure Garment 
Cardiovascular counterpressure garments (fig. 5) were launched in the 
orbital workshop for all three missions. These garments were designed
to provide mechanical counterpressure to the lower extremities to 
reduce the postural hypotension effects following landing and operations
under one-gravity conditions. The garment has a built-in capstan in 
the length of each leg. Inflation of the capstan by a pressure bu'lb 
provided a pressure gradient of 85 to 90 millimeters of mercury (111m Hg) . 
at the ankles to 10mm Hg at the waist. A garment was donned by each 
crewman prior to entry and it was inflated somet'imes during descent and 
always following landing. Subsequent papers will discuss the physio­
logical protection afforded by these garments. 
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Figure 4. Skylab Inflight Medical Support System. 
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lIFE SCIENCES EXPERIMENTS 

The Skylab medical experiments listed in Table I were designed to 
provide an indepth study of individual body systems and at the same 
time provide an overlap to give comprehensive understanding of man's 
reaction to long-term weightless flight. Added special in-flight tests 
are shown in Table II to indicate other type studies which were com­
pleted in the three missions. The inclusion of major in-flight medical 
experiments provided the capability to study physiological responses 
during exposure to weightless flight as opposed to the before and after 
studies as carried out in the Apollo and Gemini programs. Results of 
these studies are the subject of this Symposium. 
TABLE I. SKYLAB MEDICAL EXPERIMENTS 
o M071 - Ml nera 1 ba 1ance 
o M073 _ Bioassay of body fluids 
o M074 _ Specimen MaSS measurement 
o M07B _ Bone mineral measurement 
o M092 - Lower body negative pressure 
o M093 - Vectorcardiogram 
o MIlO - Hematol~9Y/lmmunolo9Y 
o Ml31 _ Human vestibular function 
o Ml33 - Sleep monitoring 
o Ml51 - Time and motion study 
o M171 - Metabollc activity 
o Ml72 _ Body MaSS measurement 
TABLE II. IN-FLIGHT SPECIAL TESTS (ADDED) 
Skylab Mission 
2 3 4 
Blood flow X X 
Facial photograph X 
Venous comp11 ance X 
AnthropOllletrl c measurements 
Treadmill exerc1ser 
Center of mass 
IR anatomical photograph 
Taste and aroma evaluation 
Atmospheric volatile concentration 
Light flash observations 
Hl!IIIDglobln X 
Urine specific gravity X 
Urine mass measurement X 
Stereophotogra.metry X 
11 
The Skylab medical experiments equipment were located on the crew living

level of the two storied orbital workshop. "rhe equipment occupied 

about one-third of the floor area of this level. Figure 6 is a photo­

graph taken during the Skylab 3 mission; it shows this medical experi­

ment area. On the right is the collapsed shower previously described. 

The two consoles against the workshop wall contain the medical experi­
ment electronic equipment. This figure also shows photographs of ~ 

two of the major medical experiments. 

The M17l ergometer and metabolic analyzer shown at the upper left of 

figure 7 are being used by the Sky1ab 2 Pilot. The metabolic analyzer 

contains a mass spectrometer for measuring oxygen, carbon dioxide, 

nitrogen, and water vapor. In addition, spirometers were provided to 

measure respiratory volumes. The bicycle ergometer was used to provide 

a quantitative stress level, for investigating physiological response

and it was also used as the prime off-duty crew exercise device. 

Blood pressure, vectorcardiograms and body temperature measurements 

were also taken as a part of the M17l Metabolic Activity experiment. 

The M092 Lower Body t~egative pressure Device is shown on the upper 

right of figure 7 as it was used in Skylab 2; this experiment was 

monitored at all times by a second crewman. The leg volume measuring 

bands used with the Lower Body Negative Pressure Device also are 

shown. The electronic center for these experiments, labeled on figure 7 

as Experiment Support System, contains the displays and experiment 

controls. 

In the lower left hand corner of figure 8, the Skylab 2 Scientist Pilot 

is shown wearing the M133 electroencephalographic sleep cap. One 

crewman, i.e., the Scientist Pilot, performed this experiment in each 

mission. The Body r~ass j·1easuring Device and Specimen Mass ~1easuring 

Devices were evaluated as experiments to establish the method and 

accuracy of determining mass in the weightless environment. In 

addition, these devices were used to provide daily body weights and 

the mass of food residues and fecal specimens. The M13l rotating litter 

chair was used to study vestibular functions and susceptibility to 

motion sickness. 

Equipment also was developed and flown to collect, process, and pre­

serve in-flight blood samples (fig~9). The crewmen acquired approxi­

mate1y 11 ml blood samples with a conventi ona 1 syri nge and then trans­

ferred the whole blood into a pre-evacuated sample processor (fig. 10).

The sample processor was then placed into a centrifuge to separate 

the plasma and cells and to transfer the plasma into a separate 

collection vial for preservation. This transfer operation had to be 

automatically accomplished while the blood was being centrifuged due 

to problems associated with weightless operations and fluid dynamics. 
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Figure 9. Skylab in-flight blood collection system. 
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Figure 10. Skylab blood sample processor. 
The cross sectional drawing of the sample processor shown on figure 10 
illustrates how the equipment functioned. Whole blood was transferred 
from the syringe through a septum into the processor. A spring-loaded 
piston was attached to the bottom of the sample processor and the unit 
was placed in the centrifuge. Following initial centrifugation, the 
cells and plasma were separated. At this pOint, the centrifuge speed 
was increased to force the piston to drive the plasma vial septum past 
a needl e and a11 ow the plasma to flow into the vi a 1. Fo 11 owi ng thi s 
separation process, the blood was placed in a freezer and preserved
for postflight analysis. 
The medical experiment equipment functioned without problems throughout
the three flights. Medical data of high quality were obtained ·for all 
experiments. Vast quantity of medical data available for reduction 
and an.alysis was processed in an orderly fashion. This could not have 
been accomplished in a timely manner without computer processing. 
The quantity of information obtained from the medical studies conducted 
with the Skylab crewmen over a relatively short period of time is 
perhaps unique in medical research. Over 600 000 biochemical analyses 
were made on food, blood, urine. and fecal samples (fig. 11). In 
completing two of the major medical exp~riments, more than 18 000 
blood pressure determinations were made and over 12 000 minutes of 
vectorcardiographic data were obtained. 
SKYLAB MEDICAL OPERATIONS 
The medical operational planning for Skylab was much more complex than 
any other U.S. manned space mission. The logistics planning required 
for crew feeding, sample collection, baseline experiment data acquisi­
tion, crew medical examinations, crew health care, data processing, and 
flight management into an integrated plan that meshed with program
milestones required a major medical team effort. 
The Skylab medical operations program was initiated in June of 1972 
with a 56-day altitude chamber test (fig. 12) and was completed in 
April 1974 with the last postflight Skylab 4 crewmen evaluation tests. 
The first launch was to place the Skylab orbital workshop in correct 
orbit; it was unmanned. The compressed schedule of the subsequent 
manned Skylab launches and the extension of mission duration after the 
first manned launch, Skylab 2, created an extremely heavy burden on the 
Skylab medical team. The medical experimental program was unique in 
that it not only provided scientific data, but, in turn, the data were 
used as the basis for operational decisions for the commitment to longer 
duration flights. This meant that at the end of each of the first two 
manned missions, the medical team had to make a recommendation for the 
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extension of the next successive mission. From figure 13 it can be 
seen that the preflight phase of Skylab 3 started before the completion 
of the Skylab 2 postflight phase and after baseline data collection 
for Skylab 4 had begun. Skylab 3 was launched only two weeks after 
the Skylab 2 postflight studies were completed. Skylab 4 was launched 
only five weeks after completion of the Skylab 3 postflight medical 
studies. This quick turnaround required careful planning, establish- , 
ment of priorities on samples and data processing, and the dedication 
and tireless effort of all members of the medical team. 
Skylab Medical Experiment Altitude Test 
The Skylab medical experiment altitude chamber test was a 56-day mission 
simulation conducted in a 6.1 meter (20 ft) diameter vacuum chamber. 
The interior of the chamber (fig. l2) was configured closely to the 
orbital workshop crew quarters level which consisted of the medical 
experiments area, wardroom, waste management compartment, sleeping 
quarters, and recreational areas. The atmosphere in the chamber was 
maintained at a composition identical to that of the orbital workshop
with a 70 percent oxygen, 30 percent nitrogen mixture at 5 pounds per
square inch (psia). Carbon dioxide levels were controlled at a nominal 
level of 5 mm Hg. 
The prime objectives of the test were to acquire background data and to 
exercise the data management and processing techniques for selected 
medical experiments. Other test objectives included the evaluation of 
medical experiment and operational equipment, the evaluation of 
operational procedures and the training of support personnel under sim­
ulated mission conditions. 
Like a flight mission, the test consisted of a 2l-day prechamber phase, 
a 56-day chamber test, and an l8-day postchamber test period. All 
preflight and postflight medical protocols were performed with astro­
naut crewmen. The inchamber test portion of the program was carried 
out using full mission simulation procedures, and included: crew check­
list, real-time mission planning, and data management. The communica­
tions with the crewmen were limited to a spacecraft communicator, 
as programed to be carried out in the mission. Simulated network 
communications were followed also, to evaluate the problems of lost 
communication between flight crews and mission control center, as they 
would be experienced in actural flight. A remote console was used by
the medical team to develop and implement ground control procedures 
for flight. This test program was successful; the required baseline 
data were obtained and the encountered equipment failures and problems 
were corrected prior to flight. The ground support personnel became 
an effective team ready to carry out the complex flight program. 
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Premission Support 
The premission support for the first manned mission started in December 
1972 with acquisition of the first baseline data for the Lower Body 
Negative Pressure (M092) and I~etabolic Activity (~1l7l) experiments.
Additional baseline tests were conducted in support of the medical 
experiments at designated periods up to approximately one week from 
the launch of Skylab 2. These baseline data were primarily obtained 
in an orbital workshop one-gravity trainer (fig. 14). This full 
scale trainer contained fully functional medical experiments and other 
operational hardware. Combined crew training and baseline data collec­
tion were conducted with both the prime and backup crewmen. A remote 
medical console and data recording system was used to monitor the 
crewmen during training sessions and to train members of the medical 
team in control procedures and in the reduction of flight data. This 
combination training and medical baseline data acquisition was excellent 
for both the crewmen and medical experimenter. A comprehensive medical 
examination was given 30 days before scheduled launch to both the 
prime and backup crews and additional baseline data were obtained for 
the experiments. 
Twenty-one days before launch, the crew was placed in semi-isolation 
to meet the requirements of the Skylab health stabilization program 
(fig. 15). The objective of this program was to protect the in resi­
dence flight crew from illnesses which might cause them to be removed 
from flight status and to preclude the occurrence of infectious disease 
in flight. All personnel who were required to work with the flight 
crews were designated as primary contacts. To protect the crewmen, 
these personnel underwent extensive medical examinations and immuniza­
tions and were required to report all personal and family illnesses. 
Those primary contacts who would come within direct contact (i.e., 
2 meters) with the crew were medically screened each day and were re­
quired to wear a surgical mask while in contact with the crew. 
Isolated crew quarters were established and personnel access into 
designated primary work areas was rigidly controlled. The Skylab
health stabilization program was effective and no major problems were 
encountered. 
During this period of isolation, the crew consumed foods identical to 
those provided from preplanned in-flight menus. Daily collections of 
urine and fecal samples were initiated. Medical examinations, micro­
biological and blood sampling, and experiment baseline testing were 
continued at the Johnson Space Center up to three days before launch 
when the prime and backup crews were moved to the Kennedy Space Center 
for the launch. 
SKYLAB 1-9 
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In-flight Operational Support 
The management of the in-flight medical operations support and the 
necessary interactions with program management personnel, personnel 
representing the scientific disciplines, and the Flight Control Team 
were accomplished through a medical management group. The medical group 
met each morning of the mission to review crew health status, to 
evaluate the current status of the medical studies, to discuss equip­
ment or other operational problems, and to establish changes in experi­
ment priorities. Health trend charts were plotted each day (fig. 16)
to provide experimental data which were useful in understanding crew 
health status. These charts included: crew weight, caloric intake, 
quantity of sleep, heart rate and blood pressure under dynamic stress, 
urine volume output, and other pertinent information. The Chairman 
of the Medical Management Group reported to a Flight Management Team on 
all medical matters and participated in operational decisions such as 
changing crew timelines, adjusting science requirements to insure 
maximum utilization of the crew and the current science opportunities, 
and to provide advice on major operational policy changes. This 
management scheme was extremely effective and was a key factor in the 
success of the Skylab program. 
The in-flight activities of Skylab 2 are shown to illustrate the 
medical activities for a typical Skylab mission (fig. 17). The first 
two to three days of each mission were spent in the activation of the 
orbital workshop. These activities included such tasks as system
checkouts and activation, transfer of equipment from the command module 
to the orbital workshop, changing air filters, et aetera. 
, In-flight medical monitoring of the crewmen started at launch through 
the use of an operational bioinstrumentation system (fig. 18). The 
crew was also monitored through the use of the bioinstrumentation system
during all extrayehicular activities. The frequency of in-flight
medical experiments for the Skylab 2 crewmen illustrates when the 
various studies and/or samples were obtained in this mission. Through­
out all Skylab missions, the Lower Body Negative Pressure (M092) and 
Metabolic Activity (M171) experiments were accomplished approximately 
every fourth day. Blood samples were collected weekly during the 
missions and biosampling was accomplished daily. 
During the flight phase, real-time monitoring of the medical experiments 
was accomplished only when the spacecraft was over a tracking station. 
This meant, in some instances, there was a complete loss of communica­
tions with the crew and the telemetered data during medical testing.
To overcome this problem, all experiment data were recorded onboard 
and subsequently telemetered through the tracking stations to the 
mission control center. Software programs were used to permit automatic 
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Figure 16. Skylab crew health trend chart - body weight. 
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Figure 18. Skylab - operational bioinstrumentation. 
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computer reduction of the experiment data. The experimenters had a 
preliminary data printout within 24 hours after completion of an 
experiment test. During the last few days of all three missions, 
work/rest cycles were changed to adjust the circadian rhythm of the 
crewmen to the length of the pre-entry day and the time of spacecraft 
splashdown. 
The"in-flight portion of the three Skylab missions lasted 168 days
during an 8-1/2 month period. Throughout this long and arduous 
period, the interest, enthusiasm, and concern for the crew was ma"in­
tained at the highest level by all members of the medical and program 
management teams. 
Postflight Activities 
The recovery procedure used for the Skylab crewmen was altered from 
the procedures used in the Apollo program. Figure 19 illustrates 
the Skylab procedures. The Command Module and the crew were retrieved 
and lifted directly onboard by the recovery aircraft carrier. The 
crew egressed onto a platform on the hanger deck. Spacecraft and 
crew retrieval took approximately 35 minutes from time of splash. 
Specialized mobile laboratories (fig. 20) were developed and equipped 
to acquire preflight and postflight medical experiments data. Six 
laboratories make up the laboratory complex. Photographs of the 
interior of two of these laboratories are shown on the left side of 
figure 20. The center photograph shows the laboratory complex as it 
was used preflight at the Johnson Space Center. The laboratories were 
designed and constructed to be moved in a C-5A transport aircraft to 
permit the medical team to cover contingency landings in the event of 
an early mission abort. For a normal mission, the laboratories were 
flown to port and were lifted onboard the recovery carrier. The 
mobile laboratories were designed with backup support systems, 
(electrical power, heating, cooling, et cetera). In addition, a data 
complex was included which permitted processing of medical data in a 
format compatible with the flight data. In use, the mobile laboratories 
proved to be useful facilities; they added to the convenience of the 
medical operations, they were operated without problems, and they
provided high quality medical data. 
Medical studies were initiated immediately after recovery operations. 
A summary of all postflight activities is shown in figure 21. The 
recovery day testing for Skylab 2 lasted for approximately 10 hours 
and included a comprehensive medical examination and the acquisition 
of data for all major medical studies as shown in figure 22. In 
subsequent missions, the length of the recovery day medical ,studies 
was shortened to reduce crew stress and fatigue from an overlong day. 
30 
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Figure 22. S~lab 2 recovery day medical testing. 
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The health stabilization program was followed throughout the first 
week following recovery to provide protection for the crew from 
infectious disease which might result from a depressed immune re­
sponse after the long isolation period of the flights. Microbiological, 
blood, and biosampling was collected as shown. Medical studies were 
completed on the days shown on figures 21 and 22. In all Skylab 
missions postflight medical testing was continued until preflight
control levels were reached. 
OPERATIONAL EXPERIENCE 
The launch of the orbital workshop on May 20, 1973, and the subsequent 
failures impacted the medical program. The loss of the micrometeoroid 
shield exposed the skin of the workshop causing an increase in orbital 
workshop temperatures and the partial deployment of the solar panels 
reduced the electrical power supply available for experiments and 
systems operation. The orbital workshop failure also caused a ten-day 
delay in the launch of Skylab 2. Tilis meant that the health stabiliza­
tion, controlled feeding, and biosample collection had to be extended. 
The exposure of the skin of the workshop (fig. 23) caused an elevation 
in both wall and spacecraft air temperatures. The plot shown in 
figure 24 illustrates the temperature increase for the early phase of 
Skylab; maximum temperatures in the food stowage area exceeded 1300 F. 
In the ten-day period before the launch of Skylab 2, a thermal screen 
was developed which the crew could deploy to shield and insulate the 
orbital workshop. In the intervening time period, however, the in­
crease in temperature caused several concerns to the medical team: 
o 	 First, would the foods be spoiled or changed by the elevated 

temperatures? 

o 	 Second, would other medical equipment be damaged by the increased 
temperatures? 
o 	 Third, would the polyurethane walls of the workshop be heated to 
a point where carbon monoxide or toluene diisocyanate 
be emitted into the spacecraft atmosphere? 
Immediate action was taken to conduct ground based test programs or to 
develop equipment which the crew could use to understand and/or solve 
the probTems . 
Food test programs were initiated to study the effects of the increasp.d 
temperature on microbial growth, food quality, and other characteris­
tics. Ideotical foods were placed in thermal chambers; the tempera­
ture data from ~he workshop were used for a thermal profile. Periodic 
35 
Figure 23. Damaged orbital workshop. 
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food sampling was accomplished to determine biological and chemical 
composition changes, and the thermal effects on taste and palatability 
were evaluated. i~o significant food failures were encountered during 
these tests and the launch of Skylab 2 proceeded without major alter­
ations to the food system. The food test program was, however, con­
tinued throughout the Skylab program and select food samples were 
returned from the three missions for analysis. 
Similar thermal testing was accomplished for many miscellaneous 
medical items such as electrode sensors, sealed containers, et cetera. 
From these tests, it was determined that certain medications shouid 
be resupplied by the Skylab 3 crewmen. Additional procedures and 
equipment were developed to allow the crew to reconstitute the 
electroencephalographic electrodes on the sleep study caps. 
The potential toxicity problems associated with the orbital workshop 
polyurethane wall insulation also was studied through thermal testing.
It was determined that toulene diisocyanate and carbon monoxide could 
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have been present in the atmosphere. Special sampling tubes and 
adapters were built in the ten-day period between the launches of the 
orbital workshop and Skylab 2. The equipment developed (figure 25) 
permitted the crew to withdraw an atmospheric sample from the airlock 
and then the workshop before opening the hatch into these areas. In 
addition, special masks were provided to allow the crew to move into 
the orbital workshop if the toluene diisocyanate and/or carbon monoxide 
levels so dictated. The Skylab 2 crew found no toluene diisocyanate 
and the carbon monoxide concentration was less than five parts per 
million. The toxicological aspects of the Skylab program are covered 
in more detail in a subsequent paper in this Symposium. 
The crew deployed the first thermal screen on the second day of the 
first mission and immediately the orbital workshop wall temperatures 
started to decrease. Within several days, the ambient gas temperature
had dropped below 800 F. The elevated temperature in the workshop
did delay the start of some medical experiments and, no doubt, influ­
enced the results of the first medical studies. However, through the 
ingenuity of man and the efforts of the Skylab 2 crewmen, the mission 
and the workshop were saved from what appeared to be an obvious total 
failure. Subsequently, the Skylab 3 crew deployed an additional 
thermal screen (fig. 26) to further protect the orbital workshop 
againse excessive heat changes for that mission and for Skylab 4. 
Throughout the Skylab flight program, alterations in equipment and 
procedures were made for each suceeding mission to capitalize on the 
flight experience of the previous mission. The Skylab 2 crew recom­
mended that the personal exercise program in-flight be expanded in 
both duration and type. To meet this recommendation, the exercise 
period for the Skylab 3 crew was expanded from one-half hour to one 
hour daily and an additional exercise device was launched with the 
crew of Skylab 3. 
On Skylab 4, the duration of crew exercise was further expanded to 
one and one-half hours daily and a unique treadmill device was used 
by the crew. In addition to these equipment-associated changes, 
additional scientific studies were added to the programs for both 
Skylab 3 and 4. The results of these studies are presented in other 
papers in this Symposium Report. These additional studies demonstrate 
the flexibility afforded the medical team and the support given to 
this team by program management and the flight crews. 
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CONCLUSION 

The Skylab Medical Program met or exceeded all of the planned objectives. 
The medical operations were conducted without any major problems and 
the medical equipment functioned flawlessly. The medical data received 
from the crew were of excellent quality. The quantity of information 
available from these three missions is staggering when viewed in its 
entirety, however, the investigator team has done a commendable job 
in presenting these results only six months after the last Skylab 
mission. Some investigators, no doubt, still consider their results 
preliminary and the Skylab medical team must still attempt to integrate 
the results of individual studies to give a more comprehensive under­
standing of what these data really mean. Skylab represents a signifi­
cant milestone in the development of space medical knowledge. From the 
information to be presented at this Symposium, we feel confident that 
man can fly longer missions as required for future space exploration. 
The Skylab crewmem have demonstrated the versatility and lngenuity of 
man to make repairs, to carry out observations, and to conduct 
scientific studies. 
Those of us responsible for the Skylab medical program are proud to have 
the opportunity to present this Symposium and hope that we do justice 
to the outstanding accomplishments of the Skylab cre~~en. 
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FLIGHT CONTROL EXPERIENCES 
F. Story Musgrave3 M.D. 
Life Saienaes Astronaut Offiae 
NationaZ Aeronautias and Spaae Administration 
Lyndon 	B. Johnson spaae Center 
Houston3 Texas 77058 
JOHNSTON: Our first papers this morning are- going to be flight crew 
reports. Our first speaker is Dr. Story Musgrave. He's an astronaut 
physician; he was the backup Scientist Pilot for Skylab 2; he was one of 
the astronauts instrumental in following many of the developments of 
Skylab medical equipment; and he also served as the spacecraft 
communicator for Skylab missions two and three. Dr. Musgrave. 
MUSGRAVE: Thank you very much, Dick. I am going to give you about 
a five minute briefing this morning on the biomedical aspects of mission 
control; or, you might entitle it, "The Management, Direction and Support 
of In-Flight Biomedical Activities". I'm not a manager, and I'm not a 
director; I hope I did support. So you'll see in places that I'll have 
my own perspective. It's a great pleasure to address you today. The 
work of ground support and CAP COMM are great; flying is even better. 
But when one has got a flight on, the next best thing to it is the 
support on the ground. 
As Dick Johnston mentioned a little bit earlier, policies and decisions 
were made, as far as medical aspects go, by a multidisciplinary medical­
managment team early every morning. Other persons concerned with flight
control were the flight surgeons, which you'll hear from later, and the 
biomedical officers. A member of each of these two groups occupied 
adjacent consoles in the Mission Operations Control room. In general,
the flight surgeons were concerned with crew health; the biomedical 
officers were concerned with the operation and collection of experiment 
data. However, they did have many overlapping functions. In support
of them and other activities, we had a biomedical scien~e support room 
consisting of between 4 and 12 scientists and technicians who: 
o 	 retrieved and compiled 
o 	 helped to build the flight plans 
o 	 and made inputs to the flight plans and the medical 

experiments checklists. 

On each mission, at least one of the CAP COMMS was a physician astronaut. 
Theoretically, this should be a plus for medical science. However, 
since I was one of them, r won't p~ss any judgement on that. 
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In the Mission Operation Control Room and in the science support room, 
we had multiple displays of real-time or recorded data from the bio­
instrumentation that were obtained, say, during launch, extravehicular 
activity, entry or other critical parts of the mission. Also, we 
could display any of the medical experiments data on a real-time basis 
simply by punching a keyboard and call illg up this "information either 
in digital or graphic form from the mission operations computers. The 
information one might get later from recorded data would seem to be 
very similar -- almost identical to that which one receives in real-time 
display; it's somewhat similar to going to a football game or watching 
the game on television. 
Daily, we built a flight plan; that is, a plan for the crew to tell 
them what to do on a given day. What would their on-orbit activities 
be on a given day? Program Director Bill Schneider alluded to this 
earlier today. With many people calling him and asking him to get 
certain things on the flight plan, he was somewhat like a worm in a 
nest of robins. The flight plan was constructed from approximately 150 
experiments depending upon such factors as: the frequency requirements 
of the individual experiments, and the orbital characteristics for that 
given day. When was the Sun available? When was the Earth available? 
What was the Earth track? Other constraints arising from the particular 
experiments to be run: Were they compatible with each other? One 
needed two men to do Earth resources; one needed two men for most of 
the major medical experiments; therefore these experiments couldn't 
be run together. What was the Sun doing? Did we have priority to 
study the Sun? Was it a particularly active Sun or a Sun in which 
the data that would be gathered on that particular day be extremely 
important? So, at first, the science planning and the flight planning 
were based mostly on mission rules that had been established beforehand 
with some form of priority for experiments. But, during the first 
mission, we, and that's a collective IIwe ll mean"ing JSC flight control­
lers and managers, developed what was called a science-planning meeting, 
in which they would plan the next week's activities taken from the 
collected inputs and requirements from all the different disciplines, 
such as the solar physics, medical, Earth resources, the corollary 
experiments, astronomy experiments, and the like. They would have 
pooled' in this one place, the requirements and the desires of all the 
different disciplines, and then, with representatives of all the 
different disciplines assembled, they would go through a series of 
trade-offs in which they would measure one against the other and try 
to arrive at an optimum flight plan. In this way, the Earth resources 
people could listen to the solar physics people and listen to their 
pleas about how important it was to get this particular Sun on a given 
day; or the Kohoutek people -- the comet people, could listen to the 
Earth resources people say, IIThis is the only time we1re going to get 
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over this site; we haven't seen this particular site once yet during
the Skylab mission ll • And so the different disciplines could listen to 
each other 	and could trade off against or for the other and bopefully
arrive at an optimum flight plan. 
Early Skylab crews demonstrated tremendous efficiency. They got way
, ahead of the time line of what was expected preflight that they would 
be able to ~et done. They were getting more and more done. In fact, 
shortly they began to ask for more things to do. \>Jhile we had many"
vehicle-type constraints and many experiment constraints, we ended 
, 	 up with more and more free crew time. So on a real-time basis, we 
started to devise what we called in the medical world (and in some 
others) DTO's (detailed test objectives). In other words, we came up
with new experiments, and we did this in three different ways. One, 
is simply to change the protocol of a given experiment. It would be 
the same experiment, but you'd change the protocol to get some 
different data. n'lO, is to come up with a brand new experiment, a 
new way of using existing hardware. And three, is simply to make nevi 
observati ons that di dn' t require new hardware. r1any of the presenta­
tions that you'll hear during this symposium concern data collected 
in this sort of way. These vlere brand new ways of collecting bio­
medical data that had not been planned for in advance, and they were 
done in real time. These kinds of real-time changes to the flight
plan and the checklist were accomplished by getting Principal Investi­
gators together with our procedures people who build our checklists to 
come up with a revised checklist or procedure. And we astronauts go
into simulators, such as our one-g trainer, with all the medical 
experiments and others and actually fly these procedures in there. He 
run them "in the simulators to see that they are workable and put the 
polish on them prior to sending them to the crews on board the space­
craft. 
Every evening, we received a report from the flight crew regarding such 
things as; 	their water gun readings, their body-mass-measurement-device
readings, and their food-consumption status. Then, every evening in 
addition to this private conference with their own flight surgeon we 
would send 	up to them a medical status report which contained a 
summary of the data that was obtained the last time they ran the 
medical experiments, such as lower body negative pressure and the 
bicycle ergometer. It included things such as their body weight, their 
water consumption and the number of calories they consumed, and also 
any mineral-type supplements that they would have to take the next day 
to stay on 	 the mineral balance. 
Lastly, on a weekly basis, we had an open-loop conversation with the 
crew and one of the scientists from the medical science community.
This representative would give the crew a summary of the medical data 
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that was being obtained from their mission; he would state the trends 
observed; he would compare those with medical data from previous
missions, such as Gemini, Apollo, or previous Skylab missions; and he 
would give them an idea of the significance of this data. Probably
the most important benefit of this conference was that it served as a 
general colloquium on space flight physiology and medicine with the 
crew on a real-time basis. 
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SKY LAB 4 CREW OBSERVATIONS 
Edward G. Gibson, Ph.D.. 
Astronaut Offiae - Saienae and Appliaations 
National Aeronautias and Spaae Administration 
Lyndon B. Johnson Spaae Center 
Houston, Texas 77025 
JOHNSTON: The next paper will be "Skylab 4 Crew Observations". Dr. 

Ed Gibson, a scientist astronaut who was the Scientist Pilot on Skylab 4, 

will make this presentation. Ed is a specialist in solar physics and 

I think that he was extremely enthusiastic about the ATM and the" conduct 

of that experiment in his mission. 

GIBSON: Thank you. lid like to first point out that for us the ATM 

observations and the medical experiments were very enjoyable aspects of 

the flight. We got involved in the understanding of the objectives of 

the medical experiments and could see some of the progress, some of the 

changes and some of the things which one is looking for during the con­

duct of those experiments. So, for us, they were extremely interesting.

They were also enjoyable from the standpoint of the people with whom we 

worked. They were very cooperative during the initial training and 

during the flight itself. We felt that the medical fo"lk were always

behind us in two ways: in getting the data as well as making sure 

that we were in a reasonable condition to carry out all the other 

objectives of the mission. 

Now, what 11m going to state is essentially how we looked at it from 

Skylab 4, and 11m going to do it from the standpoint of a person with a 

background in engineering and physics. I was appointed as the shipls 

doctor, which made the other two guys feel rather comfortable. 1111 

mention just several areas and not go into them very deeply: food, 

exercise, scheduling, medical training, the effects of the fluid shift, 

vestibular effects, and several miscellaneous items. 

First of all, the food area. We experienced hunger on two different 

occasions because of the types of diet we were on. In order to extend 

our mission, we took along some high-density food bars and every third 

day we supplemented our meals with these so we could extend our mission 

from 56 to 84 days. During those days, we had the same amount of 

minerals, the same number of calories as we would on other days, but 

the amount of food bulk was greatly reduced, so we ended up fairly 

hungry on every third day. We were glad to do this, but that was an 

effect. Second, we noticed, especially early in the mission, that we 

tended to get hungry in 3, 4, maybe 5 hours after a meal as opposed to 
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the normal 6 to 7 hours as one does down here. Whether that's an effect 
of zero gravity or whether that's an effect that we were just charging 
real hard the first couple of weeks, we can't sort out ourselves. But 
the effect was there. 
Another effact of the food was from the f1i nera 1 Balance experiment M071. 
It was a very worthwhile experiment, but it certainly did have its im­
pact on the food system. I think, in the future, once welve learned 
all we can from that experiment, weld like to see a food system where 
one can choose what one wants to eat, when one wants it, and how one 
wants to prepare it; that is, how much salt or other seasoning one wants 
to use. To have a little more flexibility of choice, we're thinking 
of a pantry as opposed to the more or 1 ess rigid di et which we were on. 
Again, these comments are directed toward what we would consider optimum 
from the crew operational standpoint, and in no way do we mean that 
this was not a worthwhile experiment. We were glad to cooperate in it. 
Exercise. As already has been mentioned, we exercised for one-and-a­
half hours a day. I think we came back in as good a shape, maybe better, 
in some respects, than previous crews. We attribute that to two things,
both of them based on the experience that we gained from the other 
flights. First of all, we exercised longer, an hour-and-a-half in our 
case; and second, we knew just what exercises we should do. For the 
arms, we used a Mark I exerciser, which is an inertial wheel resistance 
device; it worked real well. For the legs, we took along a new device 
which, for us, I think made a significant difference; this was the 
Thornton treadmill. Bill Thornton dreamed it up. We called it "Thornton ' s 
Revenge". It essentially is a very thin sheet of Teflon®, about a foot­
and-a-ha1f wide and maybe three feet long. We put it on the floor, 
got on it with our stocking feet and adjusted some bungee cords which 
went over the shoulders and held us down to the floor with essentially 
our own weight. In that way, we could walk, or run, or bounce up and 
down. This exercised the calves of the legs in a way which just couldn't 
be done on any of the other devices we had onboard. For us, it did make 
a significant difference. Also, for cardiovascular conditioning, we all 
worked out on the bicycle; we were glad we had that onboard.. We always
fp.lt good after we used it. One thing about the use of the bicycle, and 
I don't mean to be facetious at all in pointing it out, is that when 
one is working for a long time on that bike, 15, 20, 30 minutes or so 
at fairly high workloads one needs something to divert his mind. I 
think that if we had a window right by the bicycle, it would have been 
good. What we used was a tape recorder and music. And I found with music 
I could go a heck of a lot longer and harder than without it. It may 
be a small point, but it sure changed the amount of exercise which we 
could consistant1y do. 
48 

Scheduling. We've seen a progression during the manned space flight 
program from the early types of flights to the ones we had in Skylab. 
Mercury, Gemini, and Apollo were relatively short, high-effort, go-to­
the-hilt-for-a-short-period-of-time-type missions. Plan everything 
down to the last detail; that's the best way to fly that type of mission. 
In the early Shuttle Program, we'll probably experience the same type 
of flights. Skylab, however, had very long missions. One had to be­
come a jack-of-all-trades, and one had to use an awful lot of judgement 
in gathering the data in several types of experiments. That implies 
that in-flight one needs a certain time to organize, especially early 
in the mission. We all experienced this in Skylab 4, it's borne out by 
a paper which Owen Garriott will give tomorrow, and it's also borne 
out by the productivity of all three crews considering the various in­
puts. One needs a certain time to analyze one's situation and to develop 
new techniques, whether it be how to completely redo an experiment 
technique because it's just not working or whether it's just a way to 
hold a checklist. One certainly needs this extra time in order to get 
one's self efficient. Something like two to three hours per day would be 
useful to have as a time to get organized. Shopping list items could 
be used to fill the time left over. This is very much preferred to 
scheduling 16 hours a day to the hilt. What 11m saying is that the 
crew ought to be allowed to come up to their peak efficiency as opposed 
to working against a predicted efficiency. Giving them extra time to 
get to their peak efficiency will result in getting much more out of the 
total mission. 
Training. Inflight Medical Support System. I was very enthused with 
this one and really enjoyed it. We, in our training, learned a little 
bit about extracting teeth, suturing, and blood drawing. I felt fairly 
comfortable with my ability to do any of the procedures in-flight had 
we needed any of them. We certainly did do a lot of blood drawing. 
Fortunately, we did not have to get into any of the other aspects: 
suturing, tOOt11 extraction or diagnosis. We had a few small things that 
we had to diagnose but no major illness. We did have the capability of 
doing some microbiological examinations on board. I had worked quite 
heavily in that before we left and felt fairly confident. We did have 
some training from the NASA surgeons here and physicians in Houston, and 
they were always enthusiastic and exceptionally helpful. My only regret
is that we didn't get involved in it earlier. We started it when we 
got pretty heavily involved in all of the other mission training phases. 
Fluid shift. This is perhaps one of the larger points that we're still 
pondering, at least, in the crew}s mind on this flight. We had early
in the fl i ght, what I'll descri be as a general symptom ca 11 ed "head 
fullness". This is when the body fluids shift to the upper part of the 
body when one first enters into zero-g. One notices that the eyes turn 
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red which, in my case, happened after about a day or so. The eye sockets 
themselves become a little puffy; the face, a little rounder, a little 
redder; veins in the neck and forehead become distended and one's sinuses 
feel congested. And these conditions did not changes significantly
in-flight; they just tapered off. The bloodshot eyes disappeared but 
the congested sinuses were always there, although it was more severe 
at the beginning. On our flight, the Pilot noticed this. Bill Pogue
noticed this during the rendezvous; he had the headfullness during the ~ 
docking, experienced some headache and some general malaise and felt 
pretty much like he had the flu, as he described it. In order to be , 
a good buddy, we said, "Bill , why don't you have some food, it will 
make you feel better". He took some tomatoes and very shortly after 
that returned them to us. That was the only occasion we had on our 
flight of vomiting. After around 24 hours, Bill's headache disappeared. 
The congestion for all of us remained, although I think it was probably 
a little more severe for Bill. This feeling of head fullness and the 
accompanying symptoms, the Commander and I noticed for the first two 
weeks or so. If one asks one's self whether one still had them toward 
the end of the mi ss ion, one woul d have to say "yes II but they were really
not too bothersome. The Pilot noticed that for the last two weeks of 
the mission he really felt good and essentially equivalent to 100 percent 
on the ground. He was working fairly close to that during most of the 
flight, but he remarked that the last two weeks of the flight he felt 
much better. 
I noticed several variables that affected the fluid shift symptoms and 
our head fullness. One was exercise. We always felt a heck of a lot 
better after we exercised on the bicycle. Perhaps the effect of just
drawing the blood down into the larger muscles of the body took it away
from the head; it always cleared out the head, and we always felt much 
better for about a half hour to two hours afterwards. The Commander on 
our flight noticed that after eating he also experienced this to some 
degree. And also, the last effect was associated with the time of day. 
As down here, if one had anything bothering him, towards the end of the 
day it always feels worse. The same was true up there with the feeling 
of head fullness. . 
We were also able to see the leg volume changes because of the fluid 
shift. First of all, we could see them shrink when we got up there. 
You could tell it by eye, and you could tell it by measurements. A 
couple of times we measured the calf after exercise on the treadmill. 
It increased about a half an inch or so after a reasonable amount of 
exercise and, of course, it shrank down fairly rapidly as soon as we 
stopped. 
Subjectively the distress was significantly higher in-flight when we 
uS'ed the Lower Body Negative Pressure Device, which we had onboard. 
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This was borne out by the results which you will hear later. About 
four to six weeks into the mission was worst for us, and that is con­
sistent with the data. We used the symptoms of presyncope as a cutoff 
for the Lower Body Negative Pressure test. We monitored pulse pressure 
and heart rate, but pr"imarily, we used the subjective symptoms of the 
individual. In some cases, the pulse pressure and heart rate would get 
into the same ranges as they had been on a previous day for that 
individual, but he might say: II No , thatls it. I feel as though 11m 
going under and you better terminate now". Other times we could go 
right through the test without any problem. We really had to consider 
all the variables and the crew symptoms. 
Vestibular effects. Preflight we flew T38 aerobatics primarily"to 
reduce our sensitivity to motion sickness. We also did some work in a 
rotating chair with scopolamine/dexdroamphetamine (scop/dex). We never 
used scop/dex when flying a T38 because it gave us a feeling of being 
lightheaded and we did not want to be flYing under those conditions. 
The preflight T38 flying, I thought was the most significant part of our 
vestibular-type training. We did aileron rolls while putting our heads 
in one of six different orientations. We did 15 to 25 rolls in a row 
while putting the head down, to one side, or back, or one of the three 
opposite directions. One could get a great stress on onels semi­
circular canals. We noticed very significant "improvement in our ability 
to tolerate vestibular stress after we had made several flights. 
Next let us consider the relationship between our vestibular stimuli and 
nausea. First, 1111 make a comparison between myself and Bill Pogue. 
Bill did get sick early in the mission. If anybody should not have 
gotten sick, it was Bill. He had many years of flight experience and 
used to fly with the Thunderbirds. When he was first tested, he was 
able to go at 25 rpm in the rotating chair for 150 head motions. We 
called him "old lead ear". He had no problem whatsoever on the ground. 
On the other hand, 11m relatively new at the flying game. I had about 
3000 hours of flying time before I went and was just normal in my
tolerance in the chair. Maybe 12-1/2 rpm was what I could take initially,
although I was able to work up to 30 before I went because of the T38 
flying. Bill went up and, as I pointed out, after about seven or eight
hours into the mission, got sick. Both of us did about the same moving
about the command module, which was a very small amount. I experienced 
very minimal symptoms and never really anything in the way of discomfort 
at all. So, the conclusion here is that welve got to 160k for something 
else other than what normally we call "motion sickness" as a generator 
of nausea! We suggest fluid shift may be intricately tied up in this 
but 1111 not try and second-guess all the physicians. 
We never had stomach awareness when we were up there. We experienced 
a sensation of tumbling after we were in the rotating chair and during 
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acrobatics in the workshop. I used to do 15 or 20 forward rolls or 
gainers in a row and get really severe nystagmus although I never had 
any coupling to the stomach. 
On return when we first experienced one-gravity during the first deorbit 
burn, after 84 days in weightlessness, we all noticed a rather strange
sensation in the inner ear. It was like a tumbling sensation, similar 
to what one gets when lying on a table and someone puts cold or warm 
water in your ear. It had that aspect to it, but we did not feel that 
we were tumbling in a given direction. It was just an awareness of a 
sensory input that we had not experienced for a very long period of time. 
Weld had no real parallel to that one here on the ground. After recovery, 
we found rapid head movements produced vertigo. Most crews have noticed 
this. Also, the brain was not coupled to the muscles in the same way 
as they were before we left; that is, we all felt very heavy. Every 
movement we made had to be worked at. Rolling over in bed, moving an 
arm, walking; they all had to be conscious effort. And this lasted for 
a couple of days and was very much more severe at the beginning than 
at the end of those two days. We could go around corners fairly well, 
if we were careful. We terlded to walk with our feet spread apart.
I think that had we had any contingency on the return we would have . 
been able to handle those which we had planned for, but certainly we 
were a bit less able to handle them than when we left. Thatls to be 
expected, and I still think we all felt fairly comfortable as we got 
out of the Command l"1odul e. 
We all felt very thirsty on the recovery ship despite the fact that we 
had really forced the fluids before we returned. It was expected, of 
course. 
The joints, especially the knees, felt sore after we exercised a little 
bit down here on the ground. My leg muscles were sore; for the Commander, 
it was hi s back. 
One other interesting point in the vestibular area is our perception of 
orientation in flight. For example, being upside down in the wardroom 
made it look like a different room than what we were used to. When I 
started to rotate back and got to approximately 45 degrees or so of the 
attitude which we normally called "Up", the attitude in which we had 
trained, there was a very sharp transition in my mind from a room which 
was sort of familiar to one which was intimately familiar. It all of a 
sudden was a room in which we felt very much at home and comfortable 
with. It wasn't a gradual thing; it was a very sharp transition. This 
phenomena we ~bserved throughout the whole flight. I also noticed the 
feel ing of II down II • I experienced it a coupl e of times when I was work­
ing in the multiple docking adapter or the airlock. When moving around 
in those vehicles, I attached no direction to my motion at all. But 
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after I would look out the window for a long period of time, in particu­

lar the window for the Earth Resources Experiment Package, and then 

move away from the window and look from the multiple docking adapter to 

the airlock, I strongly felt that I was looking II down It . In the back of 

my mind I said, "Ilm going to fall if I don't hold on". Of course, 

I knew that it was not true, and just pressed right on. But that thought

did flicker through my mind several times. The other Itdown ll I noticed 

was a very exhilarating one, and that was outside during the extra­

vehicular activities. When I went out to the end of the Apollo Telescope 

Mount, had my feet in the foot restraint and leaned back, I felt very

far away from the space station. I no longer felt a part of it, and 

when I looked down, I suddenly realized that it really was a very long

270 miles down. 

Miscellaneous items. I did notice a ballistocardiographic effect. That 

is, a couple of times when I was trying to take pictures out a window 

and just held on to the adjoining structure rather lightly, I noticed 

that the whole Skylab cluster was beating at around 60 beats per minute. 

This was evident several times. It required that I hold myself down 

rather firmly to get around this. 

Many of us noticed, subjectively and without taking measurements, that 

the fingernails and toenails tended to grow a little bit slower in­

flight. Rather than trimming them once a week it was on the order of 

once a month or so. 

We all experienced light flashes. We noticed on our flight that they 

were well correlated with the South Atlantic anomaly. After some major

flares on the Sun during one night, we saw a high number of flashes. 

Most of them appeared as a white, double-elongated flash, perhaps double 

in some cases as other people have described, and Bill Pogue and I also 

saw the ones which looked like a whole multitude of pollywogs; very 

short ones, many of them of low intensity. For us, the latter kind 

occurred on the second orbit after we saw the very bright ones, sug­

gesting they are of lower energy but of many more particles. Also, I 

saw one green flash. Not a slightly green flash but a good old St. 

Patrick's Day green flash, and exceptionally bright. 

It was a surprise to us that we had no major illness, especially on 

our flight. We were working hard most all the time and got rather tired. 

We stayed tired for about the first half to two-thirds of the mission. 

If we had done that on the ground, I don't think we would have gotten 

by without getting at least a good cold. Up there, we did not have any

major problems. I cannot speculate the reason for it. 
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We all found it was useful to sleep using the device that we had up
there. It was a cot outfitted with four straps which held us down and 
made us feel as though we were sleeping in something similar to a bed. 
On several occasions, I tried sleeping by just floating free in the 
workshop. It was kind of fun, but I could only catnap that way. I 
floated pretty much with my arms out, 1 ike I would in a relaxed position 
underwater. You'll see some pictures later of just what our relaxed 
position was. lid mash into a wall rather slowly and five minutes later 
come up against another one. My mind was always half awake, waiting for 
the next contact. I could never really get a sound sleep that way. 
The duration of our mission was 84 days. We felt that we could have 
gone significantly longer than that. Welre talking on the order of a 
year, from the crew standpoint. First, we felt good physically, 
especially the last month. We felt much better than we did at the be­
ginning of the mission. And second, the types of tasks and the schedul­
ing which are required must be carefully considered. Let the crew get
ahead. Let them set their schedule and build up to their highest
efficiency and maintain it that way. The types of tasks which are re­
quired, especially for long missions, are those which require judgment 
and those with which one can grow and get better at, those which, for 
example, one can do better on day 102 than one could on day two, those 
which really are challenging intellectually. 
We have learned from Skylab that man makes his best contributions on 
tasks which use his intellect and require his judgement and that his 
proficiency on these types of tasks increases with mission duration. 
Thus, there should be very strong motivation for future long duration 
missions. 
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SKYLAB 2 CREW OBSERVATIONS AND SUMMARY 
J. P. Kerwin, M. D. 
Chief, Life Scienaes Astronaut Offiae 
NationaZ Aeronautias and spaae Administration 
Lyndon 	B. Johnson spaae Center 
Houston, Texas 77025 
JOHNSTON: Thank you, Ed. That was excellent. Our next speaker is 
going to give observations from Skylab 2 and kind of a summary of the 
crew. Joe Kerwin is our first U.S. astronaut physician in space. He,
of course, was the Scientist Pilot in Skylab 2. Hels currently-head of 
our Life Sciences Astronaut Office. Joe. 
KERWIN: Thank you, sir. It's a pleasure to be here at the Richard 
S. Johnston Space Center, as we call it in our office. Dr. Gibson, 
it's truly amazing to me how you could have stolen about half of what 
I was going to,talk about, considering only the fact that we were in 
the same environment in the same vehicle for varying periods of time 
in the same year. It's really nice to get back and talk to the other 
crews and find out how consistent one's descriptions of the signs and 
symptoms of weightlessness are. It's the same environment, and it's just a matter of describing it in different words or different similes. 
The diagnosis of weightlessness, by the way, is very simple. As in the 
case of many diseases, the history alone is often sufficient to estab­
lish the diagnosis. However, if you're in this situation and you are 
having some difficulty, I have devised a test - which with true humility, 
I recommend be called the Kerwin Test, for the presence of weightless­
ness. You have the patient place both hands on the examining table and 
push downward firmly; if he floats up toward the ceiling, the test is 
positive. 
I have talked before about the signs and symptoms of weightlessness and 
there are two major themes that run through my mind. Number one, of 
course, i~ that it really is extremely clear to an individual when he 
is in weightlessness that rather profound changes are rapidly-taking
place in his body. One feels this strange fullness in the head and 
this sensation of having a cold and the nasal voice, and one sees the 
puffy look on the faces of his fellow crewmen. He feels this strange 
posture that one assumes in weightlessness, with the shoulders hunched 
up, and the hands are out in the front and the knees are bent. 
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It1s not comfortable initially, sleeping in that posture, but every time 
one relaxes, one's body goes back to that posture. One can almost see 
the fluid draining out of the legs; one looks at his partners, and their 
legs are qetting little and skinny like crows I legs, and one knows that 
one's physiology is changing. But that wasn't the primary theme. The 
primary theme was one of pleasant surprise at all the things that didn't 
change, at all the things that were pleasant and easy to do. As Pete 
Conrad pointed out, we lost a few bets up there because of our appeti­
tes. But the very first system that we had pleasant surprises in was 
the vestibular system. We all keep talking about it because not 
only was it so different from what was expected but it is, subjec­
tively, one of the primary memories that one gets from this "Alice in 
Wonderland" world of weightlessness. 
Our crew was fortunate enough not to run into the motion sickness 
problem in any clinical or full-blown form. Therefore, our first 
pleasant or different impressions were the impressions of a very changed
relationship between ourselves and the outside world. And, in my own 
words, I would say that there was no vestibular sense of the upright 
whatsoever. I certainly had no idea of where the Earth was at any time 
unless I happened to be looking at it. I had no idea of the relation­
sh"ip between one compartment of the spacecraft and the other in terms 
of a feeling for up/down, and this has some peculiar effects when one 
passes from one compartment into the other and walls turn into ceilings 
and ceilings turn into floors in a very arbitrary way. But all one has 
to do is rotate one's body to the comfortable orientation and wham01 
What one thinks is up, is up. After a few days of getting used to this, 
one plays with it all the time; one just stands there and does a slow 
roll around his bellybutton. It's a feeling as though one could take 
this whole room' and by pushing a button, just rotate it around so that 
the screens up here would be the floor. It's a marvelous feeling of 
power over space - over the space around one. Closing one's eyes, 
of course, made everything go away. And now one's body is like a planet 
all to itself, and one really doesn't know where the outside world is. The 
first time I tried it, my instinct was to grab hold of whatever was 
nearest and just hang on, lest I fall. It was the only time in the 
mission when I had anything like a sensation of falling. I was telling
that to my wife, and she pOinted out that that's like the reflex that 
a baby has. When you begin to drop it, it just reaches out and clutches. 
And we thought, wouldn't it be nice to write a story about a sort of 
re-evolution of the human being in zero-g, because one certainly gets 
used to it in a hurry and it certainly is different. You will hear in 
great detail later on in the symposium about the third and last effect 
of weightlessness on the vestibular system, again alluded to by Ed, 
that rotation and head movement in weightlessness do not elicit motion 
sickness. I don't believe Dr. Graybiel will state it quite that strongly, 
but certainly we never reached the threshold. And that was most sur­
prising. 
I 
Another very pleasant surprise was our ability to maintain physical 
fitness - our ability to maintain an exercise level the same as we 
had been maintaining on the ground. I really don't think that any of 
us expected that before the flight. One was moving around in a large 
volume. One was maintaining weight in the face of what we knew was 
going to be a markedly reduced caloric intake. We just knew it; never 
mind that it was wrong. And the third was that we felt that a combin­
ation of mechanical efficiency and muscular deterioration or atrophy 
was definitely going to reduce our ability to work on the bicycle. 
Well, we were wrong again. Once we had mastered the technique or the 
mechanics of how to ride a bicycle in a weightless condition, which took 
us about 10 days, we found that essentially we remained at the preflight 
baseline through the mission. I believe some of the crewmen on the 
subsequent flights increased their ability to do that particular task, 
s"il11ply through a training effect, and that was a very pleasant surprise. 
To me, the most astonishing thing was our ability and desire to pack 
in the groceries, and there's a long preflight history to that. We 
fought and scratched with the Principal Investigators on that diet for 
four or five years. We finally settled on an in-flight diet estimation, 
which kind of went like this: We had several six-day periods of food 
intake measurement prior to the flight. These data were taken and were 
modified by certain standard height/weight/surface area tables, and so 
forth, to get a best estimate of our average caloric intake, and then 
we subtracted 300 calories from that. Most of us wer~ certain that 
even that amount of food was going to be too great. And 10 and behold! 
Didn't we discover that after a few days of decreased appetite in 
flight, we found that on most days we were able to eat all of our food. 
As Pete even pointed out, man does not live by bread alone, but by 
butter cookies and ice cream. Indeed, as the missions progressed and 
the amount of food the crew was allowed to eat increased and their 
exercise increased, they were essentially eating the same amount of 
food that they ate on the ground. That to me is a mystery. I still 
don't understand it but maybe I will by the end of the symposium. How 
in an environment in which certainly muscular work is reduced, the 
caloric demand and the relationship between caloric intake and body 
weight remain just about the same as they do on the ground, I think 
that's a very interesting problem that we haven't solved yet. 
Okay, we described a number of other phenomena on our flight, many of 
which Ed had already covered in terms of signs and symptoms, in terms 
of physical findings on physical examination, in terms of simple lab­
oratory work - which go toward a beginning of putting together a 
rational description of the physiology of weightlessness. The first 
step is a medical history and physical examination. This we follow 
with laboratory findings and the clinical course of the - I hate to call 
it a disease because it's not - but, of this change. Such a description 
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has many uses, not the least of which will be to permit the diagnosis 
of disease in weightlessness, where the presenting signs, symptoms and 
so-called normal laboratory values are going to be different. Now our 
sample population has been much too small to have experienced signifi­
cant illness in orbit, and it's been too small to allow us to predict .. 
changes in the incidence of diseases or the course of diseases due to 
the weightless environment. I think this is a matter of time and that 
these are the kind of things we need to know in order to fly frequently
and to fly for long durations and to make space flight in the Shuttle 
..... 
era, and beyond, a routi ne event, because we do not want to 1 imit our 
crews and our visiting scientists to people who are completely free 
from disease or from unusual tendencies. There are a million examples 
come to mind: for instance, when you fly older people, what is the 
rate at which they wash out nitrogen when they prebreath? Does it 
change merely as a function of age, or is it because physical fitness 
and obesity come into the picture, too? We donlt know.· That's a 
small data point that's going to be operationally important to us when 
we begin to fly people in their 50's and their 60's. I think the first 
step is to use animal subjects to make the invasive measurements 
necessary to clear up the picture, and to observe the response of 
animals to various challenges that are difficult or dangerous to do 
on human subjects, such as radiation, hypoxia, and acute blood loss. 
I think the effect of hypoxia in weightlessness would be very interesting 
to observe. Certainly, I'd love to see whole generations of animals 
reared and exposed to weightlessness for their entire lifespan, to see 
how far this evolutionary process will really go. And I th-jnk eventu­
ally we will get to the point where we will dare to study disease 
states, first in animals and then in human beings. I think that by 
studying a disease in weightlessness, we will learn more about both the 
environment and the diseas~. There are, as I said, many possibilities:
from fundamental studies on coronary and pulmonary perfusions, to bone 
and soft tissue healing, to the effect of drugs in hypoxia and radiation, 
to observations on the course of stasis ulcers and to how does edema 
in right heart failure behave in this environment. If we can make 
fundamental advances in anyone of those subjects, weIll pay the frejght
for the whole medical program. I am not suggesting a shotgun approach 
but I feel that an imaginative approach to medical research will have 
an opportunity to be used in the 80's. 
I would like to conclude with a few observations by one such human 
subject on a space flight. We had a super relationship with the medical 
team on Skylab. Each and every investigator was competent, efficient, 
and thoughtful of us, the subjects. Only en masse3 were they ever the 
tiniest bit overwhelming, as when on recovery day everybody wanted that 
significant data - "right now", I think we struck a good balance, and 
I hope we continue to do so. Medical research on Skylab has helped us 
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to document that human beings can operate efficiently in space. It's 
this fact, rather than medical research per Be that will justify con­
tinuation of manned space programs. It appears that man's potential 
efficiency in zero-g is as high as it is any place else. The degree to 
which this potential is realized is a function of the experience and 
training of the crew and of the degree to which their needs are met in 
flight. Thus, the function of medicine is not only to discover those 
needs but to meet them. And the research program we design must hamper
the crew's efficiency as little as it's possible to do and still get
• the data. And so to all you good research people, one final admonition: 
You can have all of the data some of the time, and you can have some of 
the data all of the time; but you can't have all of the data all of the 
time. Thank you. 
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SKYLAB CREW HEALTH - CREW SURGEONS' REPORTS 
J. R. Hordinsky> M.D. 
CreW Surgeon for Skylab 4 
National Aeronautics and Space Administration 
Lyndon B. Johnson Space Center 
Houston> Texas 
ABSTRACT 
A physician was designated as the Crew Surgeon for each of the three 
manned Skylab missions. He was responsible for the health of the 
Skylab crewmembers and their families, the development and use of the 
Inflight Medical Support System, the preflight medical examination and 
arrangement of all crew medical-related activities, and the post­
flight coordination of medical activity on board the recovery ship and 
afterwards at the NASA-Lyndon B. Johnson Space Center. 
Skylab 2, lasting 28 days, was the first manned Skylab mission. The 
only Skylab 2 preflight problem was gastroenteritis in one crewmember 
one month before flight. During the entire flight, the Commander had 
a left serous otitis media. Postflight adjustment was clinically 
satisfactory, but the Pilot was presyncopal after completion of the 
Metabolic Activity experiment M17l exercise protocol on recovery day, 
and the Scientist Pilot experienced significant seasickness on that 
same day. 
Skylab 3, a 59-day mission, was the second manned Skylab flight. The 
Skylab 3 preflight period was free of medical problems. During flight, 
all three crewmen experienced motion-sickness during the first three 
days. A sty and two axillary boils developed on the Commander during 
flight, but resolved without complication. On recovery day, the Pilot 
developed presyncope in the recovery phase of the experiment M17l 
exercise protocol, and the Commander was presyncopal during the stand 
test. In addition, the Commander aggravated a back problem which he 
had had preflight. Postflight, the overall clinical adjustment was 
more rapid than for the Skylab 2 mission crewmen. 
Skylab 4 was the longest and last manned Skylab mission; it lasted 
84 days. No acute medical problems occurred before the Skylab 4 
flight. The Scientist Pilot's left eardrum was variably injected, but 
followup care through the preflight period allowed flight clearance. 
During flight, two of the three crewmen experienced motion-sickness 
symptoms during the first three days. Skin dryness and head and 
nasal fullness were present as in the earlier two missions. The Pilot 
had a probable fungal infection which cleared after two weeks of 
therapy. Sleeping medications were used more throughout the Skylab 4 
mission than in the Skylab 2 or Skylab 3 missions. Food intake was 
satisfactory, and less weight was lost by the crewmen than on the two 
previous missions. Exercise time was longer than on previous missions. 
A unique treadmill was used for the first time. The expertise in 
handling flight planning problems associated with long-duration 
missions was significantly developed during this 84-day flight. On 
recovery day, the Commander experienced presyncope following a forced 
expiration test maneuver. Overall postflight crew readaptation was 
clinically very good and was even more rapid than for the two pre­
ceding flight crews. 
IIHRODUCTION 
Prior to the flights of the various Skylab missions, the Crew Surgeons
had responsibility for the following medical areas. 
o 	 To supervise the health of the Skylab crewmembers and their 
famil ies. 
o 	 To render clinical assistance in the development of the 
Inflight Medical Support System (IMSS) Checklist and 
equipment, as well as to monitor the Crew IMS$ training 
programs at the various professional sites. 
o 	 To conduct IMSS drug sensitivity testing (topical and oral), 
and electrocardiographic, vectorcardiographic and electro­
encephalographic skin sensor sensitivity test"ing. 
o 	 To monitor medical experiment baseline data. 
During the preflight, in-flight and postflight periods, the Crew 
Surgeons gave careful surveillance to the following areas of medical 
concern: 
o 	 illness events and prescribing medications, 
o 	 trends in the Flight Crew Health Stabilization Program, 
o 	 nutrition, intake and output, 
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o 	 personal daily exercise, 
o 	 work/rest schedules, and 
o 	 sleep periods, quantity/quality. 
The Crew Surgeons relied to a great extent on the daily private medi­
cal conference with the crews over an air-to-ground loop from the 
NASA Mission Control Center to monitor crew health in-flight. For 
continuous clinical evaluation of the crew, the Crew Surgeon had 
access to medical parameters derived from the experiment data and was 
also dependent on the following monitored areas for clinically related 
i nforma ti on: 
o 	 radiological health, 
o 	 Skylab environmental data, including toxicological evaluation, 
and 
o 	 medical data obtained from the Operational Bioinstrumentation 
System during the scheduled extravehicular activities. 
Postflight, the Crew Surgeon coordinated all the medical activities 
relating directly to the crew. He was the medical team leader on the 
recovery ship and had prime responsibility for the continuous clinical 
care of the crew especially during the medical experiments, and later 
at NASA-Johnson Space Center. 
SKYLAB 2 
Medical examinations performed on the three crewmen at specified
intervals beginning 40 days preflight did not reveal any major change 
in any crewmember's health status. They remained in good health 
throughout the preflight phase, except for the Pilot who developed a 
24-hour illness resembling a viral gastroenteritis about one month, 
before flight, just coincident with the initiation of the Flight Crew 
Health Stabilization Program. 
In-flight, on mission day 1, the Commander developed a left serous 
otitis media, which required the extended use of an oral decongestant 
as well as a topical nasal decongestant. On mission days 3 through 7, 
the Commander also used a topical steroid cream to relieve the symptoms
of a probable mild contact dermatitis of his right arm. Complying with 
a preflight decision, the Scientist Pilot took one scopolamine/
dextroamphetamine sulfate capsule just after insertion, but the medi·ca­
tion was not repeated. Prior to extravehicular activity, the Scientist 
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Pilot and the Pilot utilized a topical nasal decongestant prophylac­
tically; the Pilot also took an oral decongestant. 
No significant arrhythmias developed in-flight. Early terminations of 
the Lower Body Negative Pressure experiment (M092) by the Scientist 
Pilot and Pilot were sporadic, and in this mission the maximum level of 
exposure to lower body negative pressure was reduced following early 
termination of the Lower Body Negative Pressure test. 
The crewmen took hyponotic medications of choice on the night of 
mission day 27 to help accommodate a change to their work/rest schedule 
for entry and splashdown. Entry itself was nominal. Postsplash (on
the water) the heart rates were: Commander, 84; Scientist Pilot~ 84; 
and Pilot, 76 beats per minute. Aboard the ship on recovery day 
vertigo, postural instability (especially with eyes closed), reflex 
hyperactivity, and paresthesias of the lower extremeties were prominent
findings. The Scientist Pilot developed seasickness while still in the 
Command Module and the most prominent symptoms cleared in four to six 
hours. Scaling of the skin of the hands was noted on the Commander and 
the Scientist Pilot. The Pilot experienced a vagal response
(decreasing heart rate, pale and sweaty appearance) in the recovery 
period of the Metabolic Acitivty experiment (M17l), which lasted just 
a few minutes. Muscle and joint soreness, generally confined to the 
lower back and lower extremities, were first noted on the first day 
post recovery. During the ongoing postflight period of surveillance, 
no significant medical problems developed as an apparent result of the 
long duration in weightless space flight. No drugs were taken except 
for vitamins. 
SKYLAB 3 
Preflight, no infectious diseases or other medical problems were ex­
perienced by the crew during the 30-day preflight period, the last 
21 days of which included the Flight Crew Health Stabilization Program. 
Launch and orbital insertion were nominal. Shortly after orbital 
insertion, the Pilot began to experience nausea; this was aggravated
by head movement. One hour after insertion, the Pilot took an anti­
motion sickness capsule, scopolamine/dextroamphetamine sulfate, with 
good relief. The crew entered the Orbital Workshop 9 hours and 45 min­
utes after lift-off. Following strenuous work to activate the Orbital 
Workshop, the Pilot vomited once. During the second mission day, the 
Commander and Scientist Pilot also experienced some motion sickness 
during continued Orbital Workshop activation; they took scopolamine/ 
dextroamphetamine sulfate as required for alleviation of symptoms. This 
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indisposition caused a loss of work time during the first three days of 
flight. Two additional days elapsed before all symptoms had dissipated.
Since medical experiments were not run until mission day 5, subjective 
voice reports by the crew were the only means of health assessment 
during this time. On mission day 5, after the first medical experiments 
were conducted, objective clinical data were available to aid in 
evaluating the crew's health. In general, the crewmembers remained in 
excellent health except for a few minor clinical problems and rare 
sporadic early terminations of the Lower Body Negative Pressure experi­
ment by the Commander and the Scientist Pilot. 
The Pilot reported a painless sty on the left upper eyelid on mission 
day 29, which responded to an ophthalmic antibiotic ointment and 
cleared by mission day 32. On mission day 33, the Commander reported 
the beginning of a boil under his right arm. Instructions from the 
ground to the Commander were to avoid using stick-type deodorant, and 
the wearing of garments which fitted tightly under the arms. No medi­
cations were recommended and the condition cleared in about 48 hours. 
A recurrence of the boil in approximately the same area on mission 
day 50 again lasted only 48 hours, and did not require any medication. 
The crew maintained high levels of daily exercise during the mission. 
Extravehicular activities were successfully completed on mission 
days 10, 28, and 57 without medical problems. 
The crew slept 6 hours on the night prior to entry and were awake 
approximately 15 hours prior to splashdown. The Scientist Pilot took 
an antimotion sickness capsule approximately 40 minutes prior to the 
entry burn', while the Commander and the Pilot took their antimotion 
sickness medication approximately 5 to 10 minues after the burn. Prior 
to the burn, all three crewmen inflated their orthostatic counter 
measure garments. The entry was nominal. At about 20 to 30 minutes 
after splashdown while still in the Command Module, the Scientist Pilot 
checked the pulse rate of each crewman and obtained the following 
values: Commander, 88; Scientist Pilot, 70; and Pilot 62 beats per 
minute. Pulse checks by the Crew Surgeon immediately after the Command 
Module was aboard the recovery ship were similar. Blood pressures were 
within acceptable ranges for these crewmen. All three crewmen egressed
the Command Module on their own power. 
Postflight the cardiovascular deconditioning observed was carefully 
documented, but no clinically serious events occurred. As in Skylab 2, 
vertigo, postural instability, hyperreflexia, dry skin and slight
fissuring OT the hands were noted. On recovery, a previous back 
strain suffered by the Commander recurred from a situation combining
"lifting" and loss of balance. On recovery day the Commander developed 
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presyncope during the stand test. The Pilot had a vagal response, also 
associated with presyncope, during the recovery phase of the Metabolic 
Activity experiment M17l (bicycle ergometer). The overall rate of 
recovery postflight was more rapid than that observed in the first 
manned Skylab mission. . 
SKYLAB 4 
In Skylab 4, the Flight Crew Health Stabilization Program lasted 27 days 
due to a 6-day slip in the launch for evaluating and correcting poten­
tial launch vehicle problems. The crew underwent preflight evaluations, 
which were augmented by several new experiments, such as echocardio­
graphy and pulmonary function evaluation. Several items noted in 
the medical history and clinical examinations required attention for 
the upcoming flight, these were: a history of low back pain (lumbo~ 
sacral strain) experienced by the Commander in the preflight period,
and the concern as to whether there would be recurrence of this pain 
on his return to earth; some recurring variable left ear drum injection 
and lability of blood pressure noted during the preflight period in the 
Scientist Pilot; and the history of recurrent nasal congestion and a 
tendency toward lability of blood pressure in the Pilot. Cardio­
vascular review of these men showed no evidence of nor tendencies 
toward arrhythmias. These findings were well documented in order to 
permit evaluation of any in-flight changes. The crew remained in good
health throughout the preflight period. 
This crew also had no formal scheduled in-flight medical examinations. 
Data from experiments and "as necessary" medical evaluations continued 
to provide the necessary information for monitoring of health status. 
A heart rate and blood pressure stress evaluation for clinical reasons 
would be obtained on any individual at least every four days, if for 
some reason the experiments Lower Body Negative Pressure (M092), 
Vectorcardiogram (M093), and Metabolic Activity (M17l) were not able to 
be run. Fewer illnesses occurred in-flight than would have been 
predicted from ground based experience. However, it is important to 
point out that in this mission there were numerous symptomatic events 
that required variable amounts of medication. Drug utilization for the 
three manned Skylab missions are delineated in appendix A. For all 
Skylab 4 crewmen, the initial medication was the prescribed antimotion 
sickness drugs. In Skylab 4 the Scientist Pilot did not experience 
motion sickness. The Commander had minimal malaise for three days. 
The Pilot had significant nausea with vomiting for one day and then 
malaise for two more days. The second major recurrent use of medication 
was lip balm and skin cream to prevent drying of the lips and skin, 
respecti vely. The sleep medications were util ized intermittently 
throughout the mission by all the crewmen. Decongestants (topical 
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and systemic) were used during the mission. These were used both 
prophylactically during the extravehicular activities and for specific
symptomatic relief of the feeling of fullness in the head, nose and 
ears. 
The Scientist Pilot utilized aspirin twice for transient headaches on 
mission days 17 and 67. On mission days 75 through 79, the Scientist 
Pilot utilized wet packs to help resolve a minimal papular rash on the 
left neck and ear area. 
The Pilot had a rash in the upper mid-back area, which was treated as 
a fungal infection, and which did resolve after about a week and a 
half. 
The observed in-flight problems were not related to preflight problems
except remotely; one could state that the Pilot's prior history might 
have indicated the greater susceptibility to upper respirator con­
gestion. 
In following the crew, the Daily Health Status Summary sheet was a 
comprehensive guide. It was updated for this particular mission, and 
it was maintained by the person in the aeromed duty position working 
in direct support of the Mission Operation Control Room Surgeon. Data 
for this summary were prepared from the Evening Status Report which 
gave sleep, medication, exercise, and experiments M07l (Mineral 
Balance), M073 (Bioassay of Body Fluids), and M172 (Body Mass Measure­
ment) data, from the dump tapes, and from the private medical 
conference. The latter permitted subjective and objective crew obser­
vations about their responses to the stressor tests (Lower Body Negative
Pressure and Metabolic Activity) as well as to the general status of 
living in zero-g. 
Vectorcardiographic data became especially valuable as the Pilot began 
demonstrating vectorcardiographic parameters differing significantly
from preflight. None of these deviations from preflight "norms" were 
considered clinically abnormal. In a summary statement, there were 
neither clinically significant cardiac arrhythmias nor vectorcardio­
graphic changes in-flight. 
Instrumental in maintaining crew health was a maintenance of a proper 
environment. It should be stressed, there were no significant problems 
in maintaining the limits of environmental conditons of total pressure, 
oxygen, and carbon dioxide. Other parameters, such as temperature and 
relative humidity, were more variable. These parameters were influenced 
by the orbital inclination and sun angle of the Skylab complex and the 
performance of the supplementary thermal protection deviCES; additionally, 
potential off-gassing from the heated spacecraft was satisfactorily 
ci rcumvented. 
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Personal cleanliness was fairly well maintained but proved to be time 
consuming, either by use of the shower or by sponge baths. 
The increased quantity and quality of exercise available to the crew 
was important in maintaining crew health of Skylab 4. For each 
successive mission the exercise time had been increased from one-half 
hour, to one hour, to one and a half hours per day, respectively. In 
Skylab 4 the bicycle ergometer, the Mark I (an isokinetic force 
generating pulley), the Mark II (springs), the Mark III (the standard 
Apollo exercise device), the treadmill, and isometric exercises were 
available to counteract the effect of the zero-g environment; the crew had 
the highest overall average of quantifiable work output from their 
exercise. 
The maintenance of nutrition was satisfactory; the Skylab 4 crew ate 
at essentially preflight caloric levels and were quite satisfied with 
the taste of the food. The high density food bars, utilized to extend 
provisions when the Skylab 4' mission was extended to 84 days, were 
tolerated well by the crew although they left a subjective sense of 
hunger. As in Skylab J, vitamin supplementation was maintained. The 
weight losses for the Skylab 4 crewmen were less than those for the 
crewmen of the other two missions. 
The work/rest cycle was a key problem in this last mission. During the 
early phase of this mission the crew was scheduled at a pace comparable 
to the pace attained by Skylab 3 crewmen in the latter part of their 
mission. New experiments, stowage confusion, onboard equipment mal­
functions, and the sheer length of the mission were all contributing 
factors to produce psychological stresses which were slowly resolved 
over the first half of the mission. 
As the end of the mission approached, two late single-block shifts of 
sleep time were made, as the preferred mode, to adjust the crew to the 
circadian shift required. Crew comments postflight indicated this 
was a suitable and effective approach to the time shift required. 
Earlier piecemeal shifting in Skylab 2 and Skylab 3 was not subjectively 
as effective. In preparation for entry, scopolamine/dextroamphetamine
sulfate was prescribed for all three crewmen at approximately two hours 
prior to 'intended splashdown. The crew inflated their counter measure 
garments prior to burn and re-inflated them to compensate for the 
increasing internal pressure as the Command Module was pressurized 
during descent. As in Skylab 3, the splashdown was initially in 
stable-2 (heat shield up), and changed to stable-l (heat shield down)
within a nominal time frame. Initial lion water" pulse rates were: 
Commander, 70; Scientist Pilot, 80; and Pilot, 80 beats per minute. 
Blood pressure and pulse readings taken inside the spacecraft were 
acceptab 1 e and the crew egressed and wal ked essentfa11y unassisted. 
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The triad of vertigo, postural instability and reflex hyperactivity was 
again noted postflight. This time it was the Commander who experienced
a vagal response with presyncope at the end of forced expiration in 
pulmonary function testing. Petechiae were noted in the lower legs of 
all three crewmembers late on recovery day, and during the day afterwards. 
Muscle and joint soreness during exercise developed postflight, but only 
to a minimal degree. The postflight period was free of any illnesses 
or injuries. Postflight physiological readaptation, as measured by
the experiements, revealed the crew to be in as good or better status 
than the crews of the two earlier missions. 
CONCLUSIONS 
From a clinical point of view, all of the physiological and psycho­
logical responses noted in the Skylab missions were either self-limiting 
or represented work-arouhd problems requiring minimal counteraction. 
As such, these changes do not preclude extending man's duration in 
zero-gravity for longer periods of time. 
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DETAILED TEST OBJECTIVES 
, 
SKYLAB ORAL HEALTH STUDIES 
Lee R: Brohln3 Ph.D.*; William J. Frome3 D.D.S. t; 
Ms. Sandra Handler3 B.A.~; Merrill G. Wheataroft3 D.D.S§; 
Ms. Linda J. Rider3 B.S.~ 
ABSTRACT 
Oral health considerations for the Skylab series of manned space
flights included three areas of responsibility: clinical, provisions 
for in-flight care, and research. 
Clinically, prevention of dental disease was emphasized through fre­
quent oral evaluations and an intensive home care program. 
During all missions provision was made for an extension of the crew­
men's home care program and equipment and training were provided all 
astronauts for self-treatment in-flight should the need arise. 
Research was dedicated to the identification of potential oral health 
problems which might occur in prolonged space flights. Skylab crew­
members were monitored for:, shifts in oral microbial propulations,
changes in the secretion of specific salivary components, and altera­
tions in clinical indices of oral health and preexisting dental 
disease. 
Microbiological assessments were made weekl~ to biweekly from three 
intraoral sites (gingival sulcus fluid, dental plaque, and stimulated 
whole saliva) beginning as early as 57 days preflight and ending 17 
to 20 days postflight. Preflight specimens were scheduled to provide
comparison of microbial counts before and after the incorporation of 
space diets. In addition to microbial assessments, stimulated whole 
saliva was used to determine saliva flow rates and salivary protein, 
*Member and professor, University of Texas, Dental Science Institute, 
Houston, Texas 
tCo1onel, United States Air Force, Dental Corps, Johnson Space Center 
Dental Surgeon, Houston, Texas 
*Research Assistant, University of Texas, Dental Science Institute, 
Houston, Texas 
§Professor, University of Texas Dental Branch, Houston, Texas 
7~ 
lysozyme, and IgA levels. Oral clinical evaluations were performed 
at 30 and 4 days preflight, and 4 days postflight for Skylab 2; at 
43 and 5 days preflight and 4 days postflight for Skylab 3; and at 
47 and 4 days preflight, and 4 days postflight for Skylab 4 to compare
incremental changes in the accumulation of dental plaque, calculus 
formation, gingtval inflammatory responses, and alterations in teeth, 
bone, and oral mucosa. The following were the most distinctive intra­
oral changes noted. 
o Increased counts of specific anaerobic and streptococcal
populations endogenous to the intraoral sites tested. 
o 	 Elevations in levels of secretory IgA's and saliva flow rates 
with diminutions of salivary protein and lysozyme. 
o Increased increments of dental calculus and gingival inflam­
mation. 
Most microbiological changes occured in both the prime and backup 
crews of each mission, and appeared to be diet-related. Secretory IgA 
elevations occurred in the prime crews of each mission and were pre­
sumably due to subclinical infection. Explanations for increased 
saliva flow rates and decreased levels of salivary protein and lysozyme,
which were not observed in all missions, were not readily apparent. 
Similarly, increased increments of dental calculus and gingival in­
flammation appeared to be individual rather than group related. 
Assuming no future clinical detection of mission-related intraoral 
complications, the most significant finding from these investigations 
was the relatively nonexistence of health-hazardous intraoral changes. 
INTRODUCTION 
Oral health considerations for the Skylab series of manned space 
flights included three general areas of responsib-ility. These areas 
were: 
o 	 clinical dentistry, 
o provisions for in-flight care and the Inflight Medical Support
System-Dental, and 
o research dedicated to the identification of potential oral 
problems in manned space missions of long duration. 
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CLINICAL DENTISTRY 

Clinically, the emphasis in the dental health program was on the pre­
vention of dental disease. This was accomplished by a carefully
supervised home care program which was supplemented with oral examina­
tions and evaluations at least every six months. Regular topical 
applications of stannous fluoride were also provided all crewmen. 
However, because of consideration of other studies during the Skylab 
missions, the topical fluoride applications were discontinued six 
months preflight for each crew. ' 
Because of risks of inflammation to the dental pulp, no dental restora­
tions were provided the cre~nen during the last ninety days prior to 
flight. The oral health of all crewmen was at a sufficiently high 
level that the ninety-day provision was realistic. 
Complete oral Panorex radiographs were made of each crewman prior to 
his mission. These radiographs did reveal two asymtomatic, previously 
unrecognized areas of pathosis about the apex of the teeth of two 
crewmen. Both problems were successfully resolved. 
During the last nine months prior to the Skylab missions, six crewmen 
required treatment for dental problems which were other than routine 
replacement of restorations and dental prophylaxes. These ranged from 
a large, symptomatic, recurrent aphthous ulcer, to significant inflam­
mation and discomfort from local gingival inflammation, to a peri­
apical abcess. All were resolved successfully with no recurrence. 
IN-FLIGHT CARE 
The possibility for an unanticipated dental problem occurring in­
flight which could significantly impair a crewman's ability to work 
effectively was computed at 0.92 percent for a 3-man 28-day mission. 
This figure was based on studies of dental experiences in other iso­
lated environments, i.e., polar expeditions, United States Navy FBM 
submarine patrols, and from a three-year study of the astronaut popu­
lation. The most likely problems which could impair a crewman's 
effectiveness in-flight were judged to be either a painful tooth due 
to pulpitis or severe, localized gingival inflammation with or without 
a peridontal abcess. The pulpitis would be most likely to occur in a 
tooth which had previously been restored with a deep restoration which 
suddenly becomes symptomatic. This is a common ground-based dental 
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problem and the resulting potentially debilitating pain could occur 
for a number of reasons, including decreased resistance of the host 
and/or increased virulence of the organisms involved. Dental caries 
was not considered as a problem "in missions of up to three months' 
duration because of the high level of oral health of all crewmen and 
the frequent dental evaluations they received. 
Because of the risks involved, it was decided that a means be developed
for treating the most likely dental problems that might arise. To 
this end the prime and backup crews of all Sky1ab missions received 
two days of intensive training in pertinent dental procedures at 
Lack1and Air Force Base, Texas. The training included lectures, 
demonstrations, and supervised clinical procedures. The supervised 
clinical procedures performed on volunteer patients included complex
procedures such as tooth removal. Instruments and medications were 
provided as the Inf1ight r~edica1 Support System-Dental. As aids, 
this Inf1ight Medical Support System-Dental included a manual with 
line drawings of complete intraoral radiographs of each crewman as 
well as integrated, illustrated, diagnostic, and treatment procedures. 
Examples of these aids are illustrated in figures la, lb, and 1c. 
Other aids included air-to-ground communication with a dentist and/or 
surgeon who had as aids intraoral photographs and radiographs,
diagnostic casts, complete treatment records with narrative summaries, 
and complete knowledge of the treatment capabilities of each crewman 
as he was observed during the training program. No dental prob1~ms 
occurred during the Sky1ab series of missions which required use of 
the Inf1ight Medical Support System-Dental. . 
ORAL RESEARCH 
Introduction 
Sky1ab crewmembers were monitored to assess the effects of their 
missions on: 
o the population dynamics of the oral microf10ra, 
o the secretion of specific salivary components, and 
o clinical changes in oral health. 
Not only is oral health important to personal performance during pro­
longed space missions, but the oral region serves as a portal of entry 
for pathogenic agents, acts as a reservoir for infectious microorganisms, 
and plays a role in cross-contamination and disease transmission. 
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CAUSE SYMPTOMS TREATMENT PROCEDURE REMARKS 
EARLY 
/
PULPlTlS 
'LATE 
!INFLAMMATION OF 
DENTAL PULP) 
• DULL PAIN (INTERMITTENT) 
• SENSITIVE TO 
PERCUSSION HEAT 
AND COLD 
• MAY REVERSE. USE ANALGESICS • 
• IF NOT, REMOVAL MAY B£ NECESSARY. 
ANTIBIOTICS 
MAY BE 
PRESCRIBED 
BY GROUND 
• SHARP PAIN (CONTINUOUS' 
• HEAT OR PERCUSSION 
INCREASES PAIN • 
• COLD DECREASES OR 
INCREASES PAIN 
• ASPIRIN OR DARVON 
DOES NOT RELIEVE 
PAIN. 
• REMOVE TOOTH· SEE (PC; 16-7) 
• PROBABLY NO TISSUE SWELLING. 
TOOTH DECAY 
(CARIES)rUKEL V CAUSE1DUE TO TIME 
REQUIRED TO 
DEVELOP. 
• MILD PAIN (lNTERMlT-
TENT OR CONTINUOUS 
• CAVITATION OF 
ENAMEL 
• BROWNISH - BLACK 
SPOT 
• HEAT, COLD, OR 
SWEETS MAY ELICT 
PAIN 
• IDENTIFY OFFENDING TOOTH 
• EMPLOY LOCAL ANESTHESIA 06-6) 
• REMOVE SOFT DECAYED MATERIAL 
USING CURETTE 
• ISOLATE TOOTH WITH GAUZE PACKS 
AND OttY OUT CAVITY. 
• MIX SEDATIVE RESTORATIVE MATERIAL 
AND PACK INTO CAVITY 
WITH APPLICATOR 
• HAVE PATIENT BITE WHILE CEMENT IS SOFl 
. REMOVE EKCESS USING CURETTE 
• BITE ACAIN. 
SEE 
MIXING 
PROCEDURES 
PC; 16-5 
CROWN FRACTURE, 
BROKEN OR 
MISSING FILLlNC; 
• PART OF TOOTH 
VIS/Bl Y MISSING 
• FILE OFF ROUGH EDGES OF 1It000EN 
TOOTH USING FILE 
• MIX SEDATIVE RESTORATIVE MATERIAL 
ANI) 'COVER EXPOSED AREA 
• SMOOTH SURFACE 
BITE DOWN 
TO CHECK 
OCCLUSION. 
CRACKED TOOTH 
• SEVERE PAIN 
WHEN CHEWING 
• MAY HAVESYMPTOMS OF 
21 - EARLY 
• IF PAIN PERSISTS - REMOVE TOOTH -
SEE (PC; 16-7) 
CRACK COULD 
HAVE GONE 
UNDETECTED 
ON X-ItAYS. 
PERIAPICAL 
ABSCESS 
(INFECTION AT 
APEX OF TOOTH) 
• TOOTH MAY FEEL 
ELONGATED TO 
PATIENT. 
• PERCUSSION MAY 
ELICT SHARP PAIN 
• AREA OF POINTED 
SWELLING. 
• INDUCE DRAINAGE OF PUS BY: (A) INCISION OF PUS POCKET, OR 
fBI DIGITAL PRESSURE ON GUM HEAR\ 
ROOT OF TOOTH. 
• IF PAIN PERSISTS -
REMOVE TOOTH. SEE (PC; 16-7) 
ANTIBIOTICS 
MAY BE 
PRESCRIBED 
BY GROUND. 
PAIN WILL 
SUBSIDE UPON 
RELEASE OF PUS 
PRESSURE. 
PERIOOONT AL 
ABSCESS 
(GUM INFECTION) 
• DULL THROBBING 
PAIN • SHAR P PAIN 
WHEN BITING. 
• TENDERNESS OF 
SURROUNOING TISSUE 
• PROBE AROUND TOOTH WITH CURETTE 
• REMOVE ANY FOREIGN OBJECT 
• INDUCE DRAINAGE OF PUS BY INCISION 
• RINSE WITH WARM WATER 
ANTIBIOTICS 
MAY BE 
PRESCRIBED 
BY GROUND. 
PERICORONITIS 
(INFLAMMATION 
OF GUM FLAP) 
• PAIN ON OPENING 
MOUTH 
• CONTINUOUS DULL 
ACHE AND SWELLING 
AROUND LOWER 
THIRD MOLAR 
• CLEAN UNDER TISSUE FLAP 
• BRUSH THOROUGHLY. RINSE AND FLOSS 
• RINSE VIGOROUSLY WITH WARM WATER. 
ANTIBIOTICS MAY 
BE PRESCRIBED 
BY GROUND. 
BECOMES MORE 
COMFORTABLE IN 
'4·]" HRC; 
APHTHOUS UtCER 
IWHITE :~g~:ORAL M ) 
CANKER SORE 
(RED ULCER) 
• DISCOMFORT IS 
SOMETIMES 
MISTAKEN FOR 
TOOTHACHE • NO TREATMENT IS INDICATED· 
NORMAL HEALING OCCURS IN 
7 TO 14 DAYS. 
ANTIBIOTICS ARE 
USUALLY OF NO 
VALUE.
• BURNING SENSATION 
NOT SHARP PAIN 
Figure 1e. Treatment Data - Dental. 
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Laboratory detectable intraoral changes can precede clinical manifesta­
tions of acute and chronic infectious disease. Clinically detectable 
alterations of oral tissue can identify changes caused by local and/or
systemic disorders of microbial and nonmicrobial origin. 
Oral hygiene procedures consisted of brushing the teeth two minutes 
twice a day and flossing once a day. Tooth brushes with multit~fted, 1 
nylon, bristles were used in conjunction with an ingestible dentifrice 
and thin, unwaxed dental floss. Irrigating devices, mouthwashes, 
topical fluorides or other oral medication were not used. 
All creMnen were placed on a space-food diet at about 21 days pre­
flight. The backup crewmen continued on the space diet until launch 
and the prime crewmen until 18 days after recovery. 
Equipment and Procedures 
Eighteen astronaut crewmembers making up the prime and backup crews 
for the three Sky1ab missions were monitored for quantitative changes
in oral microorganisms, saliva partitions considered potentially im­
portant to oral health, and alterations in clinical indices of oral 
health and preexisting dental disease. 
Microbiological assessments 
Specimen collection. Oral specimens were collected from the crew­
members weekly or semiweekly from three intraoral sites from 31 days
preflight to 18 days postflight for Skylab 2, from 51 days preflight to 
20 days postflight for Sky1ab 3, and from 57 days preflight to 17 days 
postflight for Sky1ab 4. All collections took place between 7 a.m. 
and 8 a.m., before oral hygiene procedures or breakfast. 
The specimens included dental plaque, crevicular fluid (exudate ab­
sorbed from the gingival sulcus area), and stimulated saliva. These 
parameters were selected because of their ultimate relation to the 
development of dental caries, periodontal disease, and alveolar bone 
loss. • 
Dental plaque was removed using a modification of the technique 
by Jordon et al. (1). Crevicular fluid was obtained by inserting a 
paper point into the gingival sulcus of an upper bicuspid according to 
the method of Brown et al. (2). Each specimen was placed aseptically 
lIngestible dentifrice developed by Ira Shannon, D.D.S., M.S., 
Veterans' Administration Hospital, Houston, Texas 
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into a sterile tube containing 2 milliliters of 0.1 percent peptone 
and 0.85 percent sodium chloride. The peptone-saline solution ser­
ved as both a transport and dilution medium. 
To produce stimulated saliva, the crev~embers chewed sterile paraffin 
and expectorated into a sterile jar until a 5 milliliter indicator 
mark was reached. The time required for each crewman to collect this 
volume was recorded and used to calculate the sal iva flow rate. 
All specimens were transported in cracked ice to the University of 
Texas Dental Science Institute for immediate processing which occurred 
about one hour after collection. 
Specimen processing. Serial ten-fold dilutions of each specimen were 
plated onto a variety of bacteriologic media (3,4,5,6,7,8,9,10,11,12, 
13,14) for the enumeration of up to seventeen microbial categories. 
Duplicate platings were incubated at 37° C either aerobically or 
anaerobically. The bacteriologic media, microbial categories, and 
anaerobic procedures are shown in figure 2. 
Specific microbial types from selective and differential media were 
verified by subculture and by pertinent physiologic reactions when 
necessary. 
In addition to the microbial assessments, stimulated saliva was used 
to determine total protein, secretory IgA, and lysozyme. Salivary
protein determinations were made by the Lowry procedure (15). Secretory 
IgA was assayed by electroimmunodiffusion (16) where the samples are 
electrophoresed through a medium containing monospecific antisera. 
Plates were precoated with 0.1 percent agarose in 0.05 percent glycerol 
and layered with buffered agarose containing antisera. Wells were fill 
filled with standards or saliya. Samples were electrophoresed until 
the point of equivalence with the highest standard was attained. The 
plates were then processed for staining and the migration distances 
were measured. Samples with values beyond the standard range required 
dilution. A plot of log concentration versus log migration distanc~ 
yielded a linear curve for quantification (17). Lysozyme values were 
determined by radial quantitative diffusion using heat-killed Micrococcus 
Zysodeikticus cells as a substrate according to the procedures of 
Osserman and Lawlor (18). Plates were layered with a cell suspension
in buffered molten agarose. Wells were cut and filled with standards 
or saliva. Diffusion was allowed to proceed overnight. Values were 
determined from a plot of log concentration versus diameter of lysed 
zone. 
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Figure 2. 	 Flow chart for sampling and enumerating cultivable 
oral microorganisms. 
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The microbiologic enumeration and immunologic data were recorded for 
appropriate statistical analysis. Both a one-way and two-way un­
balanced analysis of variance were used for multiple comparisons of 
individual, paired, and grouped data. Primary comparisons were made 
within three segments of data: 1) preflight-prespace diet (31 and 
21 days preflight or 29 and 19 days preflight), 2) preflight-space 
diet (14 and 3 days preflight or 13 and 4 days preflight), and 3) re­
covery space diet (4, 13, and 18 days postflight from the prime crew 
only) . 
J. 	 Clinical evaluations. Preflight clinical scores of dental plaque,
calculus, and gingival inflammation were derived from clinical exami­
nations of both prime and backup crews at 30, 53, and 57 days pre­
flight for Sky1ab missions 2, 3, and 4, respectively. Comaparab1e 
recovery scores were obtained at c1"inica1 examinations at four days post­
flight for the prime crewmen. Dental plaque and calculus were removed 
at the preflight evaluation periods to adjust the test subjects to an 
equal baseline (score of 0) for comparisons of subsequent increments 
of plaque and calculus formation. The examinations were designed to 
determine changes in the amount of plaque and calculus that formed on 
the teeth, gingival response to the Skylab confinement, and teeth, 
bone, and tissue changes resulting from the space environment. Plaque,
calculus, and inflammation indices were derived from the findings. 
A plaque score was obtained for each astronaut by the use of disclosing 
wafers which stained the plaque adhering to the tooth surfaces. 
Calculus scores were obtained for each crewmember by dividing the 
number of tooth surfaces that had calculus by the number of teeth. The 
inflammation index was scored according to the method of Loe and 
Silnes (19) which graded the gingivae surrounding each tooth. 
Dental radiographs were made of each crewmember at 6 months and 30 days 
preflight to provide baseline records for subsequent comparison. A 
complete series of oral radiographs were taken at 6 months preflight. 
To minimize radiation exposure, only bitewing radiographs were taken 
at 30 days preflight . 
• The clinical evaluations were statistically compared by "t" analysis
using both the means difference and difference between means sta­
tistics (20). 
Results 
In Skylab 2 the microbial data illustrated in figure 3 shows increases 
in various anerobic components, i.e." Bacteriodes sp., VeiUoneUa sp., 
Fusobacterium sp. Other increases were in Neisseria sp. and Strepto­
. coccus mutans. 
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F-JO -20 -13 -4 R+4 +13 +18 
PRE-FLIGHT RECOVERY 
KEY: 
AN • Total anaerobes 
DIPH • Diphtheroids (catalase positive and catalase negative 
gra~positive nonlactobacillus rods) 

BACT • BaotsJ'O'idss sp. 

FUSO • Pusobactsl'ium sp. 
 •VEIL • VeiZZoneZta sp.

MITIS • Streptococcus mitis 

SANG • s. sanguis

IllT • S. mutans 

LACTO • LaotobacUZus sp.

NElS • Rsisseria sp. 

Figure 3. 	 Microbial counts from dental plaque of the prime

crewmembers of Skylab 2. 
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Fewer microbial changes were noted in Skylab 3. For example, in the 
graph of stimulated saliva (figure 4) the anerobic components showing
increases were Veillonella sp.~ Fusobaaterium sp.~ Leptotriahia sp.,
and Myaoplasma sp. S. mutans counts were variable. However, in this 
flight Staphloaoaaus aureus and enteric organisms showed increasing
trends toward the latter stages of sampling. 
The microbial data from the Skylab 4 mission were very similar to that 
of the Skylab 3 mission as is indicated in figure 5. The anerobic 
components to show increases in the gingival sulcus fluid in this 
slide were Baateroides sp. and Veillonella sp. There was also a rise 
in s. sanguis and Neisseria sp. 
Figure 6 represents the cumulative preflight data of all eighteen 
crewmen, before and after they were placed on the carbohydrate en­
riched space diet. At these levels of significance expressed on a 
percentage basis, there were significant increases after diet of the 
following total anerobes, Diphtheroids, S. sanguis~ Neisseria sp., 
Baateroides sp., VeiUoneUa sp., and Fusobaaterium sp. t10st of the 
oral microbial changes noted during each mission appeared to be 
associated with diet change as evidenced by the statistically signifi­
cant post diet increases. 
The saliva partitions assayed in this study of the prime crew of 
Skylab 2 are shown in figure 7. Saliva flow rates, salivary lysozyme, 
and protein concentration levels remained relatively constant through­
out this period. But the secretory IgA levels showed pronounced in­
creases beginning just prior to flight and continuing throughout the 
postflight sample period. It is believed that these changes were 
probably due to responses to a subclinical viral infection. 
Figure 8 displays the mean values for changes in salivary partitions 
of the prime crewmembers of Skylab 3. Secretory IgA showed increases 
and these increases occurred concurrently with saliva flow rate in­
creases and salivary protein decreases. Reasons for the latter 
changes are presently unexplained. 
In the Skylab 4 mission secretory IgA levels again increased and the 
levels of protein and lysozyme as well as saliva flow rates showed 
trends similar to the Skylab 3 flight (figure 9). The increase in 
secretory IgA in the crewmen for the Skylab 4 mission occurred in only 
two of the three crewmen (figure 10). The IgA levels of the Scientist 
Pilot remained relatively constant. 
A comparison of clinical scores of oral health before and after the 
Skylab 4 mission (figure 11) revealed prominently elevated increments 
of dental calculus and gingival inflammation postflight as compared 
with the preflight values. This trend was observed for all missions. 
87 

c 
:.­
-' 
c 
"'" 
.... 
~ 
..... 
z: 
= C) 
u 
C)
-CoD 
C) 
-' 
I~ 
-
8 
1 
6 
5 
4 
3 
2 "",,­
/', 
1 rEAST ~ / )II.1Pt~~llilum( 
F-51 -31 -22 -16 -5 
PRE-FLIGHT 
• 
KEY: Preflight values are Means of both the priMe and backup crew­
Medlers. Recovery values are Means of the priMe crew. 
AN • Total anaerobes SANG • S. sanguis 
MITIS • Stl'Sptoaoeous mitis FUSO· Pusol"ium sp. 
SAl. • S. sa'Uval"ivs lilT· S. mutana 
BACT • Baotal"iodss sp. LEPTO • LBptotl"iaia sp.
YElL • Vaillone1.Za sp. MYeo • IIlYcoplasma 
+4 +9 +20 
RECOVERY 
NElS • 'aissazoia sp. LACTO • Lactobacinua sp.
ML • streptococcus (mutans-like) 
Figure 4. Microbial counts from stimulated saliva before and after 
the Skylab 3 Mission. 
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Figure 5. 	 Microbial counts from gingival fluid before and after 
the Skylab 4 mission. 
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Mean clinical scores of Dental 
Calculus and Gingival Inflammation 
of the prime crewmembers of Skylab 4. 
While the overall oral health level of all crewmen remained very good
postflight, some deterioration had occurred as measured by these 
indices. 
Discussion 
The oral microbiologic, immunologic, and clinical results of the 
Skylab series of manned space flight missions were relatively con­
sistent. Oral microbial changes usually occurred after the incor­
poration of the space diet prior to flight. Statistical comparisons 
of cumulative preflight data from the 18 (prime and backup) crew­
members, before and after diet inclusion, revealed diet relatedness 
for the majority of the microbial increases observed during the 
missions. Some of the changes, although apparent after the inclusion 
of the diet during the preflight period, were more pronounced after 
flight. However, the postflight values were excluded in the diet 
related analysis to avoid any possible flight influence. 
Increases in secretory IgA observed in two of the Sky1ab 4 crewmembers 
were observed in all three crewmembers of Skylabs 2 and 3. As in the 
previous studies, the changes were believed to result from subclinical 
infections. Concurrent fluctuations in salivary protein, lysozyme and 
saliva flow rates, also observed in previous studies, are unexplained. 
Increased increments of dental calculus and gingival inflammation ob­
served in these studies were consistent with the exception that the 
changes were not observed in the Skylab 3 flight indicating ,that 
clinical changes in.oral health in space flights correspond to those 
under more conventional circumstances; i.e., individuals free of oral 
health problems are less susceptible to detrimental changes under a 
specific challenge than those with preexisting dental problems. 
Conclusion 
Skylab crewmembers were monitored for mission related effects on oral 
health. Those laboratory and clinical parameters considered to be 
ultimately related to dental injury were evaluated. Of these, the 
most distinctive changes noted were: 
o Increased counts of specific anaerobic and streptococcal 
components, primarily of the saliva and dental plaque 
microflora. 
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o Elevations in levels of secretory IgA concurrent with 
diminutions of salivary lysozyme. 
o Increased increments of dental calculus and gingival
inflammation. 
The microbial changes were mainly diet related rather than flight
related. Elevations of secretory IgA were believed to result from a 
subclinical infection. Concurrent diminutions of salivary lysozyme 
are unexplained. The clinical changes in oral health were considered 
to be influenced more by a crewmember's preexisting state of dental 
health than by any health hazardous mission related effect. 
Assuming no future clinical detection of mission-related intraoral 
complications, the most significant aspect of these investigations was 
the relative nonexistence of health hazardous intraoral changes. 
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ANALYSIS OF THE SKYLAB FLIGHT CREW HEALTH STABILIZATION PROGRAM 
J. K. Ferguson~ Ph.D.*~ G. W. MaCoZZum~ M.S.*~ and 
B. L. Portnoy~ M.D.t 
ABSTRACT 
Throughout the Skylab Program, an extensive effort was made to reduce 
the probability of an illness occurrence in the flight crewmen. The 
- Flight Crew Health Stabilization Program accomplished this objective
by isolating the flight crew during preflight periods. In addition, 
the number of personal contacts with the crewmen was limited, and ill 
persons were not permitted to enter primary work areas. 
Initially, all persons who required contact with the flight crewmen 
during a 21-day period before flight were identified. Physical exami­
nations and immunizations were given to the identified personnel. 
Voluntary reporting and active surveillance were used to detect ill­
ness occurrences and exposures to illness among the primary contact 
personnel. 
During the postflight period, the crewmen again were isolated and 
their contacts limited to medically approved personnel to reduce the 
occurrence of i 11 ness and to rei ntroduce the crewmen gradually to the 
normal environment. The methods and procedures used in the program 
are presented, together with a descriptive analysis of the surveillance 
data. 
INTRODUCT ION 
A well defined Flight Crew Health Stabilization Program was first 
introduced into the space program on the Apollo 14 mission. The 
program was initiated following a number of prime crew illnesses and 
crew exposure to persons with infectious illnesses during mission 
critical periods. As a result of these incidences, it was recognized 
throughout the National Aeronautics and Space Administration that crew 
illness could cause loss in valuable crew training time, postponement 
of missions, or could even compromise crew safety and mission success. 
*National Aeronautics and Space Administration-Lyndon B. Johnson Space 
Center, Houston, Texas 
'ru.S. Public Health Service, Center for·Disease Control, Atlanta, 

Georgia 
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The purpose of the Flight Crew Health Stabilization Program was, 
therefore, to minimize the possibility of adverse alterations in the 
health of flight crewmen during the preflight, in-flight, and post­
flight periods. The Apollo 14 Flight Crew Health Stabilization 
Program was successfully completed without an illness occurrence in 
the crewmen. Following the Apollo 14 mission, the program was effec­
tively used for the remainder of the Apollo missions. 
The need for such a program became even more evident in the development 
of the Skylab missions. The extended periods of crew time in space 
planned for Skylab increased the probability of in-flight crew illness. 
The decision was made, therefore, to provide a comprehensive Skylab 
Flight Crew Health Stabilization Program. 
PROCEDURE 
A 21-day isolation period was established for the Skylab crewmen prior 
to the launch of each mission. This isolation period was chosen to 
cover the incubation period of the majority of infectious diseases. A 
seven-day postflight isolation period was added to protect the crew­
man from any increased susceptibility to infectious diseases as a 
result of the lengthy mission. Additionally, postflight illness in 
the crewmen would have been detrimental to the understanding of medical 
results and the transfer of information to the crewmen of the next 
mission. The principal objective of the program was to reduce the 
probability that a crewman would come into contact with an infectious 
disease agent during the critical time periods of each mission. The 
initial steps taken to accomplish this objective were to: 
o 	 Establish the primary work areas of the crewmen during the 
isolation periods. 
o 	 Establish isolated crew housing at both the Johnson Space 
Center and at the Kennedy Space Center with methods to prevent 
crew exposure to infectious disease agents. 
o 	 Establish a medical program for those personnel who were 
required to work with the crewmen during the isolation period. 
o 	 Establish a Medical Surveillance Office as the coordination 
center for the operational aspects of the program (table I). 
Each functional area at the two National Aeronautics and Space
Administration Centers identified their personnel who would require 
access to the crew during the isolation period. Personnel requiring 
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TABLE I. SKYlAB flIGHT CREW HEALTH STABILIZATION PROGRAM 
Crew (Crew Surgeon)
Living Quarters 
Mobile Trai1ers (JSC) 
o 
--' Crew Quarters (KSC)
..... 
Food 

Travel 

Primary Contacts 
Class A and Class 8 
Illness Reporting (Volunta~) 
t l 
Medical Surveillance Office Primary Work Areas 
Program Coordination Active Surveillance 
-
Training - Security 
Records and Data Preventive Measures 
Medical Status Reports Surgical Masks 
8iorespiratorst1 
Cl1nic Air Filters 
Medical EXlldnltions 
PC Qualification· Disqualification 
BI.dge Contra1 
direct crew access (within two meters) were known as class A primary 
contacts. Those who worked in primary work areas, but were not in 
direct contact of the crewmen, were called class B primary contacts. 
For each primary work area identified, the area was inspected and 
procedures were established to minimize the possibility of crew ex­
posure to pathogenic microorganisms. Positive air pressures and 
80 percent (ASHRAEl) air filters were used in the principal training 
area. A security guard and a nurse were stationed at the door of the 
primary work areas on the days that crewmen would be in the area. On 
these days, only properly badged primary contacts were allowed to 
enter the area and a brief medical screening was given to class A 
primary contacts by the nurse as the only active surveillance provided 
in the program. All class A primary contacts were required to wear 
surgical masks when in the presence of the crewmen. Biorespirators 
were available for use by nonprimary contacts if an emergency occurred. 
Crew conferences with nonprimary contacts were accomplished by closed 
circuit television. 
Crew housing at the Johnson Space Center was provided by two mobile 
homes placed inside a large building. A third mobile home adjacent to 
the building served as the food service center. All food and drink 
consumed by the crew during the isolation period was specially pre­
pared Skylab food. Quality control had been designed into the food 
program, and it was, therefore, not necessary to add additional con­
trols. A fourth mobile home was available for isolation of any crew­
men who might become ill. Housing at the Kennedy Space Center was 
provided in the existing crew quarters area, and high efficiency 
particulate air (HEPA) filters were used in these living areas. 
Measures were taken to prevent crew exposures to illness while travel­
, ing between primary work areas. Nonprimary contacts were kept 100 feet 
and downwind from the crewmen. Biorespirators were near the crewmen 
at all times to be used if pn emergency occurred. 
The medical program for the primary contacts consisted of an extensive 
initial physical examination with laboratory screening (appendix A).
Immunizations were required for those persons who were not immune to a 
selected group of infectious diseases. After the examination the 
records of each person were reviewed by a physician, and the individual 
was either approved or disapproved as a primary contact. Further 
scheduled examinations were provided later in the program only for 
IAmerican Society of Heating, Refrigerating and Air-Conditioning

Engineers 
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class A primary contacts, which also included food handlers, maids and 
other specialized personnel having close direct, or indirect, contact 
with the crewmen. . 
On completion of the initial medical examination, all primary contacts 
were instructed by letters, brochures, and meetings to report any 
"j 11 ness, or contact to an i nfecti ous i 11 nes s, to the Medi ca1 
Surveillance Office. Primary contacts who reported medical problems 
related to infectious illness were referred to the clinic for medical 
examination. If a primary contact was found to have an infectious 
illness, he was temporarily withdrawn from the program and the primary 
work area. The primary contact did not return to the work area until 
a medical examination indicated that the infection was no longer 
present. Medical surveillance of the primary contacts and illness 
reporting were continued throughout each mission to provide epidemi­
ological support data for any crew illness occurring during the mission. 
A report form was completed by the clinical staff for each illness 
occurrence (appendix B). The report was forwarded to the Medical 
Surveillance Office to be coded for the type of illness by a pre­
determined list of operational definitions of infectious illness 
(appendix C). An analysis of these data was performed. 
RESULTS AND DISCUSSION 
The list of approved primary contacts changed throughout the Skylab 
program. Names were added or deleted as required. The population of 
primary contacts for each flight was assumed to be the number recorded 
on the master list at the end of each mission (table II). At all times 
class A primary contacts were only slightly less in number than class B 
primary contacts. The total number of primary contacts ranged from 
620 to 709 throughout the Skylab program until 21 days into the 
Skylab 4 mission; program coverage provided only for 140 personnel for 
the remainder of the Skylab 4 mission. In all cases, the great 
majority of primary contacts were located at the Johnson Space Center. 
Active surveillance of class A primary contacts produced a total of 
only 23 referrals to the clinic from a total of 3483 examinations 
(table III). The small number of possible illnesses discovered by
this procedure suggests that active surveillance indirectly influenced 
the primary contacts to report their illnesses voluntarily. In this 
indirect way, the presence of a nurse at the entrace of the work area 
may have protected the crewmen from infectious agents. 
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TABLE II. POPULATION OF PRIMARY CONTACTS FOR THE SKYLAB MISSIONS 

NUMBER OF PRIMARY CONTACTS LOCATION OF PRIMARY CONTACTS 
Skylab

Mission Class A Class B Total JSC KSC Other 

Ii' 
2 280 340 620 561 36 23 
3 316 393 709 620 33 56 I/' 
4(Pre-)* 300 333 633 550 35 48 ., 
4(Post- )t 108 32 140 121 0 19 
Legend: 
* = Preflight plus first 21 mission days 

t = Mission day 22 through 7 days after recovery 

TABLE II I. ACTIVE SURVEILLANCE OF CLASS A PRIMARY CONTACTS 
Skylab Mission Total 
Active Surveillance 2 3 4 Number 
Class A Contacts Examined 1124 1104 1255 3483 

Contacts Referred to Clinic 4 0 19 23 

Exami ni ng Days 29 22 29 80 

Contacts Examined/Day (avID 39 50 43 44 

A total of 197 illnesses were reported to the Medical Surveillance 

Office during the Skylab program. Of these reports, 88 percent were 

reported from the Johnson Space Center and the remain.ing 12 percent 

were from the Kennedy Space Center (table IV) . 

... 
. The rate of illness reported by the primary contacts declined from 
Skylab 2 to Skylab 4 (table V). During Skylab 2 the rate of illness 
reporting was 10.7 illnesses/1000 primary contacts/week. During
Skylab 3 the rate declined to 8.4 and during Skylab 4 to 6.7. The 
drop in illness rate is especially dramatic since the lowest rates 
occurred during the winter season where most respiratory infections 
were expected. 
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TABLE IV. LOCATION OF PRIMARY CONTACTS REPORTING ILLNESS 
Skyl ab Number of Illnesses Reported 
Mission JSC KSC Total/Mission 
2 67 3 70 
3 61 20 81 
4{Pre-}* 36 1 37 
4{Post- }t 9 0 9 
~ 
Total 173 24 197 
Legend: 
* = Preflight plus first 21 mission days 
t = Mission day 22 through 7 days after recovery 
TABLE V. RATE OF ILLNESS EVENTS REPORTED BY PRIMARY CONTACTS 
Skylab Mission 
Primary Contact Group 2 3 4{Pre-}* 4{Post-} t 
Class A Contact 10.5:!: 8.6 8.8 3.6 
Class B Contact 10.9 8.2 4.8§ 15.0§ 
Both 10.7 8.4 6.7 6.2 
Legend: 
* = Preflight plus first 21 mission days 
t = Mission day 22 through 7 days after recovery 
:j: = Rate expressed as number of illnesses reported 
per 1000 persons per week. 
§ = Based on 5 or less events 
.­
The upper respiratory infection was by far the most frequently re­
ported illness by primary contacts {table VI}. Symptom complexes other 
than the upper respiratory infection were relatively low and equally
distributed in number. All of the percentages were below 10 percent 
with the exception of the reported presence of fever which reached 
14 percent on Skylab 3 and 11 percent on Skylab 4. 
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TABLE VI. TYPES OF ILLNESSES REPORTED BY PRIMARY CONTACTS 
Total Reported Percent Reported 
(A11 Mi ssi ons) Per Skylab Mission 
Percent of 
Number Total 
Symptom Comp1ex* (2 Flights) (2 Flights) 2 3 4 
Upper Respiratory
Infection 159 81 79 83 80 
Bronchi ti s 8 4 6 2 4 
Pneumonia 0 0 0 0 0 
Upper Enteric III ness 13 7 9 4 9 
Lower Enteric III ness 13 7 6 9 4 
Fever Present 20 10 6 14 11 
Headache Present 11 6 4 9 2 
Skin Infection Present 12 6 7 7 2 
Other Infectious Illness 2 1 1 1 0 
*One illness may contain more than one symptom. 
As with the illness reporting, the vast majority of reports of contact 
to illness originated from the primary contacts at the Johnson Space
Center (table VII). Of a total of 73 reports only two came from other 
sources on the Sky1ab 2 and Skylab 4 missions. Sky1ab 3 contacts to 
illness are not reported here due to an error in recording reports. 
The rates of reporting contacts to illness are shown in table VIII. 
Although Skylab 3 data are not available, the reporting trend appears 
to decrease in rate in the same manner as illness reporting. 
Exposure to persons with upper respiratory infections was the most 
frequently reported contact with illness, with 57 percent and 
67 percent reported for Sky1ab 2 and Skylab 4, respectively (table IX). 
A greater percentage of upper and lower enteric illness contacts were 
reported for Skylab 4 than for Sky1ab 2. None of the Skylab 4 re­
ports involved skin infections while 18 percent of the Skylab 2 
reports involved contact with skin infections. 
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TABLE VII. LOCATION OF PRIMARY CONTACTS REPORTING CONTACT 

TO AN INFECTIOUS ILLNESS 
Skyl ab Number of Contacts Reported 
= Mission day 22 through 7 days after recovery 
Mission JSC KSC Total/Mission 
49 0 49 
4(Pre-)* 19 1 20 
4(Post- )t 4 0 4 
Total 72 1 73 
Legend: 
* = Preflight plus first 21 mission days 
t 
TABLE VIII. RATE OF CONTACTS TO ILLNESS REPORTED BY 
PRIMARY CONTACTS 
Skyl ab r~i ss i on 
Primary Contact Group 2 4(Pre-)* 4(Post-)t 
Class A 10.8:1: 4.6 3.6§ 
Class B 4.7 2.8 0.0 
Both 7.5 3.6 2.7§ 
Legend: 
* = Preflight plus first 21 mission days 
t = Mission day 22 through 7 days after recovery 
:I: = Rate expressed as number of contacts to illness 
reported per 1000 persons per week 
§ = Based on 4 events or less 
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Figure 3. SkYlab Flight Crew Health Stabilization Program. 
" 	
~ 
-'
.. 	 • 
TABLE X. EFFECT OF THE FLIGHT CREW HEALTH STABILIZATION PROGRAM 

ON THE OCCURRENCE OF 
Health Stabilization Program Absent 
III ness No. Crewmen Time 
Mission Type* Involved Periodt 
Apollo 	 7 URI 3 M 
8 VG 3 P,M 
9 URI 3 P 
10 URI 2 P 
11 
.... 
12 SI 2 M 
.... R 	 P
.... 
13 	 1 
Legend: 
Illness 	Type*: 
URI = Upper Respiratory Infection 
VG = Viral Gastroenteritis 
SI = Skin Infection 
R = Rubella Exposure 
ILLNESS IN PRIME CREWMEN 
Health Stabilization Program Operational 
III ness No. Crewmen Time 
Mission Type* Involved Periodt 
Apollo 14 
15 
16 
17 SI 1 P 
Skyl ab 2 
3 SI 2 M 
4 SI 2 M 
Time Periodt: 
M= During Mission 
P = Premission 
through the Skylab 4 mission. During the missions of Skylab 3 and 
Skylab 4 a minor skin infection, or rash, occurred on two of the crew­
men of each mission. It is doubtful that either of the latter could 
have been prevented by the measures taken in the health stabilization 
programs as each problem appears to have occurred for reasons other 
than preflight exposure. The results indicate that the Flight Crew 
Health Stabilization Program has successfully accomplished its goal in 
reducing the number of illness exposures to flight crewmen. 
CONCLUSION 
The majority of 'illnesses and contacts to illnesses reported by the 
primary contacts was the upper respiratory infections. Enteric ill­
nesses represented the next most common illness, but these were 
relatively rare compared to the upper respiratory infections. The 
Skylab Flight Crew Health Stabilization Program included a number of 
preventive measures to reduce the spread of respiratory infections. 
This emphasis was well placed. 
By training primary contacts to report illness and by using a nurse 
in active surveillance, the Skylab Flight Crew Health Stabilization 
Program seems to have been effective in reducing the number of in­
fectious illness contacts with the crewmen during the isolation 
period. The effort made to reduce the number of primary contacts was 
of greatest importance to the goals of the program. Limiting crew 
contact to a defined, and medically controlled, population of primary 
contacts should be continued in future programs. A Flight Crew Health 
Stabilization Program for future space missions, therefore, should 
emphasize the initial and continuous training of primary contacts, 
limited and active sureveillance, specific preventive measures for 
upper respiratory infections, and the need for concurrent analysis of 
epidemiological data throughout the program. 
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Initial Medical Examinations for all Primary Contacts 
1. 	 The personnel selected as prospective primary contacts will 
have a medical examination; emphasis will be placed on the 
detection of infectious disease(s). These examinations will 
be completed for all primary contacts between 60 and 45 days 
prior to each Skylab flight, and results will be reported on 
Form 368C by 30 days prior to each flight. 
2. 	 The Occupational Medicine Clinics at JSC and KSC will conduct 
the medical examinations of primary contacts. 
(a) 	 The JSC Occupational Medicine Dispensary will support the 
medical requirements activities for the primary contacts 
located at JSC. The Dispensary will be informed at 
F-75 days by the Medical Surveillance Office of the names 
of primary contacts to be examined. This facility will 
maintain medical records on all primary contacts. 
(b) 	 The medical requirements for primary contacts at KSC will 
be supported by the KSC Occupational Health Facility who 
will be informed at F-75 days by the Medical Surveillance 
Office of the names of primary contacts to be exam·ined. 
3. Laboratory Tests for Initial Medical Examinations 
(a) 	 To accomplish all serology and bacterial screening on 
primary contacts in a timely manner, all specimen materials 
must be collected before or at the time of medical exami­
nations. Basic clinical, routine serological and 
bacteriological analyses will be accomplished by the JSC 
Medical Support Laboratories or the KSC Occupational
Health Facility. Virological and other serological screen­
ing will be accomplished only by the JSC Medical Support 
Laboratori es. 
(b) 	 Laboratory tests will be conducted only on primary contacts 
unless family histories indicate some family members should 
be checked by laboratory tests. The basic philosophy of 
testing will be oriented toward screening for subclinical 
infectious disease. If abnormalities occur in the initial 
.. medical evaluation, follow-up testing will be done at the 
discretion of the examining physician, or Chief, Health 
Maintenance Branch. 
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(c) 	 The laboratory tests will include: 
Blood. - White cell count with a differential count if WBC 
is greater than 10 000 or less than 5000. 
Urinalysis. 
Serology for eRP, SGOT, mumps, rubella, rubeola and RPR 
(RPR will not be repeated on those who have had this 
determination as part of their annual physical examination 
within the previous six-month period). 
Throat culture for pathogenic bacteria (food handlers 
on ly) . 
Stool specimen for pathogenic bacteria (for food handlers 
only) . 
(d) 	 Specimen requirements for above tests are as follows: 
Blood. - l2-ml sample of whole blood 
5-ml sample of whole blood for WBC, and differ­
ential 
7-ml 	 sample of whole blood for RPR, CRP, and 
serology samples for determining titers for 
mumps, rubella, and rubeola. 
Uri ne sample. 
Throat culture for bacteriology - one, immersed in 2 ml 
of TSB. 
Stool specimen. 
Other specimens. - Number and type to be predicated on 
findings - i.e.~ at the discretion of the examining 
physician, or the Chief, Health Maintenance Branch. 
(e). 	Serologic studies to be accomplished by the JSC Virology
Laboratory will include screening tests (by HI or NT) for 
rubeola, rubella and mumps. 
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(f) 	 Bacteriology examinations performed on primary contact 
food handlers shall include examination for respiratory" 
pathogens (Type A Beta-hemolytic Streptococcus, 
Staphylococcus, Pneumococcus~ Klebsiella, and Haemophilus). 
Specimens for phage typing will be sent to JSC for analysis. 
Microbiology for food handlers will also include feces 
analysis for bacteriology 	(Salmonella, Shigella), ova, and 
parasites. 
(g) 	 Screening for tuberculosis will be accomplished with a 
yearly PPD (Federal stock No. 6505-105-0102, biologically 
equivalent to PPD-S). 
4. 	 X-ray of the chest - In those individuals with a previously 
positive skin test for TB, follow-up screening will be done with 
a chest X-ray only. X-ray will not be repeated on candidates 
with negative PPD who have had negative chest X-rays within the 
previous six months. 
5. 	 All primary contacts must have a current immunization for each 
required vaccine. Any primary contact who is. unable, or un­
willing to take one or more of the vaccines will be medically 
disqualified; a waiver may be granted by the Director of Flight 
Crew Operations or by the Director of Life Sciences for those 
primary contacts considered to be essential to mission opera­
tions. The required vaccines are as follows: 
Immunization Immunization 
Disease Reguired Duration 
Diphtheria 
Tetanus 
Influenza 
Pol io 
Mumps 
t 	 Rubella 
Rubeola 
* 
* 
* 
* 
* 
* 
* 
10 years
10 years
4 months 
6 years 
5 years 
10 years
10 years 
'<r 
*Immunize if no serologic response or history
of immunization 
.. 
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6. 	 Physician Review 
f 
(a) 	 The examining physician will review the laboratory analyses, 
temperature, TB skin test, chest x-ray, and examine the 
hands, face, neck, scalp, skirr, eyes, ears, nose, throat, 
and feet to determine absence or presence of infectious 
diseases. 
(b) 	 The examining physician will make a recommendation for 

medical approval/disapproval on Form 368C and submit the 

form to th~ Medical Surveillance Office. 

Additional Medical Examinations for Class A Primary Contacts 
1. 	 Class A primary contacts will be reexamined for signs of in­

fectious disease before the F-2l day period for each mission. 

Johnson Space Center and Kennedy Space Center 
(a) 	 All Class A primary contacts will be scheduled by the JSC 

or KSC Clinic for a medical examination from F-28 to F-21 

for each mission. 

(b) 	 All food handlers will be reexamined and specimens will be 
taken at F-2l, F-14, and F-7 by the JSC or KSC Clinic 
personnel for each mission. 
2. 	 Laboratory Tests for Additional Medical Examinations 
(a) 	 5 ml of whole blood for white cell count with a differential 
count if WBC is greater than 10 000 or less than 5000. 
(b) 	 Urinalysis (for food handlers only). 
(c) 	 Throat culture and stool specimens for pathogenic bacteria 
(for food handlers only). 
(d) 	 Other specimens. - number ana type to be predicated on 

findings - i.e.~ at the discretion of the examining 

physician or the Chief, Health Maintenance Branch. 

3. 	 An additional throat examination and temperature determination 

will be made on Class A primary contacts when entering a primary 

work area. 
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ILLNESS EVENT FORM DATE,__________ 
SKYLAB HEALTH STABILIZATION PROGRAM 
~E,________________~_____________ SS*_______________________ 
PERMANENT BASE: (cfrcle one) KSC JSC OTHER CONTACT CLASS: A B 
ILLNESS__OR CONTACT TO ILLNESS,_______ DATE OF ONSET OR CONTACT__________ 
CONTACT TO ILLNESS ONLY: NAME OF CONTACT__________________ 
AGE____--'RELATIONSHIP: HOUSEHOLD OR OTHER (ci rcle) 
Descrfptfon of illness fn case or contact: Check appropriate blanks and fill in 
requested fnformation. This will be used for statistical evaluation. 

Duration Symptoms: (describe) _____________ 

Tempe ra ture,________ 

Anatomical involvement: (check or answer) 
Rhinitis Nausea 
Otitis media Vomiting 
Pharyngitfs (non-exudative) How frequently?_________ 
Pharyngftfs (exudative) Loose stool 
Cervfcal adenopathy How frequently?
Laryngitis Skin rash-pustula-=r---------
Bronchitfs Skin rash-Herpes simplex 

Pneumonfa Skin rash-other(describe)

Other (describe below) 

Headache 
Laboratory studfes ordered: (date)
Hematology_____________________________ 
Chemistry______________________________ 
Bacterfology________________________________________ 
Virology_____________________________________ 
Serology________________________________________ 
X-ray________________________________________________ 
Return Visfts: (Include date, progressfon of fllness, additional signs or 
symptoms, or date of recovery.) _____________________________________ 
Date illness termfnated 
RECOMMENDATION: Return to PC Status,________ 
Remove from PC Status______
Date,__________ 
Examfnfng Physicfan 
JSC Form 3680 (Mar 73) (OT)

Form 4 NASA-JSC 

o not wrlte in 
117 

Appendix C 
Page 1 of 2 
SKYLAB FLIGHT CREW HEALTH STABILIZATION PROGRAM 
Operational Definitions of Common Illnesses 
Introduction: In order to statistically evaluate the health 
records generated by the Skylab Health Stabilization Program, 
we shall record illness episodes by operative definitions. 
From previous programs, we know that respiratory and enteric 
illnesses are numerically the most important. Therefore, 
these illnesses will be described in detail. Other infectious 
illnesses may be described by diagnosis and duration alone. 
The i nforma ti on on the i 11 ness event form wi 11 be coded by 
an epidemiologist according to the following definitions: 
Respiratory Illnesses: Symptoms must last for a period of time greater'
than 24 hours. Categories are listed by area of involvement. 
CODE 1. 	 Upper Respiratory Infection: ear, nose and pharynx
signs and symptoms either with or without associated 
exudative pharyngitis, laryngitis, or cervical adenopathy. 
CODE 2. 	 Bronchitis: cough, chest findings of secretions, no 
evidence of pneumonia. 
CODE 3. 	 Pneumonia: infiltrate on chest x-ray. 
Enteric Illnesses: 
CODE 4. 	 Upper Enteric Illness: nausea and/or vomiting lasting 
at least two hours. 
CODE 5. 	 Lower Enteric Illness: diarrhea - more than three stools 
of abnormally loose consistency in one 24-hour period, 
may be associated with upper enteric illness. 
Fever: Defined as greater than 99.6° F p.o. 
CODE 6. 	 Fever present 
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Headache: As reported by patient or doctor, either alone or in 
association with other illness. 
CODE 7. Headache present 
Skin infection: Any skin eruption determined by a physician to be 
either infectious or due to an infectious illness. 
CODE 8. Skin infection present. 
Other infectious illness: 
CODE 9. Other infectious illness present. 
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SKYLAB ENVIRONMENTAL AND CREW MICROBIOLOGY STUDIES 
R. M. Brockett~ Ph.D.*~ J. K. Ferguson~ Ph.D.t~ R. C. Graves~ M.S.t~ 
T. O. Groves~ B.S.t~ M. R. Henney~ Ph.D.t~ C. J. Hodapp~ Ph.D.t~ 
K. D. Kropp~ M.S.t~ J. L. McQueen~ D.V.M.~~ B. J. ~eszkuc~ M.S.t~ 
F. J. Pipes~ M.S.t~ G. R. Taylor~ Ph.D.t~ and C. P. Truby~ ph.D.§ 
ABSTRACT 
The results of some ground-based simulations have engendered theories 
that forecasted microbial "simplification", intercrew transfer of 
microbial pathogens, autoinfections, and postflight "microbial 
shockll. In an effort to understand the effects of space flight, micro­
biological samples from multiple sites on the crewmembers were col­
lected several times before, during, and after the space flights. 
The Skylab data are related to analogous Apollo data and are discussed 
in a manner that will allow an evaluation of the validity of the 
hypotheses presented. 
Additionally, in-flight environmental samples were acquired from 
designated sites within the spacecraft and returned to earth for 
analysis. The resulting data were used to identify potential microbial 
problems for the maintenance of a habitable environment in the orbital 
workshop. 
INTRODUCTI ON 
The objectives of the Skylab microbiology studies were to detect the 
presence of potentially pathogenic microorganisms on the crewmembers 
and their spacecraft and to obtain data which would contribute to an 
understanding of the response of the crew·s microbial flora to the 
space flight environment. These data were interpreted in light of the 
*United States Air Force School of Aerospace Medicine, Brooks Air Force 
Base, San Antonio, Texas 78235 
tNational Aeronautics and Space Administration - Lyndon B. Johnson 
Space Center, Houston, Texas 77058 
±National Cancer Institute, Bethesda, Maryland 20014 
§Serafy Laboratories, Inc., 105 W. Elizabeth, Brownsville, 
Texas 78520 
12] 
theories of microbial simplification, intercrew transfer of medically 
important microorganisms, in-flight autoinfections, and postfliQht
microbial shock, which have been proposed by various authors (1). 
Before and after each flight, the twelve areas outlined in table I v/ere
sampled from each astronaut. Two calcium alginate swabs, wetted in 
phosphate buffer, were used to sample the nostrils and each external 
body surface area. A single, dry alginate swab for virological analyis 
was used to sample the throat. Phosphate buffer was used to wash the 
oropharyngeal cavity. Additionally, a midstream urine sample was 
collected from the first void of the day and fecal specimens were 
collected at the convenience of the subject. In-flight crew samples, 
as noted on table I, were collected 16 days before termination of each 
Skylab mission and returned under chilled conditions for analyses. 
Samples were collected before, during, and after each Skylab mission, 
as shown in figure 1. The Orbital Workshop was sampled up to ten 
times, including one in-flight sample set. In-flight air samples 
were collected two days before the end of each mi ss ion. The Command 
Module was sampled on launch and recovery days for each mission. In 
all cases samples collected -in-flight were stored differently, and 
for a longer time than were preflight and postflight samples. 
Therefore, direct correlation of the result-ing data is not always 
applicable. The dates and mission designations for all sample col­
lections are illustrated in table II. 
In excess of ten thousand selected microbial isolates were analyzed
by quantitation, identification, and characterization. Because of the 
brief time available at this conference to present this quantity of 
data, the effects of space flight conditions on microbial populations
will be examined only to the first level of complexity. That is, only 
alterations affecting the total autoflora will be evaluated. More 
detailed analyses conducted at increasing degrees of complexity will 
be published elsewhere. 
RESULTS AND DISCUSSION 
Changes in the Habitability of the Skylab Environment 
Microbial Content of In-flight Skylab Air 
The concentration of bacteria recovered from air samples obtained two 
days before return from each Skylab visit are displayed in figure 2. 
Low levels of in-flight bacterial contamination were observed on the 
first two missions, whereas the recovery from Skylab 4 was considerably 
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TABLE I. CREW SAMPLE COLLECTION SITESl 
Sample 
Desi9nation Area Sampled 
Neck 13 cm2 below hairline at base of neck 
Ears 2 Right and left external auditory canals with 
two revolutions of each swab in each ear canal 
Axi 11 ae 6.5 cm2 below hair area on each side 
Hands 	 6.5 cm2 on right and left palms 
Navel 	 The internal area of the umbilicus, and a 
surrounding 13 cm2 area with at least two 
revolutions made with each swab 
Groin 	 5 cm strip from rear to front on right and 
left inguinal area between legs 
Toes 2 	 Area between the two smallest toes of each 
foot 
Nares 2 	 Both nostrils 
Throat Swab2 	 Surfaces of tonsils and posterior pharyngeal
vault swabbed with each of two dry calcium 
alginate swabs 
Gargl e 	 60 ml phosphate buffer used as gargle and 
washed through oral cavity three times 
Urine 	 60 ml midstream sample 
Feces 	 Two samples of 100 mg each taken from center 
of the fecal specimen 
lAll samples collected before and after each flight. 
2These samples also collected in-flight 16 days before return from 
Skylab. 
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TABLE II. SKYLAB MICROBIOLOGY SAMPLE COLLECTION SCHEDULE 

Skylab 2 Skyl ab 3 Skyl ab 4 
Collection Mission Mission Mission 
Sample Type Period Day Date Day Date Day Date 
Crew Preflight 	 F-70 3-14-73 F-87 8-21-73 
Samples 	 F-40 4-16-73 F-45 6-13-73 F-35 10-12-73 
F-25 5-1-73 F-14 7-12-73 F-21 10-26-73 
F-15 5-10-73 F-5 7-21-73 F-10 11-6-73 
F-O 5-25-73 F-O 7-28-73 F-O 11-16-73 
In-flight R-16 6-6-73 	 R-16 9-9-73 R-16 1-23-74 
Postflight R+O 6-22-73 R+O 9-25-73 R-O 2-8-74 
--' 
R+7 6-29-73 R+7 10-4-73 R+ll 2-19-74 
N R+18 7-9-73 R+18 10-15-73 R+17 2-25-74U1 
Orbital Workshop In-fl i ght R-2 6-20-73 R-2 9-23-73 R-2 2-6-74 
Air 
Orbital Workshop Prefl i ght F-40 4-16-73 
Surface Sites 
In-fl i ght R-16 6-6-73 R-16 9-9-73 R-16 1-23-74 
R-2 6-20-73 R-2 9-23-73 R-2 2-6-74 
Command Prefl i ght F-O 5-25-73 F-O 7-28-73 F-O 11-16-73 
Module 
Postflight R+O 6-22-73 R+O 9-25-73 R+O 2-8-74 
higher. These higher counts were due entirely to an influx of 
Serratia marcescens~ a microorganism which has been shown to produce 
various infections in man (2). Whereas this species was not recovered 
from any preflight crew sample analysis, it was recovered from multiple
sites from all three Sky1ab 4 astronauts immediately upon recovery. 
Further, this species persisted in the nasal cavity of the Pilot 
throughout the postflight quarantine period. Subsequent investigation 
demonstrated several potential sources of this organism in the Sky1ab
environment. However, these potential sources could not be sampled 
in-flight and, therefore, a direct correlation could not be made. By 
active microbial monitoring the release of this microbial contamina­
tion into the Orbital Workshop was traced from possible sources, was 
detected in the Sky1 ab ai r, was subsequently recovered as a new- speci es 
from all three crewmembers, and was ultimately shown to colonize the 
nasal passages of one astronaut. 
400 
350 
300 
COLONY-FORMING 
UNITS/M3 250 
OF AIR 200 
150 
100 
50 
SL-2 SL-3 SL-4 
Figure 2. Concentration of bacteria in the Skylab air from samples
collected two days before mission termination. 
Bacteri a 1 Recovery from Sample Sites wi thi n the Skyl ab Orbital Workshop 
The total concentrations of viable bacterial cells recovered from the 
Skylab spacecraft surface sites at various sampling periods are pre­
sented in figure 3. These in-flight samples were collected to evaluate 
the level of microbial contamination occurring in the Orbital Workshop.
The results of analysis of samples collected prior to launch are 
typical of a clean (although obviously not sterile) environment. The 
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Figure 3. Concentration of bacteria on surfaces in the Skylab spacecraft. 
reduction of aerobic bacteria recovered from the Skylab 2 in-flight
samples is probably a reflection of the thermal problems experienced 
in the Orbital Workshop after launch. Although there was a simul­
taneous ten-fold increase in the presence of anaerobic bacteria, the 
Skylab 2 crew apparently entered a very clean environment, which 
remained relatively clean during the mission. 
The recovery of both aerobic and anaerobic bacteria from the Skylab 3 
mission increased another 1 to 2 10910 units, with no apparent reason 
except for increased length of habitation by the crewmembers. During 
the 84-day Skylab 4 mission the total concentration of aerobic bacteria 
remained nearly constant although anaerobe recovery decreased signifi­
cantly. This drop was due to the loss of Propionibaaterium aanes which 
contributed strongly to the anaerobe population of the other two 
Skylab missions. This loss of P. aanes reflects a similar loss of 
anaerobic bacteria from the skin surfaces of the astronauts; this 
datum will be presented later in this paper. This decrease in 
anaerobic bacterial contamination of the Skylab, therefore, was shown 
to directly reflect a decrease in these same microbes in the contami­
nating reservoir, the skin of the astronauts. 
The recovery of aerobic bacteria from 15 sites within the Apollo Command 
Modules, sampled immediately before and after each mission to the 
Skylab, are summarized in figure 4. Whereas there was some variation 
in the contamination level of the different Command Modules, there were 
no major differences between preflight and postflight values for a 
particular Cmrnnand I~odule. Therefore, the variations noted in the 
Orbital Workshop could not be shown to affect population levels in the 
Command Modules. 
Funga1 Recovery from Sample Sites withi n the Skyl ab Orbi ta1 Workshop 
It had been suggested that molds would present problems on long term 
space flights, especially if high humidities were experienced (3). 
Figure 5 shows the number of fungal isolations from the Skylab vehicle 
before launch and during each mission. These numbers were low until 
the Skylab 4 mission. Although overall humidity was low on the 
Skylab 4 mission, local areas of high humidity cannot be entireelimi­
nated. The reasons for the large increase in fungal isolations on 
Skylab 4 have been well established. Early in the Skylab 4 mission, 
it was discovered that "mildew" was present on the liquid cool garments
which had been previously stowed aboard. A sample was taken of this 
growth, and one liquid cooled garment was returned for additional 
sampling. In general, the species of fungi isolated from surface 
samples and air samples were the same species isolated from the liquid 
cooled garment. These same microorganisms also contaminated the Petri 
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Figure 5. 	 Fungal isolations from surfaces in the 
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dishes of the ED31 experiment flown on Skylab 4. It is apparent that 
the liquid cooled garments were the source of spore contamination 
since some of these garments had not previously been removed from 
their original containers, but were subsequently found to be mildewed. 
This contamination was also reflected in the recovery of fUngi from 
the crew samples collected 16 days before return from Skylab. For 
Skylab 2 and Skylab 3 a total of two and zero filamentous fungi, 
respectively, were isolated from the crew in-flight. On Skylab 4 
a total of 11 fungi were isolated, including a significant contamina­
tion to the astronauts. It is important to note that this contamina­
tion to the crew was demonstrated 62 days after the first exposure to 
the liquid cooled garments, indicating either continued contamination 
from inanimate sources, abnormally slow return to normal levels, or 
both. 
The number of fungal species isolated from the 15 Command Module sites 
before and after each Skylab mission are shown in figure 6. These 
data illustrate that the fungal contamination of the Orbital Workshop 
during the Skylab 4 mission did not affect the Command Module samples
collected on recovery day. Although the Command Module was attached 
to the Orbital Workshop during this period of contamination, it was a 
separate entity, out of the area of heavy use, and away from the con­
taminating space suits. This relatively clean Command Module probably 
contributed to the low level of fungal contamination of the crew pos~ 
fl i ght. 
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Figure 6. Fungal isolations from surfaces in the Command Module. 
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Postflight Variation in the Major Components of the Autoflora 
Aerobic Bacteria 
Prior to the Skylab missions, several authors had theorized that major 
microflora changes might occur during space flight and that these 
changes might not be compatible with man1s health and welfare on ex­
tended missions (4,5,6,7,8,9,10,11,12,13,14,15). The theoretical 
change which was most often proposed called for a "microbial simplifi­
cation" which may be defined as a major decrease in the number of 
different types of microorganisms in the autoflora. To evaluate this 
hypothesis, the variations of the aerobic bacterial portion of the 
total autoflora within sample collection sites were analyzed as shown 
in figure 7. This analysis shows that the frequency with which 
recovery day values lie outside the preflight range is similar for 
the la-day Apollo 14 mission and the three Skylab missions. More 
specifically, the total number of viable cells recovered was frequently 
higher postflight whereas the number of genera and species decreased 
in all missions except Skylab 4. Therefore, it is possible to make 
the following observations concerning recovery of aerobic bacteria 
following these space flights. Values obtained-from immediate post­
flight sample analyses are frequently outside of the established pre­
flight range. When different, these values most often reflect an 
increase in total number of viable cells and a decrease in the number 
of different genera and species recovered. 
Anaerobic Bacteria 
A similar analysis of the anaerobic bacterial portion of the total 
autoflora is shown in figure 8. The analysis presented in this figure 
illustrates that the anaerobic portion of the autoflora behaves quite 
differently than the aerobic portion. The frequency and direction 
of postflight change is different from each Skylab mission, but 
apparently is not related to mission duration (as the la-day Apollo 14 
and the 84-day Skylab 4 results are most similar). Following the 
Apollo 14, Skylab 2 and Skylab 4 missions fewer viable anaerobe cells 
and fewer genera and species were recovered from up to 70 percent of 
the sites sampled. However, this is not a universal event as all of 
these values increased in some sample areas following the Skylab 3 
mission. These postflight increases were due to an unusually high 
level of contamination with Propionibacterium acnes on the skin of the 
Skylab 3 astronauts which matched exactly the increased contamination 
.. of Skylab surfaces mentioned earlier . 
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Figure 7. Postflight change in aerobic bacteria. 
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Figure 8. Postflight change in anaerobic bacteria. 
Legend 
Bars above the line indicate the number of the areas tested for 
which values were obtained that were higher than the preflight range. 
Bars below the line indicate the number of areas with decreased 
values postflight (R+O). All values represent the mean of 3 
astronauts. Ten sites were sampled from each astronaut. 
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o Number of Different Genera 
• Number of Different Species 
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The summaries presented in figures 7 and 8 indicate that, whereas the 
trends are not inviolate, the following conclusions may be stated. 
Gross numerical changes in the autoflora cannot be correlated with 
mission duration up to 84 days. Total numbers of viable bacterial 
• 	 cells tend to increase for aerobes and decrease for anaerobes. The 
number of different aerobic genera and species change little, whereas 
there is generally a decrease in the number of different anaerobic 
types recovered. 
Yeasts and Filamentous Fungi 
We have previously shown, as demonstrated in figure 9, that for the 
Apollo missions there was, typically, a significant reduction in the 
number of isolated fungal species up to the launch day. This was 
taken to be indicative of severely restricting opportunities of con­
tamination to the crew for three weeks before flight. Analysis of 
postflight Apollo data indicated that exposure to the space flight
environment for up to two weeks resulted in an even greater reduction 
with a relative increase in incidence of the potential pathogen, 
Candida atbieans (16). 
Essentially the same pattern may be demonstrated from the Sky1ab 2 
and Sky1ab 3 data, as shown in figures 10 and 11. However, fungal 
recovery was not depressed following the 59-day mission of Skylab 3, 
indicating increased exposure to fungi within the Skylab. Results 
of the same analyses for Sky1ab 4 are shown in figure 12 where 
essentially the same pattern is again demonstrated. This is an im­
portant observation in light of the previously mentioned in-flight 
contamination of the Orbital Workshop and Sky1ab 4 crew and the fact 
that ,the Skylab 4 Pilot sustained a "rash" in-flight which was pre­
sumed to be a mycotic infection and responded to treatment with 
Tinactin®. In spite of the gross contamination, the probable mycotic 
infection, and the epic length of the space flight, approximately the 
same number of fungal isolates were recovered from the Skylab 4 crew­
members throughout the l7-day postflight quarantine period. This 
indicates that with adequate preparation, monitoring, and treatment 
(if necessary) it is possible to control mycological problems in space 
for missions of this length where the humidity is generally low. 
Behavior of 	Medically Important Components of the Autoflora 
.. 
Opportunity for Postflight tJlicrobial Shock 
A summary of the numerical means of recovered isolates of medically 
important microorganisms from all nine prime Skylab crewmembers is 
presented in figure 13. This summary indicates that the incidence of 
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Figure 9. Total number of fungal species recovered from each set 
of Apollo 14 and 15 crew samples (21). 
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Figure 10. Total number of fungal species recovered from each set 
of Skylab 2 crew samples. 
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these species on the body decreased during the preflight quarantine 
period, to establish a low point the morning of launch. This event 
no doubt reflects decreased contact witb these species during this 
quarantine period. The largest number of medically important micro­
organisms is recovered from the immediate postflight sample set 
after which the value returns to its near normal prequarantine value. 
Several authors have warned that returning space travelers may experi­
ence a HMicrobial Shock ll and may respond negatively to renewed contact 
with potentially pathogenic microorganisms which are absent in the 
space flight environment (7,12,17,18,19,20). 
This warning is based on the assumption that contact with potential 
pathogens during space flight would be very limited, resulting in a 
reduction of immunocompetence. However, these data show that there 
is an increase in the distribution of potential pathogens immediately 
following space flight. This result supports earlier findings re­
ported for shorter duration space flights (14,17,21,22,23). Therefore, 
if a reduction in total immunocompetence were to occur during these 
missions, it is difficult to see how this reduction would be in 
response to decreased contact with medically important components of 
the autof1ora. As with the Apollo missions, there was no clinical or 
microbiological evidence of any "Microbial Shock ll following any of 
the Skylab missions. 
Intercrew Transfer of Potentially Pathogenic Microorganisms 
Transfer of pathogenic microorganisms between crewmembers during space 
flight has previously been reported for missions up to 18 days (24,17,
21,22). During the Sky1ab series it was possible to demonstrate in­
flight cross-contamination, colonization, and in-flight infection with 
Staphylococcus aureus. Most strains of this species, which is one of 
the most infectious of the common inhabitants of man's autof1ora, may 
be distinguished by their reaction with specific bacteriophages. This 
allows us to monitor the exchange of these microbes with greater
resolution. The phage-type pattern of S. aureus recovery for Skylab 2 
is shown on table III. These data show that the same S. aureus phage 
type was repeatedly recovered from the nasal passages of the Pilot, 
indicating that this crewmember was a carrier of this microorganism. 
Although spread to the Oribtal Workshop was demonstrated, there was 
apparently no transfer to the other crewmembers in-flight. Therefore, 
being restricted to a confined space for 28 days with an S. aureu8 
carrier does not necessarily result ln cross infection. 
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TABLE II I. Staphylococcus aureu" RECOVERED DURING SKYLAB 2 MISSION 
Commander Scientist Pilot Pilot 
Sample
Period Sample Phage Sample Phage Sample 
(Days) Site Type Site Type Site 
Preflight 
-70 NASAL 
-40 NASAL 
URINE 
-25 NAVEL N. T. NASAL 
-15 NASAL 
-' 
-0 NASAL 
w GARGLEco 
SCALP 
In-f1 i ght 	 NASAL 
NASAL 
Recovery
+0 NAVEL 
+7 
+18 	 NASAL 
GARGLE 
NAVEL 
*N.T. = Non Typable 
Orbital Workshop 
Phage Number Phage
Type Of Si tes Type 
52 
N.T.* 
80 
N. T. 
6/80 
80 

80 

80 

80 1 N. T. 
52/80 1 80 
52/80 
80 
52/80 
52/80 
11' • 	
-, f ... 
A more complex situation is outlined on table IV. The data summarized 
in this table indicate that the Skylab 3 Commander and Pilot were both 
nasal carriers of S. aureus, carrying phage type 3A and 29/79, re­
spectively. Prior to the flight, S. aureus was not recovered from any 
of the Scientist Pilot samples. Analyses of in-flight-collected
samples show that the workshop became contaminated with both phage 
types and that type 29/79 was temporarily transferred to the Scientist 
Pilot. Postflight analyses show that type 3A had spread to the Pilot 
but, as could be expected (25), did not colonize this subject who was 
already a carrier of another phage type. Phage type 3A was repeatedly 
isolated from the postflight specimens of the Scientist Pilot, indi­
cating actual colonization. This is a clear demonstration of in-flight
intercrew transfer of a pathogenic species where the contaminant could 
be shown to have established itself as a member of the autoflora of 
the new host. 
It is important at this point to relate these observations to crew 
in-flight illness events during the Skylab 3 mission. The Pilot, a 
29/79 carrier, developed a hordeolum (sty) which was successfully
treated with Neosporin®. The Commander, a 3A carrier, developed 
axillary swellings of a furuncle (boil) type which were treated with 
warm compresses. As neither of these infections were draining, in­
flight contingency samples were not taken, so we do not know for sure 
the identity of the causative agent. However, we do know that the 
causative agent of both of these maladies is usually S. aureus, and 
both of these individuals were carriers of this microorganism. 
Therefore, it is accurate to say that we have traced the development 
of a pathogenic microorganism from its preflight carrier state in two 
crewmembers through in-flight contamination of the Orbital Workshop, 
and colonization on the third crewmember. Also, it is highly probable 
that this species was responsible for the active in-flight infections 
of the two S. aureus carriers. 
CONCLUS IONS 
A general overview of some of the general contamination of the Skylab 
vehicle and of the major activities of the microbial autoflora of the 
Skylab astronauts has been presented. These data show that, while 
gross contamination of the Skylab environment was demonstrated and 
there were several in-flight disease events (presumably of microbial 
origin), such events were not shown to be limiting hazards for long­
term space flight. Evaluation of the major groups of microorganisms, 
comprising the microbial populations tested, te'nded to support the 
theory of microbial simplification for anaerobic bacteria, but not for 
other microbes. Intercrew transfer of pathogens was demonstrated. The 
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Table IV. StapltJll<>~ ~ RECOVERED DORING THE SKYLAB 3 MISSION 
eo..ncler Scientist Pilot pnot Orbi tal Workshop
S..,le
Period NUlDer (Days) S..,le Site Phage Type S..,le Site Phage Type Sa~le Site Phage Type Of Sites Phage Type 
Preflight
-45 NASAL ]A NASAl 29/79

2 Skin Sites 29/79 

-14 NASAl ]A NASAl 29/79

4 Skin Sites ]A 

-5 NASAl ]A NASAl 29/79 

-0 NASAL 
 ]A 
.... In-flight NASAL ]A NASAl 29/19 1 Skin Site N.T.* 6 S1 tes ]A
.j::o 
0 2 Sites 29/79 
Recovery 

+0 NASAl ]A NASAL ]A NASAl 29/19

1 Skin Site ]A GARGlE ]A GARGlE 29/79
1 Skin Site 29/79
1 Skin Site ]A 
+7 NASAl ]A NASAl ]A 

3 Skin Sites ]A 

+18 NASAl ]A NASAl ]A NASAl 29/79

GARGlE ]A 

2 Skin Sites ]A 

*N.T. ·'Non Typab1e 
/ 
., 
• 
'" 
f ~ 
-f ~ 
data mediate against- the theory of postfl ight microbial shock. The 
question of in-flight autoinfection remains unanswered because none of 
the in-flight disease events were evaluated microbiologically. 
Further general evaluations of the dynamics of the autoflora as a 
whole, and specific analyses of selected species and groups, will be 
published separately. 
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RADIOLOGICAL PROTECTION AND MEDICAL DOSIMETRY FOR THE 
SKYLAB CREWMEN 
,.' J. Vernon BaiZey~ B.S.~ M.S.*; R. A. Hoffman~ D. V.M.*; 
R. A. EngZish~ Ph. D.* 
• 
ABSTRACT 
Dose equivalent radiation exposure of the Skylab crewmen has been 
maintained well below the limits recommended by the Radiobiological 
Advisory Panel, Committee on Space Medicine, National Academy of 
Sciences. Operational procedures and mission rules were established; 
ground support specialists were responsible for overall coordination 
and evaluation of data from Skylab onboard radiation-monitoring 
instruments, satellite monitoring systems, and solar observatory reports.
Also, the Skylab crewmen were provided with instrumentation and training 
to enable autonomous response had a radiation problem arisen while the 
spacecraft was not within range of a ground communications site. A 
comparison among all Skylab crewmen of dose equivalents to skin, lens 
of the eye, and blood-forming organs is presented in this paper. 
INTRODUCTION 
Radiological protection planning for the Skylab missions encompassed 
two major areas; those radi ati on exposures that were "expected" whose 
components were known with relative certainty and those radiation 
exposures that were "unexpected" or completely indeterminant. The 
expected radiation components were the trapped protons and electrons of 
the Van Allen Belts (figure 1), galactic cosmic rays and the emissions 
of onboard sources (table 1). The possibilities of unexpected exposure 
include energetic solar particle events, high altitude nuclear tests, 
and potential problems with onboard sources. 
Premission analyses indicated that dose equivalents from the nominal 
environment of trapped (Van Allen belt) particles and galactic cosmic 
radiations would be well below the limits adopted by National 
Aeronautics and Space Administration from the National Academy of 
Sciences recommendations for manned space,flight (table II) (1). These 
analyses indicated that the Skylab 2 mission (28-day duration) would be 
*National Aeronautics and Space Administration-Lyndon B. Johnson Space
Center, Houston, Texas 
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TABLE I. RADIATION SOURCES ABOARD THE SKYLAB VEHICLE 

ACTIVITY 
ITEM SOURCE PER NOS. 
IDENTIFICATION LOCATION MATERIAL ITEM ITEMS TOTAl 
~' 
Photometer Cali- Forward P.147 811(1 8 11(1
brat10n Source C~art-
)' Experiment T027 ment 
light Source for Exper1l11ent H-3 100 11(1 2 200 11(1 
Otolith Goggles C~art-
... Experiment M131 Alent 
Dial Lettering Forward P.147 NA NA 20011(1
'" Experiment S019 C~art-
ment 
M552 Aqloules Stowage Ag-llOn1 20 \lei 4 80 "C1Compart-
Alent 
M558 Aqlou1es Stowage In-65 13 \lC1 3 39 \lC1 
Co~art-
Alent 
Dock1 ng Target External P.147 300 11(1 66 19.8 C1 
Axial On the foIlA 
Docking Taroet External Pm-147 300 n(1 66 19.8 Ci 
Radial On the MDA 
C02 Partial Internal Aln-241 454.2 \lC1 12 5.5 11(1
Pressure Sensors On AM 
GIN Main Frame Counand Th-232 NA NA 34.1 ..C1 (PSA &CDU) Module 
Astronaut Worn H-3 4.21 11(1 3 12.6 11(1
Chronographs 
Key: 	 11(1 • millicurie NA • not applicable 
\lC1 • microcurie MDA • Multiple Docking Assembly 
TABLE II. RADIATION EXPOSURE LIMITS 
BONE SKIN EYE 
CONSTRAINTS IN rem (5 cm) (0.1 _) (3 II1II) 
1 yr avg Daily Rate 0.2 0.5 0.3 
• 30 Day max 25 75 37 
.Quarter1y IYIilx 35 105 52 
Yearly max 75 225 112
.. 
Career limit 400 1200 600 
within the 3~-day limit category, while Skylab 3 and 4 (59 days and 
84 days, respectively) would be within the 90-day category. Because 
the nominal environment would result in doses well below these limits, 
operational radiation support was geared toward rapid identification 
and reaction to any enhanced radiation situation. 
SPACECRAFT RADIATION MONITORING 
The communications network for the Skylab missions could not provide 
continuous communications between the spacecraft and the ground. The 
existence of relatively large communication gaps necessitated providing 
the astronauts with instrumentation and training to insure that the 
crews could act autonomously to limit radiation exposure in a con­
tingency situation. r~ission rules establishing mandatory onboard 
decisions were written only for the relatively radiation sensitive 
intervals of extravehicular activity. 
The onboard instruments available for crew readout included a portable 
rate survey meter and three (plus a spare) personal radiation 
dosimeters which display integrated dose in 10 millirad integrals. The 
personal radiation dosimeters and rate survey meter provided the dual 
functions of extravehicular activity dosimetry and dose rate monitor­
ing, plus vehicle area monitoring in the intervals between extra­
vehicular activities. 
Routine monitoring of dose rates at a fixed loaction aboard the Skylab 
vehicle was performed by an ionization chamber instrument, the Van 
Allen Belt Dosimeter. Electron and proton fluences (particles/cm2) 
were monitored by an electron-proton spectrometer mounted on the ex­
terior of the spacecraft. Rate data from these instruments were 
telemetered or recorded for later transmission to ground, and were not 
available for direct crew readout. 
PASSIVE DOSIMETRY 
Each crewman was provided with a passive dosimeter packet to be worn 
continuously throughout the mission. The packet weighed approximately 
one-half ounce, and was designed to be worn on a soft strap on the 
ankle or wrist. The packet contained the following dosimetry materials 
for postflight analysis: densitometric film, nuclear track emulsions, 
polycarbonate and cellulose nitrate track detectors, lithium fluoride 
(TLD-700) chips, and tantalum/iridium foils. 
In addition to passive dosimeters worn by the crewmen, passive dosi­
meters were placed within the orbital workshop·s film storage vault 
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for the intervals from the beginning of Skylab 2 to the end of Skylab 2 
(28 days) and from the beginning of S.kylab 2 to the end of Skylab 3 
(123 days). The film vault dosimeters were placed in locations with 

approximate 2n shielding values of 13 and 23 g!cm2 aluminum.* 

Relative to proton range in tissue, these depths in aluminum correspond 

to soft tissue depths of approximately 10 and 19 cm, respectively. 

GROUND RADIATION MONITORING 
Radiation protection support was provided by specialists in communica­
tions, computational analysis, and radiological health. Spacecraft
data, satellite information and solar observatory reports were 
utilized in evaluating the space environment, especially relative to 
radiation enhancement. The crewmen reported their personal radiation 
dosimeter readings (as integrated dose) on a daily basis, plus 
additional readings before and after each extravehicular activity.
These readouts confirmed a continuously nominal radiation environment 
throughout each of the three missions. 
Although there were no radiation enhancements, the mission was not 
totally uneventful from a radiation standpoint. A few highlights are 
as follows. 
Solar Activity 
The Skylab missions were flown during a period when solar activity was 
approaching a minimum i~ the sun's solar cycle. Nevertheless several 
events of scientific interest occurred during the Skylab missions, 
however, particle emissions from these events were of low energy and 
relatively low intensity. These characteristics, coupled with the 
shielding effect of the Earth's magnetic field, reduced radiation doses 
from solar particles to below the limits of detectability for onboard 
dosimetry instrumentation « 10 millirad per event). 
Nuclear Events 
A series of four nuclear devices were detonated by France at their 
Murora Test Site during Skylab 3. The tests produced no ionizing
radiation problems for Skylab. However, we did recognize the possibil­
ity of eye damage to the crew from accidental observation of a test. 
This situation was handled by completely avoiding any visual observation 
of ground sites in the vicinity of the test area. 
*Due to the rectangular shape of the film vaUlt, actual 2n mean values 
are somewhat greater than 13 and 23 g/cm2. The remaining 2n shield­
ing is > 23 g/cm2 for both locations. 
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Onboard Radiation Source Problems 
One of the larger onboard sources (approximately 200 millicuries of 
promethium-147) was in the form of radioluminescent markings on knobs 
and dials of an experimental device, the Experiment S019 "Articulated 
Mirror System". Roughly half of the total activity was applied to 
digital readout belts and wheels within a readout subassembly. Two 
malfunctions occurred with the device in flight. First, a number of 
radioluminescent numerals (~ 1 mCi each) became detached from one of 
the dial wheels, and second (perhaps because of the first), a belt of 
numerals became jammed and failed to indicate instrument position in 
the lOis and 100Is places of rotational attitude. 
The possibility of numeral detachment had been recognized late in the 
preflight preparations for the missions and the dial subassembly had 
been gasket-sealed to preclude escape of promethium-147 into the space­
craft atmosphere. The problem during the flight became one of how to 
obtain valid experimental results, either by fixing the jammed belt 
(without release of promethium-147) or by finding an alternative align­
ment method for the experiment. Ground based testing with a training 
model of the experiment equipment determined that the numeral belt 
could not be freed without breaking into the sealed dial unit. In the 
meantime, an alternative alignment method was devised and tested. The 
alternative method was successful and was utilized for the remainder 
of the mission. 
DOSIMETRY RESULTS 
Integrated radiation doses at a shield depth equivalent to lens of 
the eye were obtained daily by crew readout of personal radiation 
dosimeters. These dosimeters were worn the first four days of each 
mission and for all extravehicular activities. During the rest of 
each mission, the instruments were placed in the designated assigned 
positions shown in table III. Mean dose rates for similar positions
in consecutive missions show a trend toward increased values as use 
of food, water, propellants and other expendables reduced the overall 
spacecraft shielding. Thermoluminescent dosimeter results for the crew 
worn passive packets are shown in table III for comparison with the 
rates found throughout the spacecraft. 
An upper limit estimate of the hard galactic radiation contribution 
is approximately 18 millirad per day; the approximate lower l-imit is 
12 millirad per day. Comparison of these rates with the overall mean 
dose rates shown in table III indicates that the galactic component 
accounted for 30 to 50 percent of the observed film vault doses, and 
roughly 20 to 30 percent of the crew dose means. 
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TABLE II 1. MEAN DAILY DOSES WITHIN SKYLAB VEHICLE 

SKYLAB MISSIONS (rad/day) 
LOCATION 2 3 4 
Crew TL[) (Mean ± 0) 0.057 ± 0.003 0.065 ± 0.005 0.086 ± 0.OQ9 
Film Vault. Drawer B 0.041 0.038 ------­
Film Vault, Drawer F 0.037 0.030 ------­
Command t4od., B-1 0.080 0.073}*
0.085 
0.084 
Stowed Crew PRO's 
Exper; ment Comp 0.054 0.047 0.070 
Sleep Compartment 0.083 0.082 0.091 
-Z SCI Airlock 0.071 0.110 -----­
+Z SCI Ai rlock -----­ -----­ 0.126 
Mean, Outside Vault ± 0 0.069 ± 0.013 0.077 ± 0.021 0.091 ± 0.021 
Legend: 
* A constant, 	dose independent, integration rate (0.012 rad/day) was observed in this 
instrument postflight. If initiated at launch, true in-flight rate would be 
0.073 rad/day; if initiated at splashdown, rate of 0.085 rad/day would be valid. 
TLD = Thermoluminescent Dosimeters 
PRO = Personal Radiation Dosimeters 
The majority of the remalnlng dose originates from protons of the Van 
Allen Belts and softer secondary radiations generated by passage of the 
primary particles through spacecraft materials. 
The evaluation of dose equivalents for mixed radiations in space is a 
complex subject and it is recommended that the reader consult the 
they found penetrate deeply enough (3 tissue equivalent) 
literature for rigorous discussion on this subject. 
some notable findings which should be covered. 
There are, however, 
Primary Electrons 
Van Allen belt electrons did not penetrate into the spacecraft, nor 
were to mm 
during extravehicular activities to register on either the passive 
dosimeters or personal radiation dosimeters. Consequently, electron 
doses to the skin (tissue depth: 0.1 rnm below 0.2 g/cm2 of space suit 
shielding) were calculated from electron-proton spectrometer data. 
Dose Versus Shield Depth 
Doses to the blood forming organs (tissue depth: 5 cm) were found to 
average 0.66 of the doses observed to the skin. These dose averages 
were obtained by integration of outputs from the dual sensors of the 
Van Allen Belt Dosimeter. The value of 0.66 also is in good agreement
with a value obtained by interpolation between crew-worn and film 
vault dosimeter results. 
The sole difference between skin and eye doses (0.1 mm and 3.0 mm 
tissue depth, respectively) is the added dose to skin from electrons 
during extravehicular activities. 
Quality Factor Versus Shield Depth 
Film vault shielding was found to be relatvely ineffective from a 
simple dose reduction standpoint (table III). Despite the small dose 
reduction, however, quality factor could have decreased substantially
if the dose reduction was solely due to filtering of lower energy 
particles. On the other hand, secondary buildup processes tend to 
increase quality factor as a function of shield depth. These competing
effects could not be calculated accurately prior to the mission. There-· 
fore, we have relied primarily on postmission nuclear emulsion analyses 
of the film vault dosimeters to determine space radiation quality as a 
function of shielding. 
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Comparison of emulsion data from the dosimeters worn by the crew and 
film vault dosimeters indicates that the filtering mechanism (reduced2quality factor) is slightly dominant at shield depths up to 23.3 g/cm 
aluminum. At blood forming organ depth, (5 cm tissue), quality factor 
is estimated equal to 1.5. In comparison, a qualit2 factor of 1.6 is found for the crew-worn dosimeters beneath 0.3 g/cm of tissue 
equivalent shielding. 
Neutron Dosimetry 
Details of the iridium/tantalum neutron dosimetry system have been 
published previously (2). Thermal (0.02 to 2.0 electronvolts) and 
intermediate (2.0 to 2xl03 electronvolts) neutrons were found to con­
tribute to crew dose equivalent at a combined rate of approximately 
0.1 millirem/day. 
Direct measurement of fast neutron fluence by suspended track analysis 
of crew worn nuclear emulsions was not possible due to the high track 
densities obtained on the Skylab missions. However, upper limit dose 
calculations have been made based on nuclear emulsion disintegration 
star analyses (to determine neutron production rates) and iridium/tanta­
lum evaluation, assuming that all activation is due to tissue albedo. 
Both methods show excellent agreement with upper limit rates of approxi­
mately 12.5 millirem per day for fast neutrons with mean energy of 
approximately 1 megaelectronvolts. 
CONCLUSION 
Table IV summarizes the dosimetry results for each crewman of the 
Skylab missions. As indicated in this table, there were certain vari­
ations in passive dosimeter wearing habits which required adjustments 
for data comparison purposes. 
Dose equivalents received by the Skylab 4 crewmen were the highest 
received in any NASA mission to date, but remained well within the 
limits established for the Skylab missions. Due to the low rates in­
volved (for example, less than 100 millirem per day to blood forming 
organs), dose equivalents for each crewman remain well below the 
threshold of significant clinical effect. These dose equivalents 
apply specifically to long term effects such as generalized life 
shortening, increased neoplasm incidence, and cataract production. To 
pTace the mission values in perspective, the NASA career limits were 
400 rem blood forming organs, 1200 rem skin, and 600 rem eye lens and 
were established from ancillary radiation exposure constraints recom­
mended by the National Academy of Science and based upon a reference 
risk of doubling the incidence of lukemia and other neoplastic disease. 
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TABLE IV. SKYLAB MISSION DOSE COMPARISONS 

CREWMAN ANO PARAMETER 
Commander (rid, TLO) 
p+ EVA (rid, PRO) 
e- EVA (rid, CALC) 
Skin (rem) 
Lens (rem) 
BFO (rem) 
Science Pilot (rid, TLO) 
p+ EVA (rad, PRO) 
e- EVA (rid, CALC) 
Skin (rem) 
Lens {rem} 
BFO (rem) 
Pilot (rad. TLO) 
p+ EVA (rad, PRO) 
e- EVA (rad. CALC) 
Skin (rem) 
Lens (rem) 
BFO (rem) 
PRO Mean. 4 LOCS (rid) 
Key: 
SKYLAB 2 

1.62 
0.13 
1.07 
3.66 
2.59 
1.60 
1.66 
0.10 
0.85 
3.51 
2.66 
1.64 
1.81 
0.09 
0.25 
3.15 
2.90 
1.79 
1.98 
SKYLAB 3 
3.67 
0.01 
1.50 
7.37 
5.87 
3.63 
3.73t 
0.06 
2.65 
8.62 
5.97 
3.69 
4.21 
0.09 
1.15 
7.89 
6.74 
4.17 
4.71 
SKYLAB4 
B.02* 
0.25 
1.34 
14.17 
12.83 
7.94 
7.36 
0.10 
6.07 
17.85 
11.78 
7.29 
6.80 
0.06 
5.22 
16.10 
10.88 
6.73 
7.81 
*CALC wrist equiv.lent for 8.68 ...sured .t .nkle 
tCALC wrist equivalent for 4.75 lIt.sured in sleep COlllP 
Note: Quality f.ctors used for proton doses to skin and eye • 1.6 qu.lity
factor for BFO • 1.5. Electron Dose .ppl1ed to skin only: Qu.,ity 
f.ctor ~ 1.0. 
TlD • Thennoluarlnescent dosimeter 
PRO· Person.l R.di.tion dosimeter 
BFO • Blood forming Organs 
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This reference 	risk was taken to be a dose equivalent of 400 rem. 
These career limits also entail a statisti~al risk of nonspecific life 
shortening of from 0.5 to 3.0 years (3). The Skylab 4 crewman could 
fly 	a mission comparable to one 84-day Sky1ab 4 mission per year for 
50 years before exceeding these career limits. 
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TOXICOLOGICAL ASPECTS OF THE SKYLAB PROGRAM 
Wayland J. Rippstein, Jr. and Howard J. Schneider, Ph.D. 
National Aeronautics and Space Administration 
Lyndon B. Johnson Space Center 
ABSTRACT 
A toxicology support capability for the Skylab Program was used to en­
sure a safe, habitable spacecraft environment for the crewmen. From 
previous experience with closed-loop environmental operations (e.g., 
submarines and manned chamber tests), it was known that trace-gas 
concentration buildup could cause mission-abort conditions. Therefore, 
the major toxicological consideration for the Skylab Program was to 
provide and maintain relatively low levels of contaminant gases in the 
spacecraft cabin atmosphere. To circumvent ~he possibility of the 
buildup of trace-gas levels, several preventive measures were taken. 
The most important measure was a screening test designed to eliminate 
materials that created serious outgassing problems. An atmospheric
analysis of the completed Orbital Workshop was also made. 
A significant toxicological problem developed before the Orbital Work­
shop was ~anned. The polyurethane skin insulation material was over­
heated. Laboratory tests indicated that the maximum allowable 
concentration value established for toluene diisocyanate probably had 
been exceeded and that excessive amounts of carbon monoxide probably 
were present in the Orbital Workshop. A successive series of 
atmospheric purges performed in the Orbital Workshop was followed by 
trace-gas analyses for toluene diisocyanate and carbon monoxide. When 
these analyses were completed, the crewmen safely entered the Orbital 
Workshop. 
Trace-gas Orbital Workshop atmospheric samples were obtained during the 
Skylab 4 mission. Results of these analyses indicated the presence of 
approximately 300 compounds in the Orbital Workshop atmosphere; 107 of 
these compounds were identified. Because of the absorption characteris­
tics of the sampling material, accurate quantitative data for all the 
identified compounds are unavailable. However, from these results, it 
is important to note that had an effective trace-gas removal capability 
not been contained within the environmental control system of the 
spacecraft, the atmospheric contamination buildup in the crew compart­
ment could have been a serious problem. 
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INTRODUCTION 

A toxicological support capability was established during the early 
developmental phases of the Skylab Program. From past experiences with 
closed-loop environmental operations, such as in submarines and manned 
chamber tests, it had been found that the buildup of trace contaminant 
gases could result in conditions which could cause mission termination. 
It was also recognized from the experience gained in the Apollo Program
that the use of newly developed nonmetallic material, especially the 
fluoronated polymers, required toxicological considerations, and that 
special consideration be given to the testing for outgassing products. 
It was known early in the program that the possibility of carbon 
monoxide buildup in the spacecraft cabin would also require special 
attention. None of the environmental control life support systems in 
previous spacecraft nor in Skylab were designed to provide carbon 
monoxide removal. It was therefore imperative that the selection of 
materials for use in the Skylab interior include consideration for 
the outgassing of carbon monoxide. It should be noted at this point
that toxicological support provided for the Skylab Program included 
considerations not only for inhalation toxicity, but also ingestion, 
eye contact, and skin contact toxicity. Since the latter three areas 
of toxicology required attention so infrequently, they are not dis­
cussed in this paper. 
PROCEDURES 
To provide a safe, habitable, breathing environment for the Skylab 
crew, several measures were adopted early in the program. The most 
important of these was a nonmetallic materials screening program which 
was designed to eliminate those materials that would cause problems
from their outgassed products. The screening program was based upon 
measuring the amounts of carbon monoxide and total organics outgassed 
per unit weight of each candidate material. Levels of acceptance were 
established for both carbon monoxide and total organics based upon the 
spacecraft habitable volume, the trace gas removal rate by the 
environmental control life support systems, and the cabin leak rate. 
In the case where newly developed polymers were considered for use as 
electrical component potting compounds or electrical wire insulators, 
pyrolysis products of these materials were used to determine toxico­
logical limits. The amount of material required to kill fifty percent 
of the exposed animals identified as lethal dose 50 (LD50) was determ­
ined. In these cases, material selection included both outgassing 
data and LD50 information. 
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In support of these inhalation exposures, chemical analyses, using mass 
spectral-gas chromatographic procedures, were performed to determine 
the chemical compound(s) contained in the pyrolysis products that could 
cause the toxic effect. These analytical procedures were also performed 
when a waiver was requested on any candidate spacecraft material that 
failed the carbon monoxide and total organics screening tests. 
PROBLEMS 
Following the loss of the Skylab 1 micrometeoroid shield, a significant 
toxicity problem developed as a direct result of the overheating of 
the Orb·ita1 Workshop interior wall insulation material. The wall 
temperature sensors indicated that the interior insulation of the 
Orbital Workshop had attained a projected temperature of 177° C 
(350° F) on the skin-side of the insulation and 71° C (160° F) on the 
interior volume-side of the spacecraft insulation. Since the insula­
tion was known to be a rigid polyurethane foam, it was realized that 
a potential hazard could develop as a result of the decomposition of 
the polymer to produce an isocyanate derivative. Of secondary concern 
was the accelerated offgassing rate of the entire nonmetallic materials 
contained in the Skylab habitable volume. Enough time was fortunately
available for the Life Sciences Toxicology Laboratory to exercise a 
rapid literature search for information concerning polyurethane foam 
decomposition and the related toxicity problems. An investigation was 
also initiated to determine the outgassing characteristics of the foam 
under the existent abnormal Skylab 1 environmental conditions. 
SOLUTIONS 
Using a piece of foam identical with that in Sky1ab 1 (same chemical lot 
and age), a solids probe mass spectral analysis was conducted. In 
figure 1 (1) the graphic results show that polymer decomposition begins 
at about 200° C (392° F). It should be n'oted that toluene diisocyanate 
was detected in trace quantities from 50° C (122° F) to about 200° C 
(392° F). It was learned from communication with the manufacturer of 
the foam that an excess of toluene diisocyanate is used in the process­
ing of a rigid foam. The excess toluene diisocyanate was apparently 
diffusing from the foam during the lower temperatures prior to thermal 
decomposition. It is also noted in figure 1 that the blowing agent, 
trich10rof1uoromethane, contained in the foam, reached a maximum 
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Figure 1. Polymer decomposition on heating. 
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release rate at about 150° C (302° F). No accurate quantitative
results were available from these analyses due to the unavailability 
of toluene diisocyanate standards. 
Information was obtained from the manufacturer of the Orbital Workshop 
for approximated increases in concentration values in the spacecraft 
for both toluene diisocyanate and carbon monoxide; these were 0.2 ppm
toluene diisocyanate/day at 79° C (175° F) and 2 ppm carbon monoxide/ 
day at 143° C (290° F). The D. A. Reilly analytical procedure (2) 
was used by this manufacturer's reporting group but, at the time of 
the over heating of the polyurethane foam, there existed no spacecraft 
requirements for acceptable atmospheric concentrations of toluene 
diisocyanate. The maximum allowable exposure (8-hour weighted 
average) limits established by the Occupational Safety and Health 
Administration (3) for toluene diisocyanate is 0.14 mg/m3 .[0.02 ppm
standard temperature and pressure (STP)]. Reports in the literature 
(4,5,6,7,8,9,10) all substantially support this exposure limit. 
Prior to the launch of the Sky1ab 2 crew, gas analysis tubes were 
prepared for space flight use. Two types of detector tubes were 
furnished the crew for the atmospheric analysis. These were of the 
colorimetric design and included one type of tube for carbon monoxide 
and another for toluene diisocyanate. The lower sensitivity of the 
carbon monoxide tubes was 11 mg/m3, and for the toluene diisocyanate 
tubes, 0.14 mg/m3. Atmospheric samples were taken by using a syringe­
type pump to flow air through the analyzer tubes. 
Prior to the entry of the crew into Sky1ab 1, two precautionary measures 
were undertaken to ensure that the habitable areas were safe for manned 
operations. The first was a series of pressurization-depressurization 
cycles of the Skylab 1 atmosphere designed to discharge and dilute any
contaminating gases of potentially toxic levels. The second measure 
consisted of the crew's assessment of the carbon monoxide and toluene 
diisocyanate contents by use of the supplied analyzer tubes. The 
results of their analyses indicated no detectable toluene diisocyanate 
and an extrapolated 5 mg/m3 level of carbon monoxide. 
The crew energized the Skylab 1 Environmental Control Life Support 
System which contained 9.02 kg (20 lb) of activated carbon, specifi­
cally designed to remove trace levels of contaminating compounds. From 
prior tests it was known that the spacecraft-type activated carbon 
would very efficiently remove toluene diisocynate. After a thirty­
minute atmospheric circulation period, the crew was given instructions 
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to make entry into the Skylab 1 for manned operations. This mission 
and Skylab missions 3 and 4 were accomplished without any other 
atmospheric trace gas problems. 
In addition to potential offgassing problems from excessive internal 
temperatures in the Orbital Workshop, a leak was suspected in the 
coolant system of the spacecraft. Therefore, it was of significant 
interest to toxicology, materials, and safety personnel to determine 
the compositions and concentrations of any atmospheric trace con­
taminants. The coauthor of this paper conceived and directed the 
development of a device that was used during the final mission for 
gathering this needed information. 
The device consisted of two small glass tubes, mounted in parallel in 
an aluminum cartridge, such that an atmospheric gas flow could pass 
equally through both tubes at the same time. Each of these tubes was 
partially filled (4.5 ml/tube) with a gas chromatographic absorbent 
material. Approximately 60 liters (STP) of cabin atmosphere were 
passed through the device during a time span of 15 hours. Three such 
samples were taken by the Skylab 3 crew on mission days 11, 46, and 77. 
The analyses of the absorbed contents of the three samples (three pairs 
of tubes) were accomplished under NASA contract1 and the coauthor's 
supervision. The results of these analyses indicated the presence of 
more than 300 compounds in the Skylab atmosphere during the occupancy
of the Skylab 3 crew. Of this number, 107 were identified by mass 
spectral methods. The molecular weights for the identified compounds
ranged from 60 to 584. A list of these compunds including the 
atmospheric concentration values are delineated in table I. Data from 
the compounds detected and identified revealed that there was no 
coolant fluid leaking into the interior of the Orbital Workshop. 
When the three atmospheric samples taken on mission days 11, 46, and 77 
were compared, the results (fig. 2) indicated only minor differences 
in the levels of contamination. This would indicate that a state of 
equilibrium had been attained earlier"between the gas generation rates 
of the contaminant sources and the environment control life support 
systems removal rate. 
INASA Contract, NAS9-l3457, Mod. 2S. (Principal Investigator: Albert 
Zlatkis, Ph.D., University of Houston, Houston, Texas.) 
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TABLE I. VOLATILES IN THE ATMOSPHERE OF SKY LAB 3 

Identified 
Chemi cal Cmpd 
d1fluorodichloro­
_thane 
Freon-ll2tJ)
Freon-l1 3tJ)y 
siloXlne. nOrlllll. n-Z 
.. 
eyelahexlne 
n heptane + IIIOnofluoro­
diehloromethane 
acetone 
C8 alkane 
C8 alkane 
heptene 
heptene 
n octane + heptene 
ethyl acetate 
Z-butanone 
siloxane. nOrlllll, n-3 
propanol + Freon 
(CZC14F2 tent.) 
siloxane, cyclic. n-3 
benzene + diacetyl 
Cg alkane 
4-lethyl pentanone-Z + 
s11oxane, cyc11c, n-4 
tr1methyls11anol (tent. )
... 
d1chloroethane 
toluene + tetrachloro­
" ethylene 
C10 alkane + siloxane, 
nOrllll1. n-4 
.. 
'10 alkane 
C10 alkane 
MOll 
conc (ppb) 
36.9 
5907.0 
79.5 
28.4 
96.5 
7895.0 
11.4 
17.0 
5.7 
88.0 
28.4 
454.0 
·1505.0 
105.0 
713.0 
62.5 
116.0 
2Z.7 
1990.0 
454.0 
1678.0 
4Z.6 
19.9 
5.7 
1«>46 
conc (ppb) 
59.8 
8653.0 
7.0 
13.0 
33.8 
7098.0 
7.8 
13.0 
2.6 
5Z.0 
39.0 
390.0 
lZZZ.O 
117.0 
1144.0 
Z6.0 
70.1. 
13.0 
1625.0 
93.6 
Z24.0 
1040.0 
5O.Z 
46.8 
7.8 
1«>77 
cone (ppb) Remarks 
193.0 not quantitative 
8446.0 not quantitative 
96.6 not quantitltive 
41.4 not quantitative 
77.3 not quantitative 
2760.0 not quantitative 
ZZ.l not quantitative 
27.6 not quantitative 
8Z.8 not quantitative 
116.0 not quantitative 
27.6 not qUlntitative 
221.0 not qUlntitative 
665.0 not quanti tithe 
138.0 not quantitati .. 
856.0 propanol in low 
concentration 
following sub­
stance quantitative 
38.6 dfacetyl mi nor 
19.3 
996.0 s11 oxane lIIi nor 
152 
213.0 
1717 .0 tetrlchloroethylene
lIIinor 
15Z 
41.4 
8.3 
TABLE J. continued 
Identified ..,11 M046 tl)77 
CheMi cal CtIpd conc (ppb) conc (ppb) conc (ppb) Rellllrks 
C4 benzene 33.7 13.0 49.7 
C4 benzene 19.9 10.• 16.6 
buto~ethanol 4305.0 
sl1icon ~•• MIl 504 11.4 15.6 22.1 " 
C4 benzene 11.4 13.0 13.8 '" 
C4 benzene 2.a 5.2 11.0 
dichlorobenzene 25.6 13.0 24.8 
Cs benzene 25.6 13.0 24.a 
stloxlne. cyclic. n-7 179.0 98.a 74.5 
Cs benzene + C13 alkane 19.9 10.4 19.3 
Ct benzene + C, benzene + 65.3 88.4 82.a 
s loxlne. MIl 5 a 
siHcon. ~ •• MIl 541 62.4 31.2 74.5 
benzlldehyde 114.0 62.4 102.0 not quantitative 
Ct benzene + Cs benzene + 17.0 3.0 5.4 
s licon COMP •• MIl 320 
C~ benzene + clAwalkene + 42.6 31.2 46.9 stltcon _inor 
s 11 con cC)q).. 584 
C4 benzene + C12 alkene 25.6 39.0 11.0 
C2 styrene + C4 benzene 45.4 33.8 74.5 
benzoni trile 45.4 39.0 41.4 
C5 benzene 45.4 23.4 46.9 
C5 benzene + C14 alkane 25.6 10.4 24.8 31.2 ZO.8 2.7 
C5 benzene 170.0 13.0 2.7 
acetophenone 59.6 ZO.8 77.3 not quanti tati ve 
~ 
silicon COMP •• MIl 35a 56.8 ••0 44.2 
" 
dtmethyld1hydroindlne (tent.) 11.4 7.8 13.8 
C15 alk.ne 22.8 23.4 35.1 
C5 benzene 11.4 7.8 19.3 .,. 
nlphthllene 90.9 59.8 113.0 
TABLE I. continued 
Identified ",m MD46 MD77 
Chemical Cmpd conc (ppb) conc (ppb) conc (ppb) Remarks 
n-decane 190.0 93.6 127.0 
4-methyl-4-pehtene-2-one 176.0 93.6 124.0 
Cll alkane 19.9 23.4 27.6 
" 
.. 
ethyl benzene + si10xane 
nonl'lal, MW 384 +.. sl1oxane, 
MW 370 
116.0 52.0 77 .3 
p-xy1ene 131.0 153.0 177.0 
m-xylene 272.0 164.0 166.0 
siloxane. normal, n-5 + 68.2 31.2 44.2 alkane minor 
C12 alkane 
C12 alkane 19.9 52.0 11.0 
silicone comp., MW 341 42.6 26.0 2.7 
aliphatic alcohol 
alkane 
+ C12 148.0 67.6 63.5 
o-xylene 148.0 67.6 63.5 
C3 ben~er.e 1.9 4.7 5.4 
siloxane, normal,n-5 17.0 13.0 16.6 
~ alkane + silicon comp.,
278 
54.0 31.2 60.7 
si1oxane. MW 415 + styrene 31.2 15.6 19.3 
C3 benzene 42.6 28.6 35.9 
C12 alkane 22.7 10.4 30.4 
A hydroxyketone (tent.) 582 .0 348.0 331.0 
l1monene 273.0 159.0 138.0 
~ nonene 102.0 291.0 35.9 
.. 
si1oxane. cyclic, n=6 79.5 122.0 157.0 
2-octanone 25.6 41.6 SO.O 
~ benzene silicon comp .• 
285 
11.4 13.0 13.8 
" methyl styrene + n-dodecane 25.6 10.4 5.4 
s11oxane, normal, n=6 33.7 20.8 33.1 
C3 benzene 19.9 13.0 22.1 
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TABLE I. conc;luded 
Identified MDll MD46 MDn 

Chemical ClIl'd conc (ppb) conc (ppb) conc (ppb) Remarks 

methyl naphthalene 48.3 28.6 33.1 
.. 
methyl naphthalene 2.8 2.6 2.7 
C17 alkane 45.4 33.8 46.9 
" 
.... 
,. .. i/o I< 	
.. 
... • 
MISSION DAY 11 

MISSION 	 DAY 46
CHROMATOGRAMS 
..... 
0\ 
....... 

MISSION DAY 77 
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Figure 2. 	 Comparison of the tracings of the three atmospheric 
samples taken during the Skylab 3 mission. 
CONCLUSION 
The experi ences and data gai ned in the Skyl ab Program have demons trated 
that the crew was provided with as safe an environment as coula be 
attained using the current state-of-the-art trace gas removal technology. 
The knowledge gained in solving the trace contaminant problems
encountered in the Skylab program will greatly aid in providing new and 
safe, habitable spacecraft environments for the future missions of 
man in space. .. 
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• 
EXPERIMENT M-13l. HUMAN VESTIBULAR FUNCTION 
Ashton Graybiel" M.D. *" Earl F. Miller II" Ph.D. *" and 
J. L. Hornick" Ph.D. t 
Experiment M-131 comprises three subtasks which will be reported sepa­
" 	 rately, namely, 1) susceptibility to motion sickness, 2) thresholds 
for perception of angular acceleration as indicated by the oculogyral 
illusion, and 3) the perceived direction of internal and external space. 
", 
I. SUSCEPTIBILITY TO MOTION SICKNESS 
Abstract 
Under experimental conditions tests were conducted on and after mission 
day eight by which time the astronauts were adapted to working conditions 
in the workshop. Stressful accelerations were generated by requiring 
the astronauts, with eyes covered, to execute standardized head move­
ments (front, back, left, and right) while in a chair that could be 
rotated at angular velocities up to 30 revolutions/minute. The selected 
endpoint was either 150 discrete head movements or a very mild level of 
motion sickness. In all rotation experiments aloft, the eight astro­
nauts tested (the Commander of Skylab 2 did not participate) were 
virtually symptom free, thus demonstrating lower susceptibility to 
motion sickness aloft than in preflight and postflight tests. The 
absence of an endpoint aloft, however, limited quantitation. Inasmuch 
as the eyes 	were covered and the canalicular stimuli were the same aloft 
as on the ground, it would appear that lifting the stimulus to the 
otolith organs due to gravity was an important factor in reducing sus­
ceptibility 	to motion sickness even though the transient linear and 
coriolis acceleration generated under the test conditions were substan­
tial and abnormal in pattern. 
Under operational conditions seven of the nine crewmen experienced 
motion sickness, five of the seven while in orbit. The administration 
of antimotion sickness drugs made it difficult or impossible accurately 
to determine the level of susceptibility at all times. The Skylab 2 
cre~~en did not experience clear-cut symptoms aloft and only the 
Scientist Pilot experienced seasickness; indeed, the Commander and Pilot 
did not take drugs yet remained symptom free throughout the mission. 
Among the Skylab 3 crew the Pilot experienced motion sickness shortly 
*Naval Aerospace Medical Research Laboratory, Pensacola, Florida 32512. 
tNational Aeronautics and Space Administration-Lyndon B. Johnson 
Space Center, Houston, Texas 77058. 
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after transition into orbit, the earliest diagnosis on record. The two 
remaining crewmen first experienced motion sickness shortly after enter­
ingthe workshop. For a period of three days symptoms were controlled 
by drugs and by restricting activity. Recovery was complete by mission 
day seven. The Skylab 4 crewmen were schedul ed to take antimotion 
sickness medication but only the Scientist Pilot avoided symptoms. 
Only self-evident findings are used as points of departure in discussing 
motion sickness. These findings contribute to our knowledge of the 
ways and means by which weightlessness qualifies as a unique motion 
environment. Some attempt is made to explain the findings and to 
indicate their main implications of a practical and theoretical nature. 
Introduction 
Prior to Skylab missions, nine U.S. and four U.S.S.R. crewmen reported 
motion sickness in orbital flight (table I-I). Soviet investigators 
have described in detail vestibular side effects experienced by cosmo­
nauts on transition into weightlessness (1 through 8), and it is note­
worthy that reflex motor phenomena were reported far more frequently
than was motion sickness. Postural illusions were experienced immedi­
ately after transition into orbit, and, while usually short-lived, some 
cosmonauts continued to experience the illusion until the g-load re­
appeared that was associated \'Iith reentry. Illusions evoked by rotary
motions of the head or head and body (sensations of turning and dizziness) 
were experienced not only early in flight but also over prolonged per­
iods. Among the 24 cosmonauts 4 experienced motion sickness, an inci­
dence of about 17 percent. It is interesting that all incidents 
occurred in early missions, an incidence of about 36 percent. 
The classical example of motion sickness experience in space flight was 
provided by Titov. For a very brief period immediately after transition 
into orbit Titov felt that he was flying upside down. Soon thereafter 
he described dizziness associated with head movements and sometime 
between the fourth and seventh orbit (six or more hours) he became 
motion sick, the first recorded instance in space flight. 
In the U.S. space program motion sickness aloft was not reported until 
the Apollo missions (9), although seasickness after splashdown was not 
an infrequent occurrence. In the Apollo command module where stimulus 
conditions were far more favorable for eliciting motion sickness than 
in the Mercury program, on the moon, or in the Gemini command module, 
9 among 25 Apollo astronauts were motion sick. In the Mercury space­
craft the astronauts were restrained in their couches, helmets (which 
were removed only occasionally) prevented quick head movements and the 
visual cues were adequate and plentiful. In the Gemini spacecraft
helmets were not worn but there was limited opportunity for free­
floating activities. The 12 astronauts exposed to Lunar conditions 
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did not experience motion sickness, but inasmuch as all were insuscepti­
ble in orbital flight, the benefit of a franctional g-loading was not 
tested. Moreover, their helmets prevented quick head movements except
about the vertical axis and visual cues were excellent. 
TABLE 1-1. MANNED SPACE FLIGHT PROGRAMS 
.United States Russia 
Program 
Number of 
Space Pi lots 
Incidence of 
Motion Sickness Program 
Number of 
Space P11 ots 
Incidence of 
Motion Sickness 
Mercury 6 0 Vostok 6 
Gemini 16 0 Voskhod 5 3 
Apo110 COI1I1Iand 
Module 25 9 Soyuz 13 0 
Apollo Lunar 
Landing 12 0 
In this report a distinction is made between two categories of 
vestibular side effects (10). One category comprises a great variety 
of lIimmediate reflex motor responses ll , such as postural illusions, 
sensations of rotation, nystagmus, and what often is termed dizziness 
or vertigo. The other category, motion sickness, ;s a delayed epi­
phenomenon (superimposed on any responses in the reflex category),
involving vestibular influences that cross a temporary or IIfacultative 
linkage ll , to reach nonvestibular sites where first-order responses 
that lead to motion sickness symptoms have their immediate origin.
First-order responses may, in turn, elicit second and higher order 
responses or complications until the.organism is generally involved. 
Symptoms of motion sickness are usually elicited when too rapid a tran­
sition is made from one motion environment to another (11). The 
primary or essential etiological factor is of vestibular origin, inas­
much as under such a transition persons with loss of vestibular function 
do not become motion sick (12, 13). Secondary etiological factors are 
always operative, however. In healthy, normal persons visual inputs
and psychological factors are usually the most important ones; in 
some motion environments just opening the eyes may precipitate motion 
sickness. In most motion environments visual inputs are not essential 
for the elicitation of motion sickness; blind persons who have never 
perceived light may readily become sick (14). 
Procedure 
Astronauts 
Table I-II summarizes findings in the nine Skylab astronauts dealing 
with their susceptibility to motion sickness in different motion 
environments and their responses during tests of vestibular function. 
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The Sky1ab 2 Commander had participated in the Gemini V mission and, 
along with theSky1ab 3 Commander, took part in the Apollo 12 mission 
which included landing on the ~'oon; neither had reported any symptoms 
of motion sickness during those missions. In other motion environments 
individual differences in susceptibility were demonstrated in a range 
" below average susceptibility. 
•Functional tests of the astronauts' vestibular organs revealed no 
definite abnormalities. These tests included a postural equilibrium 
test battery for which the scores, although not shown in table I-II 
were within the normal range. Of particular interest in view of the 
physiological deafferentation of the otoliths in weightlessness, how­
ever, are the low values for ocular counterro11ing. which is a test of 
otolithic function. The counterro11ing index (one-half the maximum 
roll when tilted right and left) was only 158 minutes of arc in the 
Sky1ab 2 Commander and Sky1ab 3 Scientist Pilot; whereas, among 550 
normal subjects the average was 344 minutes of arc (15). 
TABLE I-II 
HISTORY OF MOTION SICKNESS AND VESTIBULOMETRIC FINDINGS IN THE NINE ASTRONAUTS 
HISTORY Of MOTION SlCXHESS CAIIAL FlJIIICTIOII 0flJUI'H FUIICIllII COAWS 
AR:IWT OG IIWE1N£RS SP.ICE SEA ~. (NOT 1((135) fLIGIIT 11011 TO I£NY n:", FIT SUSCEPfIlllUTY SKY ­ AS1IION/IUT ,AGE IlAUI'IKE INOEX LAB : EJIIElil- STMP­ E=-~. EXP£II- STili'· EXI'£JI­ STMP­ OF RESI'IJISE Pfl£PON'ENeE TOIoIS ENCE TOIlS ENeE TOIlS OERANCE 
.2000 ~::S 4 ;­ 1'5 WfMI ctfI 42 TIllES SlIGHT MlIIMIII. _..-, .2 h LIlTS 
.1000 25-51) HAl 1-5 IIITHII 300 SPT 40 ," 4 IIOHE SlIGIIT MlAlW.. MlAlW.. 8,22 h TIlES TIlES lilTS 
.....-....., 
·2000 »100 ·100 Wl1'IIII 
liiit)T 
314 
PLT 40 h 
, 
TIllES 2 NONE NA TItlES IIORIIAl IOIMl 19.8 LIlTS 
.1000 
," ·100 I6t APOUJ) 10-51) WIT"" SIGIIFlCANT 
365 
ctfI 40 h TIllES ]]I - TItlES SlIGIIT MJIIMI.. (RETEST MJIIMI.. ' 23.1 LIlTS IIGCATEDJ 
WITHII 158 
3 SPT 41 »1000 - >0/00 4 NOlIE HA ·100 IlOO MJIIMI.. lOW 26.4h TIIo1ES TIllES lIlTS IOIIW. 
~ .2000 1111'l1li 312 i 36 - ·100 4 NOlIE HA 5-10 SlOO IOII.IIl IOII.IIl 19.2 , h TItlES TIllES LIWTS 
! ! , 
" 
Wl1'IIII 
ctfI 40 ' ~tOOO i -.. 10-25 16 I NONE NA 10-51) SLIGHT IOIIW. 
_1CAN1 
494 15h TIlES TIlES lIlTS NOAIIAl 
4 ! .1000 _•• : >ofOO I I'~ WITHII 
* 
SPT 36 e : NONE: SlIGHT IOIIW. 89h ' TIllES I 
TIlES llWTS 
i ·1000 _•• ·100 I 8 I NOlIE NA IIITHII PLT 43 0 NA MlAlW.. 528 h TIlES i i lilTS 
• ElESlS 
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A test (16) for grading susceptibility to motion sickness and yielding
a single numerical score (Coriolis Sickness Suscept"ibility Index) was 
carried out. The scores on the astronauts are compared with suscep­
tibility in 624 normal subjects in .figure 1-1. It should be pOinted 
out, however, that it was demonstrated prior to Skylab missions that 
the scores obtained in this test do not predict susceptibility to 
motion sickness in the weightless phase of parabolic flight (17). 
The results of such a comparison are shown in table I-III. It is seen 
that susceptibility on the ground predicted susceptibility aloft in 
40 45 50 75 100 
Figure 1-1. 	 Frequency distribution of motion sickness susceptibility 
scores of 624 normal subjects with scores of the nine 
Skylab astronauts indicated. The method used was similar 
to that used in Skylab missions. 
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about 22 percent of the subjects. 
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TABLE I-III. 	 CHANGES IN SUSCEPTIBILITY TO MOTION SICKNESS AMONG 74 
SUBJECTS AS DETERMINED BY CDr1PARING SYSTEtMTIC QUANTITA­
TIVE MEASUREt1ENTS MADE DURING WEIGHTLESS PHASES OF 
PARABOLIC FLIGHT AND ON THE GROUND. 
• 
Decreased 
Subjects 	 Endpoint Endpoint About Same Increased 

Reached Not Reached 

74 	 20 15 16 23 
Stimulus Conditions 
Under operationaZ conditions the astronauts made major transitions from 
land to orbital flight, to sea, and back to land. While aloft, tran­
sitions were made between the command module and the workshop and, 
during extravehicular activity, between the spacecraft and the outer 
environment. During entry there were variations in g~loading that 
terminated at splashdown, followed by transitions from the command 
module to the recovery aircraft carrier, and finally from the carrier 
to land. 
In considering the transition from one motion environment to another 
it is necessary to take into account not only the "new lt environment, 
but also the current status of adaptation effects acquired in ante­
cedent environments. Skylab conditions in the workshop were far more 
stressful than those in the command module, and highly complicated 
vestibular and visual inputs were encountered in the workshop. Acceler­
ative stimuli there were associated with passive as well as active 
movements and visual stimuli were, potentially at least, disorienting.
Thus, the opportunity was present to reveal individual differences in 
susceptibility to 'motion sickness, based on vestibular inputs as well 
as on complexly interacting vestibular and visual stimuli. 
At sea the astronauts were passively exposed to motion environments 
that stimulated the vestibular organs. The active execution of head 
(and body) movements contriubted angular and linear accelerations that, 
combined with the passive exposure to sea motions, generated cross­ .. 
coupled angular accelerations (stimulating the semicircular canals at 
suprathreshold levels) and Coriolis accelerations stimulating the 
otolithic receptors (18 through 20). 
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Under experimental (Jonditions (on and after mission day 8 aloft and on 
the ground) a stressful motion environment was generated by requiring
the astronauts, with eyes covered, to execute head movements while in 
a rotating litter chair (figs. 1-2 and 1-3). The rotating litter chair 
could be revolved at constant velocities\up to 30 revolutions per 
minute (rpm)(2l). The experimental procedures involved alternate clock­
wise and counterclockwise rotations, but rotation was more often clock­
wise than counterclockwise. Each discrete head and body movement 
("over" and "back") through an arc of 90 degrees in each of the four 
cardinal directions (front, back, left, right) required one second, 
and was followed by a "ho1d ll for one .second in the upright position. 
Movements were made in sets of five (the forward movement was executed 
twice), and after each set the astronaut kept his head in the upright 
position for 20 seconds. The maximum number of head movements required 
in a test was 150 (one endpoint) unless mild motion sickness (the other 
endpoint) was reached earlier. 
The rotating litter chair was used in the stationary as well as the 
rotating mode. In the stationary mode when head movements were ex­
ecuted aloft, the canals were stimulated in the same way as on the 
ground, but the otolith organs were stimulated in an abnormal manner 
because the impulse linear accelerations generated were not combined 
with a gravity vector as they would have been on the ground. These 
impulse linear accelerations were transient but well above threshold 
for stimulation of the otolith receptors. When the rotating litter 
chair was rotating, the intensity of the stimuli generated by head 
movement was a function of the rotational velocity, and although the 
angular and cross-coupled angular accelerations stimulating the semi­
circular canals aloft were the same as on the ground, the impulse and 
Coriolis accelerative forces generated aloft were not combined with a 
gravitational vector. These forces, nevertheless, were substantial 
at all levels of angular velocity used, and at 30 rpm the centripetal 
force was, respectively, 0.3 g and 0.6 g at radii of 1 and 2 feet. 
The Diagnosis of Motion Sickness 
The diagnostic criteria for motion sickness used in the Sky1ab experi­
ments are summarized in table I-IV and are described in detail else­
where (22). In brief, the severity of motion sickness symptoms was 
given a numerical score; sixteen points and above comprised the range 
of "frank motion sickness", and less than sixteen points, the range of 
"mild motion sickness". 
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CONTROL CONSOLE • 
STOWAGE CABINET 
ROTATING LITTER CHAIR 
Figure 1-2. The rotating litter chair motion sickness test mode. 
176 

MI31-HUMAN VESTIBULAR FUNCTION 
OCULOGYRAL ILLUSION MODE --.... 
,-INSTRUCTION---, 
~ (tMlTESTJ) 
r-- RESPONSE-----, 
l£FT N!mE RIGHTO1...~ UfiTI O[]l~~LJ 

r--ANGULAR ACCEL----.. 
67 18 19 
8 7 20 
16 214 9 
3 10 15 22@), ®
2 II 14 23 
I 12 13 24 
[3 
NEXT STEP 
REAOY LIGHT TEST [gJ 

.---MODE ----, ,...DIRECTION-.., 
OCULOGYRAL MOTION 
'~~~'"'" 
.. 

MAIN PWR 
~~~ 

TACHOMETER 
5 6 

3 8 

2 9 
I '0\fl.7 
OfF II 
Figure 1-3. Console used in connection with the rotating litter chair. 
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TABLE I-IV 
DialJlOSlic Categorization Of Different Levels Of Severity Of Acute Motion Sickness 
Pathognomonic Major Minor Minimil AQSo 
" Category 16 points 8 points 4 points 2 points 1 point 
.. 
Nausea syndrome Nausea 111,1 retching Nausea II Nausea I Epigastric discomfort Epigastric aWlreness 
or vomiting 
Skin Pallor III Pallor II Pallor I Flushing/Subjective warmth !!Oil & 
Cold sweallng III II 
Increased salivation III II 
Drowsiness III II 
Pain Headache (persistent) ltll 
Central nervous Dizziness (Persistent) 
system Eyes closed !!OIl 
Eyes open 
._--------------------_..........----_......__.._-------------------------­
III 
Levels of Severity Identified by Total Points Scored 
Frank Sickness Severe Malaise Moderate Malaise A Moderlte Malaise B Slight Mallise 
(FS) (M till (M IIAI (M liB) (M If 
e16 points ·8 - 15 points 5 - 7 points 3 - 4 points 1 - 2 points 
'AQS - Additional qualifying symptoms 
till - severe or marked, II - moderate, I - slight 
Under experimental conditions the diagnosis of acute motion sickness 
\lIas aided by the close temporal relation between exposure to stressful 
stimuli and elicitation of responses. In all Skylab experiments the 
motion sickness endpOint, moderate malaise (M II A) (a point score of 
5 to 7), was of very mild intensity; the avoidance of more severe 
symptoms was an operational requirement. 
An observer in collaboration with the subject estimated the severity
of each predesignated symptom and recorded any "other symptom" not 
mentioned in table I-IV. There was always adequate time after execu­
tion of each set of head movements to make the estimates and record 
them by depressing the appropriate push-buttons in the response matrix 
of the rotating litter chair Control Console. One-hundred and fifty 
head movements or a score> 5 points automatically triggered a signal 
that the test had been completed. 
Under operational conditions the astronauts' ability to diagnose 
different levels of severity of motion sickness was enhanced by their 
training in connection with the preflight experimental evaluation of 
.~ 
motion sickness susceptibility. Nonetheless, under operational condi­
tions diagnosis was more difficult than under experimental conditions 
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because the identification of the stressful stimuli was not always 
easy, and the symptomatology of IIchronic ll or prolonged motion sickness 
(experienced aloft) differed in some respects from that of acute motion 
sickness. 
r~edication 
r 
The astronauts in Sky1ab 2 and Skylab 3 carried with them antimotion 
sickness capsules containing 1-scopo1amine 0.35 milligrams + d-ampheta­
mine 5.0 milligrams; in addition to this drug the Sky1ab 4 crew took 
along the drug combination promethazine hydrochloride 25 milligrams + 
ephedrine sulfate 50 milligrams, drugs which had proven to be effective 
under experimental (23) and operational conditions (24). This drug
combination acts by raising the stimulus thresholds for eliciting 
motion sickness responses and is effective in any motion environment. 
Indeed, preflight drug evaluation tests were carried out on all nine 
astronauts; endpoints were not reached even at angular velocities of 
20 rpm for the Sky1ab 2 crewmen and 30 rpm for the Sky1ab 3 and Sky1ab 4 
cre\'lI11en . 
Results 
It is convenient to present the findings dealing with motion sickness 
first under lIoperationa1 conditions" then under "experimental conditions". 
Operational Conditions 
Attention will be mainly centered on motion sickness during the orbital 
phase of the mission and will be discussed with the aid of Figure 1-4. 
The horizontal lines reflect two things. First, the periods during 
which the astronauts were based in the command module and in the work­
shop during the first week in orbit. Second, the thickness and con­
tinuity of the lines indicate the onset and probable disappearance of 
symptoms of motion sickness. The onset of symptoms is indicated fairly 
accurately. The disappearance of symptoms, however, involves first a 
loss of susceptibility to the eliciting stimulus, then spontaneous 
restoration through homeostatic mechanisms and finally something termed 
convalescence, hence "disappearance ll of motion sickness symptoms is 
difficult to determine. The vertical lines indicate when an antimotion 
sickness drug was taken and its composition. The administration of 
drugs increases the difficulty of diagnosing motion sickness, hence 
accuracy in diagnosis is greater in the absence of drug effects . 
.. 
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SkyZab 2. As indicated earlier, the Commander was, in all likelihood 
the least susceptible to motion sickness among the nine Skylab astro­
nauts. He didn't take any antimotion sickness drugs and was symptom 
free under all conditions. 
The Scientist Pilot, in a debriefing, stated, "I took the one 'scopjdex' 
(antimotion sickness drug) right after insertion (into orbit) that 
.. I had preprogramed myself to take, whether I needed it or not. 1I He 
further stated. "I felt that, although we had no overt symptoms of 
motion sickness or any other specific syndrome related to transitioning 
to weightlessness, my appetite was a little bit less, neglecting day 1 
when it was 	 completely normal, and that it was a little less for some­
where like the first week. I don't know why this is. As I said, I 
had no particular symptoms. I felt fine during those first seven days, 
but I thought I felt even better after that." 
It is also noteworthy that both the Commander and Scientist Pilot re­
ported that while engaged in spinning rapidly about their long axes 
or "running" around the inside of the workshop, they experienced 
immediate reflex vestibular side effects, mainly "false sensations" 
of rotation. Based on past experience, both astronauts expected that 
motion sickness would follow the reflex effects and were surprised by 
their immunity. 
The Skylab 2 Pilot did not take an antimotion sickness drug aloft and 
remained symptom free. Unlike his comrades, however, although he was 
aware of illusory phenomena their intensities made little impression 
on him. 
During entry the Skylab 2 astronauts did not perceive the oculogravic 
illusion. The Scientist Pilot stated aften'iard, "I never picked it up 
at all. I think it just had to do with the fact that you have so many 
visual cues and you Ire so well lighted and also your attention is so 
riveted on the instruments that you have no such illusion * * *. The 
first time we were conscious of any vestibular inputs was after we were 
on the water and unstrapped and moved from the couch. There was nothing 
at all during the entry." The Skylab 2 Commander stated, 1I~1y first 
head movement was when I was unstrapped and on the water, when I rolled 
up on my right and moved around * * *. It was exactly what I would 
expect had I been riding the centrifuge and done the same thing." The 
., 	 Pilot stated, "And I did move. I got up from the couch and looked out 
the window for the ship while we were still on the chutes, and that1Ididn't bother me. 
At splashdown the sea state was 5, and the command module landed and 
remained upright. The astronauts \'Jere quite confident that they would 
not experience motion sickness on return and accordingly did not take 
antimotion sickness drugs prior to entry. Seasickness was not 
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experienced by the Commander but severe symptom's were manifested by the 
Scientist Pilot and mild symptoms by the Pilot. 
Skylab 3. The Skylab 3 astronauts were quite confident before their 
mission that they would not become motion sick in weightlessness and 
did not take antimotion sickness drugs as a preventive measure. 
The Pilot experienced mild symptoms of motion sickness within an hour 
after insertion into orbit. During launch he wore a space suit and 
helmet (as did the other crewmen). He was not aware of any illusory 
.. 
phenomena on transiton into zero gravity. Shortly after transition he 
removed his helmet and soon thereafter his space suit. It was in close 
relation to tak"ing off the suit that the first symptoms of motion sick­
ness were experienced. He took an antimotion sickness capsule that 
relieved his symptoms for a fe\v hours. Later, symptoms returned and he 
restricted his activities; he deliberately avoided, however, taking
another antimotion sickness capsule while based in the command module. 
During the activation of the workshop, about 11 hours into the flight, 
the Commander and Scientist Pilot also reported the onset of motion 
sickness. Shortly thereafter the Skylab 3 Scientist Pilot vomited. 
For three days the astronauts experienced symptoms of motion sickness 
which were intensified by movement and alleviated after taking the 
drug or restricting their movements. During this period their work­
load was lightened. ' 
On mission day 2 the Scientist Pilot executed standardized head move­
ments for 30 minutes with the object of increasing his rate of adapta­
tion. \~ith eyes closed he had "no difficulty", but with eyes open he 
experienced "developing malaise", 
On mission day 4 regular working hours were resumed, although some 
degree of susceptibility to motion sickness remained in all three 
astronauts. Recovery was complete by the seventh mission day. 
Prior to splashdown the antimotion sickness drugs were taken, and 
symptoms were prevented even though the sea state was twice as severe 
as that to which the Skylab 2 crew had been exposed. On both days at 
sea aboard the carrier, the Pilot took an antimotion sickness capsule, 
implying some susceptibility to sea sickness. 
Skylab 4. In the light of Skylab 2 and Skylab 3 findings, the Skylab 4 
crew was scheduled to take antimotion sickness drugs through mission 
day 3 and, thereafter, as required. The drugs actually administered 
are shown in table I-V. The drugs were referred to as l1uppersl1 (A)
and IIdowners u (B) and on mission day 8 the Scientist Pilot took the t 
drug combination B as a soporific rather than for its antimotion sick­
ness properties. Prior to entering the workshop the Pilot experienced 
nausea and vomiting and was not free of symptoms during the first three 
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days. The Commander reported "epigastric awareness II prior to meals 
which may have represented susceptibility to motion sickness, and the 
Scientist P-ilot was symptom free. It is interesting that all crewmen 
took antimotion sickness drugs during recovery at sea and were symptom 
free. 
TABLE I-V 
SKYLAB ANTIMOTION SICKNESS MEDICATION 
APPROX TIME 
MISSION _EVENT (HOURS c . s • t.) 
LAUNCH DAY (MD 1) 
AFTER INSERTION 0900 
AFTER NC·l* 1100 
AFTER DOCKI NG 1700 
2300 
MD·2 & MD-3 0600 
ON ARISING 1000 
1400 
MD·4 0600 
ON ARISING 1400 
MD·8 BEDTIME 
MD·33 BEDTIME 
MD·82 BEDTIME 
MD·84 
ABOUT 2 HOURS PRIOR 
TO SPLASH (ENTRY) 
* 
A SCOPOLAMINE / DEXEDRINE 
B PROMETHAZINE / EPHEDRINE 
FIRST PHASING MANEUVERS 
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Commander 
A 
B 
A 
A 
B 
A 
A 
(0.35/5.0 
(25/50 
Scientist 
Pilot 
A 
B 
A 
A 
B 
A 
B 
B 
B 
A 
mg) 
mg) 
Pilot 
B 
B 
B 
B 
B 
B 
B 
A 
Experimental Conditions 
Skylab 2. The findings in figure 1-5 demonstrate that the Scientist 
Pilot and Pilot (the Commander did not participate) were less suscepti­
ble to motion sickness when they executed head movements during rotation 
aloft than when they did so on the ground. Preflight, on three widely 
separated occasions, the M II A endpoint was consistently elicited 
after 30 to 60 head movements~while those astronauts were being rotated 
at 12.5 rpm (Scientist Pilot) or 15 rpm (Pilot). When rotation tests 
were carried out in the workshop, both of these astronauts were virtually 
symptom free; their minimal responses, which were transient, did not 
even qualify for a score of one point. This was true even when the 
angular velocities were increased (in two steps) to 30 rpm. The 
ephemeral manifestation reported by the Scientist Pilot on mission 
day 20 was a slight increase in subjective body warmth, and on mission 
day 24, a mild cold sweating. The temporary manifestations reported 
by the Pilot on mission day 6 when the rotating litter chair was sta­
tionary were epigastric awareness and increased body warmth; and, on 
mission day 24, slight dizziness and cold sweating. 
Postflight there was no significant change in the susceptibility of 
the Scientist Pilot to motion sickness compared with preflight, and, for 
the Pilot, no significant change on the third day postflight. The 
decrease in susceptibility manifested by the Pilot on day 8 postflight
does not, in all likelihood, reflect more than a temporary change in his 
suscepti bil ity. 
Skylab 3. The findings in the three astronauts are summarized in 
figure 1-6. It can be seen that they were virtually immune to experi­
mental motion sickness aloft and that their susceptibility was lower, 
at least temporarily, after the mission than before. 
The Commander was tested in the rotating litter chair on two widely
separated occasions preflight and demonstrated similar susceptibility 
levels each time. On mission days 26 and 41 he was symptom free when 
rotated clockwise, respectively, at 20 and 30 rpm. On mission day 52 
he was rotated counterclockwise at 30 rpm and experienced what he 
described as a slight vague "malaise" that persisted for approximately 
30 minutes following the test. The question arises whether secondary 
etiological factors accounted for both the appearance and nature of 
this symptom, which is not typical of acute motion sickness, or whether 
the astronaut~as not quite adapted to counterclockwise rotation. Post­
flight, the Commander was symptom free on the day after recovery when 
he executed head movements with the rotating litter chair stationary
and on the second day postflight when it was rotating clockwise at 
15 rpm. On the fifth day postflight an endpoint was reached that 
approximated his preflight susceptibility level. 
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The Scientist Pilot was tested on four widely separated occasions pre­
flight, and the M II A endpoint was always reached with approximately 
the same stressor stimulus. Aloft the Scientist Pilot was tested on 
six occasions, the first on mission day 5 with the rotating litter 
chair stationary. Thereafter, the angular velocities of the chair, 
beginning at 	20 rpm, were increased to 25 rpm, then to 30 rpm for 
.. 	 the last three tests; symptoms of motion sickness were never elicited . 
Postflight he was symptom free on the day after recovery when the 
rotating litter chair was stationary and again on day 2 postflight 
when the rotating litter chair was rotating counterclockwise at 20 rpm. 
On day 5 postflight the Scientist Pilot experienced very mild symptoms(dizziness II, drowsiness I), but an endpoint was not reached when 
the rotating 	litter chair was rotating clockwise at 25 rpm. The 
MII A endpoint was reached on day 17 postflight with the rotating
litter chair 	rotating counterclockwise. The Sky1ab 3 Pilot was tested 
on four widely separated occasions preflight and demonstrated similar 
test scores on all four occasions. Aloft he was tested on six occa­
sions. On mission day 5 he experienced slight but persistent 
Ildizziness".when the rotating litter chair was stationary. (It will 
be recalled that on mission day 5 the Pilot was just getting over his 
susceptibility to motion sickness in the workshop and that he had 
taken an antimotion sickness drug on mission day 3). Thereafter, he 
was symptom free when rotated clockwise at 20, 25, and 30 rpm and on 
mission days 	 8, 18, and 29, respectively. On mission day 43 he 
experienced "some body warmth" that did not rate a one-point score 
(moderate i(ltensity required) while rotating clock\vise at 30 rpm,
but he was symptom free ten days later'while rotating counterclockwise 
at 30 rpm. 
SkyZab 4. The findings are summarized in figure 1-7. Preflight
the ceiling on the test was closely approached in the case of the 
Commander and Pilot and nearly reached in the case of the Scientist 
Pilot. In the workshop the ceiling of the test was quickly reached 
without eliciting any symptoms of motion sickness. In view of this 
immunity a change in the procedure was instituted. This change was 
essential to determine whether the absence of responses was the 
result of complete insusceptibility or, in part, the consequence of 
adaptation to the stressful accelerations during the period of exposure 
to rotation. The latter was tested by reversing the direction of 
rotation immediately after 150 head movements had been executed in the 
initial direction of rotation. The basis for this approach rested on 
the finding that although bidirectional adaptation effects are acquired 
with either clockwise or counterclockwise rotation, the level of 
adaptation is greater in the direction of turn than in the opposite 
direction. Therefore, by reversing the direction, the elicitation or 
nonelicitation of symptoms of motion sickness served to indicate, 
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respectively, whether the absence of symptoms during the initial 

direction of turn was or was not due in part to the acquisition of 

adaptation. On mission day 73, the Commander and Pilot, and on mission 

day 75, the Scientist Pilot remained symptomless during the bidirection­

al test procedure. Consequently, they were not adapting during the test. 

Tests conducted postflight on days 1, 2 and 5 revealed either very 

mild symptoms or immunity; the motion sickness endpoint was not reached. 

On day 17 postflight the Pilot reached the motion sickness endpoint. 

On day 31 postflight both the Pilot and Scientist Pilot reached end­

points.and the Commander scored 3 points. On day 68 postflight the rpm 

were reduced to 25 rpm and none reached the motion sickness endpoints. 

Discussion 
There were clear-cut findings under operational and experimental stimu­
lus conditions that will serve as points of departure in the following 
discussion. 
Operational Conditions 
Command ModuZe. Two astronauts were motion sick when based in the 
command module, the Skylab 3 Pilot and the Sky1ab 4 Pilot. The latter 
had taken two doses of an antimotion sickness drug (Promethazine HCl 
25 milligrams and ephedrine sulfate 50 milligrams) in 8 hours, which 
may have complicated the symptomatology, hence, the attention here will 
center on the Skylab 3 Pilot. 
Shortly after transition into orbit the Skylab 3 Pilot experienced mild 
symptoms characteristic of motion sickness. The close temporal relation 
between the astronaut's activities and the onset or alleviation of 
symptoms and the relief following administration of the antimotion 
sickness capsule confirmed the diagnosis, the earliest confirmation 
among space crewmen on record. 
On entry into weightlessness few of the internal adjustments that were 
initiated during the transition were complete. Alterations such as in 
hemodynamic adjustments, redistribution of body fluids, and changes in 
electrolyte balance that might affect susceptibility to motion sickness, 
either via the vestibular system or more indirectly, were at various 
stages along their time course (25-29). Even though the stimulus to 
the macular receptors due to gravity was lost, the question had arisen 
as to whether the physiological deafferentation process had stabilized. 
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Loss of the g-load would affect the "modulating influence" of the 
otolithic system. If the otolithic influence was inhibitory the re­
sponses elicited by stimulation of the canals are said to be "exagger­
ated" (30). The observations bearing on this point in parabolic flight, 
however, indicated reduced responses to canalicular stimulation (31-33) 
during the weightless phase. 
Fortunately, in the case of the Skylab 3 Pilot, it was possible to 
follow his course which demonstrated that there was little or no support 
for the notion that nonvestibular predisposing factors in addition to 
the immediate eliciting factors were involved; he remained motion sick 
or susceptible to motion sickness at least through mission day 3 and 
probably two days longer. Moreover, the fact that the remaining seven 
astronauts did not have motion sickness while based in the command 
module argues against a common unique etiological factor. 
Workshop. Under operational conditions three astronauts were motion sick 
for the first time aloft after making the transition from the command 
module into the workshop, implying that stimulus conditions were more 
stressful then than at any time in the command module and that the 
adaptation acquired in the command module offered inadequate protection 
in the workshop. . 
The spaciousness of the workshop provided the greatest opportunity up
to the present time to reveal the great potentialities in weightlessness 
for limiting natural movements and encouraging highly unnatural move­
ments that often resembled acrobatic feats. Movies of the astronauts 
carrying out their tasks in the workshop, often involving transitions 
from one place to another, best display the relatively la~ge component 
of passive movement associated with active movements, with the oppor­
tunities for generating unusual patterns of vestibular stimulation and 
unusual or abnormal visual inputs. 
The Skylab 3 Commander and Scientist Pilot began to have symptoms 
shortly after entering the workshop, and soon thereafter the Pilot 
vomited. The question has been raised whether the motion sickness 
experienced by the Pilot influenced unfavorably the elicitation of 
symptoms in the other two crew members. This seems unlikely for two 
reasons, namely, the Pilot had been motion sick (or highly susceptible 
to motion sickness) since the first hour in flight, and symptoms
appeared in the Scientist Pilot and Commander before the Pilot vomited. 
Among these three astronauts under workshop conditions, the Pilot was 
not only most susceptible but also susceptible for the longest period 
while the Commander was least susceptible with the shortest time course. 
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It was on mission day 2 that the Scientist Pilot executed standardized 
head movements for a short period and did not have any symptoms with 
eyes closed, but, continuing the head movements with eyes open, he did 
experience symptoms. Whether symptoms would have been elicited if the 
head movements had been continued with eyes closed is not known, but 
the visual inputs contributed to the interacting sensory stimuli and 
probably were of etiological significance. This brief lIexperimentli 
represented an attempt at programing the acquisition of adaptation 
effects and underscores the possible advantage of lIeyes closed ll in the 
early stage of adaptation, something that has been demonstrated under 
laboratory conditions (34). After the third or fourth day it is 
difficult to sort out the countervailing influences of eliciting and 
restoring mechanisms, upon which were superimposed the nonspec;-fic 
general effects of a period of ill health. It is especially noteworthy 
that recovery was not complete until mission day 7. 
The Skylab 4 Commander despite the administration of antimotion sickness 
drugs 3 times daily on mission days 2 and 3 became mildly motion sick, 
and the Pilot continued, despite medication, to demonstrate, on occasion, 
. symptoms of motion sickness. 
There is much resemblance between the t-ime course of the symptomatology
of motion sickness elicited in the workshop and in a slow rotation room. 
This resemblance is due in large part to the etiological realtion be­
tween lIactivities ll and eliciting stimuli. The two environments have, 
in common, the generation of stressful stimuli when a person is engaged 
in various activities and abolition of the stressful stimuli when the 
head and body are fixed. In both environments there are: 
o 	 a delay in appearance of symptoms after the onset of the 

stressful stimuli, 

o 	 a gradual or rapid increase in severity of symptoms, 
o 	 modulation by secondary influences, 
o 	 perseveration for a time after sudden cessation of stimuli, 

and 

o 	 a response decline, indicating that restoration is taking 

place spontaneously through homeostatic events and processes. 

If the intensity of the stimuli is high, the latencies associated with 
the appearance and disappearance of symptoms will be brief. With the 
acquisition of adaptation effects and concomitant reduction in the in­
tensity of the stimuli, the latencies are increased, and, characteris­
tically, restoration may not only be prolonged but also complicated by 
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the appearance of symptoms not typical of acute motion sickness. Thus, 
in a slow rotation room it has been demonstrated that drowsiness may be 
elicited in the virtual absence of other symptoms (35) and that after 
the nausea syndrome has disappeared, drowsiness, lethargy, and fatigue
remained (36). ­
An analysis of the foregoing and similar manifestations has led to the 
definition of a unique syndrome". For clarity, it is termed the Sopite 
syndrome (from the Latin Sopo-p," meaning dt"ooping or drowsy) (Graybiel, A. 
and J. C. Knepton, "The Sopite syndrome: a component or even sole 
expression of motion sickness symptomatology", in preparation). This 
syndrome may be part of the clinical symptomatology or, if the eliciting 
stimuli are at a critical level of intensity, it may be the sole mani­
festation. In addition to drowsiness and lethargy, there is a reduced 
interest "in ongoing events and a performance decrement, especially when 
attempting to carry out tasks involving high-level mental activity. 
Lastly, just as in recovering from any illness, there is a period termed 
"convalescence". It is possibloe that the Skylab 2 Scientist Pilot 
experienced something in the nature of the Sopite syndrome in the work­
shop. 
Under experimental eonditions in the workshop the virtual failure to 
elicit symptoms of motion sickness in any of the five astronauts who 
were exposed to a stressful type of accelerative stimuli in a rotating 
chair (on or after mission day 8) implies that, under the stimulus 
conditions, susceptibility was lower aloft than on the ground, where 
symptoms were elicited preflight and postflight. The amount of this 
decrease in susceptibility could not be measured because the "ceiling" 
on the test (30 rpm) was so quickly reached. 
The difference in susceptibility between workshop and terrestrial 
conditions is readily traced to gravireceptors (mainly in the otolith 
organs; touch, pressure and kinesthetic receptor systems possibly 
contributing) for the reason that stimulation of the canals was the 
same aloft as on the ground, and visual inputs were always excluded. 
If it is assumed that the otolith system is responsible, then the 
absence of stimulation to the otolithic receptors due to gravity must 
have a greater influence (tending to reduce the vestibular disturbance) 
than the disturbing influences of the transient centrifugal linear and 
•Coriolis accelerations generated when head and trunk movements were 
executed in the rotating litter chair. Although these transient 
accelerative forces, as pointed out in the section on Procedure, are 
substantial their effectiveness as stimuli are virtually unknown. The 
otolithic zonal membrane has considerable mass, and transient accelera­ • 
tions lasting fractions of a second might have little or no effect. 
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The absence of gravity, causing what has been termed IIphysiological de­
afferentation" of the otolith receptor system, would be expected to 
reduce not only the indirect modulating influence of the otolithic 
system on the canalicular system but also its opportunity to interact 
directly with this system. 
The important question arises whether the prior adaptation to weight­
lessness "transferred ll to the rotating environment or whether it played
a secondary role; namely, simply ensuring the absence of overt as well 
as any covert symptoms of motion sickness. In this connection, the 
findings in parabolic flight are pertinent, inasmuch as the periods of 
exposure to near-weightlessness are brief. The alternating periods of 
supragravity and subgravity states in parabolic flight create a bias 
in favor of increased susceptibility to motion sickness in the rotating
litter chair. Motion sickness susceptibility has been compared in 74 
healthy subjects who executed standardized head movements while they 
rotated at constant velocity during sequential weightless phases of 
parabolic flights and during periods of exposures under laboratory 
conditions (12). ~lost subjects demonstrated either a substantial in­
crease or decrease in susceptibility, while a few experienced little 
change in susceptibility. 
Conclusions and Recommendations 
o 	 Skylab findings indicate three ways or means that permit weightless­
ness, a static state, to qualify as a unique motion environment: 
first, its quasidynamic potentialities for inducing changes in non­
rigid parts of the body; second, its unique potentialities at once 
limiting a person's natural movements and encouraging unnatural move­
ments that may result in unusual vestibular and visual sensory inputs; 
third, the demonstration under specific experimental conditions that 
susceptibility is lower aloft than on the ground. 
o 	 The lower susceptibility to vestibular stimulation aloft, compared
with that on the ground under experimental conditions, was "traced" 
to the reduction in g-load but had to meet a precondition, namely, 
either there was no need to adapt, or, as exemplified by the Skylab 3 
Pilot, adaptation to weightlessness had been achieved. The inference 
is that from the standpoint of the vestibular organs. the "basic" 
susceptibility to motion sickness is lower in weightlessness than 
under terrestrial conditions; how much lower remains to be measured. 
o 	 In the case of the Skylab 3 Pilot, the prolonged period of suscepti­
bility would seem to rule out any short-lived etiological factors 
associated with entry into orbit. 
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o 	 In the workshop three astronauts experienced motion sickness for the 
first time aloft, thus inferring at once the more stressful conditions 
in the workshop compared with those in the command module and the 
inadequate level of adaptation previously acquired. 
o 	 None of the Skylab 2 crewmen experienced motion sickness in the 
workshop, implying either there was no need to adapt (a .possibility
in the case of the Commander) or that prior adaptation in a less 
stressful environment afforded adequate protection. The period
during which the "adequate" adaptation in the command module was 
acquired by the Skylab 2 crewmen was much shorter than the period 
during which Skylab 3 and Skylab 4 crewmen were motion sick, let 
alone the additional period while recovering from motion sickness. 
Both of these findings have implications that argue for programing 
the acquisition of adaptative effects. 
o 	 Findings in some of the astronauts, under both operational and 
experimental conditions, emphasized the distinction between two 
categories of vestibular side effects, namely, immediate reflex 
phenomena (illusions, sensations of turning, et cetEra) and delayed 
epiphenomena that "incl ude the constellation of symptoms and syndromes 
comprising motion sickness. The relationship between the two cate­
gories deserves further study. 
o 	 The drug combinations l-scopolamine and d-amphetamine and promethazine
hydrochloride and ephedrine sulfate were effective in prevention and 
treatment of motion sickness; nonetheless, they are not the "ideal" 
antimotion sickness drugs. 
o 	 Although not used as a diagnostic test the antimotion sickness 
drug was helpful in diagnosing motion ~ickness, notably in the 
case of the Skylab 3 Pilot. 
o 	 Prevention of motion sickness in any stressful motion environment 
involves selection, adaptation, and the use of drugs. Today we lack 
laboratory tests that accurately predict susceptibility to motion 
sickness in weightlessness; susceptibility to motion sickness in 
the weightless phase of parabolic flight is promising but has not 
been validated. 
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II. 	 THRESHOLDS FOR PERCEPTION OF ANGULAR ACCELERATION AS 
REVEALED BY THE OCULOGYRAL ILLUSION (PRELIMINARY RESULTS) 
ABSTRACT 
The oculogyral illusion, briefly defined, is the apparent movement (in 
the direction of turn) of visual objects that are fixed relative to 
an observer who is passively exposed to angular acceleration. The 
purpose of the present study was to measure the oculogyral illusion 
response patterns of eight astronauts as determined on several 
occasions in the workshop and to compare them with measurements made 
preflight and postflight. The results show that aloft none of the 
subjects registered a consistent improvement in performance; compared
with ground-based values, four showed no change and four a slight
decrement. The results are discussed in terms of experimental cir­
cumstances in the workshop aloft and on the ground and in terms of 
underlying mechanisms. 
INTRODUCTION 
Both the oculogyral illusion and ocular nystagmus are used as indi­
cators of semicircular canal function and behavior. Nystagmography, 
generally regarded as the most useful of all indicators of vestibular 
function, was not available. In consequence, we made use of the 
oculogyral illusion (l) which, whatever its drawbacks, is a more 
sensitive indicator than nystagmus (2). The relation between the 
oculogyral illusion and nystagmus has long been an object of interest 
(3-5), and, while it seems that the illusion can be a consequence of 
nystagmoid movement, the behavior of the two responses may not only 
differ but even may simultaneously occur in the opposite sense. 
Although complete agreement regarding the effect of g-loading on 
nystagmus may be lacking, the weight of the evidence indicates that 
the intensity of the nystagmic responses increases and decreases, 
respectively, with increases and decreases in g-load (5, 7). It is 
also to be noted that these effects are quickly manifested and are 
ascribed to otolithic exaltatory or inhibitory influences. 
John Glenn conducted the first experiment in space flight that involved 
the oculogyral illusion (8). He compared the oculogyral illusion 
observed during rotation in the laboratory and in the Mercury space­
craft during the course of his o~bital flight. In Glennts. opinion, 
the illusory effects as the result of very similar angular accelerations 
were "essentially the same". 
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Roman, etal. (9), used the oculogyral illusion to measure "the 
sensitivity of the semicircular canals to stimulat;on lt during periods 
of weightlessness averaging 46 seconds in parabolic flight. This was 
accomplished by rolling the aircraft during periods of subgravity as 
well as during one-g control maneuvers and by timing the duration of 
apparent rotation of a visual target. It was concluded that there 
was no significant difference between the duration of the illusion 
under the two stimulus conditions. 
PROCEDURE 
Subjects 
Eight of the nine Skylab astronauts (the Skylab 2 Commander did not 
participate) acted as test subjects. Each had demonstrated normal 
otolithic and semicircular canal function, as indicated, respectively, 
by ocular counterrolling, and by caloric as well as oculogyral illusion 
responses. The oculogyral illusion perception threshold of each 
participant measured initially by a method (10) different from the 
one used in this study fell within the lower half of the distribution 
of 300 similarly tested normal healthy males as shown in figure 11-1. 
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Figure 11-1. Performance of the astronauts compared with that of 300 
normal subjects using a variation of the Skylab procedure. 
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~stibular Test Goggle. The vestibular test goggle, described in 
detail elsewhere (10), is a self-contained device worn over the sub­ject's eyes (fig. II-2). The' collimated line-of-light target, the 
only thing visible to the subject, is self-illuminated by a radioactive 
source and arbitrarily placed for viewing by the right eye only. The 
device is held on the face by its attachment to a biteboard assembly 
which, in turn, is secured by an adjustable support connected to the 
rotating litter chair. The distance between the ocular and occlusal 
planes is adjusted so that the subject's visual axis in its primary
position is essentially in the "horizontal" plane containing the optic 
axis of the target system. 
APPARENT 
TARGET 
t{)TION 
SELF-ILLUMINATED 
TARGET 
Figure 11-2. 	 Sketch of goggle device with slight rightward apparent 
displacement of line target as viewed by the astronaut. 
Some apparent displacement is commonly associated with 
apparent movement. 
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AaaeZeration ProfiZe. The rotating litter chair, described in part 1, 
was programed to rotate a seated subject (clockwise or counter­
clockwise) at anyone of 24 progressive logarithmic steps in velocity 
versus constant time (90 seconds) profiles within extremely narrow 
limits of precision. The man-supporting superstructure and motor of 
the rotating litter chair are directly coupled to eliminate gear slack 
and perceptible vibration and therefore meet the physiological re­
quirement of eliminating small performance errors that are normally
within the sensitivity range of the delicate vestibular organs. 
Plan 
The subject was secured in a seated postion within the rotating litter 
chair, and his biteboard and the vestibular test goggles were affixed 
to the support mechanism of the chair. He engaged the biteboard with 
his teeth and donned the vestibular test goggle by tilting his head 
forward 20°. The target viewed by his right eye was adjusted so that 
it appeared vertical and straight ahead. The purpose of the fixed 
head tilt was to place the "plane" of the lateral canals closer to the 
plane of rotation. The rotating litter chair device had the capabil­
ity of generating anyone of 24 progressive logarithmic steps of con­
stant acceleration ranging from 0.02°/sec2 (step 1) to 3.000 /sec 2 
(step 23); two log units of acceleration separated steps 23 and 24. 
However, in order to reduce in-flight experimental time, the test 
selection was limited among steps 1,4,8,10, 14 and 18. In the 
first two missions, steps 1, 4, 8, 10 and 18 were used; in the third 
mission, step 14 was introduced as a test option when appropriate to 
determine performance within the large interval between acceleration 
log steps 10 and 18. When step 14 was used, step 1 or 18 was omitted, 
the choice depending upon the pattern of prior test performance by
the subject. Testing was always done in the ascending order to 
acceleration rates. After one of the acceleration rates was selected 
on the basis of the predetermined test schedule and prior subject 
performance, the program start switch of the rotating litter chair 
was pressed. After two seconds of constant positive acceleration, the 
subject was signalled to open his eyes; after five seconds' accumula­
tive time, he was signalled again to judge whether the target appeared 
to move rightward or leftward, or to remain stationary. If the 
subject did not respond after 15 seconds' accumulative time, a third 
signal was given. If no response was received within 20 seconds' 
accumulative time, the end of the constant acceleration period and the 
beginning of the 25-second constant velocity phase, it'was assumed 
and recorded that no movement was perceived. The subject was in­
structed to close his eyes immediately after each response. 
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The down ramp of the profile required the subject, as in postive 
acceleration, to open his eyes at 2 seconds and to respond between the 
5th and 20th second after deceleration had begun. After reaching 
zero revolutions per minute, the rotating litter chair remained sta­
tionary for at least 25 seconds. 
RESULTS 
All data collected before, during and after the Skylab missions 2, 3 
and 4 are presented in table 11-1. The table lists the number of 
a) correct, b) incorrect with respect to the apparent direction of 
movement, and c) no movement responses divided by the total number of 
expected right and left responses at each level of acceleration tested 
in each session, preflight, in-flight (mission day) and postflight. 
A summary of these results are portrayed in figure 11-3 as average 
"frequency of seeing" curves with percentage of correct responses 
among eight trials for each of the acceleration test steps under the 
three major test conditions: preflight, in-flight, postflight. Com­
parisons of the tabulated preflight data indicate similar individual 
response patterns with a tendency for each subject to "improve with 
repetition of the test. 
A relatively wide range of accelerations was employed to increase the 
probability that each participant's subthreshold to suprathreshold 
range of response would, in the event of even gross changes, be cap­
tured during each test session aloft. It was found that the pronounced 
changes occurred principally at acceleration levels that produced near 
threshold levels of the oculogyral illusion perception (i.e.~ percep­
tion frequency in this study is complicated by the procedure used. 
Although each astronaut was instructed to always report any nonmove­
ment of target, he knew as the result of his dual role as subject and 
examiner that only right or left responses were appropriate. If he 
failed to ignore or was influenced by his knowledge of the procedure, 
the test became a forced-choice situation and the chance factor was 
50 percent; if he chose among the three responses the change factor 
was 33-1/3 percent. An illustration that a given set could influence 
perception of the oculogyral illusion is given in the comments of the 
Skylab 4 Commander when he said, "I close my eyes and I can * * * 
and it took me about three times as long to figure out that I was 
really rotating to the left. I think that had I been rotating to the 
right and been prejudiced I would have probably seen it very quickly. 
But it was rather interesting to see that I could prejudice myself and 
then it made it very difficult for me to figure out the real rotation. 
I had to - it is really best to think at all of rotation in either 
direction. I find out I might also add is that I saw quite a few 
white flashes - about seven - white flashes while I had the 
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TABLE II-I. 
OCULOGYRAL ILLUSION RESPONSE FOR EIGHT ASTRONAUTS 
Number of correct and incorrect responses divided by the total number of 
expected correct responses reported by eight Skylab astronauts (Skylab 2 
Commander did not participate). When exposed to constant angular accel­
eration at "indicated log step increases, preflight, in-flight, and post.. •flight. 
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TABLE II-I. (Concluded) 
R._
........ 	 RalpOtl.. ••'POnM It,,tpOn''110.....­A.. C......, 'l'I~et <:orr"c' fncotnh;;t Cot ... ct Incornet Comtct I"COC't.cl Correct fncorrwct CQJ"ct inC»TnKt 
l • ..I l.ft 'light NOM L.h lipt NOM L"h light N.... L.rt lirt NoM Left ltight Nor- l."ft light NOM 
... I
-<= 
en •
-
8 
• 
6 
7 
l-219 * , I 
0 
0 
I 
I 
0 
l~2~ 
1 I 
0 1 
I I 
0
, 
0 
l-W 
0 
0 
I 
0 
0 
I 
l-IO 
I 0 
0 I 
0 
0 
:;::: 10f I.e 6 0 I 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
0.. 18 I 0 0 0 0 0 
... 
.<:: I 
.~ .. 
I 
I 
6 
MIl It 
• 3 1 I 
0 
0 
MD II 
I 
0 
1 
0 
MO 19 
• 
, 
6 0 
0 
0 
, 
7 
MD ,7 
j 
I 
0 I 
0 
0 
0 
MO 1,7 
j 
L 
0 
0 
0 
0 
MD bII 
I 
I 
0 I 
0 
0 
0 
~ 10 
t I'
.5 18 
7
•I 
0 I 
0 0 
0 0 
0 
0 
0 
I I 
0 0 
0 0 
0 
0 
0 
8 0 
7 
e 
0 
0 
0 
0 
0 
0 
8 
8 
0 0 
0 0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
.... •• 5 .... It 
-<= ICI'> 
.~ • 
;;:: 8 
0 0 
I 7 
I 0 
0 
0 
0 
5 1 
8 0 
7 0 
0 
0 
0 
.. 10 
:g 'I,
Q.. 18 
0 0 
0 0 
0 
0 
7 0
• 0 
0 
0 
l-719 l-l30 l-.] l-W 

-<= I I 3 I 0 

... 
,1 0 0 0 I 0 I 0 0 

8 0 • 1 I 0 0 0 I 0 I 0
;;::10 I 0 0 0 0 0 0 0 0 0 

.~ • 
~ t.t 	 0 0 0 0 1 0 
0. I. 6 0 0 0 	 0 0 0 
MIl 8 MD 12 MO 26 MD '7 MO 67 MO 81
.... I I I 3 3 0 7 J 0 I 0 

CI'> • L 0 0 0 0 1 L 0 1 I I I 0 

-<= , 	 • 
.~ 8 0 I 0 0 0 0 I 0 I 2 0 0 1 0 2 0,L;: 10 I 0 0 I L 2 0 0 1 2 0 0 0 2 I 0 

~ t .. 0 0 I I 0 0 0 0 0 o. 0 0 0 0 0 0 

-II 0 0 0 0 0 

... •• 5 It '" II 
,Q -<= 1 8 0 0 0 I 2 0 
ftS ~ I 7 0 0 0 0,... . 
• 
5 
~ 8 7 I 0 0 0 I 0 ~ ..... 10 0 0 0 0 0 0 ~ ... 8 0 0 0 0 0 0 
en .f I. 
.. 	
l-O? l-lO 
I 	 3 0
-<= 
• •CI'> 	 0 0 5 2 I 0 0 I I 
1 0 7 0 0 I I 0 0 

+t ;;::10• 6• 0 0 • 1 0 3 0 0 I 0 <Il I. 0 0 0 0 0 0 
r- et 11 0 ,• I 0 2 0 0 0
.... -~- .....---..-..----.... ----_....----....---_......--_...._---_.. --------.. ----..... --- ....------------.. ----.,,------~- -----..----.. _----- -----........ -...... ---..... -------­
0.. ... MIl • MIl 12 MIl 21 MO .9 MO 67 MIl 81 
.<:: I 2 3 I 0 
..,. CI'> • • 1 I 0 I 6 0 6 0 0 
,Q"i~ ~ 0 I : 3 : I 6 ~ ~ ~ : • 3 I ~ ! 0 0 ~ : ~ 0 ~ 
ftS <=.. 6 0 0 2 ] 0 0 I • 2 0 2 6 I 0 1 • 0 0 2 I 1 0 6b ~ ~!.----:..--~----~--..-:-----~-----~----~---~.--------------------------------------- ---- ----~--- -.<'.....~-...~.--.--~-.--?--.--~.---~.-
Vl 	 +J • ., I +1I It -+- 11 
.<:: 6 1 1 
.g' .. 3 2 3 0 ] I 0 0 3 3 2 	 * l 
­ ""_ "." ......., of..,..
to 	 MltsJon Day "tI"5: ~ : : : : : : : : : o 	 *"-'Y pi... "." ....... of do",
<It" , I 0 2 6 	 I 0 I 6 I o
.f ~ 2 0 0 6 ] 0 0 0 
• 
206 

• 
• 
z 
o 
~ 
a. 
LtJ 
U 
0::: 
LtJ 
a. 
1.1.. 
o 
-r/! 
t;. 
Z 
LtJ 
:::::> 
0' 
LtJ 
0::: 
1.1.. 
LtJ 
(!) 
< 
0::: 
LtJ 
>
< 
Skylab 2 
100 SPT 
80 
60 
40 i! 
·1 \ ,... 
\ ......,..., 
20 \ i \j 
0 
Skyl ab 3 
100 PLT 
80 
60 
40 
20 
I 
0-'-----
Skylab 2 
PLT ......-::;;' 
, " d'" 
if 
i i 
i ! 
if 
if 
if 
if/i 
Skylab 4 
CDR /. .I.i\. . .I 
f .' // ....~....... 
j : 
i PREFLIGHT 
X IN-FLIGHT 
-.-.--­ X POSTFLIGHT 
Skylab 3 
CDR 
Skylab 3 
SPT 
CDR = COll1l1ander 
SPT = Scientist Pilot 
PLT = Pilot 
Skyl ab 4 
SPT ,...­
,1····· ....... 
/!
_.,,,' f 
Sky1ab 4 
PLT ./\ 
iAf 
\ ,,-' ~ \/ \ ........,. \ '. f 
l 
f 
II 
o 
I , I I II , , I, rrll--'-",'-,-'--'-',I II Itt I 
10 20 0 10 20 0 10 20 0 10 20 
ACCELERATION LEVEL (LOG STEP) 
Figure II-3. A summary of the data in table II-I shown as "frequency
of seeing" curves with percentage of correct responses 
among eight triats for each test. 
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vestibular test goggle on." It was interested to note that prior to 
unusual performance of the SL 4 PLT on mission day 81, ground-control 
provided feedback information and question his poor performance (sic)." 
In the first mission the Scientist Pilot and Pilot demonstrated higher 
thresholds under weightless conditions than on the ground; moreover, 
they showed a greater intersessional range in this response to angular 
acceleration compared to their preflight and postflight thresholds of 
response which were similar. These subjects' data reflect their sub­jective comments that the illusion It./as in general "more difficult for 
them to perceive in-flight and in particular in the midrange of the 
acceleration steps. Both subjects reported that at steps 4 through 10 
the target often spontaneously appeared to oscillate principally right­
ward and leftward at a frequency of 1 to 2 seconds. These oscillations 
were regularly perceived by the Scientist Pilot and sometimes perceived
by the Pilot. It is important to note that these oscillations were 
never observed during ground-based testing preflight or postflight. 
In the third mission, the Commander (tested only twice aloft) and Pilot 
revealed average responses that were similar to their preflight and 
postflight levels. The Scientist Pilot's performance aloft was slightly 
but not significantly below that on the ground. All three subjects 
reported some oscillatory movement aloft but were more aware of drowsi­
ness during the test aloft than on the ground. 
The Skylab 4 Scientist Pilot and Pilot of the third and longest mission 
showed a tendency to perceive the illusion less frequently as the mission 
progressed, whereas the Commander revealed no consistent change during 
or after the mission. The Scientist Pilot demonstrated recovery to 
baseline levels in the first and second postflight trials, 5 and 
11 days after recovery, respectively. The Pilot revealed a reversal in 
his pelhformance on mission day 81, i.e., his performance for the most 
part declined as the stimulus increased. This unusual response mode 
persisted in the first test postflight (five days after recovery) but 
six days thereafter his performance equalled or excelled his preflight 
scores. 
DISCUSSION 
The results show that none of the subjects aloft consistently improved 
in their ability to perceive the oculogyral illusion, whereas ·four 
revealed some decrement and the remaining four no consistent change in 
this perceptual task. In this discussion we will consider possible 
reasons for the performance decrements inC"luding decreases in 
canalicular sensitivity. 
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The potential nonvestibular influential factors that were reported by 
the crewmembers in the first two missions were a spontaneous oscillatory 
illusion and the soporific effect of the test conditions. During the 
first mission, the target line of the vestibular test goggle when 
viewed under certain conditions began to oscillate spontaneously, 
principally in the horizontal but sometimes in the vertical direction. 
Movement occurred mainly when the subject was accelerated at midrange 
levels (table II-I). The Skylab 2 Scientist Pilot, for example, re­
ported: "Remember the 1 eft-ri ght, 1-second to 2-second cyc1; ng - it 
was not present in step 1. I noticed it in step 4 and in most of the 
responses through step 10; and in step 18 I didnlt notice it * * *. 
For me, it was always of equal amplitude and approximately equal fre­
quency. It was really only noticeable at the lower levels of OGI, 
although I don't remember seeing it at level 1. You might consider 
something in the way of an optical fatigue or a progressive illusion. 
Also, it wasnrt noticeable at higher levels 10 and 18 when you were 
seeing a genuine OGI. II 
The Skyl ab 2 Pi lot observed, II I thi nk predomi nant1y, when I saw thi s 
illusion, it was at level 4. I think the frequency was essentially 
unvarying. However, I had the impression at times and I surmise itls 
strictly an impression, that instead of oscillating either side of the 
datum, it would go all to one side, to the left, to my 1efC. Although 
both astronauts felt that this oscillatory illusion did not interfere 
with their perception of the oculogyral illusion, the data would in­
dicate otherwise. This space flight illusion of movement cannot be 
explained by any physical movement of the subject or apparatus. Even 
when the astronauts attempted to produce this illusion in space by 
active head movement, they were unsuccessful as reported by the Skylab 2 
Pilot in a conversation with mission control: "And the test you wanted 
us to run, yes, you can excite a movement of the line by gradually 
very gently rocking your face back and forth. However, thatls not 
whatls causing it. I feel very confident because it just looks differ­
ent. I did not experience the back and forth, left-right oscillations 
today at any level except 4 and I got it on - lid estimate a little more 
than half of step 4. 11 It is interesting to note that the Skylab 2 
Scientist Pilot also reported a type of oscillatory movement of the 
reticle during observations through the onboard telescope. Although 
acceleration at the step 18 level tended to increase target stability, 
the registration of this relatively high stimulus level as well as the 
lesser levels was not as marked in-flight. The Skylab 2 Scientist 
Pilot describes his change in oculogyral illusion perception as: IIEven 
in step 18 I felt that the OGI responses were not marked, that they 
were being reinforced by seat of the pants which is pretty definite in 
step 18, and my general feeling is that the OGI response is not as 
clean cut as it is on the ground". 
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The genesis of the oscillatory movement may be related to the drowsiness 
that was experienced by the astronauts; pendular-type eye movements may
be a prominent feature of drowsiness just short of falling asleep. The 
exclusion of useful visual cues and normal otolithic and other gravi­
receptor inputs, the restriction of active head or bodily movements, 
the relatively constant auditory inputs and the gentle rotational move­
ments of the chair evidently constituted a high effective inducement 
to sleep and its attendant eye movements. 
•The level of inducement, furthermore, seemed dependent upon the ade­
quacy in terms of quality as well as quantity of an individual's sleep 
in space. The first mission crew maintained that their sleep was 
quite adequate; however, the Scientist Pilot who perceived the oscilla­
tory movement of the target more frequently than the Pil ot commented, 
"go"ing through the OGI test, it was very hard to stay awake. If you 
make your body motionless you just really power down." During the 
second mission, drowsiness became a more prevalent factor with only the 
occasional appearance of the oscillatory type of spontaneous illusory 
movement as reported by the Scientist Pilot and Pilot who were tested 
six times in-flight (the Commander was tested only twice during the 
final 15 days of the mission) and showed no appreciable changes. 
Drowsiness often led to sleep for brief periods. The reduction in 
scores of the Scientist Pilot and Pilot at times could be attributed 
to nonperformance due to sleeoiness. For example, the Scientist Pilot 
observed that, liThe peT noted this time and I noted on my run a couple 
days ago that you get awful sleepy underneath that set of goggles and 
you really tend to doze off. The PLT had to give a "no" response to 
a couple of questions simply because he had forgotten that a response 
was due. He didn't know that I had tapped him. I remember having
done the same thing on my run," The Pilot suggested: lilt would be 
a good idea to schedule OGI in the morning because it's awful easy to 
go to sleep with that experiment, difficult to concentrate especially 
in the afternoon. You could even go to sleep real easy in the morning. 
It's a good sleep-inducing experiment, and it should be done when 
youire fresh," His suggestion was followed and after mission day 32 
testing was carried out in the morning rather than the afternoon but 
no real changes were noted. It is significant that drowsiness was 
never experienced by any of the subjects during either preflight or 
postflight testing. Curiously, although the Skylab 3 Scientist Pilot 
aloft noticed a greater sensitivity to rotation at step 18, his 
general ability to perceive the illusion was less. 
The results obtained in the Skylab 4 mission are at once the most 
important (because of the duration) and most difficult to explain. 
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The Commanderts performance was much the same aloft as on the ground, 
but the Scientist Pilot's performance aloft was lower than on the 
ground. For as yet unexplained reasons, the Pilot showed a curious 
reversal in slope of his resultant curve on the last mission test day 
and the first test postflight. In the second test postflight his 
perception of the oculogyral illusion was excellent, comparable to his 
best performance preflight and far exceeding his scores made after 
mission day 12. 
TENTATIVE CONCLUSIONS 
o 	 The fact that the performance of all of the Skylab 3 crewmen·and 
the Skylab 4 Commander was about the same aloft as on the ground
demonstrated that they experienced no inhibitory influences re­
duci ng the effective "sensitivity" of the semi ci rcular canals. In 
consequence, the sma 11 decrements in performance manifested by the 
remaining four participants cannot be regarded as lithe rule H • 
o 	 The differences in performance between the two groups might be ex~ 
plained on the basis of less favorable testing conditions aloft or 
simply represent individual differences. 
o 	 In any event, the behavior of the oculogyral illusion in weightless­
ness is different from that reported for nystagmus measured during 
parabolic flight. This 1s of theoretical interest, at least, con­
tributing to the evidence that these two responses have different 
underlying mechanisms. ' 
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III. THE PERCEIVED DIRECTION OF INTERNAL AND EXTERNAL SPACE 
ABSTRACT 
Two series of tests were conducted. In each series the rotating litter 
chair was used in different positions: 
o upright or tilted slightly in pitch and roll~ and 
o horizontal or tilted slightly in pitch and roll. 
In one series a modification of the vestibular test goggle was used 
that enabled the subject to indicate the position of a line-target 
system within the roll and pitch planes. In the other series a rod~ 
and-sphere device was used that enabled the subject with eyes covered 
to indicate the perceived direction of space without furnishing ade­
quate cues. All of the tests were carried out in the workshop whether 
aloft or on the ground. In all test situations the subject's task was 
to use the workshop as the frame of reference and indicate either his 
internal body axes or the vertical and horizontal of the workshop~ the 
external frame of reference. The analysis of the findings is incom­
plete~ but the plots show that the results using the vestibular test 
goggle was similar aloft and on the ground. The results using the 
rod-and-sphere device were quite different in the two environments; 
the estimates were fairly accurate on the ground and the "deviations ll 
aloft exhibited characteristic patterns. 
INTRODUCTION 
In Gemini flights V and VII an experiment was conducted in which the 
astronautts task was to set a dim line of light (in an other\'1ise dark 
field) to an external horizontal reference~ Aloft this reference was 
a panel horizontal with reference to the astronaut's seat while on the 
ground the test was conducted with the astronaut secured in the gravita­
tional upright position. Except for a systematic error in the case 
of one astronaut the settings made aloft were as accurate as on the 
ground. The inference drawn was that relatively meager touch, pressure 
and kinesthetic receptor cues served as well as the more plentiful
nonvestibular and otolithic cues on the ground. It was these findings 
that generated the interest to repeat the experiment under far more 
favorable conditions in Skylab missions (l). 
Astronauts 
In the Skylab 2 mission it was decided that the Commander would not 
participate in the oculogyral illusion or motion sickness susceptibility 
tests. It was left to the Commander to determine whether and to what 
extent he would act as a subject in the space perception tests. 
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Apparatus 
Goggle Device. Devices for studying the visually perceived direction 
of space in the absence of visual cues have long been in use, but the 
principle underlying such devices is so simple that its elegance is 
seldom appreciated. The basic device is a visual target, usually a 
line pattern of light on a dark background, that can be manipulated to 
indicate the direction of space yet afford no clue to its direction. 
The so-called vestibular test goggle used in the Gemini V and VII 
experiment was modified for the specific purpose of the Skylab mission. 
The overall appearance of the goggle is shown in figure 111-1. The 
inner surface of the goggle forms the soft-cushion carrier portion 
structured so that it may be pressed firmly against the subject's face 
without discomfort. The mask section of the goggle forms the rigid base 
for 
o 	 attachment of the target and optical system, 
o 	 gear mechanisms and scales for adjustment and reading out the 

positions of the target in the roll and pitch planes, 

o 	 stabilization of the coupling to the biteboard assembly, and 
o 	 the external cover. 
The slit target consists of a single 0.1 mm x 0.55 mm sealed vial of 
tritium gas (U.S. Radium Corporation - Atomic Energy Commission 
license 09-06979-03) which requires licensing for handling. The self­
luminous light source has a relatively constant level of illumination 
over a half-life of 12 years without bulbs, batteries, and wiring
which would require periodic servicing and replacement. High reliabil­
ity and essentially complete safety of this light source are assured 
by a rugged housing qualified to withstand spacecraft launch forces. 
The target light is collimated by a triplet located near the subjectts 
eye. The position of this triplet can be adjusted toward or away from 
the target with a fine threaded screw adjustment to correct for a wide 
range of spherical refractive errors of the subject, thereby ensuring 
a sharp image of the test target for each subject. 
The pitch of the target is adjusted (throughout a range of ±20 degrees 
relative to a reference plane normally at eye level when the subject 
is upright) by means of a knurled knob (fig. 111-1) that activates a 
mechanical link to a rack and pinion gear. The target's roll position 
can be changed by rotating a second knurled knob (fig. III-l) linked 
to a helical gear arrangement (36:1 ratio); fine rotary adjustment 
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Figure 111-1. 	 Goggle device showing behavior of the target in the 
pitch and roll planes. 
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can be made without limit in the clockwise or counterclockwise direc­
tion. The line pattern target was designed with a break at its center. 
serving as a visual reference point and a break near one of its ends 
to indicate polarity. The entire target and optical system is arbitrar­
ily placed in the right half of the goggle for viewing by the right 
eye only. 
The device weighs less than one pound and is easily supported and held 
firmly against the subject's face solely by his teeth interfacing with 
the biteboard assembly. Dental impression material softened by heat 
or more permanent material fashioned by a molding process is deposited 
on the biteboard for custom fitting. One model of the goggle is pro­
vided with scales for direct readouts. another \I/ith potentiometers for 
continuous writeouts. 
Rod-and-Sphere Deviae. Most devices for indicating the upright are 
confined to movement in one plane. The rod-and-sphere device shown in 
figure 111-2 was fabricated specifically for the Skylab experiment. 
The reference sphere is a 6-inch diameter. lightweight (12 ounces). 
hollow, metallic sphere that is used in conjunction with the magnetic 
pointer. The pointer is attached to the rotaticng litter chair by 
means of a flexible arm that contains readouts for indicating the 
pointerts pitch and roll position ~ith reference to the sphere, but 
not translational movements. This arrangement allows considerable 
freedom of movement of the device without reference cues to the rotat­
ing litter chair. 
In using the rod-and-sphere device it is not possible to set the rod, 
say, to the upright in the frontal plane first, then make the setting
in the saggital plane. Instead, the final setting must be reached 
incrementally, i.e., usually two or three steps. The astronauts did 
not regard this constraint a significant handicap. 
On the ground the weak magnetic field made it necessary for the subject 
to exert pressure to keep the rod on the sphere unless the rod was 
near the gravitational upright; the rod-and~sphere device was easier 
to use in weightlessness than on the ground. 
Chair Deviae. The rotating litter chair could be perfectly positioned 
with regard to the visual upright of the workshop. When tilted for­
ward 11.01° from the upright there was an inescapable leftward roll 
of 4.5°. In the litter mode when the rotating litter chair was 
horizontal there was a roll of 0.9° leftward; When tilted head upward
12.1° the leftward roll was 4.95°. 
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Water Immersion Tank. A small facility was constructed to carry out 
the space perception tests underwater. The object was to simulate 
weightless conditions with regard to touch~ pressure and kinesthetic 
receptor systems but preserve otolith function. 
Plan 
In using the goggle device the subject grasps the bite piece with his 
teeth, which causes his face to come in firm contact (in a repeateble 
.#fixed position) with the goggle surface. He then closes his eyes 
for 60 seconds, opens his eyes, and sets the target in the roll and 
pitch planes to internal references (the target aligned with his longi­
tudinal body axis and its broken tip pointed toward his head and its 
center in the IIstraight-ahead" position). The subject closes his eyes 
and signals the observer when he has completed this task. The observer 
then reads and records (in the onboard log book) the settings, after 
which he offsets the target in some random fashion. This procedure is 
repeated for a total of five times. The subject next relaxes his bite 
and moves backward from the goggle to observe his position relative 
to the Skylab for a 10-second period. He then reassumes the test 
position and sets the target in relationship to the external reference 
(target aligned with the longitudinal axis of the Skylab and its broken 
tip pointing "upward,1I and its center at eye level with reference to the 
Skylab floor). The subject then closes his eyes and signals the ob­
server to record and offset the target. This cycle is repeated until 
five pitch and roll settings have been recorded. This entire procedure 
of internal and external spatial localization is repeated with the 
chair in its tilt positions. 
The chair is returned to upright, and the observer next attaches the 
magnetic pointer and readout device to the chair. The vestibular test 
goggle is removed, and the subject1s eyes are covered with the blind­
fold. The subject grasps the sphere in his left hand, the magnetic 
pointer in his right, and attempts to align the pOinter in a manner 
analogous to the visual judgments. For the internal reference judgments, 
the pointer is placed parallel to the apparent long axis of his body 
with its free end pointing in the direction of his head; for the exter­
nal judgments, the pointer is aligned with the perceived direction of 
the Skylab longitudinal axis and pointed upward. Five internal and .. 
external reference settings (each separated by the subject releasing 
the rod and the observer offsetting it) are obtained both in the up­
right and tilted chair positions. The rotating litter chair is finally 
converted to its litter mode and the same procedure for measuring the 
nonvisual perception of space with the rod/sphere device is conducted 
with the litter horizontal as well as tilted. 
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RESULTS 
All of the findings (none for water immersion) have been plotted in 
terms of the astronaut1s actual settings. In general, the settings 
using the goggle show a strong tendency to cluster, the settings made 
on the ground overlapping those aloft. Occasionally there is a 
systematic deviation from the IIperfectll score. The plots not only are 
difficult to envision in terms of the position of the subject but also 
in terms of the measurements of the errors. In consequence, the data 
is being replotted in terms of actual positions the subject indicates 
with reference to the workshop, and small line drawings will allow the 
reader immediately to grasp the stimulus situation. 
The plots using the rod-and-sphere device show considerable scatter 
except when 	 the chair is upright in the ground-based workshop. Settings
made aloft show a tendency toward deviations of a similar nature. 
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THE EFFECTS OF PROLONGED EXPOSURE TO WEIGHTLESSNESS ON 

POSTURAL EQUILIBRIUM 

J. L. Hornick> ph.D. *> M. F. Reschke> Ph.D. '* and E. F. Miller II> Ph.D.-r 
ABSTRACT 
Postural equilibrium performance by the Skylab 2, 3, and 4 crewmen 
following exposure to weightlessness for 28, 59 and 84 days, re­
spectively, was evaluated using a modified version of a quantitative 
ataxia test developed by Graybiel and Fregley. The test employed a 
series of narrow metal rails of varying widths on which the crewman 
was required to maintain an upright posture with his feet tandemly 
aligned and arms folded across his chest. Performance for this test 
was measured under two sets of conditions. In the first the crewman 
was required to maintain postural equilibrium on the rail (or floor) 
with his eyes open. In the second condition he attempted to balance 
with his eyes closed. In both cases performance was scored in terms 
of time (in seconds) on the rail before losing balance. Preflight
baseline data were obtained on three separate occasions for each of 
the crewmen. Tests following the 28-day, Skylab 2 mission were 
limited to balancing with eyes open and eyes closed while standing on 
the floor only. Postflight data were obtained at 1,9, and 29 days
following mission terillination for the Skylab 3 crew and at 1, 4, 11, 
and 31 days following mission termination for the Skylab 4 crew. 
A comparison of the preflight and postflight data indicated moderate 
postflight decrements in postural equilibrium in three of the crew­
men during the eyes open test condition. However, in the eyes closed 
condition, a considerable decrease in ability to maintain balance on 
the rail s was observed postfl ight for a11 CrelfJTl1en tested. The mag­
nitude of the change was most pronounced during the first postflight 
test day. Improvement was slow. However, on the basis of data ob­
tained, recovery to preflight baseline levels of performance was 
evidently complete at the end of approximately two weeks for all crew­
men. The findings are explained in terms of functional alterations 
in the kinesthetic, touch, vestibular, and neuromuscular sensory 
mechanisms induced by the prolonged absence of a normal gravitational
stimulus. 
*Neuroscience and Behavior Laboratory, NASA - Johnson Space Center, 
Houston, Texas 77058 
-rNaval Aerospace Medical Research Laboratory, Pensacola, Florida 32512 
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INTRODUCTION 

In his normal gravitational environment man has four sources of sensory 

information which can be used to maintain postural equilibrium: 

vision, vestibular inputs, kinesthesia, and touch. Of these senses 

the superiority of vision as a basis of postural stability has been 

demonstrated by a number of investigators (1,2,3,4,5,6,7,8).

Even when other systems are nonoperative, vision can be employed to 

maintain upright posture. On the other hand, provided that the 

mechanoreceptors are intact, vision is not essential as evidenced by

the observation that blind people have little difficulty in maintain­

ing postural equilibrium (3). 

There is also little doubt that functional disturbances in the ves­

tibular, kinesthetic, and tactile sensory modalities can affect 

postural stability. People who have experienced unilateral labyrinth­

ine or cerebellar damage will often fall to the side of the lesion (9).

Patients with bilateral labyrinthine disturbances, on the other hand, 

frequently appear to exhibit little disability in maintaining a steady 

posture when standing with feet together and eyes closed in the' 

Romberg position (10). When the testin9 procedure is improved, however, 

and a sharpened Romberg is employed (11), bilateral labyrinthine de­

fects as well as other less dramatic vestibular disturbances do result 

in postural difficulties that are evident when the eyes are closed (12). 

These observations suggest that, in a closed loop system, the sensory 

basis of postural stability must include inputs from kinesthetic, 

pressure, and touch receptors, as well as visual and vestibular 

i n puts ( 1 3, 1 4) . 

That exposure to the dramatically altered environment en­
countered during weightless space flight may affect postural stability 

has been under investigation by our laboratories beginning with the 

Apollo 16 mission. Although complete data are not available from 

Apollo 17, preflight and postflight testing of the Apollo 16 crewmen 

indicated some decrement in postural equilibrium three days following 

recovery when the crewmen were tested with their eyes closed (15). 

Using a measurement procedure referred to as stabi1ography, investi­

gators in the Soviet Union have reported that the crewmen of the 18-day 

Soyuz 9 mission manifested difficulty in maintaining a stable vertical 

posture which did not normalize until ten days after the flight. The 

greatest disturbances were measured during an eyes closed test condi­

tion (16). 

On the basis of these observations it was hypothesized that, with pro­

longed exposure to a weightless environment, those sensory systems, 

with the possible exception of vision, necessary for the maintenance 

of postural stability, will undergo some changes. Further, these 
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changes are most likely originally peripheral, and involve the modifi­
cation of inputs from the receptors serving kinesthesia, touch, pres­
sure, and otolith function. As exposure is prolonged, habituation 
responses occur at a central level in the nervous system which con­
stitute learning in a new environment. When the environment ;s again
changed from weightlessness to l-g reference, ataxia and postural 
instability will be manifested as the result of the neural reorganiza­
tion that has occurred in weightlessness. 
The specific objective of this investigation was to assess the 
postural equilibrium of the Skylab astronauts following their return 
to a l-g environment and to suggest possible mechanisms involved in ' 
any measured changes. 
METHOD 
Postural equilibrium was tested by a modified and shortened version of 
a standard laboratory method developed by Graybiel and Fregly (11). 
Metal rails of four widths, 1.90, 3.17,4.45, and 5.72 centimeters 
(0.75,1.25, 1.75, a~d 2.25 inches), provided the foot support for the 
crewman during the preflight and postflight tests. In addition, rail 
widths of 1.27 and 2.54 centimeters (0.5 and 1.0 inches) were avail­
able for preflight testing only. A tape approximately 10.16 centi­
meters (4.0 inches) wide and 68.5 centimeters (27.0 inches) long 
served as a foot-guide al ignment when the crelrJlTlan was required to stand 
on the floor. Each crewman was fitted with military-type shoes for 
this test, both preflight and postflight to rule out differences in 
footwear as a variable in intrasubject and intersubject comparisons. 
The test rails and required body posture are illustrated in figure 1. 
Time, which was the performance measure of balance, began when the 
crewman, while standing on the prescribed support with his feet in a 
tandem heel-to-toe arrangement, folded his arms. His eyes remained 
open in the first test series. In the second series the time measure­
ment was initiated after the crewman attained a balanced position and 
closed his eyes. During initial preflight testing several practice
trials were allowed on representative rails until the crewman demon­
strated full knowledge of the test procedure and reasonable confidence 
in his approach to this balancing task. 
During a test session the initial rail width for testing with eyes 
open was typically 3.17 centimeters (1.25 inches). Three test trials 
with a maximum required duration of 50 seconds each were given. If the 
ti me 1 i mi twas reachedi n the fi rs t two tri a 1 s, a thi rd was not per­
formed, and a perfect score of 100 seconds was recorded for the 
initial support width. If the crewman failed to obtain a perfect 
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Figure 1. Illustration of postural equilibrium test rails and a subject
demonstrating the required test posture. 
A
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score, the two largest time values for the three trials were summed to 
obtain-the final score. The choice of the second rail width depended 
upon the crewman's performance on the initial support width. If his 
score was greater than or equal to 80 seconds, the next smaller sup­
port width was used; if his score was less than 80 seconds, the next 
larger support width was used. Testing on a third rail size was re­
quired when both of the two previous support width scores fell either 
above or below the 80-second performance level. Testing with eyes 
closed followed the same procedure except that a larger rail support.
5.72 centimeters (2.25 inches) was typically used initially. Eyes 
closed testing always followed testing with eyes open. The time re­
quired to perform the entire test was approximately 18 m"inutes. All 
tests were conducted with normal laboratory illumination. 
Three preflight baseline tests were performed on each of the Sky1ab 2, 
3. and 4 crewmen approximately six months prior to their space flights. 
These postural equilibrium tests were part of a comprehensive battery 
of vestibular tests completed by each of the crewmen at the Naval 
Aerospace Medical Research Laboratory. 
Tests following the 28-day Sky1ab 2 mission were limited to balancing
with eyes open and eyes closed while standing on the floor only. These 
tests were conducted during the first and second day followinq splash­
down. Postflight tests on the Sky1ab 3 Scientist Pilot and Pilot· 
were conducted on the second, ninth and twenty-ninth day following 
termination of their 59-day mission. The Sky1ab 3 Commander was ex­
cluded from postflight testing because of an acute back muscle strain 
acquired on the first day postflight which might have been aggravated
by the test procedure and which. in any event. would have affected his 
performance on the rails. Postflight tests on each of the Sky1ab 4 
crewmen were conducted on the second, the fourth. the eleventh and 
the thirty-first day postflight. The Sky1ab 4 flight was 84 days
in duration. With both of the latter two crews the tests on the second 
day following splashdown were conducted onboard the recovery ship 
which was tied to a dock and, therefore. provided a stable platform. 
All subsequent postflight tests were conducted at the Johnson Space
Center. 
RESULTS 
Postural Equilibrium Tests 
Preflight data obtained on these crewmen indicated that they were all 
well within the range of postural equil"ibrium performance typically 
exhibited by young. healthy aviator-type subjects. 
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The limited postflight data collected on the Skylab 2 crewmen indi­
cated that th~y all experienced considerable difficulty with standing 
on the floor during the eyes closed test condition. They had no 
trouble, however, in meeting the performance criterion when permitted 
the use of visual cues. In considering the significance of these data, 
it must be remembered that the tests were performed on a moving ship. 
Data obtained preflight and postflight on the Skylab 3 Scientist 
Pilot and Pilot and the Skylab 4 Commander, Scientist Pilot, and 
Pilot are presented in figures 2 to 6, respectively. In these 
figures eyes open and eyes closed postural equilibrium performance on 
each of the rail sizes used, plus the floor, is plotted as a function 
of test day. The baseline data point shown against which the post­
flight data are compared is the mean of the preflight data for that 
condition. The standard error of the mean was selected as a descriptor 
of the variance observed in the baseline data and is represented by 
dashed lines. Approximately 50 percent of those cases where no 
variance is indicated are the result of having only a single data 
point on the rail size in question; otherwise, the standard error of 
the mean is less than one. 
Visual inspection of figures 2 and 3 indicates that the Skylab 3 
Scientist Pilot and Pilot showed a decrease of approximately the same 
magnitude in eyes open postural equilibrium performance when tested on 
the second day after splashdown. However, a more pronounced decrement 
in ability to maintain an upright posture was observed in the eyes 
closed test condition. This change was more evident in the Pilot and 
is clearly demonstrated by the 5.72 centimeter (2.25 inches) rail size 
data seen in figure 3. Indeed, without the aid of vision on the 
second day of recovery, the Pilot experienced considerable difficulty 
even when attempting to stand on the floor, a condition he was never 
confronted with preflight because of his excellent balance on the 
4.45 centimeter (1.75 inches) and 5.72 centimeter (2.25 inches) rail 
sizes. Complete recovery to preflight levels of performance did 
occur in both the eyes open and eyes closed conditions for both of 
these crewmen. However, the rate of recovery for the Pilot was ap­
parently slower as evidenced by his relatively poor score on the 
5.72 centimeter (2.25 inches) rail on the ninth day after recovery. 
In contrast to the Skylab 3 crewmen, the Skylab 4 Commander and Pilot 
demonstrated no decrease in their postflight eyes open postural 
equilibrium as measured by this procedure (figures 4 and 5). They did, 
however, show a very large deficit in ability to balance with eyes 
closed. In the case of the Commander, this postflight change is 
clearly indicated on the first day after recovery with the 5.72 centi­
meter (2.25 inches) wide rail. Also, it can be seen that on the first 
day after recovery he was almost unable to maintain the required 
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Figure 2. 	 Postural equilibrium test performance for the Skylab 3 Scientist Pilot. 
The abscissa for each rail size shown indicates the days on which 
testing occurred, including a mean baseline (BL) val~e. The ordinates 
show total time on the rails where total time is the sum of the best 
two of three trials. Data obtained with eyes open and eyes closed are 
indicated by closed circles and triangles respectively. The dashed 
lines represent values for the standard error of the baseline mean. 
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Figure 3. 	 Postural equilibrium test performance for the Skylab 3 Pilot. 
The parameters are the same as those described for figure 2. 
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Figure 4. Postural equilibrium test performance for the Skylab 4 Commander. 
The parameters are the same as those described for figure 2. 
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Figure 5. 	 Postural equilibrium test performance for the Skylab 4 Pilot. The 
parameters are the same as those described for figure 2. 
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vertical posture while standing on the floor with his eyes closed. 
Improvement was evident on the fourth day after recovery, and the 
data obtained on the eleventh day indicates that both of these crewmen 
had regained their preflight level of ability on the eyes closed 
portion of this task. 
Data obtained on the Skylab 4 Scientist Pilot are presented in 
figure 6. It can be seen that, like the Skylab 3 crewmen, the 
Skylab 4 Scientist Pilot experienced a postflight decrease in 
ability to maintain postural equilibrium in both the eyes open and 
eyes closed test conditions. The magnitude of change was much greater 
without vision. On the fourth day after recovery this change was 
still very evident, but by the eleventh day this crewman's ability to 
balance on the test rails had returned to baseline proficiency. 
Subjective Reports and Observations 
The postflight decrease in postural stability demonstrated by the 
rail tests are supported by observations of and subjective reports by
the crewmen. 
Although all of the Skylab crewmen were able to walk with minimal or 
no assistance immediately after exiting the Command IViodule, they did 
so with noticeable difficulty. During this initial postflight 
period on the recovery ship, they tended to use a wide-stanced shuf­
fling gait with the upper torso bent slightly forward. With each 
passing hour back in the one-g environment, they gained confidence 
and proficiency in their ability to walk about unaided. By the end 
of the first recovery day all of the crewmen showed considerably
improved ambulatory performance and by the time they were ready to 
disembark the recovery ship on the second day after recovery, they 
manifested few noticeable signs of ataxia or postural instability. 
During the first several days following splashdown, and especially on 
the first recovery day, all of the crewmen reported that the simple 
act of walking required a conscious effort. The Skylab 3 Commander, 
for example, reported that, when he stepped forward, he had a feeling 
that he was moving sideways. Also, nearly all of the crewmen re­
ported that they had to be especi ally careful when wa"1 king around 
corners because they had tendency to fall to the outside. This 
problem was described by a few of the crewmen as a sensation of 
forced lateral movement. 
Related to these subtle disturbances in postural stability was the 
report by all of the crewmen that rapid head movements produced a 
sensation of mild vertigo. This sensation could be effectively 
controlled by holding the head steady. Several of the crewmen, 
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Figure 6. 	 Postural equilibrium test performance scores for the Skylab 4 Scientist 
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including the Skylab 4 Commander and Pilot, indicated a particular 
need to hold their head steady while attempting to balance on the 
test rails. Any slight head movement, especially during the eyes 
closed test condition, would induce the vertigo sensation and cause 
them to lose balance. The movement-induced vertigo diminished grad­
ually and in most cases was gone within three to four days following 
splashdown; however, the Skylab 4 Pilot reported that he occasionally 
experienced mild vertigo with rapid head turns as late as eleven days
after recovery. It is also of interest to note that on the second 
and fourth days after recovery, the Skylab 4 Pilot reported experienc­
i ng a II wi de dead-band II when attempti ng to balance on the test rail s 
with his eyes closed. In other words, he was unable to accurately 
sense small displacements of his head and body. 
Because the postflight test intervals were infrequent and not at the 
same times for each crew, the time course to complete recovery cannot 
be clearly specified. However, on the basis of observations and data 
obtained, it appears that the Skylab crewmen required up to ten days 
to regain their normal postural stability. These results are in 
close agreement with the Soyuz-9 postflight postural stability 
findings reported from the Soviet Union. 
DISCUSSION 
The results from the present study provide evidence that postural 
stability can be affected by prolonged periods of exposure to weight­
lessness. Support for the hypothesis that central neural reorganiza­
tion occurs in response to environmental change is obtained when the 
postflight decrease in stability on the rails and the time course 
for recovery is compared with preflight performance. 
That adaptive changes may occur and contribute to disturbances of 
equilibrium following exposure to a weightless environment is reason­
able from a physiological point of view. As one basis of postural 
stability, vision can expect to undergo little change. However, the 
vestibular apparatus (particularly otolith input), kinesthesia, and 
touch will be those sensory systems most affected by exposure to 
zero-g. 
Subgravity levels can be experienced in parabolic flight, free fall, 
and short jumps. Water immersion and sensory deprivation procedures 
minimize stimulation of kinesthetic and touch receptor systems without 
lifting the gravitational load on the otolith receptors. It is only
in space flight that prolonged periods of weightlessness can be 
achieved. During these periods, kinesthetic and touch stimulation is 
reduced and otolith input is considerably modified. Static otolith 
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output cannot in this latter situation provide information for spatial 
orientation (spacecraft vertical) nor can kinesthesia or touch provide 
reliable sensations unless the crewman is in contact with a rigid 
surface to provide some reference pOint. 
That these sensory systems can habituate to the weightless environment 
;s suggested by the increased ability with time for the crewmen to 
maneuver with decreasing difficulty. In this regard physiological 
evidence has been obtained that suggest adaptation toward the norm in 
the frog1s otolith system following four to five days exposure to 
weightlessness (17). It is also possible that habituation in weight­
lessness of the sensory systems basic for postural stability ;s 
similar to the changes experienced in other unusual force environments 
such as prolonged exposure to slowly rotating rooms and movements 
encountered on ships. 
If this is the case, then several mechanisms could be proposed to 
account for the changes occurring as a result of exposure to weight­
lessness. First, a central nervous system "pattern center" con­
cept (18) could be postulated to help understand the possible mechanism 
encountered in the habituation process. For example, following inser­
tion into orbit the crewmen may experience difficulty in maneuvering 
and find orientation to be a problem. After four to five days, move­
ment from one area of the vehicle to another would become somewhat 
easier. Fine motor control to determine displacement would be 
established. Adaptation in the postural mechanicomotor system would 
have occurred. 
On the basis of the postulated pattern center, the radical environ­
mental change encountered in transitioning from one-g to zero-g 
would result in vastly different outputs from the otolith, kinesthetic, 
and touch receptors. These altered outputs would then be sent to their 
corresponding centers and these in turn relayed to the pattern center, 
where a copy of the appropriate movement was stored progressively over 
time. Once an adequate memory of the pattern is built up, the pattern 
center would take over movement and automatic balance control. 
Further, under control of peripheral inputs from the otolith, kines­
thetic, and touch receptors relaying the actual movement, the center 
would permit anticipation of the coming movement. Return to a one-g 
environment would result in a recurrence of difficulty, both in 
locomotion and postural equilibrium. Habituation to a gravity refer­
ence would beg"in almost immediately and a new effective pattern in the 
pattern center would be established possibly in a time proportional 
to the previous duration of weightless exposure. 
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A second mechanism could possibly be responsible for the changes noted 
in postural stability. Biostereometric analysis of body form indicated 
that the crewmen experienced a measurable postflight reduction in body
tissue volume, part of which was muscle tissue (19). A significant 
percentage of the total volume loss noted was in the thigh,s and calves. 
A postflight decrease in leg strength was also measured (20). In the 
case of the Skylab 3 crew the average leg strength loss was approxi­
mately 20 percent. As the present task required standing on the rails 
in a sharpened Romberg position, it is possible that the crewmen were 
physically incapable of completing the task due to disuse atrophy of 
the major weight bearing muscles. 
A third alternative is also possible. Both a hyper Achilles tendon 
reflex and an increased gastrocnemis muscle potential were observed pos~ 
flight in the Skylab 3 and Skylab 4 crewmen (21). This hyperactivity 
could have resulted in overreaction and overcompensation on the part
of the crewman, thus making rail performance difficult. 
The fourth mechanism that could be responsible for the degradation of 
postural stability observed postflight in the Sky]ab crewmen is one 
which would include as contributing factors all of the possibilities 
mentioned. Once the pattern center serving the postural, mechanico­
motor system has been established in weightless and must begin 
habituation to a one-g reference, increased reflex sensitivity may be 
only one aspect of the process. A second aspect may be that the loss 
of tissue volume would contribute to a reduction in mechanical damping
of leg movements. For example, if we look at the pattern center serv­
ing the postural, mechanicomotor system as one in which control 
depends on negative feedback (as the muscle spindle control system
does), then it -is possible for instability to occur both in locomotion 
and postural equilibrium. The -instability results because the error 
signal takes time to generate a corrective response. This means that, 
if no compensation for the error is programed, the corrective signal 
would arrive at such a time that the leg, in this case, has already 
moved on to a new position. A second correction would be necessary
which would also result in overshooting. To stop this oscillation 
around the desired point, the limb movement must be damped. Pure 
mechanical damping is provided by the in-series elastic elements in 
the muscles as well as the viscosity of muscle tissue and joints (22).
More tissue in the leg adds increased mechanical damping while less 
tissue would tend, to permit underdamped movements. 
An alternate way of viewing damping is to suggest that the reflex 
control system depends on an output determining both position error 
and the ra te-of-change of muscle 1 ength . When the sys tem has rate-of­
change infor~ation available, anticipation of the new limb position 
is predictable and a corrective signal can be initiated to begin 
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corrective adjustment (23). The hyperreflex activity observed could 
be a compensatory reaction generated in the mechanism responsible for 
programlng the position center as a result of modified otolith input
and a mechanically underdamped system. 
Our results tend to support this fourth hypothesized mechanism. 
Decreased postural stability was observed in all crewmen when tested 
postflight. Although the larger deficits were obtained when visual 
cues were not available, there were greater changes in postflight 
equilibrium in the Skylab 3 crew with vision than there were in the 
Skylab 4 crew. Correspondingly, the Skylab 3 crew did not exercise 
to the same degree in-flight as the Skylab crew and, as a result, 
exhibited a greater loss in leg muscle strength and muscle tissue. 
This suggests that vision compensated less with increasing muscle mass 
loss. 
These overall findings argue for an environment dependent memory store 
(pattern center) of frequently repeated sensory inputs that is under 
the guidance of a combined otolith, kinesthetic, and touch system 
which registers the actual movement and allows for anticipation and 
compensation of each movement as it occurs. Being environmentally 
dependent, such a mechanism could account for the buildup of postural 
responses (such as hyperreflex activity) in zero-g that would be 
inappropriate upon return to a one-g reference. A mechanism of this 
type could be applied to account for sensory physiological habituation 
in a variety of situations. In particular, such a mechanism could 
provide an adequate basis for change when the acquired response 
patterns are no longer congruent with the environment. 
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SKYL~B SLEEP MONITORING EXPERIMENT (M133) 
James D. Frost~ Jr.~ M.D. *; William H. Bhumate~ Ph.D.t; 
Joseph G. Balamy~ Ph.D.*; and Cletis R. Boohep~ B.B.E.E. § 
ABSTRACT 
Astronauts on pre-Skylab missions commonly complained of insomnia, and 
in some cases periods of sleep loss degraded crew performance. 
Investigation of this situation was important in planning future long­
term flights. Subsequently, the first objective measurements of man's 
ability to obtain adequate sleep during prolonged space flight were 
made during the three manned Skylab missions. 
Electroencephalographic, electro-oculographic, and head-motion signals 
were acquired during sleep by use of an elastic recording cap contain­
ing sponge electrodes and an attached miniature preamplifier! 
accelerometer unit. A control-panel assembly, mounted in the sleep 
compartment, tested electrodes, preserved analog signals, and auto­
matically analyzed data in real time (providing a telemetered indica­
tion of sleep stage). 
One subject was studied during each manned mission, and, while there 
was considerable variation among individuals, several characteristics 
were common to all three: stage 3 sleep increased during the flight 
and decreased in the postflight period; stage 4 was consistently 
decreased postflight, although this stage was variable during the 
flight; stage REM (rapid eye movement) was elevated, and REM latency 
decreased in the late postflight period (after day three post re­
covery); and the number of awakenings during sleep either showed no 
change or decreased during the flight. 
In only the 28-day mission (Skylab 2) was there a significant decrease 
in total sleep time; in that case it was a result of voluntarily re­
duced rest time and was not due to difficulty in sleeping nor frequent 
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awakening. The subject on the 84-day mission (Sky1ab 4) experienced 
some difficulty in the first half of the flight. showing a decreased 
total sleep time and increased sleep latency. but this resolved itself 
with time. Sleep latency presented no problem in the other flights. 
While many of the findings are statistically significant. in no case 
would they be expected to produce a noticeable decrement of performance 
capabi 1 i ty. 
These findings suggest that men are able to obtain adequate sleep in 
regularly scheduled eight-hour rest· periods during extended space 
flights. It seems likely. based upon these results. that the problems 
encountered in earlier space flights did not arise from the zero-g 
environment per se~ but possibly they were a result of more restricted 
living and working areas in the pre-Sky1ab spacecraft. 
INTRODUCTION 
Prior to Skylab. very little objective information had been obtained 
concerning man·s ability to sleep in space. Only by continuous 
electroencephalographic monitoring can such information be obtained. 
and the technical problems associated with acquisition and analysis 
in space are significant. Before the advent of manned space flight. 
there was some concern about the possible adverse effects of this 
weightless environment upon sleep characteristics (1). During the 
Gemini program. however. it became apparent that fairly long duration 
space flight was not associated with drastic alterations of sleeping 
behavior. Astronauts could sleep in space and. on at least some 
occasions. did so fairly well. In the Gemini and Apollo programs. 
though. it became clear that in many instances "insomnia was a problem. 
Sleep loss. while not absolute. was apparently sufficient in some 
instances to result in performance decrements. In several instances. 
sleeping difficulties resulted in the use of hypnotic drugs to promote 
sleep and an amphetami ne-type medi cati on to increase alertness fo 11 ow­
ing sleep loss. 
It has long been recognized that sleep deprivation is associated with 
degradation of performance. the amount or severity of the performance 
decrement generally increasing in proportion to the length of the 
sleep loss (2). Since crew members are expected to perform at a high 
level throughout a mission. their ability to obtain sufficient sleep 
becomes an important variable in terms of overall mission planning and 
scheduling of daily work-rest periods. 
The United States· first attempt to record the electroencephalogram 
during space flight was carried out during the Gemini 7 mission in 
1965 (3-6). Technical difficulties associated with electrode 
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attachment limited recording to slightly under 55 hours. However, two 
sleep periods were observed, and, while the first was found to be 
inadequate in terms of duration and quality, the second was considered 
to be normal. Postflight examination of the recorded electronen­
cephalogram showed no pathological changes or definite alterations 
attributable to weightlessness. The limited nature of this recording 
precluded an adequate analysis of sleep characteristics during long­
term space flight; consequently, the purpose of the Skylab M133 sleep 
monitoring experiment was to obtain the first truly objective evalua­
tion of manls ability to sleep during extended space travel. 
The Skylab astronauts carried out a wide varity of work during the 
three missions, accomplishing numerous research projects in the 
physical and biomedical sciences. The working volume of the Skylab 
orbiting laboratory was over 12 000 cubic feet (comparable to a 
moderate-sized house), with adequate space to provide separate facili~ 
ties for work, recreation, meals, and sleep. The crews maintained a 
24-hour schedule based upon Central Standard Time, to which they were 
accustomed on the ground. At an altitude of approximately 270 statute 
miles, Skylab circled the earth approximately every 93 minutes. 
Each astronaut had his own sleeping compartment, which was equipped 
with a sleep-restraint system quite similar in appearance and function 
to a sleeping bag. An eight-hour rest period was typically scheduled 
between 10 p.m. and 6 a.m. for all three crewmembers, although varia­
tions in this protocol were occasionally necessitated by specific work 
requirements. 
Sleep was studied in an objective manner on three of the Skylab astro­
nauts, one each during the 28-, 59-, and 84-day missions. 
~1ETHOOS 
The complete sleep-analysis system designed for this experiment in­
cluded data-acquisition hardware, onboard analysis components, and a 
capability for real-time telemetry. 
Onboard equipment accomplished automatic analysis of the electro­
encephalogram, electro-oculogram, and head-motion signals. The 
system's output, consisting of sleep-stage information, was telemetered 
in near real time to ~1iss;on Control, where a profile of sleep state 
versus time was accumulated. The analoq siqnals (electroencephalo­
graphic, electro-9culographic, and head motion) were also preserved 
by onboard magnetic-tape recorders, thus allowing a more detailed 
post flight analysis. 
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Flight Hardware 
The components for the hardware are shown in figure 1. The astronaut 
wore a recording cap contain-ing electrodes for detecting electro­
encephalographic and electro-oculographic activity. A preamplifica­
tion unit, attached to the cap near the vertex of the head, amplified 
the signals, and a dual-axis accelerometer, housed within the pre­
amplifier, provided information concerning movement of the subject's
head. A flexible cable connected the preamplifier with a control­
panel assembly mounted on the wall in the subject's sleep compartment. 
Within the control-panel assembly, additional circuitry accomplished
automatic electrode testing, sleep analysis, and generation of the 
telemetry output signal, indicative of the subject's current level of 
consciousness. Two tape recorders, attached to the rear of the 
control-panel assembly, provided an analog record of the subject's 
sleep. 
The methodology has been extensively described in prior publications 
(7-10) and will be reviewed only briefly below. 
The recording cap (fig. 2),. made of an elastic-type fabric, stretches 
to conform comfortably to the subject's head. Ins i de the cap, sponge­
type electrodes are attached at the positions necessary for acquisi­
tion of electroencephalo9raphic and electro-oculographic signals; wires 
join the electrodes to a miniature electrical connector at the vertex 
of the cap, enabling rapid linkage with the preamplifier/accelerometer 
assembly. The cap contains seven electrodes, arranged such that four 
electrodes (left and right central positions, Cl and C2, and left and 
right occipital pOSitions, 01 and 02) provide a composite electro­
encephalogram channel (Cl and C2 paired together and referred to 01 
and 02 paired); two electrodes provide one electro-oculogram channel 
(one electrode lateral to, and one above, the left eye); while the 
seventh electrode serves as a ground. 
The electrodes are prefilled with a gelled, conductive electrolyte;
then the cap is stored in a plastic bag until needed. The donning 
procedure requires less than five m-inutes of the subject's time prior 
to retiring, and, since each cap is used only once, post recording 
breakdown is limited to removal of the cap, disconnection of the 
preamplifier/accelerometer unit, and disposal of the cap. 
The small, lightweight, preamplifier/accelerometer unit contains 
electroencephalographic and electro-oculographic preamplifiers (the 
gain is approximately six), electroshock-protection circuitry, and 
dual-axis accelerometers for detecting the subject's head motion in the 
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Figure 1. 	 Skylab M133 sleep monitoring experi ment hardware: 
control-panel assembly (l eft) recording cap and 
preampl if ier unit (lower right). 
Figure 2. Scientist Pilot, 59-day mission, in his sleep restraint. 
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lateral (side-to-side) and vertical (up-down) axes. The amplified 
signals pass through the flexible cable to the control-panel assembly, 
which provides final amplification. 
The preamplifier/accelerometer unit quickly attaches to the cap at the 
vertex, using a Velcro patch; an electrical connector provides elec­
trical continuity with the electrodes. 
The control-panel assembly, mounted on the wall of the sleeping com­
partment, is within easy reach of the sleep restraint. 
At bedtime, after the astronaut dons the recording cap, each electrode 
is automatically tested to insure proper function. The control-panel
front, easily visible from the sleep restraint, contains indicator 
lamps arranged in a configuration simulating the position of the 
recording electrodes on the head. As the astronaut activates the test 
circuit, a small current (approximately 10~A) passes in succession 
through the single ground electrode to each of the recording electrodes. 
In this manner, interelectrode resistance is determined; if a given 
electrode has achieved proper scalp contact (resistance 50 000 g or 
less), the lamp corresponding to that electrode is illuminated. 
Improper contact is indicated by the failure of a lamp to illuminate, 
and the subject corrects this by gently rocking the electrode in 
question from side to side to position the tip through the hair. 
Continuous monitoring of electroencephalographic, electro-oculographic, 
and head motion signals is done during the sleep period. Following
final amplification within the control-panel assembly, the signals 
proceed to data-analysis circuitry and to analog magnetic-tape re­
corders. Two recording units compose the analog recording system, each 
unit's storage capacity being up to 150 hours of data. 
As the monitoring sessions progress, the data-analysis circuitry
within the control-panel assembly supplies sleep-stage information in 
near real time to observers in Mission Control. Onboard, the electro­
encephalographic, electro-oculographic, and head-motion signals are 
processed in real time. Electroencephalographic signals alone 
determine stages Awake, 1,2, 3, and 4 of sleep; electroencephalo­
graphic and electro-ocu10graphic signals differentiate stage REM. 
Signals likely to be contaminated by artifacts do not reach the 
analysis section, since the electroencephalographic and accelerometer 
circuits specifically exclude them. 
Automatic electroencephalogram analysis is based upon the decline in 
frequency and the general increase in amplitude seen as an individual 
progresses from the awake state to stage 4 sleep - criteria very 
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similar to those used in visual scoring techniques. Initial filtering 
limits further consideration of the single electroencephalographic 
channel to 0.7-13 Hz activity. The filtered signal then enters an 
amp1 itude-wei ghted frequency-meter ci rcui t with a va ryi ng d. c. 1eve1 
output: it is highest when the input signal is intermediate in ampli­
tude and high in frequency, and it is lowest when the input is high 
in amplitude and low in frequency. 
In consequence, this signal is proportional to sleep states encompass­
ing Awake to stage 4, the highest output value being associated with 
the waking state. A series of comparator circuits sense this voltage 
and compare it to previously determined voltage ranges, each range 
corresponding to one of the clinical sleep stages. So, while the 
output remains within the parameters designated for a given sleep 
stage, a constant indication of that stage flows to the final output 
logic of the system. 
The electroencephalographic-analysis circuitry cannot distinguish 
stage REM, and, because of its simtlarity in frequency and amplitude
to stage 1 or 2, the ci rcui try typi ca lly regards it as one or the 
other. Additional circuitry monitoring the single electro-oculographic 
channel detects events resembling rapid eye motion. Certain electro­
oculographic events, such as K-complexes, may develop in the 
electro-oculographic channel and mimic real eye movements, and these 
are recognized and excluded from further consideration. Other circuits 
use electroencephalographic and head-motion signals to prevent signals 
with high probability of artifactual contamination from influencing
the electroencephalographic and electro-oculographic sleep-determination 
circuits. The final output-logic scheme combines outputs from the 
electroencephalographic, electro-oculographic, and artifact-detection 
circuitry into a single value representing one of the possible sleep 
states and supplies it continuously to the spacecraft telemetry. 
Stage REM is indicated if periods of rapid eye movement coincide with 
an electroencephalographic-section output indicating either stage 1 
or 2. Rapid eye movements occurring in other stages are ignored, and 
the electroencephalographic-section output alone is accepted. 
Thus, the analysis-circuitry output continuously displays one of seven 
possible states: Awake; stage 1 through 4 and REM of sleep; or 
stage 0, indicating the absence of adequate data. This output, essen­
tiallya three-bit code, arrives at Mi,?slon Control in real time as 
the spacecraft passes over tracking stations. Between stations, the 
digital signals are recorded onboard and then transmitted at a high 
rate during a subsequent tracking-station pass. 
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Ground-Based Data Analysis 
During a sleep monitoring session, true real-time data was available 

only during the few minutes when the spacecraft was passing over a 

. ground tracking station. Throughout the frequent periods when the 
spacecraft was out of communication range, the spacecraft telemetry 
recorder accumulated sleep-stage data and transmitted it to the ground 
at a high rate during a subsequent tracking-station pass. The tracking
stations, in turn, relayed the information to Mission Control. 
Consequently, the data ultimately received during a sleep period was 
somewhat sporadic, ranging from actual real time to delays of up to 
several hours. Data-processing equipment in Mission Control collated 
the incoming data so that the time relationships were preserved, and 
eventually a complete tabulation of sleep state versus elapsed time 
evolved. 
Although data was te1emetered at a rate of 1.25 sleep-stage samples 
per second (75 samples per minute), a subject's sleep stage does not 
typically change more often than two or three times each minute, and 
it ;s often stable for several minutes. The data-processing system 
was therefore programmed to indicate only the time and the sleep stage 
when a change of sleep level occurred. The resultant listing of 
sleep-stage information versus time was transferred to The Methodist 
Hospital, where the computer facilities of the Neurophysiology 
Laboratory and the Baylor Institute of Computer Science were employed 
to provide the final data analysis. 
The end product was a compact graphic plot showing the complete profile 
of sleep stage versus time over the course of a sleep period. The data 
was displayed at a horizontal resolution of approximately 5 centimeters 
per hour, with a vertical span of approximately 10 centimeters, thereby 
providing an observer with an overall summary or profile of the sleep 
period (see example, fig. 3). A statistical summary of the all-night
data was also supplied for each sleep period, and values for the 
following parameters were included: total rest-period time, total 
sleep time, total awake time, sleep latency, number of arousals, 
accumulated time in each sleep stage, percentage of total sleep time 
occupied by each sleep stage, and REM latency. 
At the conclusion of each Skylab mission, the onboard data tapes were 
returned by the crew, and this data was then analyzed by conventional 
visual scoring techniques (11) after playback onto a graphic recorder. 
247 

STAGE R 
N 
~ jll.L jllllll~lJ~[oIUUlL_ LIIlJ 1JJJ 
.j::>. 
00 
3 -'n'~! ~ 
4 ----' I I.. : II lL" 
0 
I I I I I I I I 
0 I 2 3 4 5 6 7 
TIME, HOURS 
Figure 3. Sleep plot generated by computer: Scientist Pilot, day 21 of the 28-day mission. 
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Experimental Design 
One crewmember participated in the sleep monitoring activities during 
each Skylab flight. Baseline data was obtained on the participating 
subjects before flight during three consecutive nights of sleep moni­
toring, using portable apparatus functionally identical to the onboard 
hardware. The astronaut studied during the 28-day mission was recorded 
in his own home two months prior to launch, while the subjects of the 
59- and 84-day missions were monitored in the preflight quarantine 
facility two weeks before their respective launches. In addition, a 
standard clinical electroencephalogram was performed on each subject 
prior to the flight to permit precise electroencephalographic amplitude 
determinations for calibration of the flight hardware. 
Monitoring during flight was accomplished during 12 selected nights of 
the 28-day mission (nights 5, 6, 7, 10, 11, 15, 17, 19, 21, 24, 25, 
and 26), during 20 nights of the 59-day mission {nights 7, 8, 9, 12, 
15,18,21,24,27,29,33,36,39,42,45,48,52,55,56, and 57}, 
and during 18 nights of the 84-day flight (nights 3, 4, 10, 14, 19, 
24, 29, 34, 40, 45, 50, 55, 60,72,77,80,81, and 82). Operational 
factors associated with the activation and function of various space­
craft systems prevented recordings during the initial period of each 
fl i ght. 
Crew bedtime was typically 2200 hours d.s.t., and the scheduled sleep 
period terminated at 0600 hours d.s.t., although occasional deviations 
from this schedule were necessitated by work requirements not associated 
with the sleep monitoring experiment. During the last week of the 28­
and 59-day missions, sleeping schedules were adjusted forward by a 
total of four hours (i.e~~ typical bedt"ime became 1800 hours d.s.t.). 
An adjustment of two hours was made on days 20 and 22 of the 28-day 
mission, and there was a similar change of two hours on days 51 and 
53 of the 59-day mission. During the 84-day mission, schedule altera­
tions were made during the last three days only, and consequently only 
one day (day 82) of sleep monitoring was affected. On this day, the 
bedtime was advanced approximately two hours (approximately 2000 hours 
d.s.t.), and the subject was permitted a 10-hour total rest time 
(i.e., the time of awakening remained approximately 0600 hours d.s.t.). 
These scheduled alterations were necessitated by the activities associ­
ated with splashdown and recovery operations, which required early 
awakening on the final day of the mission. 
Upon return to Earth, postflight baseline studies were performed on 
each sleep monitoring participant. After the 28-day mission, record­
ings were done on nights 4, 6, 8, and in the case of the 59-day 
• 
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mission, on the second, fourth, and sixth nights following splashdown. 
Following the 84-day flight, recordings were made on the first, second, 
and fifth nights. 
Operational Factors 
A period of elevated temperature, present in the Skylab workshop prior 
to the arrival of the first crew (an effect of loss of a portion of 
the solar heat shield during launch), resulted in two problems with 
respect to the sleep monitoring activities scheduled for the first 
manned mission. Several recording-cap electrodes suffered partial 
dehydration, and as a result most of the data were lost during one 
scheduled recording night. In addition, the analog-tape recording 
system was damaged, and only two nights were successfully recorded. 
The recording-cap problem necessitated the use during the first 
(28-day) mission of caps intended for subsequent flights, which had 
been stored onboard the spacecraft in a location that remained cooler 
during the period of elevated temperature. 
The crew of the second manned Skylab mission (59 days) took a repair 
kit to refurbish the damaged recording caps by injection of supple­
mentary electrolyte gel prior to use. In addition, repair of the 
recording system was attempted prior to the first night of recording. 
These steps were generally successful, although one additional night 
was lost during the 59-day mission due to recording-cap problems, 
and six nights of tape-recorded data were lost near the end of the 
mission when the recording system again failed. 
Prior to launch of the Skylab workshop, the plan was to monitor sleep 
during only the first and second manned missions, so just enough 
recording caps were placed aboard to provide one for each scheduled 
night. When the schedule was later changed to include sleep monitoring 
on the final, or 84-day, flight, there were not enough caps remaining 
to permit use of a new unit for each recording session. Instead, the 
subject reused a cap several times and injected additional electrolyte
gel into the sponge electrodes before donning the cap each night. 
This technique was satisfactory, and the data quality remained high. 
Of the 18 sessions attempted during the 84-day mission, 17 were suc­
cessfully accomplished. One night (night 50) was lost when power to 
the on board hardware was lost after approximately two hours of record­
ing. A significant data loss also occurred on two additional nights 
of the 28-day mission and on one other night of the 59-day mission, 
stemming from ground-based problems in the data-processing system. 
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Despite the unforeseen problems, however, successful near-real-time 
monitoring was accomplished on 9 of the 12 attempted recording nights 
duri ng the 28-day mi ssi on, on 18 of the 20 ni,ghts attempted on the 
59-day mission, and on 17 of the 18 attempted sessions of the 84-day 
mission. Postflight return of the ana1og,tapes permitted visual 
confirmation of the results on 2 of the 9 nights of the 28-day mission, 
on 12 of the 18 ni ghts of the 59-day mi ss i on, and on 17 of the 18 
nights of the 84-day mission. 
STATISTICAL ANALYSIS 
The final results described below represent the best available esti­
mates of the various sleep parameters. The results are, when possible, 
those obtained by visual analysis of the tape-recorded electro­
encephalographic, electro-oculographic, and head-motion signals, since 
this method is considered the most reliable and the least influenced 
by various artifactual components that may be present. In the in­
stances where this was not possible due to loss of recorded data on 
several nights, the results of onboard automatic analysis have been 
utilized after application of certain corrective factors based upon 
past performance of the system and, in the case of the 59-day mission, 
upon correlation of the results during flight with those of visual 
analysis for the nights on which both types of information were 
available. 
Modification of Automatic-Analysis Results 
The uncorrected results of automatic analysis consistently under­
estimate stage REM sleep. This occurs because the criteria for con­
tinuous stage REM indication used by the automatic system include the 
occurrence of at least one detectable rapid eye motion per 3D-second 
time epoch. If such an eye motion does not occur, the output will 
revert to stage 1 or 2, as determined by electroencephalographic
criteria alone. In most individuals, true stage REM occasionally 
occurs for periods longer than 30 seconds in the absence of eye motion 
of sufficient amplitude to be detected by the automatic circuitry.
Typically, then, the output of the automatic system during a continuous 
stage REM peri od is a fl uctuati on between stages 1, REII1, and 2. Such 
periods usually are readily identified by inspection of the plotted
sleep profile (fig. 3). When the automatic data is modified by the 
assignment to stage REM of all time within such a period, the overall 
results are significantly enhanced. Such modification introduces an 
el ement of subjecti vity into otherwi se objecti ve data; however, we 
believe this is justified in this case, since past experience has 
confirmed its validity. 
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Other than eliminating certain obviously artifactual sections of 
data (e.g., sections near the start of each sleep period associated 
with cap donning and electrode-testing procedures), the REM­
modification step (MA, table I) was the only corrective factor 
instituted during the in-flight portions of the Skylab missions. 
Reliability of Automatic-Analysis Results 
After the 59-day mission, we compared the results of modified in­
flight analysis with those of visual analysis of the taped data for 11 
of the first 12 recording nights. The average (mean) error of auto­
matic analysis based upon visually determined total rest-period time 
was as follows: total rest-period time, +1 percent; total sleep time, 
+4 percent; sleep latency, -0.3 percent. The average (mean) error of 
automatic analysis in sleep-stage determination (as compared to the 
same visually determined parameter) was as follows: stage 1, 
+5.6 percent; stage 2, -0.4 percent; stage 3, -10.6 percent; stage 4, 
-0.7 percent; and stage REM, +6.1 percent. 
In most cases, then, automatic analysis gave satisfactory estimates 
of the actual value. The worst case, percent of stage 3 sleep, was 
apparently a result of the particular subject's sleeping pattern, in 
which a large proportion of the misclassified epochs were borderline 
in terms of stage 2 versus stage 3. The underestimation was consistent 
throughtout all 11 comparison nights. The stage REM overestimation, 
on the other hand, was not consistent and appeared to result solely from 
the inherent l"j Illitati ons of the automati c-ana 1 sys is scheme in detect­
ing this stage and in rejecting certain artifacts. 
Similar comparisons between visual and automatic analysis were made 
following the 84-day flight for the 17 successful monitoring sessions. 
In this case, the average (mean) error of automatic analysis com­
pared to the visually determined total rest-period time was as follows: 
total rest-period time, +1.2 percent; total sleep time, +4.4 percent; 
sleep latency, +0.9 percent. The average error of automatic analysis 
in sleep-stage determination (as compared to the visually determined 
parameter) was as follows: stage 1, +1.6 percent; stage 2, -11.4 per­
cent; stage 3, +7.9 percent; stage 4, +6.1 percent; and stage REM, 
-4.2 percent. 
Correlation and Regression Techniques 
Regression analysis, after correlation of automatic and visual results, 
provided a means for further modifying the results of automatic 
analysis (MeA, table II) for those six nights of the 59-day mission 
unconfirmed by visual analysis (i.e.~ nights 42, 45, 48, 52, 56, and 
57, for which the analog-tape data was lost). 
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TABLE I 
28 - DAY MISSION 
PREFLIGHT AVG. IN -FLIGHT /lWG POSTFLIGHT AVG 
N 
'(J'I 
'W 
MISSION DAY -60 -59 -58 5 6 10 15 17 19 21 24 26 +3 +5 +7 
ANALYSIS TYPE V V V V V MA MA MA MA MA MA MA V V V 
TOTAL REST TIME 7.3 7.3 8.7 7.6 6.6 6.3 7.7 7.4 5.6 7.7 6.5 8.0 6.0 6.B6 9.3 9.0 8.5 8.9 
TOTAL SLEEP TIME 6.5 6.5 7.7 6.9 6.1 5.4 5.3 7.0 5.2 6.6 6.2 7.2 5.4 6.04 9.0 8.5 8.0 8.51 
TOTAL AWAKE TIME 0.74 0.81 0.96 0.84 0.31 0.85 2.43 0.45 0.47 0.81 0.25 0.67 0.26 0.72 0.26 0.45 0.44 0.38 
SLEEP LATENCY 0.46 0.70 0.73 0.63 0.35 0.33 0.28 0.35 0.18 0.76 0.06 0.10 0.30 Q30 0.17 0.24 0.16 0.19 
STAGE I (%) 7.4 4.3 4.2 5.3 6.8 9.5 9.8 8.3 7.7 1.1 5.4 4.4 0.6 5.95 4.0 6.5 4.8 5.1 
STAGE 2 (%) 60.3 49.6 54.5 54.8 60.2 56.4 43.4 56.4 26.7 50.9 43.8 28.9 24.0 43.4 58.5 53.8 57.4 56.6i 
STAGE 3 (oto) 12.8 17.9 13.6 14.8 18.3 14.6 10.0 12.6 8.8 13,1 11.2 28.0 27.8 16.0 11.8 11.1 13.7 12.2 
STAGE 4 (oto) 2.9 3.4 2.4 2.9 4.6 0.8 12.6 17.1 14.9 14.5 16.5 27.7 41.6 16.7 1.0 1.0 1.3 1.1 
STAGE REM (oto) 16.6 24.8 25.1 22.2 10.1 18.6 24.1 5.5 41.9 20.4 23.2 11.0 5.9 17.9 24.7 27.5 22.8 25.0i 
REM LATENCY 1.24 1.24 1.91 1.46 2.31 1.66 1.98 0.93' 1.18 1.11 1.07 
NO. OF AWAKENINGS 
__ 
19 
.....L 
16 
~---
24 19.7 10 14 
. 
--­
-
--­
~--
, 
12 20 20 26 22 
TABLE II 
59 • DAY· MI$SOI 
N 
(J'I 
-Ilao 
MISSION DAY 
ANALYSIS T'/Pf 
TO TAL FIEST TIME 
TO rAL SLEEP TIME 
TOTAL AWAKE nljlE 
SLEEP LATENCY 
STAGE I (".J 
STAGE 2 1"1.) 
STAGE 3 1"4} 
STAGE 4 I,..) 
STAGE FlEIjI ('\I.) 
III[IjI LATENCY 
NO. OF IIIoIIAKVlNGS 
PREfliGHT IIWG • 
-IS -14 -13 
V V V V 
7.7 8.4 6.5 7.5 
6.4 7.6 5.2 6.4 
1.3 0.8 1.3 1.1 
0.3 0.09 10.2 0.2 
1 8.3 1.6 10.6 8.8 
513 sa3 53.3 56.3 
I 
18.0 16.4 17.1 17.4 
3.1 4.9 0.3 28 
13.2 12.7 111.2 14.1 
1.6 2.2 1.11 1.11 
37 51 34 40.7 
7 I 9 12 IS II 
V V V V V V 
6.90 6.59 823 7.14 7.32 7.05 
5.95 6.os 6.94 6.24 6.8E 5.75 
0.95 0.51 1.28 0.90 0.4E 1.30 
0.21 024 0.32 0.32 0.13 0.15 
7.5 5.9 11.2 10.6 81 11.9 
59.5 51.4 63.2 60.4 60.7 51.8 
19.1 13.5 13.8 11.2 18.6 15.1 
1.8 1.9 0.8 1.6 US 1.0 
12.1 21.3 ItO 10.2 10.7 13.4 
1.5 1.1 U 2.6 2.2 2.1 
39 32 70 52 62 43 
IN·fUGHT 
21 24 27 29 33 
V V V V V 
6.95 7.27 la7 1.90 7.19 
5.47 6..50 7.03 6.96 6.46 
1.49 0.77 0.87 1.94 0.73 
0.06 0.15 0.26 0.36 0.19 
11.6 9.5 11.3 13.5 4.3 
492 62.4 63.6 S6.6 60.' 
24.6 13.9 15.1 20.0 19.1 
3.1 1.3 0.8 1.3 1.1 
as 130 9.2 8.6 14.7 
1.6 2.2 2.3 2.9 1.6 
21 51 44 25 • 
36 3t 42 45 
V .., A 
.. 
CA 
.. 
'A 
7.38 7.21 7.23 7.55 
6.99 6.16 6.47 
0.38 1.07 1.08 
0.12 0.14 0.37 
5.0 7'5 9.4 
59.1 6.0 60.5 
194 15.4 17.9 
1.4 1.3 1.3 
15.1 Il' 132 
1.6 2.0 
25 
IIWG
-
POSTfliGHT .MO
.",- ,..=:: 
41 52 55 56 57 ., .3 .5 
M M, .. IjIC M 
'A CA CA V V IIA A 
7.68 6.82 6.78 732 6.61 7.32 1.09 8.44 7.77 
614 5.04 6.48 6.44 6.31 5.77 7'38 6.58 
1.54 1.71 0.114 0.17 1.00 1.32 1.06 119 
0.12 0.36 0.10 0.16 0.17 0.21 0.08 0.15 0.24 0.16 
10.5 1:3 6.4 U 8.9 10.4 9.9 10.2 
59,6 60.9 61.0 60.1 59.7 51.1 58.4 51'8 
16.2 16.6 11'4 21.1 11.5 12.0 8.2 10.1 
1.3 1.3 1.3 1.3 1.4 0.4 0.4 0.4 ' 
10.' 1.5 10.1 .2.1 20.1 210 21.6 
2.05 0.8 1.1 0.1 0.17 
119.3 26 31 21.5 
T
.... 
... ~ r 
As noted above, the overall correlation between visual and automatic 

results for stage REM percentage was low and consequently could not be 

utilized for reliable pre9iction of the remaining six values. 

However, it was determined that stage REM values below 20 percent, 

as indicated by automatic analysis, were better correlated with visual 

results; consequently, regression analysis for this stage was based 

upon correlations of only 6 of the 11 nights (discarding nights 7, 8, 

9,12, and 29). Corrected REM values were thus predicted for 5'of 

the 6 remaining nights, discarding the value (30.4 percent) for day 48, 

which exceeded 20 percent. 

These statistical maneuvers provided a consistent means for utilizing 
all the available information. The values obtained are included in 
the results presented below and were subjected to further statistical 
analysis along with the visual-analysis results, although it was 
determined that the overall significance of the results was the same, 
whether or not these values were included. 
Analysis of Variance 
Finally, for each mission, preflight, in-flight, and postflight con­
ditions for each parameter were treated by an analysis of variance. 
A posteriori comparisons were made in cases where the overall F test 
reached conventional levels of st~t;stical significance(p < 0.05). 
In summary, with respect to the final results outlined below, of the 
9 nights recorded during the 28-day mission, only the first 2 are 
based upon visual analysis. The remainder are based upon the modified 
results of automatic analysis. For the 59-day mission, the results of 
the first 12 nights are based upon visual analysis, while the last 6 
are automatic results modified both in-flight in terms of REM time and 
postflight by the application of corrective factors based uP9n visual/ 
automatic comparison of the first 12 nights. For the 84-day mission, 
all 17 nights are based upon the results of visual analysis. 
Data Quality 
Data quality, as evaluated by visual inspection of the signals played 
back from the analog tapes returned at the conclusion of each mission, 
was generally excellent. AlthOUgh recorder malfunctions occurred 
• during the 28- and 59-day missions, the data recorded prior to the 
failures were, in both instances, of high quality. During the 84-day 
f mission, the recorded signals were of clinical quality throughout. 
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Selected examples of the electroencephalographic, electro.oculographic, 
and head-motion signals, as played back from the onboard tapes, are 
shown in figures 4 through 6. Figure 4 illustrates the transition from 
the awake, alert state through the various stages of sleep for the 
Scientist Pilot on day 6 of the 28-day mission. A similar series for 
the subject of the 59-day mission is illustrated in figure 5, which 
were obtained during day 29. Examples from day 3 of the 84-day mission 
are shown in figure 6. 
RESULTS 
Sleep Latency 
The amount of elapsed time from the actual onset of the rest period 
until the first appearance of stage 2 sleep is defined as sleep 
latency. Sleep-latency characteristics observed during the three 
Skylab missions are summarized in figure 7 and tables I, II, and III. 
Average in-flight, preflight, and postflight figures for this 
parameter are indicated in the tables. Sleep latency varied con­
siderably during the 28-day mission (fig. 7 part A), ranging from a 
low value of 3.6 minutes on day 21 to a maximum of 45 minutes on 
day 19. Day 19 was, however, the only instance in which the latency 
exceeded the preflight values, and the average in-flight value of 
18 minutes actually represents a decrease of 20 minutes as compared to 
the preflight average of 37.8 minutes. Postflight values were all 
relatively low but well within the in-flight range. Statistically,
the in-flight and postflight latencies were less than the 'preflight 
values (p < 0.01). 
No statistically significant changes in sleep latency were noted 
during the 59-day mission, as indicated in figure 7 part B, although 
on several days the values were somewhat above the preflight average
of 12 minutes. This parameter ranged from a low of 4 minutes on 
day 21 to a maximum of 24 minutes on day 45. A cyclic fluctuation 
of sleep latency was suggested, with maxima near days 10, 29, 45, 
and 52. The in-flight average value (12.6 minutes), however, was 
almost exactly the same as the preflight value. The postflight 
latencies, averaging 9.6 minutes, were only slightly less than either 
the preflight or in-flight measurements. 
Sleep latency during the 84-day mission averaged almost the same in­
flight (15.6 minutes) as preflight (16.2 minutes) but dropped to an 
average of 7.8 minutes postflight (table III). Although the averages 
do not reflect a significant change, inspection of figure 7 part C 
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Figure 4. Examples of sleep recording, Scientist Pilot, day 6 of the 28-day mission. 
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Figure 6. Examples of sleep recording, Scientist Pilot, day 3 of the 84-day mission. 
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TABlE III 
84 -[)AY- MISSION 
PlllUl.IGHT -.0 "-FLIGHT AVG POSTFLIGHT .,c; 
N 
0"1 
MISSION DAY 
ANALYSIS TYP[ 
TOTAL REST TN[ 
TOTAl. SLEEP TIllE 
TOTAL MAKE TlMf: 
SLap LATENCY 
STAGE I ('I\,' 
STAGE 2 ''I\,' 
STAGE 3 ''I\,) 
ST:.GE 4 ,%) 
STAGE II£M l"-J 
REM LATENCY 
NO. OF MAKENIIIGS 
-13 -12' -II 
V V V 
7.4"S 8.11 
'.64 8.06 
6.59 7.43 7..5 7.29 
A... 0.68 0.18 0.17 
0.16 0.55 0.10 0.27 
10.6 1.1 1.2 .., 
59.5 54.1 6.2.0 5..5 
3.7 11.1 U 1.1 
0.0 0.4 0.1 0.2 
26.2 26.0 238 U3 
0.96 2.45 1.01 1.41 
20 21 21 20.7 
3 4 10 
V V V 
6.51 6.'2 6.40 
5.90 4.88 6.00 
0.61 1.94 0.39 
0.26 0..2 0.33 
4.9 113 !.7 
51.) 50.2 5.... 
1).0 10.6 6.4 
1.2 0.5 0.2 
23.6 25.4 29.) 
1.2" 0.12 0.19 
10 I 15 
I" ., 24 2' 34 40 45 
V V V V V V V 
1.30 1.2' '.11 6.92 '.33 1.61 6.49 
615 ~93 9.31 6.2E 6.83 7.49 6.16 
0.65 1.35 0.40 0.66 1.50 0." 0.33 
0.53 0.26 OJ. 059 020 0.0" 0.24 
8.6 6.4 6.& 10.4 ... 4.0 4.9 
61.4 50.& 56.1 54.3 50.9 65.5 65.0 
10.3 12.2 ~4 12.2 13.5 4.6 16 
0.6 1.3 0.1 1.6 1.5 0.1 0.4 
19.2 29.4 31.6 21.4 2~2 2~1 22.1 
0.95 1.15 1.03 1.19 2.22 1.11 1.08 
15 13 20 12 16 14 6 
50 55 10 72 77 80 II 82 +0 +1 +5 
V V V V V V V V V V V 
8.65 613 6.69 '.60 1.32 7.21 9.~ 7.56 8.61 6.25 8.09 761 
'.39 6.43 6.29 7.3. 5.43 5.58 8.8C 6.69 7.69 45Oi7.4O 653 
0.26 0,31 0.)9 1.22 1.90 1.64 1.01 0.81 o98!0.1'10,69 10&2 
008 0.14 0.19 0.,0.9 0.21 0.11 0..22 10..12 0..26 0.0.4 0.13 jO.2) 0..13 
~) 4.6 ~o ~4 6.9 1.. 6.2 6.16 ' I Ii14.2 , 1.0 ; 1,0 9.4 
53.' 61.& 66.8 61.8 &0.7 58.0 i6.2.5 58.5 i11.5 i11.1 15!-& 66.1 
9.2 U ).6 H 11.0 1.3 jlO.o 8.8 i2.2 33 i 2.5 2.7 
0.2 0.5 0.04 0.0 0.5 0.1 !0.). 0.5 10.0 I 0.1 ,004 ~.~ 
31.6 21& 24.5 29.5 20.9 26.1 20.~ 25.3 1 12 .1 11.61)4.6 21.8 
1.49 0.84 2.55 1.2) 1.1) 1.11 LOI 134 1.31 2.68,0.19 0.90 1.46 
22 6 6 I 12 II 10 12 21 
" 
24 1,,7 
reveals a preponderance of longer latencies in the first half of the 
mission and a decline as the flight progressed. The average value for 
the first half (days 3 through 40) was 21.4 minutes, while that for 
the latter half (days 45 through 82) was 9.7 minutes, a st~tistically 
significant difference (P < 0.05). 
In general, then, there was no evidence of difficulty in falling asleep 
in either the 28- or 59-day mission, while in the 84-day mission, 
values somewhat above baseline were seen in the first half of the 
mission but declined to normal or below normal in the final portion. 
Total Sleep Time 
A commonly used measure of sleep adequacy is the total sleep time ob­
tained in a given sleep period (i.e.~ total rest-period time minus 
total time spent awake). Figure 8 illustrates the total rest-period 
length (overall amplitude of vertical bars), the total sleep time 
(solid portion of bars), and the total awake time (dashed portion of 
bars) for each Skylab recording night and for the preflight and post­
flight baseline studies. 
It is apparent that in the 28-day mission (fig. 8 part A), there was a 
reduction in total sleep time throughout the in-flight period as com­
pared to the preflight and postflight studies. Postflight, total 
sleep time was significantly greater than the preflight and in-flight
values (p < 0.05 and 0.01, respectively). As indicated in table I, 
the in-flight average of 6.0 hours is almost one hour less than the 
preflight value of 6.9 hours and more than two hours less than the 
postflight average (8.5 hours). This decrease in sleep time, however, 
was due not to an unusual amount of time spent in the awake state but 
instead to a reducti on in the tota1 res t-peri od ti me itself. The 
subject thus slept quite well on most nights while he was in bed; 
however, he did not spend as much time in bed as he did during 
studies either before or after the mission. 
The postflight average value for total rest-period time (8.9 hours) 
was significantly higher than the in-flight average (p < 0.01) but did 
not differ significantly from the preflight value. 
No significant changes in the total sleep/total rest characteristics 
were obtained during the 59-~ay mission, as shown graphically in 
figure 8 part B. The total rest time (overall height of bars, 
fig. 8 part B), which averaged 7.3 hours in-flight (table II), was 
only slightly lower than either the preflight average of 7.5 hours or 
the postflight values of 7.8 hours. In terms of total sleep time 
(solid bars, fig. 8 part B) although there was considerable fluctua­
tion, only one day (52) was below the range established during the 
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preflight series, and the subject obtained in excess of 5 hours' sleep 
on all other nights. The in-flight average value of 6.3 hours (table II) 
is nearly the same as the preflight average (6.4 hours) and slightly 
lower than the postflight results (average, 6.6 hours). 
A wide range of variation in the total rest and total sleep times was 
seen during the 84-day mission (fig. 8 part C). Total rest time ranged 
from a minimum of 6.4 hours on day 10 to a maximum of 9.8 hours on days 
24 and 82. This parameter averaged 8.06 hours preflight, dropped by 
30 minutes to 7.56 hours in-flight, and then rose to 7.67 hours post­
flight; but these variations were not statistically significant. 
Although most of the in-flight period was marked by considerable 
variation from one recording session to the next, there was a con­
sistently lowered total rest time during the observations of the first 
19 days. The five values of this period averaged 6.86 hours, or 1.2 
hours below the preflight average. 
Total sleep time tended to parallel total rest time, and thus long 
periods of time spent awake during the night were, in this mission as 
in the others, rare. Sleep time ranged from a low of 4.88 hours on 
day 4 to a high of 9.37 hours on day 24. The in-flight average value 
of 6.69 hours is about 36 minutes below the preflight average of 7.29 
hours, but it is approximately 10 minutes higher than the postflight 
result of 6.53 hours. As in the case of total rest time, although the 
overall averages were not significantly altered, total sleep time was 
considerably lower during the first 19-day period. During this time, 
the average value was 5.87 hours, or 1.42 hours below the preflight 
average. 
It is of interest that, while the initial 19-day period was character­
ized by a reduced time in bed and correspondingly reduced total rest 
time, it was also marked by a higher value for total awake time 
(0.99 hours average) compared to either the preflight average
(0.77 hours) or the overall in-flight average (0.87 hours). 
Sleep-Stage Characteristics 
Sleep-stage characteristics for the three missions (expressed as 
percentages of the total sleep time for each recording night) are 
illustrated in figures 9, 10, and 11. Average percent figures for the 
various stages in the preflight, in-flight, and postflight periods are 
listed in tables I, II, and III. Comparisons of individual stage 
characteristics for the three missions are illustrated in figures 12 
through 16. 
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If the average values are considered, stages 1, 2, 3, and REM were not 
significantly altered during the in-flight period of the 28-day mission 
(fig. 9). Stage 1 occupied 5.3 percent of the total sleep time 
preflight and averaged 6.0 percent in-flight and 5.1 percent postflight .. 
The day-to-day in-flight characteristics show a considerable fluctua­
tion in stage 1 percent, with a tendency toward slightly decreased 
values in the latter portions of the flight (days 19 through 26). 
Stage 3, averaging 14.8 percent in the preflight period, rose slightly 
to an average of 16.0 percent in-flight and dropped to 12.2 percent 
postflight. As seen in figure 9, a small increase in the stage 3 
percent average was largely a result of moderate increases in this 
stage on days 24 and 26 at the end of the mission. Stage REM decreased 
only slightly from a 22.2 percent preflight average to 17.9 percent 
in-flight, although again there was considerable variation throughout
the flight, with some tendency toward a more marked decrease near the 
end of the mission. The postflight stage REM average (25.0 percent) 
was somewhat higher than either the preflight or in-flight values, but 
it did not attain statistical significance. 
Fairly clear-cut changes were seen in stage 2 and stage 4 percentages. 
In both cases, the most obvious alterations were seen in the last few 
days of the flight. Stage 2 dropped from an average of 54.8 percent 
preflight to 43.4 percent in-flight, returning to 56.6 percent post­
flight. These differences, however, were not statistically Significant. 
Similarly, stage 4 rose from 2.9 percent preflight to 16.7 percent 
in-flight, then dropped significantly (p < 0.05) postflight to 
1.1 percent. 
Thus, the 28-day mission was characterized by increased percentages of 
stages 3 and 4 and corresponding decreases of stages REM, 1, and 2, 
with the alterations confined primarily to the last few days of the 
flight. 
Sleep-stage features for the 59-day mission are illustrated in figure 10, 
and average values are tabulated in table II. Stage 1, averaging 
8.8 percent preflight, showed considerable variation in-flight but 
averaged almost the same (8.9 percent). The postflight average value 
of 10.2 percent was only slightly above the in-flight result. Stage 2 
remained fairly consistent throughout (preflight, 56.3 percent; 
in-flight, 59.7 percent; postflight, 57.8 percent), although there was 
a decrease during the final days of the flight (days 56 and 57). Thus, 
neither stage 1 nor stage 2 changed significantly. Stage 3 was similar 
in-flight (17.5 percent) and preflight (17.4 percent) and also 
exhibited a change near the termination of the flight, tending to 
increase slightly. The postflig~t average of 10.1 p~rcent, however, 
was Significantly lower (p < 0.01) than either the preflight or 
27~ 
in-flight values. This subject showed very little stage 4 sleep in his 
preflight study (2.8 percent), and this parameter decreased signifi­
cantly (P < 0.05) in-flight (1.4 percent) and postflight (0.4 percent) 
(p < 0.05), Stage REM showed the greatest alteration, dropping from 
14.7 percent during the preflight baseline series to 12.1 percent in­
flight and then rising significantly (p < 0.01) to 21~6 percent post­
flight. This postflight increase in REM was also significantly 
greater than the preflight value (p < 0.05). The REM decrease seen in­
flight was most prominent in the final phase of the study (days 52, 56, 
and 57). 
Sleep-stage characteristics for the 84-day flight are summarized in­
figure 11, and tpe average values are tabulated in table III. Stage 1, 
averaging 8.9 percent preflight, dropped in-flight to 6.8 percent~ then 
rose postflight to 9.4 -percent, a value slightly higher than the 
preflight average. There were no clear-cut trends discernible over the 
in-flight course of the mission. The stage 2 values were relatively 
consistent during the in-flight period, and the average value of 
58.5 percent was identical to the preflight average. Postflight
stage 2 showed a small increase, averaging 66.1 percent for the three 
days. As i ndi cated in fi gure 11, the fi rs t two postf1 i ght days \'Jere 
significantly higher than any of the preflight or in-flight values. 
Stage 3 was not significantly different in-flight (8.8 percent) as 
compared to the preflight value (7.1 percent). Postflight, however, 
this parameter fell to an average of 2.7 percent with all three values 
falljng well below the preflight and in-flight averages (p < 0.01). 
This subject showed very little stage 4 preflight, averaging only 
0.2 percent, and maintained a low level throughout the flight. with the 
in-flight average at 0.5 percent. There was a further reduction post­
flight, with the average value less than 0.1 percent. Stage REM 
percent averaged 25.3 percent preflight, and the in-flight average 
remained at 25.3 percent. There was considerable variation in this 
parameter over the course of the mission, however, but no definite 
trends were observed. Although the postflight average of 21.8 percent 
was slightly lower than either the preflight or in-flight average value, 
it is obvious (fig. 11) that this parameter was not stable in the post­
flight period. The value of 12.1 percent on the first postflight 
night is substantially lower than any of the preflight or in-flight 
values for this characteristic. On the other hand, the value of 
34.6 percent seen on the sixth postflight night is considerably higher 
than any of the values seen preflight or in-flight. 
REM Latency 
REM latency is defined as the elapsed time from sleep onset (i.e.~ the 
first appearance of stage 2 sleep) until the onset of the first stage 
REM period of the night. Because of the relative unreliability of this 
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measurement when derived from the results of automatic analysis, only 
the values obtained from visual analysis have been reported below. 
Compared 	 to preflight values, this measure was shortened during the 
postflight period of the 28- and 59-day missions. During the 28-day 
mission (fig. 17 part A), the REM latency averaged 1.5 hours preflight
and 1.1 hours postflight, or a decrease of 24 minutes. Although sub~ 
stantial, this decrease was not statistically significant. The 
phenomenon was more apparent duri ng the 59-day mi ss ion, as i 11 us trated 
"Yi in figure 17 part B. In the preflight baseline period, the values 
ranged from 1.6 to 2.2 hours, with an average latency of 1.9 hours. 
.. 	 The in-flight values showed considerable fluctuation, but the average 
of 2.1 hours was not significantly different compared to the preflight 
results. In the postflight period, however, the latency dropped to 
0.9 hours, which represented a decrease of 1 hour below the preflight 
findings. This postflight REM latency was significantly (p < 0.01)
less than both preflight and in-flight values. 
REM latencies during the 84-day mission (fig. 17 part C) showed little 
change in the in-flight period compared to either preflight or post­
flight studies. The in-flight average value of 1.31 hours is not 
significantly different from the 1.47 hours figure seen preflight,
while the value of 1.46 hours seen postflight is almost identical to 
the preflight result. It is worthy of note that the first postflight
night exhibited a relatively long REM latency, while the second and 
third postflight nights were marked by much shorter periods. 
Number of Awakenings 
The number of awakenings per night was calculated for the data based 
upon human visual analysis only, and this information is presented
comparatively in figure 18. 
The 28-day flight was characterized in the preflight period by an 
average of 19.7 awakenings per night, \'Iith a range of 16 to 24. Post­
flight, the average was 22, with a range of 20 to 26. Although only 
two in-flight nights are available for comparison, in both instances 
the number of awakenings was below the preflight and postflight levels. 
The number of awakenings during the preflight baseline series for the 
59-day mission ranged from 34 to 51, with an average of 40.7. In­
flight, a greater range was seen, extending from a low of eight on 
day 33 to a high of 70 on day 9, with an average of 39.3. Postflight,
the average number of awakenings dropped to 28.5, with a range of 26 to 
31. The number of arousals seen during the in-flight portion of this 
mission peaked at day 9 and showed a tendency to decline toward base­
line or sub-baseline levels as the flight progressed. 
275 
HOURS 
1 
:s 
Skylab 2 2 

28 DAY 

..SSION 

JlJ
-69 0 5 10 15 20 25 0 5 
1
:s 
Skylab 3 2 

59 DAY 

MISSIONN 
""-l 
en I """1111 III I I I I I I I I I ill
-14 0 5 10 15 20 25 30 35 40 45 50 55 0 5 
:s 
Skylab 4 2 
14 DAY 

MISSION 
 IJ 
-12 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 0 5 
PREFLIGHT IN-FLIGHT POSTFLIGHT 
Recording Days 
Figure 17. REM latency, all three SkYlab missions . 
.. 
" 
~ # 
«' ,. 
N
....., 
....., 
"", 
" 
J ',­ ~- •
... 
..a OfF .lIIIA.KENINGS 
60 
S~lab 2 .0 
28 DAY 
MISSION 
20 
60 
S~lab 3 40 
59 DAY 
MISSION 
20 
60 
S~1ab 4 40 
84 DAY 
MISSION 
20 
II JJJ 
-59 0 5 10 15 20 25 o 5 
I j 
·14 0 5 10 15 20 25 30 35 40 45 50 55 o 5 
...11... ..1...1.. .. 1.. .. 1....1... .1.. .. .1.. .. 1........ .1.. ..I ........... 1 .... 1..111.. lJ
·12 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 0 5 
PREFLIGHT IN-FLIGHT POSTFLIGHT 
Recording Days 
Figure 18. Number of awakenings, all three Skylab missions. 
In the 84-day mission, the number of awakenings declined from a 
preflight average of 20.7 (20 to 21) to an in-flight average value of 
12, with a range of 6 to 22 (p < 0.01). 'Postf1ight, the level rose 
to an average of 18.7, with a range of 11 to 24 (p < 0.05). Although 
the in-flight period was characterized by a good deal of variation in 
this measure, there was no consistent trend noticeable. 
DISCUSSION 
Overview 
Sleep Latency. The three Sky1ab flights differed with respect to 
sleep-latency characteristics. No significant changes in this param­
eter were noted during the 59-day mission. In the 28-day mission, the 
in-flight and postflight latencies were significantly lower than the 
preflight values. The 84-day flight was characterized by relatively
long sleep latencies in the early portion, with the return to values 
typical of the preflight and postflight periods in the latter half of 
the mission. 
The alterations seen during the 28-day mission are apparently explain­
able, at least in part, by a difference in the subject's routine rather 
than by a direct influence of the environment. This individual 
typically spent a few minutes reading in bed prior to falling asleep 
during preflight studies in his own home. However, he did not continue 
this practice either during the flight or in the postflight period. 
In only the initial portion of the 84-day mission was a degradation in 
sleep latency seen. As illustrated in figure 7, even in this case the 
magnitude of the alterations seen was not great, and on only two nights 
were the values outside the range seen during the preflight studies. 
In addition, it is significant that these alterations occurred in the 
early portion of the study and thus cannot be attributed to the longer 
duration of this mission. Consequently, it appears reasonable to 
conclude that space flight and the associated weightless condition do 
not significantly interfere with the process of falling asleep, 
although in some individuals there may be an adaptive period during 
which some difficulty is experienced. 
Sleep Time. The greatest overall change in total sleep time occurred 
during the 28-day mission, when a decrease of approximately one hour 
was seen in-flight compared to preflight. As indicated previously, 
this was a voluntary reduction in sleep time by the subject himself and 
thus cannot be considered as insomnia. The subject did not complain of 
sleep loss and apparently was sleeping as much as he actually required. 
No significant changes in sleep times were noted during the 
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59- or 84-day missions. If the initial portion of the 84-day flight is 
considered separately, however, it is evident that the subject 
experienced some difficulty in sleeping in this time. Sleep was also 
more of a problem subjectively to this individual , and he indicated on 
several occasion$ that his sleep was not adequate. Sleeping medication 
was occasionally used by the subject, although not on the nights which 
were monitored. 
Of the three subjects, then, only the one studied during the 84-day 
flight experienced real difficulty in terms of total sleep time. In 
this case, the problem diminished with time, although sleeping medica­
tion was used sporadically throughout the flight. In terms of any 
possible adverse effect upon performance capability, it seems that only
during the initial period of the 84-day mission would this have been 
likely to be caused by sleep loss. This cannot be precisely assessed 
because of the long sample intervals; however, even generalizing the 
worst case (4.9 hours on day 4), a severe influence upon performance 
would not be expected. 
Stage Characteristics. Several changes in sleep-stage characteristics 
were common to all three flights. Stage 3 (fig. 12), which was 
significantly elevated during the in-flight portion of the 28-day 
mission, also rose in-flight in the 59- and 84-day missions. Post­
flight, the stage 3 (fig. 14) and stage 4 (fig. 15) values were below 
the prefli9ht average in all three flights. A consistent elevation of 
stage REM (fig. 16) was seen in the late postflight period of all 
flights and was accompanied by a shortening of REM latency. 
Number of Awakenin s. Although this measure was highly variable, in 
general the in-f 19 t period of all missions was characterized by no 
overall increase in number of arousals, and in the case of the 84-day 
mission, there were significantly fewer awakenings . 
. 
Significance of Results. The results obtained during the three Skylab 
missions suggest that prolonged space flight, with its accompanying
weightless state, is not directly associated with major adverse changes 
in sleep characteristics. The alterations in sleep patterns that were 
observed were not of sufficient magnitude to result in significant
degradation of performance capability. These conclusions were somewhat 
unsuspected, since previous studies of confinement, social isolation, 
and unusual environments involving polar explorers (12-15), underwater 
habitats (16), long-duration flight operations (17), and astronauts (1) 
have all reported sle~p loss and/or disturbances of sleep. 
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Early in the manned space flight program, speculation arose that the 
zero-g state might, itself, in some way disrupt the normal sleep/wake­
ful ness mechani SillS. It had been suspected that the altered sensory 
input to the central nervous system associated with weightlessness 
might interfere with sleep onset and result in prolongation of sleep 
latency and lead to long periods of wakefulness following arousals 
from sleep. The Skylab results, however, show that in none of the 
missions was sleep latency a significant problem over the course of the 
flight, and in only one case, that of the 84-day flight, was it even a 
temporary difficulty. Furthermore, there was no evidence of consist­
ently increased amounts of time spent awake during the night; in fact, 
the number of awakenings tended to decrease in-flight. The results 
indicate that during space flights of long duration, it is possible to 
obtain adequate amounts of sleep during regularly scheduled eight-hour 
rest periods. 
The most consistent and most significant changes were actually observed 
in the postflight period of all flights and pertained to sleep-stage 
characteristics. Thus, stages 3 and 4 tended to be decreased in the 
postflight period as compared to both preflight and in-flight results, 
while stage REM was elevated in the late postflight period (after 
day three following recovery) and was accompanied by a shortening of 
RE~1 1 atency. 
The postflight changes in stage REM are worthy of further consideration. 
Since such findings are typical of the rebound effect seen following 
periods of relative deprivation of stage REM (18), the question of a 
significant deprivation in-flight arises. This question is, however, 
somewhat difficult to accurately assess. When the overall averages are 
considered, there appears to be no significant decrease in REM in­
flight. However, when the individual data points are considered 
- (fig. 16), there is a suggestion that perhaps RE~1 percent did decline 
in the terminal portion of the flights. This tendency is most promi­
nent in the case of the 28-day mission, where a relatively steady 
decline in stage REM percent is evident after day 17. Such a trend is 
less obvious in the case of the 59-day l11ission, although the last two 
days are below the preflight average value. In the case of the 84-day 
flight, the latter portion of the mission shows only a slight indica­
tion of a decrease in stage REM. Even though the results appear to 
argue against a prior period of REM deprivation in-flight as a 
contributing factor, it must be emphasized that recordings were not 
made during the last two nights of each mission, and consequently this 
situation cannot be fully assessed. 
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A shortening of REtl! latency was observed "in the late postflight
period of all missions and accompanied the increase in REM percent 
noted during that time. This phenomenon has also been reported as a 
manifestation of a prior period of REM deprivation. Arguing against
REM deprivation as a causative agent of this change is that no 
lessening of the effect was evident even on the sixth night following 
recovery of the 59- and 84-day missions nor after the eighth night 
following the 28-day mission. Similarly, it seems unlikely that the 
changes in stage REM can be attributed to alterations in the astronauts' 
sleep schedules (i.e.> the advances in bedtime near the termination of 
each mission). It has been reported that delaying sleep periods by 
four hours results in a shortening of REt~ latency, but such findings 
have not been reported with comparable advances in sleep onset. 
Furthermore, while delaying sleep periods has been found to increase 
REM percent, advancing sleep periods resulted in a decrease in REM 
percent (19). 
Postflight data from the 84-day mission further suggests that the 
increase in REM percent seen late postflight is actually a delayed 
phenomenon and follows a period of relative REM suppression in the 
immediate recovery period. In fact, the REM percent value of 
12.1 percent on the fi rs t ni ght fo 11 owi ng recovery is we11 below any
REM percent value seen either preflight or in-flight. Th~ value seen 
on day five after recovery, in the late postflight period, is 
correspondingly well above any value seen either preflight or in-flight. 
Delayed REM rebound is not a typical finding in experimental situations 
involving REM deprivation. It has been reported following periods of 
total sleep deprivation, in which case there is an elevation of stages 
3 and 4 in the first recovery night and a later elevation of stage 
REM (20). However, in none of the three Skylab flights was a post­
flight elevation of stages 3 and 4 noted, and in fact these paramters 
tended to decline. Consequently, in these cases a delayed REM rebound 
appears to argue against prior sleep deprivation as the cause of the 
postflight REM changes. 
In view of these findings, it seems plausible that the decreased REM 
latency and increased REM percent represent a true influence of the 
reinstated one-g condition and that this signifies a basic alteration 
in the sleep/wakefulness mechanism of the central nervous system. 
It has been postulated that sleep, and in particular the REM stage, 
may be of importance in the organization and maintenance of memory
(21-23). According to this view, REM may be involved in consolidation 
or reprograming of short-term memory into a more permanent or long­
term form. If this hypothesis is correct, then it might be predicted 
that tasks associated with acquisition of new motor skills and coor­
dinated motor activity might be associated with an increased need for 
stage REM sleep. 
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In support of this hypothesis, it has been found that during the period 
of adaptation to an inverted visual field, REM time was increased (24, 
25). After declining to relatively normal levels after adaptation, 
reverting the visual field to normal was again accompanied by an 
increase in REM-sleep amount .. The situation in space flight may be 
analogous, since the withdrawal of gravitational cues and the decrease 
in proprioceptive input and altered vestibular input place a consider­
able burden upon the visual system as the sole means of maintaining 
spatial orientation. Following the mission, the return to ~arth 
similarly requires a period of adaptation to the one-g condition. It 
might be speculated, then, that the increase in REM time seen post­
flight was a manifestation of this hypothesized mechanism. There is no 
evidence in the Skylab data that adaptation to zero-g is accompanied by 
an increase in REM time; in fact, the in-flight values were either the 
same or lower than preflight values. The hypothesis cannot, however, 
be adequately evaluated, since no sleep data was obtained prior to 
day 3 in any of the flights; thus, pertinent changes could conceivably 
have been missed. If such in-flight changes were present, however, 
they evidently were of shorter duration than those seen postflight, 
where changes were seen until the eighth day after recovery. 
CONCLUSIONS 
The objective results of these sleep monitoring experiments indicate 
that man is able to obtain at least adequate sleep over prolonged 
periods of time in space and during regularly scheduled eight-hour 
sleep periods. The alterations in sleep patterns which were observed 
during these missions were not of the type, nor of sufficient magnitude 
(with the possible exception of the initial portion of the 84-day 
mission), to result in significant degradation of performance capa­
bility. The most notable changes seen actually occurred in the pos~ 
flight period, and this suggests that perhaps the readaptation to one-g 
is somewhat more disruptive to sleep than the adaptation to zero-g. 
Yet, even in this case, the alterations seen were those of sleep 
quality and not quantity. It is also worthy of emphasis, particularly
with respect to the results seen during prior space flights, that none· 
of the Skylab crewmen complained excessively of sleeping difficulties. 
In fact, most reported no problems with respect to sleep, and some 
expressed the opinion that sleep was perhaps better in space. Viewed 
overall, these results are somewhat surprising because of the frequent 
complaints of insomnia during pre-Skylab missions. Apparently, the 
problems encountered during earlier space flights were not simply due 
to the imposed zero-g environment. The Skylab orbiting laboratory
differed considerably from spacecraft of the Apollo and Gemini types, 
although the gravitational and atmospheric factors were the same in all 
cases. The working volume of the spacecraft is most likely the 
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influential factor in terms of sleep. Sky1ab provided adequate room 
for separate eating, exercising, working, and sleeping areas within 
12 763 cubic feet of living area. The Apollo spacecraft measured only 
approximately three percent of this volume, while the Gemini craft con­
tained less than,one percent. In these smaller spacecraft, all daily 
tasks were more difficult, and the astronauts undoubtedly had a greater 
sense of confinement. In addition, Skylab allowed the establishment of 
a daily routine which was, in most respects, directly comparable to 
ground-based, everyday activity. The crewmen maintained their Houston­
based time reference throughout the flights and, for the most part,
worked during conventional hours. The individual sleeping compart­
ments were a definite improvement over the prior spacecraft systems, 
and this undoubtedly greatly minimized or eliminated interference with 
sleep caused by activity of other crewmen. In general, the element of 
risk or danger present in all space flights seemed to be minimized in 
Sky1ab by the presence of an established daily routine, and this also 
may have contributed to the improvement in sleeping conditions. 
The results also suggest areas for future study with respect to the 
acquisition of scientific data and in terms of man1s overall adaptation 
to life in space. As indicated previously, the changes in sleep-stage 
characteristics seen postflight possibly do represent a direct 
influence of the altered gravitational factors upon the sleep/wakeful­
ness mechanisms. Future experiments, if properly designed, could 
provide information of basic importance to our understanding of sleep. 
In terms of human capabilities, we feel confident that flights of two 
to three months will not be jeopardized by sleeping difficulties, but 
beyond this point we must continue to carefully evaluate sleep and 
insure proper work-rest scheduling. 
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VISUAL LIGHT FLASH OBSERVATIONS ON SKYLAB 4 
R. A. Hoffman" D. V. M" M. s. *; L. S. Pinsky" Ph. D.;'; 
Z. Osborne" Ph.D. "1-; and J. V. Bailey" B.S." M.S. * 
ABSTRACT 
During the Skylab 4 mission, two separate light flash observation 
sessions were performed on mission days 74 and 81 by the pilot,
William R. Pogue. These sessions occurred during orbits that allowed 
observations from high northern geomagnetic latitudes, through the 
equatorial region, and on to southern geomagnetic latitudes. The South 
Atlantic Anomaly was also traversed during each session. During each 
session, the Pilot (in the sleep-restraint mode) donned a blindfold and 
recorded his observations of flashes on the voice recorder. 
The data obtained indicate a latitude effect on the frequency of the 
flashes; this effect would be expected if primary cosmic particles 
cause the flashes. Additionally, high flash rates (15 to 20 flashes/
min) were observed when the spacecraft was over the center of the 
South Atlantic Anomaly. This observation has stimulated questions 
regarding the possible presence of trapped particles (larger than 
protons) in the South Atlantic Anomaly. Further observations and 
measurements regarding light flashes are planned for the Apollo-Soyuz 
Test Project. 
ItHRODUCT ION 
The observation of light flashes was first reported by the Apollo 11 
Lunar Module pilot, Edwin Aldrin, with subsequent observations made on 
all Apollo missions (1,2). Professor C. A. Tobias predicted as early 
as 1952 (3) that this type of visual phenomenon would be experienced
by humans when exposed to heavily ionizing cosmic particles. Although
it has been quite generally accepted that the light flashes observed 
were caused by passage of cosmic particles through the visual apparatus,
the exact mechanism of particle interaction is still uncertain. Some 
investigations (4,5,1,6,7,10) support the premise that the visual flashes 
are caused by direct particle/retina interaction while others (8,9)
tend to favor Cerenkov radiation from re1atavistic particles as their 
*National Aeronautics and Space Administration, L. B. Johnson Space
Center, Houston, Texas 
tUniversity of Houston, Houston, Texas 
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etiology. While both mechanisms probably contribute, the current con­
sensus seems to be that most of the flashes result from direct ioniza­
tion energy loss as the particle traverses retinal cells. In either 
case, if cosmic particles are the cause, a strong latitude effect of 
the light flash rate would exist for an observer in earth orbit. This 
effect is a consequence of the geomagnetic cutoff and the steep energy 
spectrum of cosmic ray fluxes. In other words, near the equator only 
cosmic particles with very high energy can reach orbital altitudes, 
while near the magnetic poles particles of much lower energies can 
reach comparable altitudes. 
The primary objective of the study reported here was to investigate 
the frequency and character of visual light flashes in near ea~th 
orbit as the Skylab trajectory passes from northern to southern 
latitudes. Because the trajectory periodically passed through the 
South Atlantic Anomaly, another study objective was the investigation 
of possible visual flashes during passage through this region. 
PROCEDURE 
Two periods of observation by the pilot were planned. These observa­
tion sessions were accomplished on orbits selected to provide data on 
both latitude and South Atlantic Anomaly effects. Unfortunately, no 
single orbit possessed ideal geomagnetic latitude and anomaly condi­
tions. Hence the first session provided the best latitude conditions 
but passed only through the edge of the South Atlantic Anomaly region. 
The second session passed through the center of the South Atlantic 
Anomaly but did not achieve as high geomagnetic latitudes. The first 
observation session occurred on mission day 74 and was 70 minutes in 
duration, while the second occur~ed on mission day 81 and was 55 min­
utes long. The second period was shorter because of very critical 
time limitations during the last few days of the mission. 
At the start of each session the Pilot got into his sleep restraint, 
set a timer for the prescribed period (either 70 or 55 minutes),
donned a blindfold, and began observing for light flashes. Approximately 
the first 10 minutes of each session was allocated for dark adaptation 
by the subject. During the first session no particular position in the 
sleep restraint was specified. The Orbital Workshop was in a Solar 
Inertial Mode during both periods and local noon occurred very close to 
equator passage in both cases. For the second session, directions were 
given for head positioning which placed the anterior-posterior axis of 
head parallel to the Earth 1 s magnetic field lines in the anomaly. 
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The occurrence of each light flash event along with its description 
was voice recorded on the on board tape recorder and a transcript of 
the recording for each of the two periods was obtained for analysis. 
RESULTS 
A total of 168 flashes was reported: 24 during the first session and 
..1 144 during the second. Figure 1 shows a plot of the trajectory ground 
tracks for both observation sessions with each light flash occurrence 
_ 	 marked. The numbers shown in the South Atlantic Anomaly on the ground 
track for session number two indicate the number of flashes observed 
during one minute intervals. Because the frequency of flashes in the 
South Atlantic Anomaly was much less in session number one, event 
marks instead of numbers were used. 
It is almost impossible, because of the relatively few flashes observed 
and because of varying lengths of time spent at different latitudes, 
to show in a simple way the relationship between flash occurrence and 
geomagnetic latitude or HZE flux. However, figures 2 and 3 attempt to 
demonstrate this for the two observation sessions. As can be seen by 
referring to figure 1, time from equator passage is directly related 
to latitude. The calculated cosmic ray flux for latitude positions 
of the spacecraft corresponding to the times from equator passage is 
shown on both figures 2 and 3. Although there is evidence for correla­
tion of flash occurrence with cosmic ray flux (or geomagnetic latitude) 
in figure 2, figure 3 more clearly demonstrates this relationship. 
The Van Allen belt dosimeter data for the observation periods are also 
shown on figures 2 and 3. The units shown on the ordinate of figures 2 
and 3 do not apply to those curves; instead only relative units need 
to be visualized. It is apparent that the flash rate in the South 
Atlantic Anomaly coincides remarkably well with the increased radiation 
levels detected by the Van Allen belt dosimeter. 
COMMENTS AND CONCLUSIONS 
Although a few light flashes were reported as casual observations by 
the crews of Skylab 2 and Skylab 3, the events reported here represent 
the first observations made in Earth orbit. No flashes were observed 
during previous Mercury or Gemini flights or duing Apollo missions 
prior to Apollo 11. Why no flashes were observed prior to Apollo 11 
has been considered before (1) and even now no clear explanation exists. 
The most logical explanation appears to be that the eye must be dark 
adapted and the observer must be reasonably relaxed and free from most 
distracting activities to observe light flashes. This was not the case 
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on earlier flights. Also without a precedent for their observation, 
there would probably be the tendency to discount minor flashes as 
nothing unusual and simply an innocous event in a milieu of more 
important observations. It seems obvious now that with eyes trained 
for observing these events their occurrence will be noted whenever 
proper conditions exist . 
The following conclusions can be drawn from the data presented: 
6 	 Dark adaptation of at least 10 minutes duration is required 
to begin observing the flashes. 
o 	 There is a strong correlation of very high flash rates with 
passage through the South Atlantic Anomaly, and, from physical 
arguments and event descriptions, it appears certain that 
these flashes are due to the trapped radiation. 
o 	 There is evidence for the predicted latitude effect, although 
existing data are insufficient for a thorough statistical 
evaluation. 
o 	 A greater particle flux in the trajectory through the South 
Atlantic Anomaly during the second observation period probably 
explains the increased number of flashes observed at that 
time, but there were also more flashes observed outside the 
anomaly during this second period where the cosmic particle 
environment should have been comparable. This variation 
remains unexplained at this time. 
There is an additional suggestion from the event rates and descriptions
of flashes during the South Atlantic Anomaly passes, that there may 
be particles heavier than protons in the inner belt of trapped radia­
tion. The current knowledge of the inner belt includes an upper 
limit of only approximately 1 heavy nucleus per 1000 protons. The 
Skylab 4 light flash data are compatible with this limit, but still 
suggest the existence of a significant flux of ~ > 2 particles. This 
provides strong motivation for making detailed and accurate measure­
ments of the South Atlantic Anomaly (inner belt) heavy component. 
The observation of flashes during space flight reported here and those 
reported previously represent very few events from a statistical 
standpoint. I~ore such observations need to be made and are planned l 
for the Apollo-Soyuz Test Program mission. Although there is a basic 
lExperiment MA106: Principal Investigator - Dr. T. F. Budinger 
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interest in studying the visual flashes per se, the real importance to 
manned space flight is the question of their significance. Are they 
mere flashes similar to other visual observations we make continually 
and represent no danger? Does each flash signify the destruction of 
one or more retinal cells? Are the flashes observed and the resultant 
damage, although potentially serious in itself, indicative of even 
more damaging interaction of HZE particles with other tissues,e.g., 
the brain? The need for extensive ground investigations using 
accelerator produced radiation is apparent. Space observations as 
reported here must serve as guidelines for ground studies currently 
underway and others yet to be conducted. 
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CHANGES IN THE ACHILLES TENDON REFLEXES FOLLOWING SKYLAB MISSIONS 
J. T. Baker, B.S. ", A. E. Nicogossian, M.D. -1', G. W. Hoffler,',1.D. t, 
R. L. Johnson, ~.D. t, and J. Hordinsky, M.D. t 
ABSTRACT 
A generalized hyperreflexia was clinically reported in the crew of the 
first manned Skylab mission. To assess possible neuromuscular altera­
tions following extended space flight a decision was made to conduct 
duration measurements of the Achilles tendon reflex and its assDciated 
muscle potential. Reflex duration was measured from the initial stroke 
upon the tendon until all oscillations had ceased. The muscle potential 
interval for each reflex was measured from the initial tendon stroke to 
the point of greatest amplitude of the muscle potential spike. Crew­
members of Skylab 3 and 4 exhibited a significantly (p<O.Ol) shortened 
reflex in the immediate postflight period. A compensatory prolonga­
tion of the reflex duration was exhibited between 4 and 12 days after 
recovery followed by a gradual return to the preflight values. In 
general, the muscle potential interval corresponded with the increase 
and decrease in the reflex duration. 
INTRODUCTION 
A generalized hyperreflexia was reported in the crewmembers of the first 
Skylab mission during the immediate postfligbt clinical evaluations (1). 
This finding supports earlier reports of an increase in reflex ampli­
tude by Soviet researchers (2). To document possible neuromuscular 
changes, a decision was made to conduct measurements of the Achilles 
tendon reflex during the subsequent Skylab missions. 
Various devices have been utilized to measure the Achilles reflex 
duration. Some of these devices are a light beam and photocell
arrangement; capacitance changes and various types of mechanical trans­
ducers. Reported normal duration time for the Achilles reflex varies 
widely and depends heavily on the transducer type and interpretation
of the data by the investigator. Nordyke, et al., (3) report normal 
reflex durations from 250 to 410 milliseconds while Bow.1ey, et al.,(4) 
*Technology Incorporated, Houston, Texas 
tNational Aeronautics and Space Administration - Johnson Space 
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report a normal range of 160 to 280 milliseconds. Such wide variation 
in reflex durations dictated that each crewman serve as his own control 
in the experiment. 
The present study is an attempt to quantitate in time 
o 	 any changes in the duration of the Achilles reflex relative 

to extended space flight, and 

o 	 the duration of the muscle potential associated with the reflex. 
METHODS AND MATERIALS 
Each one of the Skylab 4 crewmembers participated in three preflight 
and six postfli~ht tests. On Skylab 3 crev~ep, one preflight test (F-5)
and four postfllght tests were obtained. The postflight tests were 
done immediately on recovery day and thereafter on a regular basis at 
the end of Lower Body Negative Pressure (M092) experiments. The 
schedules for Skylab 3 and 4 tests were as follows: 
Skyl ab 
Mission Preflight (days) 	 Postflight (days) 
3 F-5 	 R+O, R+4, P+16, R+29 
4 F-30, F-15, F-5 R+O, R+1, R+5, R+11, R+17, R+3l 
In a typical test session, the erect crewmember positioned his right
knee on a firm support, with additional support as necessary, to 
achieve relaxation of the gastrocnemius muscle. A relative displacement
transducer was firmly attached to the plantar bearing surface. Three 
electrode sites were prepared on the midsection of the gastrocnemi~s 
muscle to obtain muscle potentials, and silver electrodes of two centi­
meter area were fixed to these sites with a conducting gel. The 
-Achilles tendon was struck several times as a warm up and to check the 
gain setting of the recorders. The signals from both the displacement 
..transducer and the electrodes were amplified and recorded simultaneously 
on strip chart and FM magnetic tape. To elicit reproducible and well 
inscribed tendon reflexes the Achilles tendon was struck every two 
seconds for thirty seconds with a precussion hammer. No reinforcement 
maneuver was used to augment the reflex. 
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Data Analysis 
For each experiment, an average number of twelve complexes on strip 
chart were analyzed. The Achilles reflex duration was measured from 
the initial stroking of the tendon until all movement had ceased. This 
method of determining duration should detect change occurring in the 
contraction and/or relaxation phases of the reflex. The muscle potenial 
interval for each reflex was measured from the beginning of the mechan­
ical upstroke to the point of greatest amplitude of the muscle potential 
spike (fig. 1). 
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Figure 1. Illustration depicting method of measurement of the· 
reflex duration and muscle potential intervals. 
For the Skylab 3 mission the ~ean and standard deviation were computed
for both the Achilles reflex duration and the muscle potential interval. 
Student's t-test was used to determine if any postflight data was 
significantly different from the preflight data. 
For the Skylab 4 mission fiducial limits for the normal were calculated 
since a preflight baseline consisting of three separate test values was 
available. 
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RESULTS 
The results of the single preflight and the four postflight tests for 
the Skylab 3 mission are presented in figure 2. The duration of the 
Achilles reflex immediately postflight showed a significant (p < 0.01)
shortening for all three crewmen. The reflex duration exhibited 
further significant shortening on the fourth day after recovery. At 
the sixteenth postflight day there was a significant (p ~ 0.01) lengthen­
ing of the reflex for the Scientist Pilot and Pilot while the Commander 
showed lengthening which was not quite statistically significant. By 
29 days post recovery, the reflex duration of the Commander had essen­
tially returned to its preflight value. However, the Scientist Pilot 
and Pilot continued to show a significant lengthening of the reflex 
duration with a suggested trend toward their preflight values. 
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Figure 2. Duration of the Achilles tendon reflex for the Skylab 3 
crewmembers. 
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The results for the Skylab 4 mission are presented in figure 3. The 
Commander showed an initial shortening of his reflex time that was 
within his preflight baseline. By the 5-day postflight test there 
was a significant lengthening of his reflexes well outside the fiducial 
limits of his baseline testing. In subsequent tests the Commander's 
reflex time decreased slowly until he was well within his baseline 
values by the 3l-day postflight test. 
The Scientist Pilot presented reflex times shorter than his baseline 
1ill1its on recovery day. The refl ex time 1engthened on day 1 and by 
day 5 postflight it had increased to the P9int of being greater than 
his baseline limits. Subsequent testing showed an oscillatinq reflex 
time which by the 3l-day postflight test had returned to within base­
line limits. 
The Pilot showed an immediate decrease in reflex time on recovery day. 
This condition lasted through the day 5 test. At the postflight day 11 
test there was a significant lengthening of reflex times. In sub­
sequent tests the Pilot's reflex times decreased until he was within 
his baseline limits by day 31 postflight. 
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Test Day 
Figure 3. Duration of the Achilles tendon reflex for the 
Skylab 4 crewmembers. 
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The muscle electrical component of the reflex for the Skylab 3 mission 
proved to be difficult to obtain on the Scientist Pilot and Pilot. 
However, a full set of data was obtained on the Commander (fig. 4). 
The course of the Commander's postflight muscle potential interval 
paralleled his reflex duration, i.e.~ the first two tests showed a 
shortening of the time interval while the last two tests showed a 
slowly increasing time interval not quite reaching his preflight value. 
Despite spotty data. the other two crewmembers also showed a similar 
response in muscle potential intervals. 
50 
TIME IN 
MILLISECONDS 40 
35 
Pilot l1 
30~------~~ ~l--~I--------~------_I~----~I 
F-5 FLIGHT R+O R+4 R+16 R+29 
Preflfght Recovery 
Test Day 
Figure 4. Muscle potential lntervals for the Skylab 3 
crewmen. 
The electrical component of the reflex still proved difficult to obtain 
on the crewmembers of the Skylab 4 mission. No data were collected 
on the Pilot but fairly complete data were obtained on the Commander 
and Scientist Pilot. Inspection of the muscle potential intervals 
shows good agreement. i.e. , when the reflex time increased the muscle 
potential interval increased and vise versa (fig. 5), 
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Figure 5. Muscle potential intervals for the Skylab 4 
crewmen. 
DISCUSSION 
The six Skylab crewmen tested and some of the Cosmonauts have exhibited 
similar findings. These findings include a peculiar gait upon return 
to one-g field; muscular soreness and weakness; overcompensation in 
movements while in a vertical position and changes in the reflexes. 
While a fully satisfactory explanation for these neuromuscular findings 
is still lacking, several factors have been implicated. 
Dealing specifically with the alterations in reflex times it might be 
postulated that an imbalance is present between the postural muscle 
groups. These muscle groups specifically support the body against the 
pull of gravity and if not adequately exercised might be expected to 
undergo selective relative disuse atrophy in a weightless environment. 
After return to the Earth's gravitational field, following partial or 
total acclimatization to weightlessness, the sudden burden imposed on 
these muscles could possibly result in a state of disequilibrium be­
tween the flexor and extensor groups. This gravity stressor may be 
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implicated in the altered reflex durations seen in the Skylab 3 and 4 
crewmen. Interestingly, the reflex duration had approximately returned 
to preflight values at the time muscular soreness disappeared and the 
gait had returned to normal. 
Another causal possibility is that of interaction between biochemical 
and hormonal factors and reflex duration. In the second manned Skylab 
mission the postflight thyroxin and epjnephrine values were reported 
to be slightly elevated (5) which conceivably could account for some of 
the changes seen in reflex duration. An increase in both calcium and 
potassium was noted the first two days postflight and there was a 
transient increase in the concentration of ionized serum calcium {6}. 
It seems unlikely, however, that these biochemical and humoral changes
would affect the reflex durations for the time periods seen here. 
It is interesting to observe that the crews of the Skylab 4 mission 
seemed perhaps slightly less affected, as regards reflex durations, by
their increased time in space. There is also the added factor of 
progressively increased exercise regimens, both on the bicycle ergo­
meter and the other devi ces {mini gym Skyl ab 3 and 4, "Treadmi 11" 
Skylab 4}. 
CONCLUSION 
At this point, the best explanation for the changes in reflex duration 
is perhaps related to the servofeedback system of the postural muscles 
themselves. These muscles, after weeks of inactivity and a loss of 
mass, must suddenly resume upright support of the body in a one-g 
environment, with an attendent strain and stretch in these muscles re­
slJlting in an over stimulation of the neuromuscular system causing the 
initial decrease in reflex duration. As the muscles regain strength 
and mass {7. 8} there occurs an over compensation reflected by the in­
creased reflex duration. Finally, when a normal neuromuscular state 
is reached the reflex duration returns to baseline value. In general
the available data seem to suppo~t this proposed hypothesis. 
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ABSTRACT 
The purpose of the Time and Motion Study experiment (M15l) was to study 

the effects of the Skylab environment on a variety of work tasks in­

volving different types of activity. In-flight crewman performance, 

sampled over the duration of the missi.on, was compared with correspond­

ing preflight training data in terms of efficiency and possible behav­

ioral stress effects associated with length of exposure to the working 

and living conditions of the Skylab environment. Experimental data were 

acquired through motion-picture film and video tape, and time and 

motion analytic techniques were used to study the data. Efficiency 

was evaluated by using the adaptation function, namely, the relation of 

performance time over task trials. 

The basic finding from this experiment was the uniformity-of crew 

performance over the three missions. Initial changeover from preflight 

to in-flight environment (or from one-g to zero-g) was accompanied by 

an increase in performance, time for the majority of work task activities 

studied. By the end of the second in-flight trial, more than half of 

the activities were performed as efficiently as on the last preflight

trial; performance proficiency increased during each Skylab mission. 

In general, crewmen adjusted rapidly to the weightless environment and 

became proficient in developing techniques to optimize task performance. 

Performance time varied with method change and with task and hardware 

configurations. The use of arms and legs (and the entire body) as 

subtle guidance and restraint systems facilitated the efficient trans­

lation and control of large and small masses, including the crewman 

himself. Differences in crew performance were not pronounced; varia­

tions in training procedure, the natural tempo and style of each crew­

man, and method changes were critical explanatory factors. 

*Fordham University; Bronx, New VorL 

t NAsA , Office of Life Sciences; Washington, D.C. 
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INTRODUCTION 
The purpose of the Time and Motion Study was to determine how well man 
can perform specified tasks under zero-g conditons over the course of 
long-duration space flights. Among its objectives, experiment M15l 
studied the in-flight adaptation of crewmen to a variety of task situa­
tions involving different types of activity. Training data provided 
the basis for comparison of preflight and in-flight performance. 
It was anticipated that in-flight performance of some tasks would be 
but slightly affected, while the performance of others in the zero-g ~ 
environment would exhibit more pronounced changes in time and/or in 
the patterning of the elements comprising the tasks. On the assumption 
that overall work time would increase in the zero-g environment, ini­
tially at least, an additional objective was to determine at what point
work efficiency in-flight would be restored to that manifested during 
the last preflight performance. 
The adaptation function, or, the relation expressing the amount of 
time it takes to perform the same task in successive trials (task time 
as a function of task trial), was used to evaluate the effect of the 
Skylab environment on task performance. As graphed, this function is 
represented by a curve which decreases (i.e., performance time gets 
shorter) from trial to trial, ultimately reaching a point where succes­
sive trials yield similar values (i.e' J approach to asymptote). The 
rate of decrease, which indicates improvement, differs for different 
tasks. The character of this curve also varies from individual to 
individual. Unexpected changes in slope or in variability can be used 
to identify difficulties with hardware, changes in environmental condi­
tions, or alterations in method of performance. Change in performance 
level or in variability may also reflect fundamental changes in the 
attitude or physiological condition of the subject. The adaptation
function can also be used to identify the point at which in-flight
task efficiency is restored to the level of preflight proficiency. It 
also provides a basis for developing criteria of performance deteriora­
tion, specifically relevant to space flights of long duration. 
OBJECTIVE OF PRESENT REPORT 
The specific objective of this report was to present data on those 
work and task activities encompassed by experiment M15l and common to 
Skylab missions 2, 3, and 4. The emphasis, then, was on the replica­
tion and comparison of crewman performance on flights of varying time 
lengths. It was thus possible to study the effects of increasing 
performance trials on the characteristics of the adaptation function. 
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Similarly the effect of increasing zero-g exposure on work and task 
performance was available for analysis. 
DATA ACQUISITION 
A Maurer 16 mm Data Acquisition Camera, supplied with S0168 color film, 
was used to photograph selected tasks on each mission. Two Maurer 
lenses were employed: a 5 mm lens with wide angle field-of-view to 
photograph activities in the lower area of the Orbital Workshop where 
the camera was constrained by close proximity to the filmed activity;
and a standard 10 mm lens to photograph activities in the Orbital 
Workshop forward area. A portable high intensity light was used where 
onboard lighting was incapable of yielding acceptable photography. 
On Skylab 2 all data were photographed at six frames per second to pro­
vide reliable criteria for determining the end points of the elements 
comprising the task. On Skylab 3, frame rates were reduced from six 
frames per second to two frames per second for some activities in 
order to conserve film for an adequate sampling of data over a mission 
twice the duration of the first. Mass handling tasks were maintained 
at six frames per second. Skylab 4 data collection followed the same 
guidelines as those for Skylab 3. 
Illumination levels varied from four to nine foot-candles depending on 
location, and as has been mentioned, the portable high-intensity light 
was used only where onboard lighting was totally unacceptable for 
photography. Power conservation practices during early portions of 
Skylab 2 to relieve power and thermal problems, required some con­
cessions in normal lighting levels, but usable data were obtained. 
Because of accumulating radiation damage to film, new lighting criteria 
were initiated for Skylab 4. The increased use of portable high­
intensity light in addition to normal lighting reduced the effects of 
radiation. Image enhancement procedures were also utilized to counter­
act radiation damage. 
Film Analysis 
Approximately 4350 feet of film were taken on Skylab 2, while more than 
three times this amount, 14 700 feet, were available from preflight
training. Corresponding data for Skylab 3 were 3800 and 10 400; for 
Skylab 4, 2500 and 6800. 
To process this large volume of film a three-level analysis procedure 
was developed to filter the data into classes according to the depth 
and detail of analysis required. With this procedure the film as a 
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whole was analyzed, but portions of critical importance were given 
detailed treatment. 
The film was examined on a special film viewer which had the capabil­
ity of controlling rate of presentation and alignment, while attaining 
high precision in measuring the dimensions and orientations of the 
image. In the first level of analysis, each task or activity was broken 
down into the elements required for its performance. These elements 
were identified and defined during the training sessions. Along with 
the basic identifying information, such as date filmed and analyzed,
film rate, work activity, et aetera, the first level analysis gave the 
element description and the frame number or time at the end of each 
element. 
The second and third levels of analysis built on the data obtained from 
the first level. More detail was provided and relevant accessory vari­
ables were identified. Thus, for each element the second level of 
analysis included torso configuration, position restraints, restrictions, 
detailed motion patterns, et aetera. The third level added to the 
second level such items as crewman elevation, roll and heading, plus 
details as to elbow, torso, and knee angles. From this information it 
was possible to reproduce in a quantitative fashion and to a high de­
gree of fidelity the patterning and temporal course of any activity. 
The work of the film analyst was facilitated by the use of a Coding
Dictionary. The dictionary provided the necessary definitions for 
identifying, classifying, and measuring the activity as depicted on 
film. It gave exact instructions for computer coding - the data to 
assign to specific card fields, the use of various programing cards, 
and all other programing instructions. The use of the Coding Diction­
ary maximized the objectivity and accuracy of film analysis. 
Task Selection 
Selection of activities to be filmed was governed by a number of rather 
restrictive criteria. Repetitive and relatively standardized tasks 
were required to satisfy replication and uniformity conditions. At 
the same time, relevant and natural, rather than contrived, activities 
were desired. Consequently, they had to be part of the planned 
schedule, not added to or modified for experiment M15l. Additionally,
variety in tasks was sought in order to permit the study of a broad 
spectrum of human performance. 
Activities associated with the preparation and execution of approved 
medical and scientific experiments met all of these requirements. Thus, 
the regularities of experimental procedures in other experiments pro­
vided M151 with a source of homogeneous data for analysis and evaluation. 
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Experiment Data Sources 
The experiments and operational activities serving as sources for 
photographic data are listed below, together with a brief description
of some of the activities of interest. 
M092 Inflight Lower Body Negative Pressure. The preparation for this 
experiment involved the coordinated interaction of two men who utilized 
both fine and gross motor activity in the unstowing, preparation and 
donning of electrodes, probes, and measuring devices. In ~ddition, 
precision of translation and ingress of the Lower Body -Negative Pres­
sure Device was required. 
M171 Metabolic Activity. This experiment also involved a two-man 
interaction in the mounting of the ergometer and donning of the restraint 
system (which was deleted in-flight) and metabolic apparatus. Opera­
tions involving unstowing, assembling, and connecting required gross 
motor activity. Specialized restraint systems were utilized. 
T027/S073 ATM Contamination Measurement - Gegenschein/Zodiacal Light. 
The removal, deployment, transfer, installation, and retrieval of the 
photometer (and associated activities) involved two-man interaction 
(reduced to one-man activity in-flight) in handling and translating
with hardware of very large mass and size. The photometer weighed 
95 kilograms and had dimensions of 140 x 50 x 30 centimeters. Gross 
and fine motor dexteri~y was involved in the varied activities associ­
ated with this operation. 
S190B Earth Terrain Camera. The removal, preparation, installation, 
deployment, and retrieval of the Earth Terrain Camera required a one­
man/mass interaction utilizing medium-sized hardware. The camera 
weighed 29 kilograms and had dimensions of 70 x 20 x 30 centimeters. 
Fine and gross motor activity was involved as well as translation with 
load. 
S183 UV Panorama. Photography of this experiment yielded data encom­
passing unstowage, transfer, installation and film loading of large
hardware which weighed 48 kilograms and had dimensions of 
130 x 40 x 40 centimeters. Fine and gross motor activity was involved 
as well as translation with or without loads of varying size. 
M509 Astronaut Maneuvering Eguipment. One-man maintenance activity
involved removal, stowage, unstowage, transfer and installation of 
hardware subassemblies. Two-man interaction in donning experiment 
hardware employed fine, medium and gross motor activity. 
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EVA Suit Donning and Doffing. Donning of the suit from the Liquid 
Cooled Garment to pressurization required two-man interaction involving 
fine and gross motor activity. Suit doffing involved similar types 
of acti vity . 
Food Preparation. Removal, collection, and preparation of food re­
quired relatively gross motor activity. Use of a thigh restraint was 
involved. 
Not all of the data obtained from the tasks listed above were used in 
this report. The primary emphasis was on comparable data obtained 
from all three missions. 
Sampling and Replication 
Weight and stowage restrictions placed a limit on the amount of film 
ass i gned to experiments. The 'crowded complexity of an astronaut 1 s 
workday presented schedule difficulties for filming the desired experi­
mental trials. These constraints created problems of sampling the 
experimental trials and allocating them to the Skylab missions. 
On the Skylab 2 mission, sampling density was maximized for the initial 
group of trials of an experiment. During Skylab missions 3 and 4 more 
emphasis was given to performance towards the end of the mission, to 
better detect performance variability, should any have occurred due to 
extended exposure to the Skylab environment. 
It will be observed that the final or last trial was not generally used 
for filming. There were two reasons for this decision. In the first 
place, the well-documented lIend-effectll was avoided. This effect, 
observed in traditional learning as well as in isolation situations, 
reflects the frequently occurring change in attitude of the subject as 
he realizes that this is his last trial, or last day of isolation. Thus 
toward the end of a flight, the attitudes and interests of the astro­
nauts were expected to become more focused on II clean ing Upll or II getting 
ready to leave". The second reason was concerned with the practical
matter of work slippage. Small but annoying problems could develop 
during the course of a mission with the result that experimental trials 
late in the series might have to be sacrificed. 
Preflight training involved the crewmen in various types of work and 
task performance. First, there were walk-throughs, then heavily 
assisted performances, and finally the crewmen on their own wlth very 
little or no assistance from training personnel. These latter perfor­
mances, the last four or five before flight, were used as baseline or 
contrast data for comparison with in-flight performance. The data 
points comprising the baseline extended over a period of many months, 
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from December 1972 to May 1973 for Sky1ab 2, from August 1972 to 
June 1973 for Sky1ab 3, and from November 1972 to October 1973 for 
Skylab 4. 	 There were, of course, earlier training sessions. In M092, 
for example, the Sky1ab 2 crewmen as observers had a total of 25 train­
ing sessions; Sky1ab 3 crewmen, 14; and Sky1ab 4 crewmen, 27. The 
Skylab 3 crew had the fewest, approximately half the number of the 
other crews. 
Time Measurements 
The time to complete a task was measured in several ways. The most 
inclusive was Voice/Telemetry Time, the end points of which were either 
voice recorded by the crewman or automatically indicated by the start- ~ 
stop controls of a timer. Thus, the beginning of a task may have been 
recorded by the statement "Started M092 at __," while the completion 
of M092 data acquisition was automatically indicated by the crewman 
stopping the experiment timer. Termination was sometimes also announced 
by voice, as "End Ml71 at II 
Camera Running Time included only the time during which activity was 
being photographed. It eliminated such preparatory activity as, 
arranging material for the experiment, making final calibrations, and 
other such 	activity which was included in Voice/Telemetry Time. In­
cluded in Camera Running Time, and in Voice/Telemetry Time as well, 
were such categories as foreign elements, waits and idles, anomalies, 
and redundancies. These categories will be discussed in more detail 
in the Performance Anomaly Section. 
Basic Element Time was the least inclusive of the three measurement 
procedures, comprising the sum of the times associated with the basic 
elements. 	 The basic elements were the set of elements which were 
necessary to complete the task; they appeared in every performance of 
the task, preflight or in-flight; and they were performed only by the 
crewmen to 	whom the task was assigned. Basic Element Time, then, was 
comparable 	from person to person, from mission to mission, and from 
preflight to in-flight performance. In contrast nonbasic elements 
were those 	which sometimes were omitted by the crewmen (e.g., stow 
legbands), 	or modified, or done before the camera was activated or after 
the camera 	was turned off. In calculating Basic Element Time, such 
variables as foreign elements, waits, and idles which are defined in 
the next section were removed from the time for the element in which 
they occurred. 
Element Time was the time determined for each element by time and motion 
.. 	 techniques. This included basic as well as nonbasic elements. The 
time taken to complete each element listed in appendix A. at each task 
performance by each crewman, comprised the fundamental data source from 
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which special analyses were potentially available. As an example,
elements could be grouped into classes, such as, fine or gross motor 
dexterity, translation with or without load, large versus small mass 
handling. 
In the present report Voice/Telemetry Time measurements were included 
to demonstrate the type of adaptation function they produced. The 
major portion of the analyses, however, were based on Basic Element 
Time which provided valid comparisons across missions and between 
training and in-flight performance. Nevertheless, Voice/Telemetry 
Time provided a realistic estimate of the time it took to complete a 
particular in-flight task. 
Performance Anomaly 
The time required to perform a given task, subtask or element varies 
from performance to performance. Differences in method, procedure or 
motion pattern are also observed during task performance. These varia­
tions are due to a complex set of factors and where they are minor and 
no assignable cause (or causes) can be discovered, they are character­
ized as random. However, film analysis frequently reveals identifiable 
perturbations in task performance which have assignable causes. The 
situations giving rise to such perturbations have been categorized as: 
foreign elements, waits and idles, and task-related anomalies. 
A foreign element is any activity or motion pattern unrelated to the 
ongoing task but initiated or caused by the crewman during the per­
formance of the task. Examples would be a crewman stopping his task to 
take a message or to perform some other and more urgent activity. The 
time for foreign elements was recorded separately and removed from the 
time for the element (task) in which it occurred. These intrusive and 
task-independent activities may be occasioned by human lapses, needs, 
or distractions and by mechanical or hardware failure. 
Waits and idles are characterized by breaks in the work cycle in which 
the crewman must wait for someone else to work with him, or for a 
mechanical process to be completed. Or the crewman may "take a break", 
or be idle, that is, nonproductive. He may also be engaged in mental 
activity (e.g., reviewing progress) not observable to the analyst. As 
was done with foreign elements, waits and idles were removed from the 
time measurement of the task (or element) in which they occurred. 
Task-related anomalies are those activities, -initiated by a crewman, 
or by hardware difficulties, which occur during the performance of a 
task and are essentially a part of it. This class is represented by
the "fumble", an incorrect procedure or sequence, a dropped object,
or other task-related error. The time occupied by the anomaly is 
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usually included in the element time. If it is possible or advanta­
geous to evaluate the causative factors involved, the anomaly can be 
treated as an element and isolated for more intensive study. As 
noted above for foreign elements and for waits and idles, task-related 
anomalies may have_human as well as mechanical (hardware) origins. 
Task-related anomalies are of special importance in that they can point
to deficiencies in the man/machine interface and/or in hardware design. 
GRAPHIC RESULTS 
One of the simplest, and in many ways most effective, methods of 
presenting experimental results is through graphic procedures. A 
representative picture of M15l data can be seen in a series of four 
graphs, figures 1 through 4, which depict the adaptation function for 
the basic activities involved in M092 Lower Body Negative Pressure, as 
these were performed on Skylab missions 2, 3, and 4. Training data 
comprise the left section of each graph; the right hand portion pre­
sents the in-flight results. 
Figure 1 shows the results for the Pilot and Scientist Pilot as subjects
in M092 Prerun Activity. The most striking feature of these graphs is 
the seeming continuity of in-flight performance as it followed the last 
preflight performance. The same tendency can be observed in figure 2 
which summarized M092 Postrun Subject Activity, again for the Pilot 
and Scientist Pilot on each of the three Skylab missions. 
The time to perform the basic M092 Prerun Observer Activity showed a 
different pattern in figure 3. In-flight performance was generally
elevated in comparison to terminal preflight training data. This was 
most clearly shown in the performance of the Commander for each of the 
three missions. 
In figure 4, in-flight performance time was at approximately the same 
level as that for preflight training data. Excepting the preflight 
performance for the Skylab 4 Scientist Pilot, the data showed very
little variation. 
Preflight training data for Skylab 3 and Skylab 4 was widely scattered 
over the twelve months preceding launch. In contrast, most of the 
training data for Skylab 2 was obtained within the last five months of 
launch time. 
One important fact emerged from the analysis of the four graphs. Of 
the 23 in-flight curves presented in the four figures, 18 of them had 
their initial performance at a level higher than that found in the last 
preflight trial. 
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(Scaling reflected the greater importance attached to in-flight per­
formance. Providing larger units for Mission Days, made it possible
for the in-flight performances to be more clearly differentiated among
the three missions.) 
STATISTICAL ANALYSES 
First In-flight Task Performance 
The first trial of an in-flight task was considered a significant
datum for evaluating the effects of zero-g environment on task perfor­
mance. In one sense, the zero-g effect was already diluted by the time 
the experiments began because crewmen had been busily working in the 
zero-g environment during the activation period, and for several days
had been slowly divesting themselves of one-g habits and quickly
acquiring zero-g maneuverability and expertise. Nevertheless, the 
previously presented graphs have strongly indicated that the first 
in-flight trial generally took longer than the last preflight trial of 
the same task. 
To better evaluate the effect of the zero-g environment on the initial 
trials of in-flight performance, the tasks were subdivided into ele­
ments and the times associated with the performance of each element 
were compared, first trial in-flight versus last trial preflight. The 
data for these elements were presented in terms of frequencies, namely 
the number of instances that time for the first in-flight trial was 
greater than that for last preflight trial, and viee versa. The results 
are found in table I. Thus, in the Skylab 2 mission, 95 elements took 
longer to complete in-flight than preflight. For 44 elements, the 
situation was reversed. In 68 percent of the cases, then, the first in­
flight trial took longer than the last preflight trial. 
TABLE I. IN-FLIGHT (I) ELEMENT TIME (FIRST TRIAL) COMPARED 
WITH CORRESPONDING PREFLIGHT (p) ELEMENT TIME (LAST TRIAL) FOR THE SKYLAB MISSIONS 
Skylab
Mission I > P P > I 
Percent (I > p) 
2 95 (36)° 44 (19) 68 (64) 
3 61 (32) 52 (21) 54 (60) 
4 94 (37) 66 (32) ~ (54) 
Total 250 (105) 162 (72) 61 (59) 
°Figures in parenthesis refer to Basic Elements only 
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Although the effect was not so pronounced for the remalnlng two mis­
sions, the results were consistent. When the results of the three 
missions were combined, it was observed that 61 percent of the first in­
flight trials took longer than the corresponding last preflight trials. 
Data in parentheses refer to Basic Elements. As shown in the table, 
percentages based on the basic elements appeared more consistent from 
mission to mission while summary results based on all three missions 
yielded almost identical percentages (59 versus 61). 
The elements were also categorized into three classes representing 
tasks requiring fine, medium, and gross motor dexterity. Because of 
the consistency of results from mission to mission, the data were 
combined across the three missions. The basic comparisons, first 
in-flight versus last preflight, were thus available for the three 
types of motor activity involved in task performance. These are pre­
sented in table II. 
TABLE II. COMPARISON OF PREFLIGHT AND IN-FLIGHT PERFORMANCE 
TIMES FOR ELEMENTS CATEGORIZED INTO FINE, MEDIUM, 
AND GROSS MOTOR ACTIVITY CLASSES 
Type of Motor First In-flight First In-flight Percent 
Last Preflight Last PreflightActivit~ Involved > < (I > P} 
Fine 83 49 63 
Medium 122 81 60 
Gross 39 30 57 
Although the first in-flight trial generally took longer than the last 
preflight trial, a result established in the previous analyses, the 
percent increase was most pronounced for fine motor activity, less so 
for medium and least for gross motor activity. The percentage differ­
ences are small and insignificant but the systematic decrement is 
important. Such a decrement would reinforce the debriefing comments of 
the astronauts who reported that the control of small objects caused 
more difficulty than the control of larger masses. 
Return to Preflight Baseline 
It has been noted that the first in-flight trial generally took longer 
to perform than the last preflight trial of the same task. The question 
arose as to how long it would take to adapt to the Skylab work environ­
ment, or more specifically, how many trials it would take before an 
in-flight task was done as speedily as it was on the last preflight 
• 
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trial. The criterion of equivalent performance was taken to be that 
particular ~rial at which half or 50 percent of the task elements were 
done as speedily as in the last preflight performance. 
The sources for this analysis were the activities involved in Experi­
ment M092 (Prerun and Postrun, Subject and Observer), Experiment S073, 
and Suit Donning and Doffing. Table III presents the number of activi­
ties which, at first or second in-flight trial, were done as rapidly 
as they were on the last preflight trial. For example, by the end of 
trial 2, 44 at the 86 elements on Skylab 2 were completed within the 
time taken on the last preflight trial. 
From an overall viewpoint, the results for the three missions were 
fairly consistent. When the elements were totalled across the three 
missions, exactly half of the elements returned to preflight baseline 
(last preflight trial) by the end of the second trial. 
TABLE III. NUMBER OF ELEMENTS PERFORMED IN-FLIGHT (FIRST 
OR SECOND TRIAL)
FLIGHT TRIAL 
AS SPEEDILY AS ON LAST PRE­
Skylab
Mission 
. In-flight Time 
> Last Preflight 
In-flight Time 
~ Last Preflight 
Percent (I > p) 
2 44 42 51 
3 46 53 46 
4 51 46 53 
Total 141 141 50 
The specific mission day on which the criterion was reached could not 
be precisely determined since some of the activities, such as Suit 
Don/Doff, were not scheduled as regularly as experiment M092. If one 
were to take experiment M092 as the more consistent indicator, then the 
mission day equivalences for the three flights were as follows: 
Skylab Mission Mission Day of Second Trial 
2 7th or 10th day 
3 8th day 
4 10th or 11th day 
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In general, the second trial of experiment M092 was scheduled within the 
second week of the mission. It was anticipated, then, that the crewmen 
should have begun to feel adapted to their work schedules, or should 
have felt a reduction of the work pressure at about this time. The 
debriefing comments were not altogether clear on this point. For 
example, the Skylab 3 crew (and the Skylab 2 crew to some extent) in­
dicated that the critical point in adaptation occurred in the vicinity 
of 10 days. As for the Skylab 4 crew, one member mentioned a period 
of a week or two, another a period of a month or so. From an object­
ive viewpoint, however, the data suggested a point in time somewhere 
in the vicinity of a week or two. 
The time period mentioned above was, in many respects, an artifact of 
work-schedule planning. There was some evidence in the data to indi­
cate that trials were more important than mission days in the evalua­
tion of adaptation to task or work performance. It has been observed 
that by the second trial, whether performed on the same day or a week 
later, the time tended to approximate that obtained on the last pre­
flight trial. 
In summary, the time to perform a task on the second in-flight trial 
tended to approach the baseline time of the last preflight trial. For 
short missions, then, the early repetition of tasks critical for mission 
success would seem to be the mos~ effective allocation of in-flight
work activities. 
Pattern of Task Performance 
It was anticipated that some tasks would be done differently in the 
zero-g environment than under the one-g training conditions. In 
particular, it was expected that the pattern of in-flight work activity 
would differ from that exhibited in preflight training. For the pre­
sent analysis, the basis for differentiating preflight from in-flight 
work patterns was the order in which the elements of a task were per­
formed. The standard was the order determined by the checklist. 
Against this standard were compared the orders in which the elements 
were performed in-flight and in training. A measure of how closely
these orderings corresponded to the standard was obtained by the 
Spearman Rank Difference Correlation Coefficient. 
The following four tasks associated with experiment M092 were used in 
the analyses: 
Prerun Subject (15 element array) 
Prerun Observer (27 element array) 
Postrun Subject (15 element array) 
Postrun Observer (12 element array) 
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As an example of a typical array, the checklist ordering of elements in 
the PrerunSubject task follows: 
1. 	 Translate to Waste Management Compartment from Data 

Acquition Camera - Remote Control 

2. 	 Unstow harness and sponges 
3. 	 Clip harness to garment 
4. 	 Prepare vectorcardiograph harness 
5. 	 Don vectorcardiograph harness 
6. 	 Attach Body Temperature Measurement System cable to 

harness 

7. 	 Translate to Lower Body Negative Pressure Device from 
Waste Management Compartment 
8. 	 Open seal zipper fully 
9. 	 Adjust plates 
10. 	 Ingress Lower Body Negative Pressure Device 
11. 	 Mate vectorcardiograph to Subject Interface Box on Lower 
Body Negative Pressure Device 
12. 	 Close plates 
13. 	 Zip/adjust seal 
14. 	 Fasten/adjust seal belt 
15. 	 Don Blood Pressure Measurement System 
Spearman correlation coefficients were computed for each trial of each 
crewman in his capacity as subject or observer. Since number of trials 
differed in-flight and in training, the number of coefficients for these 
conditions also differed. 
Table IV presents the preflight and in-flight median correlation coef­
ficients ("r") for the three Skylab missions. In general, the median 
preflight coefficients were larger than the in-flight coefficients for 
all three missions. The results indicated that the crewmen performed 
preflight tasks more in line with the checklist order than they did 
"in-flight. The result made sense in that a crewman was more likely to 
follow instructions much more closely during training than after having 
mastered the task. Once mastery was achieved he could with more confi­
dence experiment with better ways of doing the task. In addition, the 
crewman's weightlessness and the weightlessness of the masses he was 
handling made it more likely for his work pattern to change. 
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Another trend was also apparent in the data. Whereas the preflight 
coefficients remained relatively the same for each mission, the magni­
tude of the in-flight coefficients diminished steadily from the first 
to the last mission. This, too, was a reasonable result in view of 
the general transmission of information from one crew to another. In 
particular, any new and efficient methods of performing in-flight tasks 
were always transmitted to the crews of subsequent missions. Such 
methods would have very likely involved the ordering of elements com­
prising a task. 
Despite the differences noted between the preflight and in-flight co­
efficients, both sets were of high magnitude. Coefficients of such 
magnitude indicated that the order in which the elements of a task were 
performed, preflight or in-flight, adhered relatively close to the order 
prescribed by the checklist. 
TABLE IV. 	 MEDIAN PREFLIGHT AND IN-FLIGHT SPEARMAN COEFFICIENTS 
FOR THE THREE SKYLAB MISSIONS 
Skylab Preflight 	 In-flight
Mission No. Median "r" No. Median lOr" 
2 40 0.982 32 0.976 
3 30 .978 43 .961 
4 49 .982 53 .929 
The Spearman coefficients were analyzed also in terms of the function 
the crewman performed, namely, whether as subject or as observer: 
Table V presents the median coefficients for these crewman roles, 
preflight and in-flight, for the three missions. The data indicated 
not only that the preflight-in-flight differences were consistent 
across the new subdivisions but that there was a strong trend for the 
Subject coefficients to be higher in magnitude than the Observer co­
efficients. These results flowed directly from the roles assumed by
the crewmen. The subject, once in or attached to an instrument, was 
constrained by the sequential functioning of the mechanical system much 
more rigidly than was the observer whose options were more numerous 
because of his role in the experiment. 
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TABLE V. MEDIAN SPEARMAN COEFFICIENTS FOR SUBJECT AND 
OBSERVER, PREFLIGHT AND IN-FLIGHT FOR SKYLAB 
MISSIONS 2, 3, AND 4 
Skylab Mission Role Preflight In-flight 
2 	 Subject 0.994 1.000 
Observer 0.952 0.935 
3 	 Subject .992 .988 
Observer .968 .954 
4 	 Subject .982 .928 
Observer .972 .938 
Across all Subject .991 .964 
Missions Observer .963 .943 
In summary, then, the sequential pattern of a task as described in the 
checklist, was more rigidly adhered to in training than in-flight. 
Further, subject activity adhered to the checklist order more closely
than observer activity because of the constraints of the instrumental 
system to which the subject was attached. 
SUIT DONNING RESULTS 
Suit donning is of vital concern to crew safety and operation during 
extravehicular activity. In addition, this activity (as well as suit 
dOffing) has always been of interest to M151 investigators because it 
requires the full scope of the crewman's capabilities from fine motor 
dexterity, such as the precise alignment of connectors, to gross act­
tivities such as placing the helmet and gloves for later use. Crewman 
interaction is also involved, primarily during the zipper closures of 
the pressure garment assemblies. As the later crews studied the M15l 
films of the earlier crews, it was anticipated that significant changes
in method from crew to crew would develop. Suit donn"ing was nominally 
to be performed early, middle, and late in the mission on Skylab 3 and 
Sky1ab 4, thus providing some indication of zero-g adaptation. 
The Skylab crewmen wore their suits for many different types of train­
ing in preparation for their respective missions. In most cases, they
received assistance from suit technicians in donning and doffing the 
suits and as a result had a minimal number of training sessions where 
they actually simulated the donning and doffing procedures required 
for the Apollo telescope mount extravehicular activities. However, 
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from the exposure of having the suits custom fitted and from having
the suits on for various exercises, the crewmen became familiar with 
the components required for extravehicular activity. During Skylab 
training, a maximum of only four extravehicular activity suit donning
(and doffing) sessions were recorded by M151 for any crew. Table VI 
presents a summary of Skylab preflight training, with total time shown 
for 21 basic (and common) elements which must occur in the suit 
donning activity. The performance number refers to the crewman don­
ing the suit. 
Figure 5 presents the graphs of the averaged data in table VI. The 
outstanding characteristic of the three functions is the terminal 
pOint, the time for the last training session before flight. Whatever 
the differences in the initial training sessions, and these were large 
among the three crews, the final trainin9 performance required about 
the same amount of time (800-850 seconds) for the different crews. 
Although there was some inconsistency in the pairing of crewmen during
the training sessions, it was felt that this had a minimal impact on the 
total times. There is certainly every indication that proficiency 
consistently improved. 
Although all three crewmen donned the pressure garment assemblies prior 
to each extravehicular activity, only the two crewmen who would actually
perform the extravehicular activity donned the necessary items specific
to extravehicular activity. The third crewman did gain the additional 
experience of donning and doffing the basic part of the suit but did 
not participate to the extent of the two extravehicular activity crew­
men. The performance number alluded to in this section refers to an 
assignment as extravehicular activity crewman. 
PERFOIII1ANCE HlllBER 
Figure 5. 	 Preflight suit donning average time. 
(Sum of basic Elements) 
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TABLE VI. EVA SUIT DONNING TRAINING SUMMARY 
(Sum of Basic El~ments) 
Skylab
Mission 
Perfonn. 
No. 
Time to 
launch 
(months} Crelooman AssistingCrelooman ~ 
Time 
(Seconds} 
2 9 tDR* PlT t 763 
9 PlT CDR 1043 
(avg) 903 
1 7 SPT:I: CDR 1231 
~2 7 CDR PlT 811 

(avg) 1021 

2 3 SPT CDR 1061 

3 3 CDR PlT 864 

(avg) 962 

3 SPT CDR 874 

4 CDR PlT 715 

(avg) 795 

3 	 11 CDR SPT 1334 
11 SPT CDR 1089 ' 
(avg) 1211 

1 8 PlT CDR 912 

2 8 CDR PlT 1159 

2 6 SPT PlT 1072 

(avg) 1048 
3 6 CDR PlT 1030 

3 6 PlT CDR 879 

(avg) 955 

4 1.5 CDR PlT 	 796 
4 1.5 PlT CDR 	 914 
(avg) 855 
4 5 SPT CDR N/A
5 CDR SPT N/A 
2 4 SPT PlT 1666 .6­
1 4 PlT SPT 1194 
(avg) 1430 • 
4 2 CDR PlT 938 
4 2 PlT CDR 730 ~ 
(avg) 834 
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Table VII and figure 6 which follow summarize the in-flight suit don­
ning performances. Only one performance (on mission day 25) was filmed 
for Skylab 2, but it was the second time the Commander had donned his 
suit prior to extravehicular activity, while it was the first suit 
donning for the Pilot as an extravehicular activity crewman. An earlier 
extravehicular activity on mission day 14, involving the Commander and 
Scientist Pilot, was required on Skylab 2 during which the Pilot per­
formed a non-extravehicular activity suit don. Three trials were 
recorded during each Skylab mission 3 and 4, but not always with the 
same pair of crewmen. The effect of total number of performances, 
difficultites (on Skylab 4) with the zipping operation because of snug­
fitting suits, occasional intrusions of the non-extravehicular activity
crewmember into the operation, and the small number of observations, 
created difficulties in identifying relationships between the timing 
(number of months or days, before launch) of training sessions and the 
timing of in-flight performances. 
Large differences were found in the average times of extravehicular 
activity crewmen for the last performances: 669, 740, and 910 seconds 
respectively. These differences are probably due to factors other than 
the effect of training schedules, adaptation to zero gravity, learning, 
et aetera. Suit fit, for example, could have obvious effects on the 
time required to don the pressure garment assembly. This may be the 
reason that the Skylab 4 crewman took longer to don the pressure gar­
ment assembly late in the mission. In-flight anthropometric data* from 
Skylab 4 indicates that the heights of the crewmen significantly in­
creased over the course of the mission and that the greater part of 
this increase was in the upper torso. This, then, would explain the 
much longer time required to zip the pressure garment assembly, a fact 
which M151 data disclosed. Correlation of the results of the antro­
pometric findings and M151 were further substantiated by Skylab 4 crew 
comments in their postflight debriefings. 
On Skylab 4 mission day 7, the Scientist Pilot and Pilot donned their 
suits (see table VII) with considerable difference in time required; 
1192 seconds for the Scientist Pilot and 818 seconds for the Pilot. 
During this extravehicular activity preparation the Pilot seldom used 
the portable foot restraint while donning his own suit. He accomplished
the suit donning in a free-floating mode or used his hands as a 
restraint system. Although it appeared difficult or awkward, the time 
was 31 percent less than that of the Scientist Pilot who remained in 
the foot restraint while donning his suit. 
During the portion of the suit donning task where the crewmen assisted 
each other, the time taken by the "unrestrained" Pilot to zip the 
Scientist Pilot's pressure garment assembly zippers was 279 seconds, 
*See Anthopometric Changes and Fluid Shifts by Dr. W. E. Thornton in 
vol ume II. 
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TABLE VII. EXTRAVEHICULAR ACTIVITY SUIT DONNING 1ft-FLIGHT SUMMARY 
(Sum of Basic Elements) 
Sky1ab 2 Sky1ab 3 Sky1ab 4 
Perfonn. 
No. 
Mission 
Dal 
Crew­
man 
Assist 
CrNllan 
Time 
(Seconds) 
Perfonn. 
tlo. 
MiSSion 
Da~ 
Crew­
man 
Assist 
,Crewman 
Time 
(Seconds) 
Perfonn. 
tlo. 
Mission 
Da~ 
Crew­
man 
Assist 
Crewman 
Time 
(Seconds) 
14 CDR* SPTt tllA 10 SPT PLT* 1096 7 SPT PLT 1192 
14 SPT CDR N/A 10 PLT SPT 1094 7 PLT SPT 818 
(avg) 1095 (avg) 1005 
1 25 PLT COR 802 2 28 SPT PLT 837 2 40 PLT CDR N/A 
2 25 COR PLT 536 2 28 PLT SPT 866 40 COR PLT N/A 
(avg) 669 (avg) 852 
57 SPT COR 740 2 44 COR SPT 1036 
W 57 COR SPT tllA 2 44 SPT COR 1057 
W 
0 (avg) 1046 
3 80 CDR SPT 980 
3 80 SPT COR 840 
(avg) 910 
*CDR • Commander 
tSPT ~ Scientist Pilot 
±PLT • Pilot 
.. 
... ...)­
'1 1: 
while the "foot-restrained" Scientist Pilot took only 222 seconds to 
zip the Pilot's zippers. In the first case the Pilot maneuvered around 
the Scientist Pilot, using the Scientist Pilot to restrain himself, 
as he performed the zipping operation. In the second case, the Scientist 
Pilot had the Pilot free-floating in front of him, and turned him as 
necessary to put the zipper in the best working position . 
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Figure 6. 	 In-flight suit donning average time. 
(Sum of basic elements) 
Although the Pilot took the shortest time for the total suit donning
task, it would appear that in, a two man operation, the "operator" should 
be restrained when working on a task that offers resistance such as a 
zipper; while restrained he is also in a better position to control the 
physical attitude of the subject. 
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FUNDAMENTAL TIME MEASURES 
Camera Running Time and Basic Element Time 
In addition to accurate time information, photographic methods also 
provided the basis for understanding why anomalous results could have 
been obtained. Two time measures based on photography were described 
in an earlier section - camera running time and basic element time. 
Although camera running time was the more complete measure, it also 
included the timing of activities not necessarily relevant to those 
being observed and measured. More limited in coverage, basic element 
time provided a measure for making valid comparisons between preflight
and in-flight performance, between missions, and between crewmen. 
Experiment M092 Prerun Subject data for the three missions were used 
to give a comparative picture of the two photographic measures. Fig­
ures 7 to 9 present the data for the three missions. The most readily
observable characteristic of basic element time was its consistency and 
stability in contrast to the wide variations exhibited in camera running
time. This may be observed most clearly in the respective graphs of 
the Skylab 2 Pilot (fig. 7), the Skylab 3 Pilot (fig. 8), and the 
preflight graph of the Skylab 4 Pilot (fig. 9). Despite the lower 
values obtained with the basic element time measure, it was a sensitive 
and realistic indicator of changes in the adaptation function. As an 
example of the value of basic element time, attention is directed to 
the two curves for the preflight performance of the Pilot o~ Skylab 3 
(fig. 8). The upper curve, representing camera running time, would 
have indicated that performance became worse with practice. Basic 
element time, on the other hand, presented a more realistic picture of 
the adaptation function. 
Both time measures, camera running time and basic element time, served 
important functions in the analyses of crewman task and work activities. 
Camera running time provided a basis for explaining unusual and un­
expected results by isolating and identifying nonrelevant perturbations 
intruding on the efficient performance of a task. Basic element time 
served as the fundamental comparative measure and helped in identi­
fying the nature of the differences in performance - in-flight and 
preflight, between missions, and between crewmen. 
Voice/Telemetry as a Method of Data Acquistion 
Because of film restrictions, it was not possible to photograph the 
totality of trials comprising each of the M15l experiments on the 
Skylab missions. A procedure was devised to sample those trials most 
critical to M15l objectives. The partial but carefully sampled data 
were used to generate the adaptation function which served as the basis 
for estimating data points not sampled by M15l film procedures. 
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Data for the complete set of trials would have been highly desirable; 
they were, however, unobtainable because of the limited amount of film 
available to M151. 
The cooperation of the Skylab 4 crew was obtained to gather and report 
data on the performance of tasks done repeatedly and regularly over 
the entire 84-day mission. This involved the major medical experiments: 
M092, Lower Body Negative Pressure; M093, Vectorcardiogram; and M171, 
Metabolic Activity. These experiments were scheduled back-to-back in 
combinations of ~1092/M093 or M092/M171 and were perfor-med with'in three 
or four day cycles with each crewman as subject. The result was that 
virtually every mission day from day 5 to day 83 had at least one of 
the combinations M092/M093 or M092/M171 as part of the daily flight 
plan. The only exceptions were the days the crewmen rested or per­
formed extravehicular activity. Also twice during the mission, two 
major medical runs were made in the same day to free another day for 
multiple Earth Resource passes. Although subjects were scheduled on 
a regular basis, this was not the case for the observers. By the end 
of Skylab 4, the Commander was the observer for experiment M092 a total 
of 26 times, the Pilot a total' of 23 times, and the Scientist Pilot only 
18 times. 
Performance time was obtained from the voice records and these indicated 
the points at which crewmen began or finished a task. In the course 
of the experiment, telemetry automatically recorded other events, such 
as calibrations, and these time points provided a check on possible 
discrepancies in the voice records. 
No attempt was made to factor out anomalies or task interruptions 
present during the nominal run of the experiment. Interruptions caused 
by air-to-ground communications or other crewmen were considered, in 
the present analysis, as part of the total time required to perform the 
task. Other factors, however, not,associated with the experiment 
proper, were eliminated from the tape-recorded time interval assigned
to the experiment. These were the special tests which were introduced 
late in Skylab missions 3 or 4. They included Limb Blood Flow, Leg 
Blood Pressure, Facial Photos and Anthropometric Measurements to 
study body fluid shifts, venous compliance*, and changes in body size 
due to prolonged exposure to zero gravityt. In some tests, such as 
Limb Blood Flow, the time required could be factored out on the basis 
of telemetry associated with the test. In others, an estimate was 
determined from baseline data or from in-flight photos taken from M151 
*HemodynamicStudies of the Legs Under Weightlessness and Anthropometric 
Changes and Fluid Shifts by Dr. W. E. Thornton; see volume II. 
tBiostereometric Analysis of Body Form by Dr. Michael Whittle; see 
volume I. 
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data. Early in Skylab 4, the special tests had significant impact on 
performance because the crew had little or no training on these tests 
prior to flight. 
Accurate Voice/Telemetry data across the three Skylab missions were 
available in only one segment of the M092/M093/M171 complex of activi­
ties. The segment consisted of those activities following the comple­
tion of M092 data collection up to the point when M171 data acquisition 
was begun. In sequence, these activities included: 
Time Count - Stop (End of M092) 
Cuff/Inflate - Stop/Reset 
Perform Hi-Calibration - (Hold 20-25 seconds) 
System Select - Off 
Tape Recorders - Off 
Data Acquition Camera - On (If required) 
Open Marmon Clamp and Lower Body Negative Pressure Device 
Remove Legbands and Reference Adaptor from Subject 
Close Lower Body Negative Pressure Device and Secure 
Marmon Clamp 
Begin Metabolic Activity Calibration Check 

Configure Experiment Support Systems for M171 Data 

Electrode Impedance Check 

Perform Hi-Calibration (Hold 20-25 seconds)

Vital Capacity Calibration (If required) 

Vital Capacity Measurements (3 trials) 

Time Count - Start (M171 Data Collection) 

The time interval between the two time counts was used to compute aver­

ages for the three crewmen acting as observers in each of the Skylab 

missions. These data are presented in graphic form in figure 10. For 

two of the Skylab missions, 2 and 4, and partially for the third 

(Skylab 3) the graphs demonstrate the characteristic features of the 

adaptation function: high initial values and a progressive decrement 

over the course of the experiment. 

The Skylab 2 graph was smoothest and most regular, uniformly lower than .~ 

the others over the six trials, and decreasing at a relatively slow 

rate. Of the three graphs, it also suggested the most consistent per­ • 

formance. 

The Skylab 4 graph, on the other hand, began at a much higher level and 

descended in a rapid but irregular manner over seven trials. A sharp 
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increase at the eighth trial reversed the trend momentarily. The rapid 
descent continued for the last three trials, of which the last two took 
substantially less time because the Skylab 4 crew had completed some 
of the required activity before the time period for which it was 
scheduled. The last two points, then, did not validly indicate the 
times for the corresponding trials. 
The data from the Skylab 3 crew exhibited two radically different trends. 
For the first half of the mission, trials 1 through 5, the graph was a 
classic representation of the adaptation function. A sharp increase at 
trial 6 introduced a relatively stationary level of performance for the 
remainder of the mission, a level uniformly and sub~tantia11y higher
than that at which the other two crews were performing. The explana­
tion of this anomalous segment of the graph is not readily apparent. 
Although it was well known that the M092/M093/M17l sequence of activi­
ties was not popular with the Sky1ab crewmen, the Skylab 3 crew were 
most direct and explicit in expressing their feelings. They felt it 
was boring, menial, and nonproductive of at least one person's time. 
It may well be that these feelings crystallized midway during the mis­
sion with a correlative loss of motivation and a consequent loss of 
efficiency. 
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In summary, Voice/Telemetry data were a valuable adjunct in the evalu­

ation of task performance. When the tasks were done in a nominal 

manner, Voice/Telemetry gave a valid estimate of the actual time ex­

pended during the performance of the task. The drawback in using Voice/ 

Telemetry was that the measure also included everything else that ,. 

happened within that time period even though it may have had no definite 

relation to the task at hand. VOice/Telemetry data also failed to 

correct for such unusual situations as demonstrated in the last two 

performance trials of the Skylab 4 crew. 

PERFORMANCE LATE IN MISSION 
An important objective of experiment M15l was to examine the performance 
late in the mission for signs of anomalous performance due to the long 
exposure in the Skylab environment. In terms of the adaptation function 
an anomalous result would be either a significant increase in time to 
perform tasks or a significant increase in variability towards the 
latter part of the mission. 
To determine whether these two effects were operating on the Skylab 4 
mission, the vOice/telemetry data for M092, M17l, and M093 were divided 
into thi~ds; the<initial third, the middle third, and the final third 
of the Skylab 4 mission. These data, in the form of means and standard 
deviations, are presented in table VIII. 
As the data in the table indicate, the means for the initial, middle, 
and final portions of the mission decreased steadily for the three 
experiments. The standard deviations decreased sharply from the initial 
third to the middle third and became stabilized at about this period of 
the mission. The slight increases in standard deviation from the middle 
to final third for experiments M092 and M17l could be considered as 
random variations about a relatively stable level. Some sUbstantiation 
for this conclusion can be found in the standard deviations observed 
in experiment M093 where there was a decrement from the middle to the 
final third. 
TABLE VIII. MEANS AND STANDARD DEVIATIONS OF TASK PERFORMANCE 
FOR THE INITIAL. MIDDLE. AND FINAL THIRDS OF THE 
SKYLAB 4 MISSION 

Initial Middle Final 

EXl!erlment Third Third Third 

X S.D. X S.D. X S.D. 

M092 34.7Q 6.3 27.2 2.8 23.3 3.1 
M171 30.2 5.4 19.0 2.4 15.9 2.9 " 
M093 14.9 2.9 10.7 1.6 9.7 1.2 
(lin minutes 
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In summary, then, there was no significant evidence for deterioration 
of performance on Skylab 4 as the mission approached its culmination. 
As a matter of fact, performance continued to improve while variabil­
ity did not increase significantly during the final third of the Sky­
lab 4 mission. 
CONCLUSIONS 
The fundamental results from the above analyses can be summarized in 
several brief conclusions. 
o 	 Despite pronounced variability in training schedules and in 
initial reaction to the Skylab environment, in-flight task 
performance was relatively equivalent among the three Skylab 
crews. 
o 	 Behavioral performance continued to improve from beginning to 
end of all Skylab missions. 
o 	 There was no evidence of performance deterioration that could 
be attributed to the effects of long-duration exposure to the 
Skylab environment. 
c, 	 The first in-flight performance of a task generally took a 
longer period of time than the last preflight performance. 
The longer performance time could be the result of a number 
of factors - stress of last-minute flight preparations,
change to zero-g Skylab environment, greater care and cau­
tion in the performance of in-flight tasks, an experience
of work overload during the early period of the mission. 
o 	 Performance adaptation was very rapid. By the end of the 
second performance trial, about 50 percent of all task 
elements were completed within the time observed for the 
last preflight trial. 
o 	 The pattern of work performance changed more in-flight than 
it did during preflight performance. 
o 	 Three fundamental time measures, i.e., Basic Element Time, 
Camera Running Time, and VOice/Telemetry Time, were shown 
to have specific application in situations relevant to their 
use. 
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ABSTRACT 
The many individual work tasks accomplished by each of the three Skylab
flight crews in their early activation phase have been identified 
and their respective performance times estimated. These work perfor­
mances were compared both with preflight estimates of the rate at which 
work would be done and with crew output later in the mission when 
adaptation was complete and when the crewmembers were experienced in 
zero-gravity operations. The very substantial amount of work devoted 
to repair tasks during the early missi~n days was also included. 
It was found that on only two of the total of nine full or partial
activation days was the crew work output significantly reduced. On the 
day of lowest efficiency, mission day 2 of the Skylab 3 mission, it 
appears that the crewmen were working at approximately 75 percent of 
their "normalll efficiency and may have lost approximately 7 man-hours 
of work. Overall, a nearly constant level of work was achieved on 
these activation days. However. as crew proficiency improved later in 
the missions. the daily crew work output in these same categories in­
creased from approximately a 26 man-hour/day to at least a 34 man-houri 
day. 
INTRODUCTI ON 
Soon after reaching orbit several crewmembers of both Apollo and Skylab
flights (as well as Russian cosmonauts) have reported symptoms of 
malaise or stomach discomfort, occasionally reaching the point of 
vomiting. While these symptoms have always disappeared after a few 
days, they have generated some concern about the ability of crewmen to 
work efficiently in the first few days of a space mission. This is a 
particularly important consideration for Shuttle operations. since 
many flights will probably be limited to about seven days in orbit, 
until a sufficient number of Orbiters are available to allow longer 
periods in space. 
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METHODS AND DATA 

Skylab data may allow a reasonably objective analysis of crew effici­
ency to be made during the first few days in flight since an "activa­
tion" schedule was prepared preflight for each crew. A rather close 
accounting was made to the ground controllers as the activaton tasks 
were completed, as well as an accounting of any additional work accomp­
lished that had not been scheduled preflight. Part of the concern 
about crew efficiency has arisen because some of the scheduled activa­
tion tasks were delayed; in addition, it is essential to consider the 
added tasks required, usually of a "trouble shooting" nature, before 
the true picture of efficiency can be evaluated. The basic data 
reported here has been collected by G. Doerre, J. Arbet, and S. Graham 
from the records of each of three Skylab missions as it was flown (1). 
As Doerre was also responsible for the lIactivation" phase crew training
prior to launch, he and his associates are most familiar with the 
individual tasks that are listed below. 
Perhaps the most useful portion of their data for this study is the 
tabulation of "activation tasks accomplished" on each of the first few 
days after rendezvous with the Skylab for each of the three crews. 
These tables list individual tasks completed by each of the three crew­
members, with the time investment estimated to the nearest five minutes. 
These estimates are based on the time it took for a trained crewman to 
perform each task in preflight training at Johnson Space Center. Al­
though not exact, it has been the general concensus of crewmembers that 
the times allotted are reasonable. The tasks listed are intended to 
include all the useful work accomplished, exoluding food preparation,
eating, sleeping, rest periods, personal hygiene and housekeeping
activities. As an example of the depth of detail, the table for Sky­
lab 3 (the second manned mission) is attached as appendix A. 
The total time accumulated each day in "activation tasks accomplished" 
divided by the number of "man-hours available" for work will be defined 
as the efficiency ratio, E.R. The "man-hours available ll is simply 
a measure of the total crew t'ime awake duri ng the activation phase of 
each flight. If every waking moment was spent on activation tasks or 
repairs, this ratio would be unity. However, since the many essential 
tasks of food preparation, eating, sleeping, personal hygiene and 
houskeeping are excluded, the efficiency ratio will obviously be less 
than one. In fact, if we consider·a normal day here on Earth to con­
ta'in 16 hours awake, sp'lit evenly between useful work (8 hours) and 
other "overhead" or housekeeping functions, this day would have an 
efficiency ratio of 0.5 by our definition. Justification for this 
definition of E.R. will be provided a little later. Table 1 shows 
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the activation man-hours accomplished for each crew on each applicable
mission day, through mission day 4, and also the number of man-hours 
available on each day. From these data the efficiency ratio may be 
obtained, as is shown in table I and figure 1. 
Some explanation of the table entries is required. The first mission 
crew (Skylab 2) had. a larger activation task than succeeding missions; 
they were scheduled for three full days of activation, starting on 
mission day 2. The next two crews were scheduled only for about 2.5 days
each. For the second crew (Skylab 3), the activities were begun on 
mission day one, after launch and rendezvous were completed. The 
third crew remained in the command module on mission day one and were 
scheduled to begin activation on mission day 2. Therefore, only ha1f­
days are shown under man-hours available for Skylab 3 on mission day 1 
and Skylab 4 on mission day 4. A somewhat abbreviated activation day 
was also scheduled preflight for Sky1ab 3 on missions day 3. The 
entries under man-hours accomplished were, of course, accumulated only 
in these available hours. 
From these data it may be seen that on seven of the nine activation days, 
the efficiency ratio average was just over 0.54. Only on mission 
day 2 of Skylab 3.and mission day 3 of Skylab 4 did it drop signifi­
cantly below this value. Mission day 2 of Skylab 3 was the day in 
which this crew felt most handicapped by motion sickness. On this day
there was an attempt to provide the crew with about two hours of rest 
in midday, although they were required almost immediately to respond 
to a Master Alarm indication of low bus voltage. Much of the scheduled 
rest period was then spent in tracking down the source of the large 
power drain. (It was a short in an experiment carried in the Command­
Service Module.) 
The Skylab 3 crew had been awake on mission day 1 for a total time of 
22 hours (only 7.5 available for activation), followed by 18 waking
hours on mission day 2. These long days may well have contributed to 
reduced efficiency on mission day 2, as well as the motion sensitivity. 
Assuming that an E.R. =0.54 is ~normal", we estimate from table I that 
the time lost due to reduced efficiency is approximately (0.54 - 0.41) 
54~7.0 man-hours. Similarly, the Skylab 4 crew on mission day 3 may
have lost about (0.54 - 0.45) 52.5:4.7 man-hours, at least some of, 
which was due to motion sensitivity. 
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TABLE I. ACTIVATION MAN-HOURS: ACCOMPLISHED AND AVAILABLE 
MISSION DAY 1 MISSION DAY 2 
Skylab
Mlssion AccOl11Rlished Available 
Efficiency
Ratio AccomR11 shed Available 
Efficiency
Ratio 
2 24.4 46.5 0.52 
3 12.3 22.5 0.55 22.0 54.0 0.41 
4 27.5 51.0 0.54 
•. 
MISSION DAY 3 MISSION DAY 4. 
Skylab
Mission AccOl11Rlfshed Available 
Efficiency
Ratio AccomRllshed Avai lable 
Efficiency
Ratio 
2 27.7 51.0 0.54 26.3 48.0 0.55 
3 22.3 40.5 0.55 
4 23.8 52.5 0.45 10.3 18.0 0.57 
0.6 
EFFICIENCY 0.5 

RATIO, E .R. 

____ Skylab 2 0.4 
---- Skylab 3 
•••••••••••••••• Skylab 4 
1rL______~______~I______~I______~1 
2 3 4 
MISSION DAY 
Efficiency Ratio (E.R.), defined as the ratio of activation tasks accomplished to 
the number of man-hours available during the activation phase of each Skylab flight.
The text describes these quantities in more detail and justifies the exclusion of 
the many "overhead". yet essential, tasks of food preparation, eating, sleeping, 
rest. personal hy,giene and housekeeping. 
Figure 1. Efficiency ratio. 
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Crew performance early in the flight can be viewed from still another 
aspect. We may ask "how many man-hours of activation tasks remained 
incomplete at the end of the scheduled activation interval"? For the 
three crews respectively, the answers are 0.1,13.5, and 4.8 man-hours. 
For all three flights, essentially all of these remaining tasks were 
completed by the end of mission day 4. Although 13.5 man-hours of 
activation tasks remained to be accomplished at the end of mission 
day 3 on Skylab 3, additional repair tasks of 12.9 man-hours had been 
completed. The Sky1ab 4 crew completed an extra 4.2 man-hours of 
added tasks in their activation phase. These results indicate that 
all three crews were able to deliver, in the first three or four days 
of their respective flights, rather close to the amount of work they
had been scheduled preflight, to accomplish. We will see later that 
flight planning had been somewhat conservative by late mission standards, 
but was apparently quite realistic for these first few days. 
It may not be clear why the rather large number of essential "overheaa" 
tasks (food preparation, eating, sleep, rest, personal hygiene and 
housekeeping) have been excluded in computing an efficiency ratio. 
There are two principal reasons. First, we have just seen that all 
three crews 	were working at very close to the preplanned rate during
these first 	few days. To have included these "overhead" tasks in 
computing an efficiency ratio would simply have resulted in a value 
very near unity and we would not have been able to see later shift 
from less "overhead" work into a greater percentage of productive 
activity. Second, we have selected only activation and repair tasks 
which can be compared directly to experiment and related operations 
later in the flight. In this way, we can see most clearly the number 
of man-hours it is reasonable to expect a crew to deliver both early
and late in a mission for activation and payload operational tasks. 
We should now turn to the comparison of productive work accomplished
in the first few days of flight with that accomplished later on when 
adaptation was complete and the routine well established. In addition 
to the direct performance of experiment operations, there are several 
other "operational tasks" which should be included before the amount 
of work produced later in the mission can be compared with work output
in the activation phase. These operational tasks include physical 
exercise, some "post-sleep" activities related to experiments, tele­
vision, photography, and repairs. When these tasks are added to the 
.... specific experiment operations, the Sky1ab 3 crew delivered over 31 man­
hours of productive work per day, and increased this to about 36 man­
( 	 hours per day toward the end of the mission, which would correspond to 
and E.R. = 0.75 as defined before. These are the numbers most directly
comparable to a Inorma1ly" efficient activation day of about 
(0.54 x 48 man-hours awake) ~26 man-hours/day of work accomplished 
(2, 3, 4). 
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Figure 2 shows the trend of productive work rate for all three crews 
from activation phase through the completion of their experiment opera­
tion. Each point shown is an average of three to seven days work, with 
days of I!restl! or extravehicular activities excluded. 
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The tasks included in productive work consist not only of direct experiment perform­
ance, but also experiment related activities of physical exercise. photography. 
television, science demonstrations and repairs. These totals may be compared with 
the activation and repair work rate early in the mission and are representative of 
the amounts of work available to experimenters. Each pOint shown is an average of 
from three to seven days activity and excludes days of "rest" or extravehicular 
activity preparation and performance. 
Figure 2. Productive work rate V8. Mission Day. 
SUMMARY 
Summarizing all these results, we have found that all three of the 
three-man Skylab crews accomplished activation work at an efficiency
ratio of about 0.54, equivalent to 26 man-hours/day, assuming they 
were all awake for 16 hours and asleep for eight hours each day. On 
on~ of the nine total days spent all or partially in activation,
mission day 2 of Skylab 3, the crew,efficiency dropped about 25 percent.
(E.R. = 0.41), attributable largely to transient motion sickness. 
After experiment operations began, the Skylab 3 crew soon accomplished
similar work tasks at a rate in excess of 31 man-hours/day, increasing 
to about 36 man-hours/day toward the end of the mission (2). The Sky­
lab 4 crew accomplished work in these same categories at a rate of 
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about 28 man-hours/day early to above 33 man-hours/day late in their 
mission (3). 
We believe the improvement in productivity has come about for two 
reasons, 
o 	 greater training and proficiency in experiment operations as 

compared to activation tasks, and 

o 	 improved efficiency as experience is gained living in zero-

gravity. 

The activation tasks were to be performed only once by each crew and 
consisted of many largely unrelated activities. Each crew had the 
opportunity to practice the full procedures in their trainers at 
Johnson Space Center only a few times prior to launch. However, train­
ing for experiments and especially those consuming the most time 
(solar, medical, Earth resources) was very thorough and extensive. 
Still, operations in zero-gravity could not be precisely simulated 
preflight, and a further training improvement was noticed during the 
course of the mission. More time became available to experiments 
because the time required for the lI overhead" tasks of food preparation,
eating, housekeeping, et aetera was reduced as experience was achieved 
in the routine of zero-gravity living. 
CONCLUSIONS 
It appears that a relatively modest amount of crew time may have been 
lost due to motion sickness on Skylab missions 3 and 4 but that each 
crew1s performance was never substantially impaired for more than one 
day. 
During the three activation intervals, less than 12 man-hours were lost 
to reduced efficiency (including the effects of motion sensitivity)
while almost 200 man-hours of productive work were delivered. 
A very substantial improvement in work rate is found, however, for tasks 
in which simulation and training time was extensive and for tasks of a 
repetitive nature which allowed zero-gravity operations to be optimized. 
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APPENDIX A 
SKYLAB 3 ACTIVATION TASKS ACCOMPLISHED 
NetrE: The time listed for each task is the requirement estimated 
for a trained crewmen based on preflight simulations. It is not 
the actual time consumed in-flight. which could be longer. Crew­
men abbreviations are CDR/SPT/PLT for Commander. Scientist­
Pilot and Pilot. Tasks added to the preflight schedule. usually 
troubleshooting, are identified with preceding asterisk. 
I. M!ssion DJ!L!. (1930-0300 UT = 7. 5 hr, for activation tasks) 
TASK 
1. CM/MDA Tunnel Pressure Integrity Check 
2. Sec. Glycol Evaporator Dryout 
3. Bat. A Charge 
4. Tunnel Hatch Removal 
5. Docking Latch Verification 
6. Probe Removal 
7. Drogue Removal 
8. Pri. Glycol Evaporator Dryout 
9. Command Module Suit .Circuit Dead. 
10. Drogue & Probe Stowage 
11. Air Duct Installation 
*12. General Clean Up of CSM 
13. Pri. Glycol Dryotit Termination 
14. Glycol Circuit Reconfiguration 
15. Update 
16. Umbilical Connection Preparation 
17. CM 02 System Configuration 
18. CSM/SWS Basic Communication Configuration 
19. Center Couch Stowage 
20. Sextant P52 (Option Sextant 3) 
21. GDC Align 
22. S190A Window Protector Installation 
, 23. Observe Pilot Operations 
24. CSM/MDA Umbilical Connection 
25. Caution & Warning Activation 
26. Airlock Ground Disconnection 
27. Communications Activation Check 
28. Mission Timer Update 
29. Sec. Glycol Dryout Termination 
30. MOA Hatch Opening 
31. MbA Light Turn On 
32. CSM RCS Propellant Reconfiguration 
33. MDA/ST8 Entry 
34. ST8 Circuit Breaker Panel Configuration 
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CREWMAN TIME~MAN-MIN) 
CDR/SPT 10 
PLT 5 
PLT 5 
CDR/SPT 60 
CDR/SPT 
CDR/8PT 
CDR/SPT 
CDR 5 
CDR 10 
CDR/8PT 20 
CDR/8PT 20 
CDR/SPT 50 
CDR 5 
CDR 5 
CDR 
CDR/SPT 10 
CDR 10 
CDR 10 
CDR 15 
CDR 10 
CDR 
8PT 10 
8PT 10 
8PT 10 
8PT 10 
8PT 5 
8PT 5 
PLT 5 
PLT 5 
8PT/PLT 15 
8PT/PLT 10 
PLT 5 
PLT 20 
PLT 15 
L MISSION DAY 1 <CONT) 
TASK 
35. STS Panel Contigurat ion 
36. S190 WindQw Heater Activation 
3'1. Video Tape Recorder Activation 
38. 02/N2 Activation 
39. Oxy~en Mask &. Supply Configuration 
40. AM Dome Entry 
41. OWS Fan Activation 
42. OWS Switch Configuration . 
43. Thermal Control System Activation 
44. CSM Caution &. Warning Check 
45. SWS Caution &. Warning Checkout 
46. CM Stowage Reconfiguration 
4'1. Evening Status Report 
48. 	 Assist CDR with CSM Caution &. Warning 
Check 
49. Fire Sensor Cre ck 
50. Urine/Fecal Collector Activation 
51. Fecal Processing 
52. Water System Gas Bleed 
53. Pressure Suit Transfer/Drying 
54. Bed. 1 Bakeout Initia.te 
55. Bat. B Charge 
56. Sleep Compartment Activation 
5'1. Bed. 1 Temperature Verification 
CREWMAN TIME<MAN-MI~) 
PLT 5 
PLT 5 
PLT 
PLT 5 
PLT 20 
PLT 5 
PLT 5 
PLT 15 
PLT 5 
CDR 10 
CDR/SPT 45 
CDR/SPT 30 
CDR 10 
SPT 5 
SPT 15 
SPT 45 
SPT 30 
PLT 10 
PLT 30 
PLT 5 
CDR 5 
SPT/PLT 55 
PLT 5 
TOTAL MAN-MIN. =740 

TOTAL MAN-HOURS =12.3 

--
/I 
n. MISSION DAY 2 (1100-0500 UT ,. 18 hr) 
TASK 	 CREWMAN TIME (MAN -l\UN) 
I. Post Sleep Activities 	 ALL 90 
2. Battery A Charge 	 CDR 5 
3. Sextant P52 (Option 3) 	 CDR 10 
4. Medical Resupply Canister Transfer CDR 20 
5. Report N23 & N93 CDR 
,( 6. H20 Separator Plate Wetting Preparation CDR 15 
7. 	 ATM Controls & Displays Coolant Loop SPT 5 
Activation 
8. ATM Console Activation 	 SPT 45 
9. Bed. 2 Bakeout Initiation 	 PLT p 
10. Bed. 2 Temperature Verification 	 PLT 5 
11. Water Sample 	 PLT 25 
12. Water System Activation 	 PLT 30 
*13. 	 Trouble Shooting H20 Dump Pressure PLT 10 
Indicator 
14. Stowage Reconfiguration 	 CDR 180 
15. P50·IMU/ATM Orientation Determination CDR 25 
16. P52 IMU Realign 	 CDR 
17. E-Mod CDR 5 
*18. Battery-Regulator 113 Trouble Shooting SPT 20 
19. Assist CDR with P50 & P52 	 SPT 25 
20. CM Urine/LiOH/Fecal Bag Transfer SP'l' 15 
21. Urine Collection System Sampling 	 SPT 105 
22. Wardroom Water System Activation 	 PLT 40 
23. Potable Water Chlorination 	 PLT 15 
24. CSM Navigation Power Down 	 CDR 10 
25. CM Condensate Blan.1{et Installation 	 CDR 5 
26. CM Evaporator Reconfiguration 	 CDR 5 
27. Entry Bat. Isolation 	 CDR 5 
28. Suit Drying (2nd. Suit) 	 CDR 20 
29. CSM 'Quiescent Panel Configuration 	 CDR 60 
30. Wardroom Window Activation 	 SPT 20 
31. 100 PPM Drain & Flush 	 PLT 15 
32. Trash Bag Installation 	 PLT 15 
33. Bed. 2 Bakeout Termination PLT 5 
*~4. S071/72 Trouble Shooting PLT 80 
*35. CM Waste H20 Dump to OWS CDR 20 
36. H20 Separator Plate ServiCing 	 CDR 50 
37. CM Food Transfer 	 SPT 60 
38. H20 System Flush 	 PLT 10 
39. Wardroom H20 System Bleed 	 PLT 50 
40. Condensate System Activation 	 CDR 10 
41. Molecular Seive A Activation 	 CDR 10 
42. Flight Data File Transfer Update CDR 60 
~ 43. Evening Status Report CDR 10 
44. Experiments Transfer/Preparation SPT 80 
*45. 02 Fuel Cell Purge CDR 5 
46. 	 Suit Drying (3rd Suit) CDR 20 
TOTAL MAN-MIN:"""1"3'2lr 
:TOTAL MAN-HOURS 22.0 
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III. MISSION DAY 3 (1400-0300 =13 hr) 
TASK CREWMAN TIME (MAN - MIN) 
1. Post Sleep with MIlO ALL 330 
2. Flight Data File CDR 20 
3. 
*4. 
*5. 
*s. 
Suit Drying Termination 
Condensate System Trouble Shooting 
Condensate System Trouble Shooting 
Lighting Assembly Trouble Shooting 
CDR 
CDR 
PLT 
CDR 
15 
390 
60 
5 
7. 
8. 
Weigh Food Residue 
Body Mass Measuring Device Calibration 
SPT 
cgPT 
30 
70 
9. 
*10. 
Return Water Container Fill/Transfer 
Urine Separator Trouble Shooting 
PLT 
SPT 
30 
45 
11. Trans"fer Return Clothing to Command Module PLT 10 
12. Command Module Stowage Transfer PLT 30 
13. 
14. 
Film Transfer 
PP02 Sensor Replacement 
SPT/PLT 
CDR 
90 
25 
15. 
IS. 
Squeezer Bag Dump 
Sample Mass Measuring Device Transfer 
CDR 
SPT/PLT 
10 
90 
and Calibration 
*17. Trash Airlock Leak Trouble/Shooting ALL 90 
TOI'AL MAN-MIN = l"3"4(f 
TOTAL MAN-HOURS = 22.3 
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MUSCULOSKELETAL CHANGES 

MINERAL AND NITROGEN METABOLIC STUDIES, EXPERIMENT M071 
G. Donald Whedon~ M.D.*; Leo Lutwak~ M.D. t ; Paul C. Rambaut~ Sc.D.±; 
Michael w. Whittle~ M.Sc.~ M.B.~ B.S. *; Malcolm C. Smith~ D.V.M. t 

Jeanne Reid*; Carolyn Leach~ Ph.D. i; Connie Rae Stadler§; 

and Deanna D. Sanford§ 

ABSTRACT 
Metabolic study of the effects of space flight on various chemical 
elements, particularly those with special relevance to the musculo­
skeletal system, was performed on the nine astronauts who participated
in the three Skylab flights of 28, 59, and 84 days, respectively, 
during 1973 and 1974. The study required of the cooperating crewmen 
quite constant dietary intake, continuous 24-hour urine collections, 
and total fecal collections for 21 to 31 days before each flight,
throughout each flight, and for 17 to 18 days after each flight for 
a total of 909 man-days of metabolic study. Results of similar but 
much earlier metabolic studies of bed rest had indicated that weight­
lessness of space flight would cause derangements in musculoskeletal 
metabolism, but the only previous contro11~d measurements in space were 
made on the 14-day Gemini VII flight in 1965. 
In the Sky1ab "experiment", increases in urinary calcium during space 
flight and in-flight changes in calcium balance were closely similar 
in degree to those found in bedrest immobilization. The similarity to 
bed rest in the pattern of urinary calcium increases and of total cal­
cium shifts suggested that calcium losses would continue for a very long 
time. Significant losses on nitrogen and phosphorus occurred that were 
associated with observed reduction in muscle tissue. Both mineral and 
muscle losses occurred despite vigorous exercise regimens during flight. 
It was concluded that these studies give warning that capable musculo­
skeletal function may be significantly impaired during prolonged space 
flights lasting one and one-half to three years unless protective mea­
sures are developed. 
*Nationa1 Institute of Arthritis, Metabolism, and Digestive Diseases, 
National Institutes of Health, Bethesda, MD 20014 
~ . 
lUCLA School of Medicine, and Veterans Administration Hospital, 
Sepulveda, CA 91343 
iBiomedical Research Division, National Aeronautics and Space
Administration-Lyndon B. Johnson Space Center, Houston, TX 77058 
§Life Sciences Division, Technology, Incorporated, 17311 E1 Camino Real, 
Houston, Texas 77058 
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INTRODUCTI ON 

Experiment M071 was an effort to use a relatively precise but arduous 
technique of study of human metabolic (or chemical) processess - called 
"Metabo1ic Balance Study" - to determine major changes in chemical 
state of the muscular and skeletal systems. This technique is diffi­
cult to use correctly even under near-ideal clinical research center 
conditions, but in Skylab it had to be applied under the peculiar and 
very limiting conditions of space flight and of the preparation for 
and recovery from it. The metabolic balance technique requires extra­
ordinarily meticulous attention to detail in dietary intake and 
collection of excreta hour-bY-hour. In Skylab this was possible only 
because of the dedicated cooperation throughout of dietitians, "dietetic 
staff, specimen collection staff, laboratory staff, NASA management 
staff at all levels and particularly of the participants - the astro­
naut crews. The advantage of the balance technique, when properly
carried out, is the precisiqn with which changes in body elements in 
milligram quantities can be measured and the ability with which 
patterns of almost day-by-day chemical change can be described. No 
metabolic study was ever perfect and this one, we must say, lived up 
to that tradition; but the study was clearly successful enough to 
provide definite conclusions and to permit sensible interpretations of 
significance for "the future. 
Prediction that the various stresses of space flight, particularly 
weightlessness, would bring about significant derangements in the 
metabolism of the musculoskeletal system had been based on various 
mineral and nitrogen balance study observations of normal healthy 
subjects at long immobilized or inactive bedrest. The earliest was 
that of Deitrick, Whedon and Shorr (1) in 1948, the calcium balance 
results of which are graphed here in figure 1. 
Immobilization of four healthy young men in body casts for six to 
seven weeks led to marked increases in urinary calcium and signifi­
cantly negative calcium balances, and there were related losses of 
nitrogen and phosphorus. Several subsequent bedrest studies of 
normal subjects confirmed these substantial metabolic derangements (2). 
The longest observation (Donaldson, Hu1ley and associates, 1970)(3)
showed that although the elevated urinary calcium subsided partially 
during the third and fourth months of bedrest, it nevertheless remained 
significantly higher than control levels for as long as bedrest was 
continued (for 7 months) and, furthermore, did not fall to normal 
until the subjects were put back on their feet. 
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Figure 1. 	 Effect of immobilization on the calcium metabolism of 
four normal male subjects. In each subject the daily 
calcium intake was kept constant throughout all per­
iods of the experiment. For each subject the control 
baseline (interrupted horizontal line) is an average
of the total outputs of the last four control weeks. 
In this graph the intake and output are both plott~ . 
upward from the zero baseline. (Reproduced by permlsslon 
of Medical Clinics of North America, 35, No.2: 545, 
March 1951.) 
The only attempt at control led metabolic observations in space flight
prior to Skylab was performed by us (4) in conjunction with the l4-day 
Gemini VII flight in 1965. That r~lative1y short study revealed quite 
modest losses of calcium and phosphorus and varied changes in the 
metabolism of other elements. 
PROCEDURE 
A cardinal principle of metabolic study is that changes in the excretion 
of key nutrient elements, such as calcium or nitrogen, can only be 
interpreted as due to the influence or agent under test if environ­
mental factors are kept as constant as possibl.e from phase-to-phase
and from day-to-day. One of the most important of these environmental 
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factors in metabolic study is the dietary intake. The dietary intake 

in the M071 study was dependent upon the selection, for various reasons 

of stability and acceptability, of some 70-odd space food items by

NASA food technologists. Selection was constrained for most items by

the requirements of stability at room temperature in space for more 

than a year; only seven frozen food items could be used. In addition, 

in efforts for best acceptability by the astronauts, many items were 

mixtures of foods and thus not conducive to exactness of composition 

in their production. Although these foods were far from ideal for 

balance studies, nevertheless, by skillful, lengthy consultations 

with the astronaut crewmembers, our dietitians developed for each 

crewman, sequences of six daily menus of similar elemental composition

which were rotated on a regular schedule throughout the preflight, 

in-flight and postflight study phases. Whenever a particular food 

could not be consumed, a system of rapid calculation and provision of 

supplement tablets for pertinent elements helped to maintain dietary 

elemental constancy. During the flight phase, the crew's evening 

report included the relatively infrequent dietary omissions, rapid 

ground calculations were made for deficits in key elements and the 

correct number of supplement tablets or capsules prescribed up to the 

flight crew; these previously stowed supplies of tablets (or capsules) 

were taken the next morning. 

Our relative success in dietary control is indicated in table I which 
shows for the Commander of the 59-day flight, as representative of the 
group, the phase-by-phase means of actual consumption of a few key
elements and shows also the standard deviations from these means of 
day-by-day actual consumption. No significant differences occured 
from phase-to-phase. 
TABLE I. 	 MEAN (± STANDARD DEVIATION) DAILY DIETARY INTAKE, 

COMMANDER OF SKYLAB 3 (59-DAY FLIGHT) 

Preflight In-flight Postfl ight 
Kcal 	 2732.0 (± 113) 2781.0 (± 259) 2940.0 (± 149) 
Protein, g 95.0 (± 5) 85.0 (± 11) 96.0 (± 6) 
Nitrogen, 	g 15.2 (± 0.9) 13.6 (± 1.17) 15.4 (± 1.0) 
Potassium, mg 1517.0 (± 57) 1431.0 (± 116) 1537.0 (± 68) 
Calcium, mg. 725.0 (± 31) 729.0 (± 72) 742.0 (± 40) 
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It should be emphasized that all food items were analyzed in representa­
tive samples for pertinent elements and vitamins. All diets were 
found to be adequate in terms of recommended vitamin intakes. However, 
because of concern for possible effect on the vitamins previously 
stowed in the Workshop from the high temperatures in the early days 
after launch, a supplemental vitamin capsule of RDA level was taken 
daily by each crewman on Skylab 3 and 4 (before, during and after 
flight). 
Twenty-four hour urine collections were made throughout the studies. 
In-flight, because of limitations in return weight and volume approxi­
mately 120 milliliter aliquots of each day1s urine collection were 
taken, frozen and returned to Earth, using a very complex system 
because of the absence of gravity. In weightlessness there are diffi­
cult technical problems of collecting urine, separating liquid from 
air and taking a well-mixed measured aliquot, all without the aid of 
gravity which we so take for granted in our clinical research units and 
laboratories. In addition, because volume cannot be measured in the 
weightless state in the same way as on Earth, in-flight 24-hour urine 
volumes were determined by a tracer dilution technique, using lithium 
chloride pre-injected into the 24-hour collection bags. In-flight
stool samples were dried in the Workshop and returned to Earth in toto. 
RESULTS 
Urinary creatinine excretion, (shown in figure 2 for the 28-day flight 
for three astronauts) revealed considerably more fluctuation than is 
found under ideal research unit urine collection conditions, but the 
values were consistent enough to indicate that average 24-hour 
urinary creatinine excretion was not changed by space flight. 
Figure 3 shows the urinary calcium excretion for the 28-day flight. 
Urinary calcium in-flight increased steadily to a plateau in virtually
the same pattern and degree as previously seen in bedrest studies. 
Also as seen in bedrest, interindividual variation occurred in degree 
of loss; the peak reached during the latter part of flight was from 
80 percent greater to more than double the control, preflight levels. 
During recovery, postflight, urinary calcium excretion subsided 
promptly toward control levels. 
Figure 4, for the 59-day flight, shows the same pattern of gradual 
rise in two crewmen and a rather abrupt rise in the third, and also 
shows interindividual variation in degree of loss, which in one was 
to much more than double control levels. 
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Figure 2. Urinary creatinine 
excretion. in means for 4- to 
6-daymetabolic periods. in the 
Commander (COR), Scientist 
Pilot (SPT) and Pilot (PLT), 
of Skylab 2, before, during 
and after this 28-day flight 
(Skyl ab 2). 
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Figure 3. Effect of space flight 
on urinary calcium excretion in 
the astronauts of the 28-day 
flight (Skylab 2). 
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Figure 4. 	 Effect of space flight on urinary calcium excretion 
in the astronauts of the 59-day flight (Skylab 3). 
Urinary calcium data in the 84-day flight (fig. 5) showed the same 
characteristics, 'plus the added pOint of interest of no suggestion of 
decline toward the end of the flight in the high level of excretion. 
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Figure 5. Effect of space flight on urinary calcium excretion 
in the astronauts of the 84-day flight (Skylab 4). 
Urinary hydroxyproline (indicative of skeletal turnover and breakdown)
increased in flight with considerable interindividual differences; 
the mean increase for the six crewmen of the first two flights was 
33 percent. 
Figure 6 displays the calcium balances for the 28-day flight; fecal 
calcium increased during flight in one crewman (Commander) and decreased 
slightly in the other two, and the balance became negative in two 
crewmen and changed imperceptively in the third (Scientist Pilot). 
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Figure 6. Calcium balances before, during and after space flight 
in the astronauts of the 28-day flight. In this and 
subsequen~ balance graphs the data are plotted in 
conventional Albright-Reifenstein style, the intake 
downward from the zero base-line, then urinary (light
shading) and fecal (heavy shading) excretion upward 
from the intake lines; shaded areas above the zero 
baseline indicate negative balance or loss. 
361 
For the 59-day flight, the negative shift in calcium balance was more 
apparent (fig. 7), resulting from increases in both urinary and fecal 
calcium. The mean shift in calcium balance for all six crewmen from 
control phase to the last 16 to 18 days in-flight was minus 184 mg/day.
The mean negative calcium balance during the second month in space 
for the three astronauts on the 59-day flight was 140 mg/day. This 
calcium loss was of the same order of magnitude as occurred in the 
early bedrest-immobi1ization study (1). Analyses of fecal calcium for 
the 84-day flight are still undergoing checking and reanalysis. 
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Figure 7. Calcium balances before, during and after space flight
in the astronauts of the 59-day flight. 
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Phosphorus balance data (fig. 8) show for Skylab 2 a distinct in­
crease in-flight in urinary phosphate, a small increase in fecal 
phosphate, and negative balance in all. In the Skylab 3, the increases 
i.n uri nary phospha te were 1 ess marked than in Skyl ab 2, for reasons 
that are not apparent at this time. The mean negative shift in 
balance in Skylab 3 was 222 mgjday, in comparison with very nearly 
400 mgjday in Skylab 2. In Skylab 4 the increases in urinary phosphate 
were again to about the same extent as in Skylab 2. 
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Figure 8. Phosphorus balances before, during and after space
flight in the astronauts of the 28-day flight. 
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Nitrogen balance data (fig. 9) in-flight on Skylab 2 revealed a pro­
nounced increase in urinary nitrogen excretion, while fecal nitrogen
remained characteristically unchanged. In the 59-day flight (fig. 10). 
the highly negative balance of the first 6-day period was due to the 
lowered intake resulting from marked anorexia during the first two 
to three days in the new weightless environment; nitrogen balance 
continued negative for a few weeks and then was only slightly positive
despite high protein and calorie intake levels. The mean shift in 
nitrogen balance (for the 6 crewmen of the first two flights) from 
preflight phase to flight was 4.0 g/day. In the 84-day flight in­
creases in urinary nitrogen excretion of similar magnitude were 
observed (fig. 11). 
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Figure 9, 	 Nitrogen balances before, during and after space flight in 
the astronauts of the 28-day flight. 
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Figure 10. Nitrogen balances be­
fore, during and after 
space flight in the 
astronauts of the 59­
day flight. 
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Figure 11. Urinary nitrogen ex­
cretion before, during 
and after space flight
in the astronauts of 
the 84-day flight.
The 18-day mid-flight 
gap in the graph is 
due to the fact that 
analyses had not been 
completed at the time 
of preparation of the 
graph. 
Magnesium excretion in the urine increased during the in-flight phases 
of all three Skylab flights, with considerable interindividual vari­
ation and, for reasons that are not clear, to a somewhat lesser 
extent in the 59-day Skylab 3 than in the other two flights. Figure 12 
presents the magnesium balances for Sky1ab 2, showing modest increases 
in urinary magnesium and the balances less positive but not true loss 
of the element. 
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Figure 12. Magnesium balances before, during and 
after space flight in the astronauts of 
the 28-day fl:i ght. 
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Potassium balances became slightly less positive during flight, in 
line with other measurements suggesting potassium loss from the body, 
and indicated significant retention of this element in the recovery 
phase. Figure 13 shows the potassium balance data for Skylab 2. 
The changes were similar in Skylab 3. 
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Figure 13. Potassium balances before, during and 
after space flight in the astronauts of 
the 28-day flight. 
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The sodium balance data for Skylab 2 and 3 also indicated modest 
negative shifts during flight. Sharp sodium retention occurred in all 
crewmen during the first few recovery days after each of the flights.
Figure 14 shows the data for Skylab 2. 
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Figure 14. Sodium balances before, during and after 
space flight in the astronauts of the 
28-day flight. 
The potassium and sodium balance data and the significance of the 
changes therein will be discussed in the presentation of the M073 
Endocrine Hormone and Body Fluid Study. 
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COMMENT 
The urinary creatinine data obtained in both the 28 and 59 day Skylab 
flights settled a matter in doubt since Gemini VII in 1965. The 
Skylab data showed that, despite greater fluctuation than is seen 
under ideal research ward conditions, the average 24-hour urinary 
creatinine excretion was not changed by space flight. Thus the 
assumption made to this effect in order to salvage the Gemini VII 
urinary metabolic data was valid. 
The increases in urinary calcium were strikingly similar in both 
pattern and degree to the rises in urinary calcium seen in bedrest. In 
addition, as compared with i~mobile bedrest (1), the negative shift 
in calcium balances during flight in the six Skylab 2 and Skylab 3 
crewmen was of the same magnitude, and the mean actual calcium loss of 
the three 59-day flight crewmen was virtually identical. Although the 
total calcium loss rate generated by the second month in space 
(approximately 4 grams per month or 0.3to 0.4 percent of total body
calcium per month), appears small in relation to the whole skeleton, 
the similarity to bedrest in pattern and degree, as well as failure 
to show any tendency to abatement in three months' time, makes it 
necessary to deal with an assumption that mineral loss might continue 
for a very long indefinite time. Since mineral is lost differentially
in greater total amounts from trabecular areas of bone, one must 
consider the possibility that in very long space flights local area 
losses of mineral of a degree equivalent to osteoporosis visible by 
ordinary X-ray would take place and that the strength of critical 
bones would be endangered. In paralytic poliomyelitis (5) long bone 
rarefaction visible by X-ray appeared at a mean loss of 2.0 percent 
of total body calcium; in these paralyzed patients in whom the calcium 
loss rate was about double that in immobile bedrest and in the 59-day 
space flight, osteoporosis was first seen within two to four months. 
Assuming that it would continue, the calcium loss rate of 0.3 to 0.4 per­
cent per month observed in Skylab takes on clearer and more ominous 
significance when it is realized that flights to Mars and return, when 
ultimately conducted, will take from one and one-half to three years. 
The increased excretion of nitrogen and phosphorus, also similar to 
that in bedrest, reflected substantial loss of muscle tissue, which 
was clearly observed in the astronauts' legs. Both muscle and min~ral 
loss occurred despite an exercise regimen on all flights, which was 
extremely vigorous on the second and third flights. 
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We must conclude that although it seems reasonable to predict

musculoskeletal "safety" in space flight for up to probably six to 

nine months, capable musculoskeletal function is likely to be impaired 

in crews on space flights of extreme duration unZeSB proteative measures 

aan be deveZoped. The likelihood of need for protective measures' in 

flight is accentuated by the following consideration: although the 

bone losses thus far observed have been reversible upon return to 

normal gravity (or to ambulation after bedrest), no observations are 

available to permit estimation of a magnitude of loss that would 

represent a "point of no return". Thin trabeculae in bone can be 

returned to normal thickness but,_ from our present understanding of 

the adult skeleton, completely lost trabeculae cannot be restored. 

Despite the threatening import of these Skylab mineral balance 

studies, they should not be interpreted as indicating a bar to long 

space flights. They do, however, clearly suggest that more work must 

be done, primarily in ground-based research, to provide techniques or 

procedures which, used in flight, will give reasonable assurance of 

healthfully functioning astronaut skeletal systems during and at the 

end of extremely long flights. 

Finally, these observations may have significance for Earth medicine. 

In reminding us of the deleterious effects of disuse on bone mass, 

they reemphasize the importance of direct physical longitudinal stress 

(weight bearing) to the integrity of bone. In research on osteoporosis, 

greater attention than heretofore might be given to this factor for 

the possible value of inareased weight-bearing stress as a deterrent 

to or even as aid to correction of this extremely prevalent bone dis­

order. 

SUMMARY 
A metabolic study of the effects of space flight on various chemical 
elements, particularly those with special relevance to the musculo­
skeletal system, was carried out on the nine astron~uts who partici­
pated in the three Skylab flights of 28, 59 and 84 days in 1973-74. 
The study required of the cooperating crewmen constant dietary intake, 
continuQus 24-hour urine collections and total fecal collections for 
21 to 31 days before each flight, throughout each flight and for 
17 to 18 days postflight. 
Increases in urinary calcium during space flight and in-flight changes
in calcium balance were closely similar in degree to those found in 
immobilization-bedrest. Similarity to bedrest in pattern of urinary
calcium increases and of total calcium shifts suggested that calcium 
losses would continue for a very long time. Significant losses of 
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nitrogen and phosphorus occurred, associated with observed reduction in 
muscle tissue. Both mineral and muscle losses occurred despite vigorous 
exercise regimens in flight. It was concluded that unless protective 
measures can be developed, capable musculoskeletal function is likely to 
be impaired in space flights, ultimatelJ to be conducted to Mars, of 
one and one-half to three years duration. 
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PHYSIOLOGICAL MASS MEASUREMENTS IN SKYLAB 
tWilliam E. Thornton, M.D.*, and Col. J. Ord, M.D., U.S.A.F. M.C. 
ABSTRACT 
One of the first changes noted in man following space flight was a 
loss in weight. To study the mechanism of such changes during flight,
intake/output balance studies and measurements of crew mass were re­
quired. These measurements depended on the availability of nongravi­
metric mass-measurement devices. Such devices were flown and 
successful operation was demonstrated for the first time during Skylab 
missions. Electronically timed spring/mass oscillators were used to 
routinely determine all crew food residue and fecal masses to accuracies 
of a few grams. Daily body mass measurements were made with errors of 
a small fraction of a pound. 
Two general patterns of body mass loss, usually mixed, were apparent. 
The first is a more or less continuous loss beginning before flight
with an increase in rate of loss during flight. A second pattern is 
indicated by relative stability except for a small loss during the 
first few days of weightlessness with a reciprocal gain during the 
first few days after flight. Interpretation was complicated by heat 
stresses, changing exercise, and increased food as the missions pro­
gressed. However, the following observations are consistent with 
the data: a surprisingly high metabolic cost occurred on the mission; 
a metabo1 i closs was present "j n a 11 crewmen except the Skyl ab 4 
Commander; and a small fluid loss, on the order of a liter, appears 
to occur during the "initial few days of weightlessness followed by a 
reciprocal change on return to normal gravity. This latter loss is 
small and self-limited, and appears to be the only obligatory loss with 
other losses seen to date being primarily metabolic. 
INTRODUCTI ON 
I would like to thank you for this opportunity of telling you about 
our medical experiments on Skylab, some of the things we discovered, 
and a few we did not. Many of you in the audience have worked 
directly or indirectly on these experiments and made these results 
possible. 
*Astronaut Scientist, National Aeronautics and Space Administration ­
Lyndon B. Johnson Space Center, Houston, Texas 
i'Hospital Commander, Scott Air Force Base 
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Some of us and some of you, have waited quite a while for these results; 
in the case of this experiment almost eight years. Nine years ago
while working on the Manned Orbiting Laboratory Project at the Aero­
space Medical Division of the Air Force, we concluded that one of the 
first priorities in space medical research was to determine the cause 
and time course of the weight loss which always seemed to accompany 
space flight. It was obvious to us and to many others that a carefully 
controlled intake/output study with accurate daily mass measurements 
in-flight would be required. At that time, the insurmountable 
problem to such a study was the lack of an instrument for nongravi­
metri c mass measurement .. The fi rs t pri ority, then, was development
of a mass measurement device which did not depend on weight. Develop­
ment was started and by 1966 I had built protypes of the instruments 
flown on Skylab. 
As time went on, the Manned Orbiting Laboratory program had an un­
fortunate end, we had mass measuring devices, and Nasa had a planned 
in-flight balance study without a mass measuring device so we formed a joint effort which was implemented on Skylab. This morning, I will 
describe the methods used to measure mass in weightlessness since 
this technique had not been used before, and then, as time allows, 
I will discuss the results obtained, results which affect many other 
experiments and future planning. 
Gravimetric mass determination or weighting is such a simple and 
accurate process that no other methods have been developed or really
needed since the Egyptians began using balances 5000 or more years 
ago. The only practical alternative to gravimetric attraction is 
some determination of the mass! inertial property. The method chosen 
to do this in 1965, and not necessarily the present method of choice, 
was the spring-mass oscillator constrained to linear motion. 
PROCEDURE 
Figure 1 is a schematic of the 'method. A sample mass is placed be­
tween two springs and constrained to linear motion in the 10ngitudian1 
axes of the springs. If the mass is displaced from its rest postion
Xo to a new position X and released, it will undergo essentially
undamped natural ocillation at a frequency given by the well known 
relationship shown. If this period of oscillation is accurately
measured by a high resolution timer, mass may be calculated. Rather 
than attempt a calculation based on machine quantities such as spring 
rates, a calibration which would have inevitable errors from gravita­
tional effects, an in-flight calibration using precision masses was 
done. 
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Figure 1. Schematic of Spring/Mass Osctllator and its 
motion. 
Figure 2 is a plot showing a calibration record chosen at random from 
one of the small or specimen mass measuring devices used on Skylab and it 
simply shows that it follows the theoretical curve reasonably well. 
It really was chosen at random for linearity is usually approximately 
0.1 percent and normally no pOints can be found off the curve. With 
care and by using a modified calibration curve, accuracy of 0.01 per­
cent, or better, can be obtained with solid masses. 
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Figure 2. Calibration curve Skylab 2 small mass measuring
device, mission day-g. 
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This system is sensitive to any nonrigidity (slosh) in either sample 
or mounting and to any external or sample oscillation (jitter) if 
either of these effects are near the fundamental frequency of oscilla­
tion. Thus, in the case of some food, liquids, and the human body, 
special arrangements must be made. 
Let me describe these arrangements and the in-flight operation by 
showing you a film of the hardware that was flown on Skylab. 
This ftlm (16 mm cine film shown) was made in the Skylab crew trainer 
which is as close as possible to the in-flight arrangement. Two small 
instruments each with a capacity of one kilogram were flown - one in 
the Wardroom which 11m now entering. All food was carefully weighed, 
analyzed, and identified preflight. Any package which was not totally
consumed, and only six or so out of the thousands were not, was placed
in the device shown here, and measured. 
This is the OSCillating specimen tray, and the perforated elastic sheet 
_holds the food package to it. Operation consists of turning the counter 
on, adjusting it to, and rotating and holding the lever which success­
ively unlocks, displaces, and then releases the specimen tray. 
The time for three periods of oscillation is then registered by the 
opto-electronic counter to 10 seconds. This time is recorded and 
voice relayed to Earth where mass is calculated and suitable nutritional 
adjustments are made to meals for the next day. 
Now moving on to the Head, there is a second and identical instrument 
on which all vomitus, of which there was only three or four samples, 
and all feces, collected in such bags, were measured. An onboard 
graphic conversion to mass was made to allow proper setting of the 
fecal drying timers. All fecal samples were dried and returned to 
Earth in toto with the oscillation ,time periods for anaylses. 
Figure 3 shows a large or body mass measuring device with a capacity 
of 100 kilograms. A basal body mass was made by each crewman every
morning after arising and voiding. The same type of clothing of known 
mass was worn each day and any extra objects were removed from the 
pockets. Although the human body is supposed to move as a single 
rigid structure below one cycle per second, this proved to be only 
approximately true; and it was necessary to reduce slosh to a minimum 
by folding the body into the most~rigid configuration possible, as 
you see here, and to reduce the per,; od of one cycle of osci 11 ati on to 
two seconds. Straps are necessary under weightlessness to constrain 
the body to the seat. 
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The same timer and timing arrangement is used as those on the Small 

Mass Measurement Devices. After strapping in, the seat is unlocked 

and cocked by the large handle. The timer is turned on and the 

device is adjusted to zero. One takes a breath, holds it to avoid 

"jitter" and then releases the seat to oscillate by means of a 

trigger on the hand bar. After three cycles of timing has has been 

completed, the period is recorded and returned to Earth where mass 

is calculated. 

Figure 3. 	 In-flight photo of Skylab 3 Commander making daily body mass 
measurement. "Chair" oscillates along back-to-front axis of 
subject. Timer is at the subject's left and the forward 
elastic flexure pivots may be seen (diagonal braced lightened 
frame) . 
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Figure 4 is a record of the total uncorrected deviations of the 
Specimen Mass Measuring Device in the Head at the 50-gram calibration 
point. These pOints were taken over three missions as shown. Without 
going further into the engineering aspects, maximum error for food 
and vomitus samples, was less than three grams. Repeatability of 
body mass measurements was ±O.l pounds, and absolute accuracy was 
between +1/4 and +1.0 pounds and probably nearer +1/4 pounds. 
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Figure 4. 	 Variation in 50-gram calibration pOint, Small 
Mass Measurement Device - Skylab Mission 
A number of hardware support measurements were made during the mission 
with excellent results: for example the 24-hour urine pools were 
measured to an accuracy of a few milliliters. 
RATIONALE 
Until Skylab, there was an unexplained loss of weight on every American 
and, so far as I know, Russian flight and in every astronaut except 
Alan Shepard* on Apollo 14. 
There were 	 three common theories to account for these losses: 
o 	 Under weightlessness, fluid was shifted from the lower portions
of the body to the chest area where it was sensed as an excess 
and secreted by the kidneys in accord with the Gauer-Henry 
theory. 
*Recent publication of data indicates a loss in this crewman also. 
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o 	 At least a portion of the loss was sometimes thought to 

be metabolic since food quantities and opportunities to 

eat were frequently minimal. 

o 	 Under certain conditions there were periods of high physical

activity with heat and other stresses which resulted in 

rapid loss .. 

A comment may be in order: One often thinks of daily weights as a 

highly variable measurement, as indeed they are unless carefully 

made. But if they are carefully made under basal conditions and if 

the subject is on a controlled diet, losses of a fraction of a pound 

per week become not only detectable but significant. While a few 

ounces loss or gain per week is normally of no importance, if they

are continued for months, especially under conditions which can't be 

altered, they become significant indeed. 

The slides (figs. 5 to 13) i will show now are the plots of Skylab crew 

body weights - preflight and postflight from experiment M07l and the in­

flight equivalent weights measured with the Body Mass ~1easurement Device. 

The data has been smoothed by taking a three-day sliding average. 

These plots cover the period that the crew were on the Skylab diet. 

The plots shown in figures 5 and 6 are from the Commander and Pilot 

of Skylab 2. The Scientist Pilot (fig. 7) had a similar curve with 

a total loss between the previous two shown. The first few days'

data was lost during vehicle repairs, and this was also a period of 

heat stress. One sees a loss which began with initiation of the 

diet and accelerated during the mission itself. The sharp dip in-

flight was coincident with extravehicular activity. Immediately 

postflight, there was a transient increase in weight followed by a 

plateau. The predominant loss pattern of the first manned Skylab

flight is consistent with a simple metabolic deficit. 

While the losses were easily sustained in this short mission they 

could not be tolerated on missions of long duration. Even the 

3-1/2 pound loss of the Commander is significant in a small crewman 

who launched with a body fat of less than 10 percent. 

On Skylab 3 both food and exercise were increased, and we see a 

different pattern. The Commander was relatively stable preflight,

had a sharp loss for the first few days in flight, and another loss 

near the end. On recovery, there was the usual increase and plateau 
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Figure 5. Body mass measurement of the Skylab 2 Commander. 
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Figure 6. Body mass measurement of Skylab 2 Pilot. 
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Figure 7. Body mass measurement of Skylab 2 Scientist Pilot. 
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or inflection point (fig. 8). The Pilot, had an almost identical 
curve (fig. 9). Remember, that these crewmen had nausea and were 
not eating properly the first few days, and that there was a period 
of increased activity, especially for the Pilot and Commander prior 
to entry. The Scientist Pilot had a sharp loss on exposure to 
weightlessness and a small continued loss in-flight consistent with 
a metabolic deficit and a typical recovery pattern (fig. 10). Here, 
I feel that we see two other loss mechanisms demonstrated. 
From the time cours~ of the losses and gains on orbital insertion and 
recovery, it seems reasonable to conclude that fluids are involved. 
This will be discussed further in a moment. At the same time, there 
are periods of increased stress, such as preparation for entry or 
extravehicular activity on Skylab 2 which temporarily exceed caloric 
intake. 
On Skylab 4, food and exercise was again increased, and we have the 
second American astronaut in space who lost essentially no body mass 
in flight - the Commander (fig. 11). His profile shows a preflight 
gain, a small initial loss, and a postflight gain. His crewmen had 
losses similar to or smaller than the astronauts on Skylab 3 
(figs. 12,13). 
At this point, we seem to have come full circle and have demonstrated 
that all three mechanisms originally proposed are operative. It would 
appear that the most significant on this mission was a simple metabolic 
loss. In further support of this, the average weight loss of all 
crewmen was plotted versus the normalized average caloric intake 
(fig. 14). The caloric data shown is the latest obtainable from the 
food section. Although the sample is small, the relationship seems 
clear, the three subjects off the "main line" relation were also the 
three crewmen with the smallest body fat -- all three well under 
10 percent. 
Caloric intake required for an extrapolated zero loss is extremely 
high indicating a surprisingly high in-flight metabolic cost. 
It must be recognized that simply adding food to the diet is not the 
whole answer, for while this will assuage hunger and maintain mass, 
body muscle might be exchanged for fat. This closely related problem 
of exercise and conditioning will be discussed next. 
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Figure 9. Body mass measurement of the Sky1ab 3 Pilot. 
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Figure 10. Body mass measurement of the Sky1ab 3 Scientist Pilot. 
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Figure 11. Body mass measurement of the Sky1ab 4 Commander. 
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Figure 12. Body mass measurement of the Skylab 4 Scientist Pilot. 
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Figure 13. Body mass measurement of the Skylab 4 Pilot. 
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Figure 14. Weight loss vB. caloric intake for the nine Skylab 
astronauts in flight. 
The plots in figures 15 and 16 are two-day sliding averages of crew 
mass from Skylab 3 and 4 for ten days following insertion and recovery 
to demonstrate fluid losses. On Skylab 3, there was a sharp loss of 
three to four percent of body weight over the first four or five days
following exposure to weightlessness. On return to one-g, there was 
an approximate reciprocal gain. On Skylab 4, we see the same pattern
in one crewman; the crewman who was nauseated and not eating and 
drinking, just as had been the case with all three Skylab 3 crewmen. 
The other two crewmen showed a much less pronounced drop, and on 
recovery, there was a smaller reciprocal gain except for the Scientist 
Pilot. It is my suspicion that transient fluid losses or gains will 
be small, probably on the order of one percent in crewmen who eat and 
drink adequate amounts throughout the mission. This intriguing ques­
tion of fluid loss and the Gauer-Henry theory will undoubtedly be 
further addressed by the appropriate investigators to show routes and 
mechanism of loss and gain. 
DISCUSSION 
For the future; dietary standards must be revised to meet the metabolic 
requirements of given missions and tasks. In-flight studies of 
metabolic costs of realistic activities will allow better definition 
of overall requirements. The requirements on this mission with its 
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Figure 16. Body weight change Sky1ab, 4 insertion and recovery. 
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jammed, 14-hour day work schedule should not necessarily be considered 
typical of all missions. 
To those of you concerned with future planning; as long as man flies 
and measures in flight, he will continue to need mass measuremefits. 
Although the present system met the requirements, they were complex, 
heavy, and expensive. I' trust that they will not become the accepted 
standard, for in the eight years since development of these devices, 
we have devised a number of other models with marked advantages over 
the spring/mass oscillator. 
SUMMARY 
In summary, we have demonstrated a new instrument for in-flight space
operations and research, have demonstrated the previously unproven
mechanisms of weight losses under weightlessness, and most importantly,
helped to prove that the human body properly fed can sustain missions 
of long duration without significant obligatory mass loss. 
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prototypes. Wray Fogwell suggested the flexure pivot as a simplifica­
tion of the original design. Larry Dietlein, Weyland Hull, Paul 
LaChance and Sherm Vinograd at NASA were instrumental in establishing 
the mass measuring devices as experiments. 
Flight hardware was constructed by Southwest Research Institute and 
the NASA project engineers were Vern Kerner and Ray McKinney. 
386 

BONE MINERAL MEASUREMENT - EXPERIMENT M078 

JohnM. VogeZ~ M.D.* and Sqn. LdY'. M.W. WhittZe~ M.Sc.. ~ M.B.~ B.S.~ R.A.F. t 
ABSTRACT 
The probability of significant bone mineral loss being initiated by

extended periods of weightlessness has been predicted on the basis of 

observations in bedrested and immobilized subjects. Radiographic 

estimates of bone mineral loss conducted on the crewmen of Gemini 4, 

5 and 7 led to greater concern since the losses documented during

these rather short missions were large. To test the validity of 

these observations, studies utilizing a newer and more precise tech­

nique were performed on six-to-nine month bedrested subjects. No 

mineral losses were observed in the radius and ulna and variable losses 

were observed in the os caZcis. This variability was reconciled when 

the rate of loss was found to be correlated to the initial mineral 

content and "inversely correlated with the baseline hydroxyproline 

excretion. 

The mineral content of the distal right radius and ulna and the central 

left os caZcis was measured preflight and postflight on the nine 

crewmen of the three Skylab manned missions using the photon absorptio­

metric technique. No significant mineral losses were observed in any 

of the three Skylab 2 crewmen. Only the Scientist Pilot of Skylab 3 

and Scientist Pilot and Pilot of Skylab 4 had significant mineral 

losses in the os caZcis. No losses in the radius and ulna were seen. 

The losses observed generally followed the loss patterns observed in 

a heterogeneous group of bedrested subjects. 

It is concluded that mineral losses do occur from the bones of the 

lower extremities during missions of up to 84 days and that in general, 

they follow the loss patterns of the bedrested situation. The levels 

of loss observed in the Skylab crews have been of no clinical concern 

but it was fortuitous that all of the Skylab 4 crewmen had high pre­

diction terms. 

INTRODUCTION 
The pro~ability of significant bone mineral loss being initiated by 

extended periods of weightlessness has been predicted on the basis of 

observations in bedrested and immobilized subjects. Radiographic 

*University of California, School of Medicine, Davis, California. 
tNational Aeronautics and Space Administration-Lyndon B. Johnson 

Space Center, Houston, Texas 
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estimates of bone mineral loss conducted on the crewmen of Gemini 4, 5 
and 7 led to even greater concern since the os calcis losses ranged 
from 2 to 15 percent, the radius from 3 to 25 percent and the ulna 
from 3 to 16 percent (1). Subsequent reevaluation of this data led 
to the conclusion that there had been an approximate 6.7 percent 
overestimation of loss due to the inherent difficulties with the 
technique employed (2). Nevertheless, the magnitude of these mineral 
losses for 4 to 14 day missions if extrapolated to the longer Skylab 
missions could prove to be hazardous both in terms of potential 
fractures or in the production of renal stones. 
Since the validity of the Gemini data needed to be reevaluated prior
to the S~lab missions, fifteen bedrest volunteers were studied using 
a newer and more precise technique, namely, gamma ray absorptiometry. 
METHOD 
Bone mineral content was determined in the central left os calcis and 
the right distal radius and ulna using the photon absorptiometric
technique. It employed an essentially monoenergetic photon source, 
the 27.5 KeV X-ray of lodine-125, and a sodium iodide crystal 
scintillation detector. These essential elements are mounted on a 
scanner yoke in direct opposition to each other and collimated so that 
a 3 millimeter beam is similarly viewed by a 3 millimeter entrance 
collimator on the detector, (fig. 1). The yoke is mounted on a scanner 
which is able to scan a limb placed between the source and detector 
in a rectilinear raster pattern. When scanning the upper extremity 
the scanner is reconfigured as shown in figure 2. The limb to be 
scanned is placed in tissue equivalent material to compensate for the 
irregular thickness of tissue cover that surrounds the bone. The 
foot is placed in a Plexiglas® box filled with water (fig. 1), and 
the arm is encased in Superstuff®when placed on a platform between 
uprights (fig. 2). 
The most distal two centimeter portion of the radius and ulna were 
measured and reported as mean mineral content in grams of ash per 
centimeter of bone length. The mineral content of the central two 
and one-half centimeter section of the os calcis is reported in mg/cm2 
of hydroxyapatite. Mineral content is obtained from the basic attenu­
ation equation, (fig. 3). The count rate of the transmitted beam 
through the tissue and tissue equivalent is designated as 10*' Each 
data point through bone is designated as I. Transmission or absorb­
ance through this segment is given as the log of the ratio 10*/1 and 
the sum of these ~alues across the bone is proportional to the mineral 
content in this segment. 
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Figure 1. 	 Scanning apparatus in the heel scanning configuration. 
Foot rests in a Plexigla~ box containing water as a 
tissue equivalent. Plastic box and holder is placed
between source S and detector 0 on corresponding points 
AIB1C10 1 • 
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Figure 2. 	 Scanning apparatus in the arm scanning configuration. 
Arm rests on a holder between two uprights and is 
encased in Superstuff-. a tissue equivalent material. 
Arm holder is placed between source S and detector 0 
on corresponding points AIBICIO'. 
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Figure 3. Method of computing mineral content. 
The entire system is calibrated before and after each subject scan by 
measuring a Witt-Cameron standard (3) which consists of three chambers 
containing dipotassium hydrogen phosphate to simulate bone attenuation 
and a hydroxyapatite step wedge (4), (fig 4). 
This technique, in addition to careful calcium balance studies, was 
applied to the study of 15 young male volunteers during bedrest periods 
of 24 to 36 weeks duration. The following observations were made. 
o Prolonged bedrest can result in significant mineral losses 
in the central os calcis (fig. 5). Losses up to 40 percent
have been observed. This bone is both highly trabecular as 
well as weight bearing. In contrast, the radius, a prima~ily 
cortical and non-weight-bearing bone, has failed to exhibit 
mineral losses during periods of up to 30 weeks of bedrest. 
o The mean rate of whole body calcium loss was about 0.5 percent 
per month. Urinary calcium increased approximately 100 milli­
grams per day greater than the basal value, (fig. 6). A 
similar pattern occurred in the calcium balance. The losses 
reached 200 to 300 milligrams per day by the fifth to eighth 
week and persisted throughout the bedrest period (5), (fig. 7). 
391 
w 
~ 
N 
Figure 4. Standards. Witt-Cameron standard on the left and 
hydroxyapatite step wedge on the right. 
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Figure 6. Hypercalciuria during bedrest without 
treatment. 
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Figure 7. 	 Negative calcium balance during bedrest without 
treatment. 
o 	 Little or no os aaZais mineral loss was observed during the 
first month of bedrest, i.e., a mean of -2.6 percent with 
±2.7 percent Standard Deviation (table I). Mineral loss 
thereafter averaged about 5 percent per month. The two­
month mean losses in fifteen subjects was -7.0 percent with 
one Standard Deviation limits of -1.5 to -12.5 percent. At 
approximately three months, the mean loss increased to 
11.2 percent ±7 percent. 
This wide variability of data was reconciled when it was observed that 
the loss could be correlated with the initial 24-hour urinary hydroxy­
proline excretion and the "initial os aaZais bone mineral content. We 
postulated that persons with a high calcaneal mineral content and/or 
a low urinary hydroxyproline excretion rate would be likely to reta"in 
more mineral during bed rest. Thus, the calcaneal mineral which 
remains at any time dur"ing bedrest would be a function of the baseline 
calcaneal mineral divided by urinary hydroxyproline (corrected for 
creatinine excretion). We will refer to this as the prediction term. 
The prediction term appropriate to each of these subjects is given in 
tab 1 e 1.­
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TABLE I. OS CALCIS MINERAL 
15 Bedrest Subjects 
Percent Change From Mean Baseline 
.' 
Prediction 
Subject Term 28 Oa,z::s 59 Oa,z::s 84 Oa,z::s 
1 11.2 -3.1% - 9.3 -15.1 
2 13.7 -3.9 - 9.7 -14.1 
3 14.1 -8.6 -17.5 -23.1 
4 14.8 -3.7 -10.9 -17.5 
5 16.3 -5.2 -12.9 -19.4 
6 18.0 -4.2 - 9.3 -13.6 
7 20.5 -4.2 -11.0 -16.3 
8 20.8 -3.3 - 8.7 -14.1 
9 21.7 -0.4 - 2.0 - 4.0 
10 23.7 -0.1 - 3.5 - 8.2 
11 25.7 -0.3 - 1.5 - 3.4 
12 28.1 -3.6 - 8.8 -14.8 
13 29.7 +0.1 + 0.6 + 0.9 
14 30.5 +2.3 + 2.2 - 1.9 
15 36.3 -0.9 - 2.5 - 3.5 
Mean -2.6% - 7.0 -11 .2 
±S.O. ±2.7% ± 5.5 ± 7.3 
When the prediction term for each subject is plotted against the 
mineral losses observed, a series of regression lines were derived 
which can be used to estimate potential mineral losses for any subject 
whose prediction term has been determined, (fig. 8). It can be seen 
that a high prediction term is associated with little 08 aaZais 
mineral loss and a low prediction term is associated with larger losses. 
Having established these bone mineral loss profiles for simulated 
weightlessness here on Earth we then applied our technique to the 
estimation of mineral content change in the distal right radius and 
ulna and the central left os aaZais of the nine Skylab crewmen. 
Measurements were carried out preflight at about 30, 15 and 5 days 
before launch and on recovery day and days 1 and 7 postflight, and 
at variable times thereafter. The crew of Sky1ab 2 and Skylab 3 were 
studied until each had returned to baseline. The Sky1ab 4 crew 
study had to be terminated before two of the crewmen had returned to 
baseline levels. A series of control subject measurements were also 
made in parallel with the crew. Seven subjects were studied during 
Sky1ab 2 and Skylab 4 and six during Skylab 3. 
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RESULTS 

The mineral content changes for the Skylab crewmen are given in table II 
and the controls in table III. When the values for crew and controls 
are compared, it is clear that no losses were observed in either the 
radius or ulna and that loss of as eaZeis mineral was observed only in 
the Scientist Pilot of Skylab 3 and the Scientist Pilot and Pilot of 
Skylab 4. The Scientist Pilot of Skylab 3 had regained his as eaZeis 
mineral by day 87 postflight whereas the Scientist Pilot and Pilot 
of Skylab 4 had not returned to preflight levels by day 95 postflight. 
TABLE II. SKYLAB CREWMEN BONE MINERAL DATA 
Postflight* Percent of Mean Baseline 
MISSION, LEFT RIGHT RIGHT 
DURATION CREWMAN as CALCIS RADIUS ULNA 
Skylab 2 	 Commander +0.5 -0.5 -0.9 
Scientist Pilot -0.9 +1.4 +1.928 Days Pilot 	 +2.7 +0.2 +3.1 
Skylab 3 	 Commander +2.3 -1.4 +0.4 
Scientist Pilot -7.4 +0.2 -1.659 Days Pilot 	 +1.4 -1.6 -0.4 
Skylab 4 	 Commander +0.7 -1.1 -1. 7 
Scientist Pilot -4.5 +1.0 0.084 Days Pilot 	 -7.9 -0.6 +1.4 
*Skylab 2 and Skylab 3: recovery day 

Skylab 4 day 1 postflight 

The losses observed generally followed the loss patterns observed in 
the heterogeneous group of bedrested subjects. The prediction terms 
for four of the Skylab 2 and Sky1ab 3 crewmen fell within the limits 
observed in the bedrested subjects and mineral loss was predicted and 
seen only in the Scientist Pilot of Sky1ab 3, (open circles in fig. 8).
The two crewmen who had higher prediction terms did not lose mineral. 
The Skylab 4 crew had high prediction terms outside of the limits 
set by the bedrest experience and therefore predictions for this crew 
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TABLE III. CONTROLS 
Bone Mineral 
Post Flight Percent of Mean Baseline 
Mission 
Days 
CA 
S8 
JH 
FK 
CLP 
CR 

AS 

JU 
JV 
MW 
Mean ± SD 
CA 
S8 
JH 
FK 
CLP 
CR 
AS 
JU 
JV 
MW 
Mean ± SO 
CA 
S8 
JH 
FK 
CLP 
CR 

AS 

JU 
JV 
MW 
Mean ± SD 
Skylab 2 Skylab 3 
28 59 
LEFT os CALCIS 
+1.2% +2.1 
+1.6 +2.0 
-0.2 

+2.3 +0.7 

+2.4 

+0.2 

-1. 7 -0.2 

-0.7 +1.8 

+O.B±1.6 +1. 0±1.1 
RIGHT RADIUS 
-2.2% +0.9 

-0.8 +0.4 

-0.8 

-0.4 -0.3 

-0.4 

0.0 

+0.6 +0.9 

-0.7 -0.8 

-O.6±O.9 +O.1±O.B 
RIGHT ULNA 
-2.1% -2.1 
+0.8 -2.4 
-2.2 

-0.6 +1.6 

+0.5 

-0.8 

+2.8 -0.2 

+0.7 -3.5 

+O.2±1.5 -1.5±1.8 
Sky1ab 4 
84 
+1.5 
+2.1 
+2.2 
+0.7 
-1.3 
+0.9 
+0.6 
+1.O±1.2 
-2.9* 
+0.5 
+0.8 
-0.4 
-0.7 
-1.2 
-0.5 
-O.6±1.2 
-3.2* 
-1.1 
+1.1 
+0.2 
+0.7 
-0.6 
-2.0 
-O.7±l.S 
*Arm in plaster for short period during the mission. 
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based upon the bedrested data was not possible, (table IV). It was 
expected, however, that losses in the os calcis would not exceed 5 per­
cent. The 7.9 percent loss seen in the Pilot cannot be explained on 
this basis. 
TABLE IV. SKYLAB CREWS 
Prediction Terms* 
Sk~lab 2 Skylab 3 Sk~lab 4 
Commander 	 15.0 35.3 38.7 
Scientist Pilot 41.6 27.7 51.5 
Pilot 	 30.0 54.9 44.3 
* 	 mean preflight os calcis mineral (mg/cm2 ) 
mean preflight urinary hydroxyproline/g creatinine 
DISCUSSION 
Based upon all of this data we have the following evidence that the 
bedrest situation is a closer approximation of the flight situation 
with regard to bone mineral than heretofore suspected. 
o 	 Calcium balances are similar for a 30 day period with 0.3 per­
cent being lost on the first Skylab mission and 0.5 percent 
being lost during a comparable period of bed rest. 
o 	 Mineral loss from the os calcis was not evident during the 

28 days of the first Skylab mission, nor after a similar 

period of bed rest. 

o 	 Mineral losses from the os caZcis during the 59 day mission 

fell within the limits set by the bedrest experience, i.e., 

-7.0 ± 5.5 percent. 

o 	 Mineral losses from the os calcis during the 84 day mission 

fell within the limits set by the bedrest experience, i.e., 

-11.2 ± 7.3 percent. 

o 	 In neither situation were mineral losses seen in the radius 

or ulna. 
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o 	 Of the nine crewmen studied, only four had prediction terms 
within the range of the bedrested subjects. The os aalais 
mineral changes observed in these four crewmen fell within 
the predicted limits. 
o 	 During Skylab 3 the Scientist Pilot doubled his urinary 
calcium whereas the Commander and Pilot only increased 
50 percent of preflight level. Only the Scientist Pilot 
had os aalais mineral loss. 
o 	 During Skylab 4 urinary calcium more than doubled during 
flight in the Pilot, increased by 65 percent in the 
Scientist Pilot and increased by 60 percent in the 
Commander. Os aalais mineral losses occurred in the 
same order, i.e., greatest in the Pilot. 
CONCLUSIONS 
It is concluded that mineral losses do occur from the bones of the 
lower extremities during missions of up to 84 days and that in general 
they follow the loss patterns of the bedrested situation. The levels 
of loss observed in the Skylab crews have been of no clinical concern. 
A prediction term has been proposed in an attempt to translate bedrest 
data into the weightless condition. In general, this had been 
applicable to weightlessness in all crewmen whose prediction term fell 
within the limits set by the bed rest study. 
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MUSCULAR DECONDITIONING AND ITS PREVENTION IN SPACE FLIGHT 
William E. Thorton~ ~. D. and J. A. Rummel~ Ph. D. 
National Aeronautios and Spaoe Administration
• Lyndon B. JohnsonSpaoe Center 
Houston~ Texas 
ABSTRACT 
Under weightlessness without countermeasures, a rapid disuse atrophy 
of weight-bearing muscular groups appears to occur. For the Skylab 
Program,such losses were measured with a constant speed (isokinetic)
dynamometer. Ten maximum-effort, full-range flexion/extensions of the 
elbow and hip/knee at 45 degrees/second were recorded and evaluated 
for each crewman before and after flight. Anthropometric measurements 
allowed computation of volume changes of limb segments. 
During the Skylab 2 mission (28 days), a bicycle ergometer and an 
isometric device were used for exercise. Losses of strength and of 
muscle mass, especially in leg antigravity groups, were such that 
additional exercise, devices were launched and exercise time was sharply
increased on the Skylab 3 mission (59 days). Good arm exercises and 
acceptable trunk exercises were provided, but loads and types of leg
exercise were limited. This imbalance was reflected after flight by
the lack of measurable loss in arm function. Leg function and muscle 
mass had improved relatively over the Skylab 2 mission, but large de­
creases continued to be apparent. In addition to the other devices, 
a simul ated treadmill consi sti ng of a Tefl on® wal ki'ng surface, a harness, 
and elastic bungees to provide 170 pounds equivalent weight was used 
daily throughout the Skylab 4 mission (84 days). This flight crew 
returned in unexpectedly good condition; slight losses in muscle 
functions of arms or legs were measured. 
Although weightlessness could cause rapid atrophy of many major muscle 
groups and disability on return to normal gravity could result after 
long missions, it has been demonstrated that such deconditioning, can 
... 	 De prevented relatively easily through use of familiar exercise 
techniques. Future research efforts should focus on optimum methods 
of exercise with respect to crew time and crew acceptance, interrela­
tionship of musculoskeletal fitness with cardiovascular fitness, and 
design of practical, efficient, total body exercisers. 
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INTRODUCTION 

A major portion of man's musculoskeletal system is dedicated to support­
ing and moving his body against Earth's gravity. This mass of muscle 
places heavy requirements for support on other body systems. For 
example, maximum capacity of the cardiovascular and respiratory systems,
and to a large measure their condition, is a function of demands from 
the body's musculature. It is a common experience that removal of 
muscle stresses under one-g, that is, lack of suitable exercise, re­
sults in atrophy of both muscle and its supporting systems. Itcould 
be confidently predicted that atrophy would occur rapidly under weight­
lessness unless suitable exercise was provided. 
The time taken for such atrophy to occur allowed short missions such 
as Apollo to proceed without significant problems. But it was no 
longer possible to consider a long mission like Skylab without 
o some method of evaluating muscle condition, and 
o suitable in-flight exercise. 
On Skylab, we instituted first a miniml.Jm impact muscle function test, 
and as the mission demanded, added exercise and exercise devices and 
expanded the testing. The result was a different exercise environment 
on each flight, such that we had three experiments, with the results of 
each flight affecting the next. The flights will be described chrono­
logically. This report will, insofar as possible, address only aspects 
of skeletal muscle since the cardiovascular aspects of conditioning 
and use of the bicycle ergometer are covered in another experiment. 
PROCEDURE 
Evaluation of the right arm and leg was done preflight and postflight 
on all missions with the Cybex Isokinetic Dynamometer. This dynamometer 
may be rotated in either direction without resistance until an adjusta­
ble limit speed is reached. Speed cannot be increased above this limit 
by forces of any magnitude, that is, the constant speed-maximum force 
of isokinesis is achieved. Input or muscle forces are continuously
recorded. Various arms, handles, and the like may be attached to the 
dynamometer to couple any desired segment of the body to the machine. 
The arrangement used on Skylab is shown in figure 1. A crewman, after 
thorough warm up, made 10 max'imum effort full flexions and extensions 
of the arm at the elbow and of the hip and knee at an angular rate of 
45 degrees per second. 
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Figure 1. Test arrangement, Cybex Isokinetic Dynamometer. 
A continuous force record was made of each repetition at a rate of 
25 millimeters per second and the integral of force, or under these 
conditions, work is recorded on a second channel (fig. 2). 
Machine errors are small, two to three percent or less. The test gives 
a measurement of strength comparable to the more commonly used iso­
metric testing, but has the great advantage of recording this force 
throughout the whole range of motion as well as allowing a number of 
repetitions for statistical purposes. It is sensitive enough to show 
small changes in performance which may occur in days. 
A great deal of information is contained in the recordings made, but 
only one quantity will be used here - the peak force of each repetition 
at the same point in the cycle. Use of a single point on the tension 
curve to represent the entire curve may be open to criticism, especially
in the leg where a number of muscles are involved. However, for the 
purposes here, I feel this is a valid measure of strength of the 
muscles tested. 
A plot of such peak points from a preflight and postflight curve is 
shown in figure 3. The strength for a given movement is taken as the 
average of 10 repetitions. As you can see, a fatigue decrement is 
present and may vary. It is included in the strength figure by virtue 
of averaging the 10 repetitions. 
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On Skylab 2 only the bicycle ergometer was used for in-flight exercise. 
Pete Conrad used it in the normal fashion and was the only person on 
Skylab to use it in the hand-pedal mode and also the only person on 
this crew to exercise at rates comparable to those of later missions. 
On Skylab 3, testing was performed 18 days before launch and five days 
postflight. It was recognized that this was too far removed from the 
flight, but this was the best that could be done under schedule 
constraints. 
By the time muscle testing was done on day 5, there had been a signifi­
cant recovery in function; however, a marked decrement remained. 
Results from Skylab 2 will be shown in a moment in conjunction with 
the results from Skylab 3. The decrement in leg extensor strength 
approached 25 percent, while the arms had suffered less but also had 
marked losses. The Commander's arm extensors had no loss, since he 
used these muscles in hand-pedalling the bicycle. This illustrates 
a crucial point in muscle conditioning: to maintain the strength of 
a muscle, it must be stressed to or near the level at which it will 
have to function. Leg extensor mOscles which support us in standing 
and propel us in walking must develop forces of hundreds-of-pounds,
while the arm extensor forces are measured in tens-of-pounds. Forces 
developed in pedalling the bicycle ergometer are typically tens­
of-pounds and are totally incapable of maintaining leg strength. The 
bicycle ergometer is an excellent machine for aerobic exercise and 
cardiovascular conditioning, but it simply cannot develop either the 
type or level of forces to maintain strength for walking under one-g. 
Immediately after Skylab 2, work was started on devices to provide 
adequate exercise to arms, trunk, and legs. A mass-produced commercial 
device, called Mini Gym, was extensively modified and designated "MK I". 
A centrifugal brake arrangement approximated isokinetic action on this 
device. 
Only exercises which primarily benefitted arms and trunk were available 
as shown in figure 4. Forces transmitted to the legs were higher than 
those from the ergometer, but they were still limited to an inadequate
level, since this level could not exceed the maximum strength of the 
arms which is a fraction of leg strength. 
A second device, designated "MK 11", consisted of a pair of handles 
between which up to five extension springs could be attached, allowing 
maximum forces of 25 pounds per foot of extension to be developed. 
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These two devices were flown on Skylab 3, and 	 food and time for 
exercise was increased in-flight. The crew performed many repetitions 
per day of thei r favori te maneuvers on the "MK I II and to a 1 esser 
extent, the "MK 11". Also, the average amount of work done on the 
bicycle ergometer was more than doubled on Skylab 3 with all crewmen 
participating actively. 
Results of muscle testing of Skylab 3 crewmen 	 demonstrated marked
.. differences from the Skylab 2 crew . 
Looking at changes in arm forces on Skylab 3, one sees complete pre­
servation of flexor function in contrast to Skylab 2 (fig. 5). The 
Scientist Pilot showed a marked gain in arm strength. This is the 
result of putting a good distance runner, which Owen is, on the equi­
valent of a weightlifting program. 
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Figure 5. 	 Changes in arm forces on Skylab 2 and 
Skylab 3. 
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Looking now at leg function in figure 6, we see a different picture. 
Only two Skylab 3 crewmen are shown since the Commander suffered a 
recurrence of a back strain from a lurch resulting from a roll of 
the recovery ship - possibly another demonstration of the hazard of 
muscle deconditioning. 
Although there is a relative improvement or less loss over Skylab 2, 
there nevertheless remains a significant reduction in muscle strength. 
It seems rather obvious that the "MK III and "MK II" exercise devices 
did a good job in arm preservation but were still inadequate to 
maintain leg function. 
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Fi gure 6. Changes in 1 eg forces on Skyl ab 2 and Skyl ab 3. 
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Some device which allowed walking and running under forces equivalent 
to gravity appeared to be the ideal answer to this problem. This had 
long been recognized and immediately after Skylab 2, work was started 
on a treadmill for Skylab 4. As the mission progressed, launch 
... 
weight of Skylab 4 became crucial such that the final design was simu­
lation of a treadmill in response to the weight constraints. The 
final weight for the device was 3-1/2 pounds. 
The treadmill, shown in figure 7, consisted of an aluminum TeflonQD• 
walking surface attached to the iso-grid floor. Four rubber bungees
providing an equivalent weight of 175 pounds (80 kg) were attached 
to a shoulder and waist harness. By angling the bungees, an equivalent 
to a slippery hill is presented to the subject who must climb it. 
High loads were placed on some leg muscles, especially in the calf, 
and fatigue was rapid such that the device could not be used for 
significant aerobic work. 
(1751b, 
80 kg) 
ON80ARD HARNESS 
8UNGEE----~~~~ 
Figure 7. Treadmill arrangement. 
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On Skylab 4, the crew used the bicycle ergometer at essentially the 
same rate as Sky1ab 3, and the MK I and II exercisers. In addition, 
they typically performed ten minutes per day of walking, jumping, and jogging on the treadmill. Food intake had again been increased. 
'Even prior to muscle testing, it was obvious that the Sky1ab 4 crew 
was in surprisingly good condition. They stood and walked for long 
periods without apparent difficulty on the day after recovery in 
contrast to the earlier missions. Results of the testing confirmed a •
surprisingly small loss in leg strength after almost three months in 
weightlessness. A summary of the exercise and strength testing shown 
in averaged values for the three missions is depicted in figures 8 and 9. 
One point to be noted is the relatively small losses in arms as com­
pared to legs in all missions. This is reasonable for in space 
ordinary work provides loads for the arms that are relatively much 
greater; the legs receive virtually no effective loading. With the 
MK I and II exercisers, arm,losses were reduced to negligible values 
except in arm extensors on Sky1ab 4, most of which was accounted for 
by the Commander. 
Size is another common measure of muscle condition, and a plot of 
average change in leg volume for each crew in the postflight period
is shown in figure 10. Changes for the first two days must be primarily
fluid. The crews of Skylab 2 and 3 lost essentially the same volume 
in spite of a two-fold difference in mission duration which indicates 
partial protection from increased ergometer work, other exercise de­
vices and increased food on Sky1ab 3. The longest mission, Skylab 4, 
lost only one-half of the volume of the shorter ones. A second point
is that Sky1ab 4 crewmen quickly recovered their preflight volume in 
contrast to the crewmen of the other two missions. Notice that this 
data parallels that of leg extensor strength losses which were roughly
equal on Skylab 2 and 3, and sharply reduced on Skylab 4. 
There was a six and one-half to nine-fold reduction in rate-of-loss 
of leg extensor strength, leg volume, lean body mass and total body 
mass from Skylab 2 to Skylab 4. One might argue that this reduction 
simply represents some kind of equilibrium with increasing mission 
duration, but this is not consistent with data shown in Table I which 
shows absolute losses. • 
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TABLE I. SUMMARY OF CREW AVERAGES OF EXERCISE RELATED DATA 
Change
In Leg Change
Extension Change In In Lean Change in 
Forces Leg Volume Body Mass Body Weight 
10 11 
Average
Da11y
Ergometer
Exercisel 
Skylab F-15 to R+1. F-15 toR+5. F-15 to R+l, F-l to R+O. 
PercentlDa.l 
Body Weight
Crew PercentlDa~ PercentlDa~ 
*2 -0.89 -0.160 
t3 
-0.44 -0.088 
t4 
-0.09 -0.023 
Exercise devices available 
*Bicycle ergometer 
PercentlDa.l 
-0.089 
-0.019 
-0.011 
tBicycle ergometer, MK-I and MK-II exercisers 
-0.13 
-0.08 
-0.02 
tBicycle ergometer. MK-I and MK-II exercisers. treadmill 
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watt-minlkg 
31.3 
65.0 
71.0 
As shown in figure 11, Skylab 4 shows again a marked improvement as 
regards weight, leg strength and leg volume. I think I am correct in 
attributing these reductions in loss of muscle strength and bulk to 
the exercise devices and exercise time that were added. There can be 
little doubt that adding the MK I and II improved the arm performance 
of the crewmen on Skylab 2 and 3; and equally little doubt that the 
treadmill sharply reduced loss of leg strength and mass, since there 
was negligible increase in leg exercise with- other devices on Skylab 4. 
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Figure 11. Exercise related quantities on Sky1ab missions. 
However, it must be recognized that another variable was present - food. 
Virtually all the nutritionists that I know recognize that metabolic 
losses in normal subjects are mixed, i.e., both fat and muscle are 
lost. Vanderveen and Allen 1 deliberately reduced caloric intake during 
a one-g chamber test simulation of space flight conditions using 
subjects chosen to be as equivalent as possible to the astronaut 
population. They found an almost pure muscle loss. 
IVanderveen, J. E. and T. H. Allen. 1972. Energy Requirements of 
Man Living In a Weightless Environment. CaSPAR, Life Sciences and 
Space Research X - AKADEMIE-VERLAG-BERLIN. 
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...At this time, I cannot escape the conclusion that muscle in space is 

no different from muscle on Earth, if it is properly nourished and 

exercised at reasonable load levels, it will maintain its function. 

I think that a properly designed treadmill used for considerably less 

than an hour a day will not only protect leg and trunk musculature, 

but will also provide aerobic exercise to cover the cardiorespiratory 

system. It will not be difficult to add arm exercise at the same 

time such that we meet the requirements for a single total body 

exerciser. 

The muscle-system is rightly described as the musculoskeletal sy~tem 

since they are inseparable. While I would not dare comment on the 

Ca+ ion and its dynamics, I will say that bone-like muscle, when 

properly stressed and nourished, will in all probability retain its 

strength. Bed rest studies not withstanding, it seems entirely 

possible to design such stressors that are compatible with space flight. 

Finally we see another system of the human body which, properly nourish­

ed and provided with a minimum of support, in this case physical stress, 

can adapt to weightlessness and retain its function for return to 

one-g. 
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BIOSTEREOMETRIC ANALYSIS OF BODY FORM 
Sqn. LdY'. Michael WhitUe~ M.Sc.~ M.B.~ B.S.~ R.A. E *~ 
Robin HeY'Y'on~ Ph.D.t and Jaime Cuzzi~ B.Sc. t 
ABSTRACT 
Biostereometrics is the measurement and the mathematical description 
of the three-dimensional form of biological objects. Stereophotogram­
metry was used to derive the Cartesian coordinates of numerous points 
on the body surface of the Skylab crewmen, both before and after flight, 
on all three Skylab missions. Mathematical analysis of the coordinate 
description allows the computation of whole body surface area and 
volume, as well as the volume of body segments, and the area and 
shape of cross sections. Loss of body weight in the first two Skylab
flight crews was accompanied by comparable loss of volume and little 
change in density. Volume loss was divided about equally between. the 
trunk and the legs; however, because the volume of the legs is less 
than that of the trunk, this finding represented a greater proportional 
volume loss in the legs. Comparison of cross-sectional areas suggests
that the calf undergoes shrinkage to a greater extent than does the 
thigh. The suggested interpretation of these changes is that during 
flight there was a reduction in body fluid, a partial muscle atrophy, 
particularly in the legs, and, in all but two of the crewmen, a loss of 
body fat. The partial muscle atrophy probably resulted from relative 
disuse in the absence of gravity, and was lessened to some extent by
the in-flight exercise program. The stereoscopic images of the crew­
men form a permanent archival record of body form on which more de­
tailed measurements may be made in the future when advances in analytical 
technique make more detailed measurement possible. 
INTRODUCTION 
Biostereometrics is the science of measuring, and describing in mathe­
matical terms, the three-dimensional form of biological objects. An 
extensive background to the subject has been given by Herron (1972)(1).
Exposure to weightlessness results in a dramatic change in the patterns 
of muscular activity in the hUman body insofar as they control posture 
and are responsible for locomotion. These changes in muscular activity
might be expected to result in changes in the bulk of particular 
muscle groups, and in the overall energy consumption of the body, which, 
*Nationa1 Aeronautics and Space Administration, Lyndon B. Johnson 
Space Center, Houston, TX. 
tTexas Institute for Rehabilitation and Research, Houston, Texas 
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unless accompanied by a compensating change in food intake, would 

cause a change in body fat. Biostereometric analysis enables changes 

in muscle bulk to be measured, and by examining those areas of the 

body containing fat deposits, enables general conclusions to be 

drawn about changes in body fat. 

METHOD 
The biostereometric measurements of the Sky1ab crewmen were made by
four-camera stereophotogrammetry, during the immediate preflight and 
postf1igbt periods. An attempt was made during.the final Sky1ab
mission (Skylab 4) to take in-flight stereopairs of the crewmen - these 
photographs have not yet been analyzed. Photographs were taken of 
the first (Skylab 2) crew 39, 14, and 2 days prior to flight, on 
recovery day, and 19 days after recovery. The second (Skylab 3) crew 
was photographed 31, 14, and 5 days prior to flight, and 1 and 31 days 
after recovery. The final (Skylab 4) crew was photographed 35,21,10, 
and 6 days prior to flight, and on recovery day, and 1, 4,30, and 68 
days after recovery. The subjects were weighed within a few minutes 
of taking the photographs. 
The layout of the apparatus is shown in figure 1. The subject stands 

between two control stands, which provide dimensional information in 

the three oY'thogona1 axes. He is photographed simultaneously by two 

-cameras in front, and two cameras behind. The subject is nude except
for an athletic supporter, and a skullcap to press his hair down. To 
minim1ze variations in chest volume, photographs are taken in maximal 
forced exhalntion. Between each pair of cameras is a strobe-projector,
which through a focusing lens projects a pattern of lines onto the 
subject's skin, making it ecsier to visualize during the subsequent 
plotting process. The cameras are modified wide-angle Hasselb1ads 
using fine-grain glass plates, for dimensional stability of the image.
Duplicate sets of plates are exposed to insure against breakage, or 
camera malfunction. The equipment is portable, and photographs were 
taken at Johnson Space Center, Kennedy Space Center, and on the 
recovery ships. After development the plates are analyzed on a 
stereoplotter, which derives the three-dimensional coordinates of . 
thousands of points on the body surface, punching them on IBM cards 
for subsequent computer analysis. The computer program derives 
area, shape and perimeter of between 80 and 100 sections of different 
parts of the body, and volume and surface area of any segment of the ..body, and of the body as a whole. 
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Figure 1. Layout of stereophotogrammetry. 
RESULTS AND DISCUSSION 
Figure 2 compares measurements of leg circumference derived from 
stereometric analysis with tape measure circumferences 'obtained on the 
same day (Thornton et aZ.~ 1974) (2). The. pattern seen in figure 2 is 
typical of all the comparisons which have been made between the two 
methods, the leg circumference measured by stereometric techniques 
exceeding that by the tape measure by 10 to 20 millimeters. There 
are two probable causes for this difference. Firstly, the stereoscopic 
photographs are made with the subject standing, whereas the tape mea­
surements are made with the subject supine; the leg volume standing
would exceed that supine by the volume of blood and interstitial tissue 
fluid brought into the leg under the influence of gravity. Secondly, 
stereometric analysis, being a noncontact method, does not involve 
the compression of tissues, however small, which results from the use 
of a tape measure. The 10 to 20 millimeter discrepancy between the 
methods represents a difference in limb volume of 250 to 500 milli­
liters which is entirely reasonable for the increased volume of blood 
and tissue fluid in the leg after transferring from the supine to 
standing position. These differences would in no way invalidate com­
parisons made at different times on a single subject using the same 
technique. 
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Comparison between tape measure and stereometric circumfer­
ence measurements, Commander, Skylab 4, ten days preflight. 
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Figure 3 is a comparison between the meqn preflight weight and volume 
of the nine Sky1ab astronauts and the first postflight determination. 
Density for all measurements is within the range 0.98 to 1.04. This 
is less than the normal range of density (1.02 to 1.10) derived from 
hydrostatic weighing or gas displacement (Wrignt & Wilmore, 1974) (3),
because the volume figure includes, as well as the residual lung volume, 
the volume of air enmeshed in the hair, and the volume of those areas 
which cannot be visualized by the cameras - t~e axillae and perineum.
These additional volumes should be reasonably reproducible from one 
measurement to another on the same subject, except for the hair volume, 
which is probably the largest single source of error. The Commander 
and Pilot of the final (Skylab 4) crew grew beards during the course 
of the flight, whi~h again will have added slightly to their measured 
body volumes. It is unrealistic to calculate the density of the 
tissue lost during the course of the flight, as small errors in the 
volume determination would lead to impossible values for tissue density.
Two of the crewmen - the Commander and Pilot on Sky1ab 4 - showed 
little or no weight change, although a redistribution of body volume 
did occur. Generally speaking, the changes in weight and total body 
volume were of similar magnitude, and the apparent changes in density 
are probably not significant. 
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420 

'. 

• 

_111 
Table I gives differences between the mean preflight and first post­
flight measurements of regional and total body volume, and body weight.
It is difficult to reproduce the "cutoff" plane between the arms and 
the trunk, so that the arm volumes are subjected to considerable random 
variation, as is evidenced by the high standard deviation. There is no 
statistically significant difference in mean arm volume between pre­
flight and postflight measurements. The mean losses of volume of 
1.2 liters in the head and trunk, and 1.3 liters in the legs, are 
significantly different from zero (P<O.005). The mean prefli~ht volume 
of the head and trunk is 45.8 liters, and that of the legs 18.9 liters, 
'so that the postflight change in volume is proportionately.much 
greater in the legs. 
The head 	 and trunk segment of the body contains the extensively fatty 
areas of the buttocks and abdomen. It is probable that the volume 
changes seen in this body segment are due more to changes in fat than 
to changes in muscle, whereas the legs contain much more muscle than 
fat, except in the grossly obese, and are more sensitive to changes 
in muscle bu·lk. Both regions of the body would be affected by changes 
; n body fl u i d . 
TABLE I. 	 DIFFERENCES BETWEEN MEAN PREFLIGHT AND FIRST POSTFLIGHT 

DETERMINATIONS OF REGIONAL AND TOTAL BODY VOLUME, AND 

BODY WEIGHT 

SKYLAB 	 VOLUME (Liters) WEIGHT 
MISSION CREWMAN ARMS HEAD &TRUNK LEGS TOTAL BODY (Kg) 
2 Conmander -0.03 -0.63 -1.00 -1.66 -2 ..56 (R+O) Scientist Pilot -0.54 -1.51 -1.80 -3.84 -3.81 
Pi lot 	 -0.86 -1.71 -2.25 -4.81 -5.17 
3 Conmander -0.10 -2.13 -0.81 -3.03 -4.50 (R+l) Scientist Pilot +0.20 -1.58 -0.94 -2.32 -3.66 
Pilot -0.59 -1.82 -1.42 -3.83 -3.93 
4 Conmander +0.22 +1.50 -0.84 +0.87 -0.18 (R+O) Scientist Pilot -0.3-3 -2.52 -1.50 -4.36 -2.49 
Pilot +0.36 -0.33 -1.03 -1.00 -0.94 
MEAN 	 -0.19 -1.19 -1.29 -2.66 -3.03 
S.D. 	 0.42 1.22 0.49 1.83 1.64 
Figure 4 is a typical plot of the cross sectional area .of the body
measured against distance from the floor. The area beneath the curve 
represents volume. The differences between preflight and postflight 
measurements in the regions of the head, shoulder, and arms are slight,
and result from differences in postu~e~ Marked loss of volume is seen 
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in the abdomen,-buttocks, and calves, and a less striking loss in the 
thighs. The abdominal area shows a flattening of the abdomen, and 
the gluteal region a reduction in volume of the buttocks, both probably 
resulting predominantly from loss of fat. Loss of volume from the 
. buttocks was not observed in the Commander and Pilot on Skylab 4, who 
lost very little weight in the course of the flight; all crewmen lost 
volume from the abdomen, although the loss from this area was much 
greater in those who showed significant weight loss. The striking
reduction in leg volume immediately postflight was investigated in 
more detail on the final (Skylab 4) mission, in an attempt to elucidate 
how much of it resulted from partial muscle atrophy, due to relative 
disuse of the legs in the weightless environment, and how much repre­
sented a purely temporary dehydration. The absolute loss of volume 
from the thigh and calf was of similar magnitude, although the much 
smaller dimensions of the calf resulted in a much greater proportional 
loss and a greater change in cross sectional area, as illustrated in 
figure 5. 
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Figure 4. Preflight and postflight volume distribution, 
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of right calf and thigh, Pilot, Skylab 3. 
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Table II gives the differences between the volume of thigh and calf 
postflight 	in the Skylab 4 crewmen and the mean preflight value. On 
recovery day there was a deficit in the lower limbs of nearly
1000 milliliters, which had reduced by about a third by the following 
day, and had diminished to around 300 milliliters three days later. 
Both calf and thigh volume had returned to preflight values by the 
measurement 	made 30 days following recovery. It is clear that at 
least part 	of the deficient volume must represent missing fluid, which 
is replaced within a day or two of recovery, but there is probably
• 	 also a reduction in bulk of the tissues of the leg. If, as seems 
probable, this loss of tissue represents partial atrophy of the leg 
muscles due to relative disuse in zero gravity, it would probably be 
restored fairly rapidly on return to Earth, so that the 300 milliliters 
deficit measured on day 4 postflight may be an underestimate of the 
total leg muscle lost during the flight. 
TABLE II. 	 DIFFERENCES BETWEEN MEAN PREFLIGHT AND FIRST THREE 
POSTFLIGHT DETERMINATIONS OF LOWER LIMB VOLUMES (SKY LAB 4) 
Thigh (Both Legs) 
Commander 
Scientist Pilot 
Pilot 
Mean 
(L iters) 
R+O R+1 R+4 
-0.37 -0.35 -0.14 
-0.69 -0.40 -0.14 
-0.34 -0.35 -0.09 
-0.47 	 -0.37 -0.12 
Calf (Both Legs)
(Liters) 
Commander -0.41 -0.12 -0.17 
Scientist Pilot -0.58 -0.47 -0.22 
Pilot 	 -0.46 -0.34 -0.13 
,if; 
~1ean 	 -0.48 -0.31 -0.17 
The mean loss of leg volume on recovery day was 1.68 liters for the 
• 	 Skylab 2 crew, and 1.12 liters for the Skylab 4 crew. The mean loss 
on day 1 postflight was 1.06 liters for the Skylab 3 crew, and 
0.77 liters for the Sky1ab 4 crew. While it is not possible directly 
to compare the Sky1ab 2 and Sky1ab 3 crews, there does appear to be a 
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decrease in the loss of leg volume on succeeding missions. On the 
basis of these measurements, it seems likely that in-flight exercise, 
which was increased on successive flights, may have acted in opposition 
to the postflight loss of leg volume. How much of this opposition
is mediated by the prevention of muscular atrophy, and how much by an • 
effect on the cardiovascular system, and hence on body fluids, it is 
not possible to say. 
•CONCLUSIONS 
Biostereometric analysis of body form on the nine Skylab astronauts, 
preflight and postflight, reveals a loss of volume of one to one and 
one-half liters from the legs, much of which is replaced during the 
first four days postflight. It is estimated that about one third 
of this loss represents partial atrophy of the leg muscles due to 
relative disuse in zero gravity, the remainder being due to a deficit 
in body fluid. Reduction in volume of the abdomen has been noted also, 
and this probably represents a small loss of body fluid, combined with 
a loss of body fat in all but two of the crewmen. Difficulties in 
distinguishing between the upper arm and the shoulder region have pre­
vented any useful conclusions being drawn from the measurement of arm 
volume. 
Detailed analysis of the coordinate data on body form is only partially
complete, and much more detailed conclusions may be possible in the 
future. In contradistinction to any other form of anthropometry, the 
stereoscopic photographs of the Skylab astronauts are a permanent
detailed record of body form, which may be reexamined at some future 
date to answer new questions, or to take advantage of the increased 
accuracy resulting from advances in technique. 
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